"gene","baseMean","log2FoldChange","lfcSE","stat","pvalue","padj","start","end","saccver","spid","gene_uni","evalue","protein_names","gene_ontology_biological_process","gene_ontology_i_ds"
"g30042",106.357388665719,5.8552993872063,0.728495471220419,8.03752338692944,9.16724059171678e-16,5.56359831511292e-11,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12054",692.03156298201,8.21584419665339,1.04972022023985,7.82669899868764,5.00846275147926e-15,1.51981802193638e-10,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55150",890.459662735156,6.82980148638942,0.91130743480616,7.49450868667845,6.65471609311522e-14,1.34624906563721e-09,0,9464,"sp|Q4R4T8|LGMN_MACFA","Q4R4T8","LGMN",5.67e-32,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)","negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]","GO:0003014; GO:0004197; GO:0005764; GO:0006508; GO:0032801; GO:0051603; GO:1901185"
"g29611",90.6421545311478,4.45747859101979,0.610323352565877,7.30347048376894,2.80438418605324e-13,2.66798966478912e-09,0,35434,"sp|B3EWZ5|MLRP1_ACRMI","B3EWZ5","MLRP1",9.38e-173,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)",NA,"GO:0005576; GO:0016020"
"g30043",259.785564119009,6.17441532284368,0.846857631430412,7.29097205207278,3.07726604935308e-13,2.66798966478912e-09,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52273",54.1451037892613,6.37948626379572,0.874649889234551,7.29375987159699,3.01422469998179e-13,2.66798966478912e-09,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67692",117.758847249438,4.7340297145721,0.644604893661178,7.34407970079798,2.07179646566187e-13,2.66798966478912e-09,0,11389,"sp|P22985|XDH_RAT","P22985","XDH",2.67e-11,"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; response to azide [GO:0097184]; response to carbon monoxide [GO:0034465]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; xanthine catabolic process [GO:0009115]","GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007568; GO:0007595; GO:0009114; GO:0009115; GO:0009408; GO:0010044; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0030856; GO:0032496; GO:0034465; GO:0042542; GO:0042802; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071347; GO:0071356; GO:0071949; GO:0097184; GO:1900745; GO:1900747; GO:2000379; GO:2001213"
"g11730",150.517103123504,6.57704799060678,0.932565098201412,7.05264222657654,1.75551821511278e-12,1.33178000593994e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g58468",67.1429379754093,3.2039550539244,0.458542976470182,6.98725139917772,2.80323677269214e-12,1.70128439734686e-08,0,13937,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.03e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g103777",185.271687396029,4.58644604278465,0.656260308625213,6.98876037832108,2.7732560526741e-12,1.70128439734686e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96133",48.9270740972731,4.64491078827169,0.668115373396348,6.95225850687944,3.59483881587937e-12,1.98337061577926e-08,1193,6945,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.5e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g11904",104.163753200365,3.78088085272213,0.547350778839332,6.90760111959567,4.92917594236379e-12,2.49293073285049e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36661",70.1855268069926,6.23996191473009,0.908394133522646,6.86922304367185,6.45525104430847e-12,3.01360912214678e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68732",132.822608110026,4.60603897981638,0.680512768788708,6.76848281335704,1.30139844441912e-11,5.64156225655687e-08,0,11159,"sp|P22985|XDH_RAT","P22985","XDH",2.61e-11,"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; response to azide [GO:0097184]; response to carbon monoxide [GO:0034465]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; xanthine catabolic process [GO:0009115]","GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007568; GO:0007595; GO:0009114; GO:0009115; GO:0009408; GO:0010044; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0030856; GO:0032496; GO:0034465; GO:0042542; GO:0042802; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071347; GO:0071356; GO:0071949; GO:0097184; GO:1900745; GO:1900747; GO:2000379; GO:2001213"
"g23420",75.9457938886204,3.66466660315097,0.545064019129771,6.72336913561428,1.77569966506902e-11,7.18448084486924e-08,0,32832,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",0,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g58444",36.8953435484053,5.09770230287594,0.760565616133137,6.70251480574898,2.04862810692792e-11,7.77070248809098e-08,0,8264,"sp|Q5VYJ5|MALR1_HUMAN","Q5VYJ5","MALR1",6.67e-11,"MAM and LDL-receptor class A domain-containing protein 1","cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858]","GO:0005794; GO:0016021; GO:0030659; GO:0042632; GO:0070858"
"g98008",32.028287641542,4.82549918034814,0.722897805275678,6.67521625481755,2.46867863379882e-11,8.81318272266179e-08,0,6726,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",5.55e-08,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g52187",62.2881199494972,6.47303471997462,0.971139170290515,6.66540380411,2.63938642400494e-11,8.89913122626998e-08,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146797",24.6995771305146,4.50372156018656,0.679407379862304,6.62889702655178,3.38204398651801e-11,1.08029605021989e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157582",113.620928107725,5.04748824887306,0.775307844378145,6.5103020503056,7.49998420275553e-11,2.27587020632617e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122771",36.4520715506102,4.55460650058799,0.702329140154316,6.48500288566591,8.87300869085375e-11,2.56429951165673e-07,0,4239,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",1.85e-128,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g29384",117.586839712528,2.65046438666062,0.41599998568681,6.3713088409961,1.87421792564967e-10,5.1702857230763e-07,0,36208,"sp|B3EWZ5|MLRP1_ACRMI","B3EWZ5","MLRP1",1.16e-172,"MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1) (Fragment)",NA,"GO:0005576; GO:0016020"
"g72496",62.1756072857837,5.44643636301177,0.864111915810969,6.30292935828837,2.92072033243043e-10,7.70689204240013e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94664",91.8128422798398,3.77408439805286,0.603544776568945,6.25319701962781,4.02134303182704e-10,9.78068892742361e-07,0,5641,"sp|P08793|XDH_CALVI","P08793","XDH",3.5e-07,"Xanthine dehydrogenase (XD) (EC 1.17.1.4)","xanthine catabolic process [GO:0009115]","GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949"
"g99479",45.4885327919426,4.0743658522412,0.651596004785637,6.25290183229651,4.02895408115983e-10,9.78068892742361e-07,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94663",89.9847512842749,3.83832449782289,0.617805988987709,6.21283148146894,5.2038249415344e-10,1.21469282962201e-06,0,5641,"sp|P08793|XDH_CALVI","P08793","XDH",3.5e-07,"Xanthine dehydrogenase (XD) (EC 1.17.1.4)","xanthine catabolic process [GO:0009115]","GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949"
"g114167",61.6869753623178,3.11631625617388,0.503601973081561,6.18805410373001,6.09114243061949e-10,1.36915345968258e-06,0,5044,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",1.68e-27,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g104041",27.8895075981641,6.44639921381511,1.04591160957991,6.16342638782285,7.11874795675273e-10,1.54298861962616e-06,1831,6054,"sp|P08793|XDH_CALVI","P08793","XDH",1.88e-07,"Xanthine dehydrogenase (XD) (EC 1.17.1.4)","xanthine catabolic process [GO:0009115]","GO:0004854; GO:0004855; GO:0005506; GO:0005777; GO:0009115; GO:0043546; GO:0050660; GO:0051537; GO:0071949"
"g37881",32.3631429995884,3.20279457784629,0.524169839802073,6.11022293662617,9.949206055398e-10,2.0281463187336e-06,0,21764,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.78e-12,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g43367",23.8939341201334,2.7373329142283,0.448081653025956,6.10900467747947,1.00254390446545e-09,2.0281463187336e-06,0,13135,"sp|P05187|PPB1_HUMAN","P05187","PPB1",3.39e-15,"Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)","dephosphorylation [GO:0016311]","GO:0000287; GO:0004035; GO:0005886; GO:0008270; GO:0009986; GO:0016021; GO:0016311; GO:0031225"
"g9738",121.907529586421,3.24433474453326,0.535814021251146,6.05496425225606,1.40448850684797e-09,2.51417278794423e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72502",31.854518760883,5.85651417444877,0.964968213933411,6.06912651617446,1.28607804817991e-09,2.51417278794423e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91194",44.3106861664398,4.95742275244828,0.817872716376694,6.06136218164906,1.34973513251991e-09,2.51417278794423e-06,0,6917,"sp|P22985|XDH_RAT","P22985","XDH",3.83e-12,"Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of epithelial cell differentiation [GO:0030856]; response to aluminum ion [GO:0010044]; response to azide [GO:0097184]; response to carbon monoxide [GO:0034465]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to lipopolysaccharide [GO:0032496]; xanthine catabolic process [GO:0009115]","GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007568; GO:0007595; GO:0009114; GO:0009115; GO:0009408; GO:0010044; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0030856; GO:0032496; GO:0034465; GO:0042542; GO:0042802; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050421; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071347; GO:0071356; GO:0071949; GO:0097184; GO:1900745; GO:1900747; GO:2000379; GO:2001213"
"g152513",26.1936401984225,4.08713362148634,0.675056599435705,6.05450509616951,1.40850016131329e-09,2.51417278794423e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78509",27.4883430167498,3.76900768869499,0.623642228781111,6.04354149663886,1.50767575566462e-09,2.54169004475793e-06,0,9359,"sp|P21328|RTJK_DROME","P21328","RTJK",1.01e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g148164",40.0161165263616,6.38317189181745,1.05545590747268,6.04778640834192,1.46849460105945e-09,2.54169004475793e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113541",94.2927012979224,4.77588021214475,0.792150568928653,6.02900559498922,1.64971577513971e-09,2.70597974035753e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87706",35.7015069703596,5.57058476267634,0.926498124862886,6.0125159600304,1.82665841935688e-09,2.85659730387071e-06,0,6628,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",9.78e-17,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g104526",59.419723259272,4.47680461498069,0.744679781330631,6.01171769022829,1.83567795107856e-09,2.85659730387071e-06,0,5017,"sp|Q6AUV1|XDH_ORYSJ","Q6AUV1","XDH",8.48e-10,"Xanthine dehydrogenase (EC 1.17.1.4)",NA,"GO:0004854; GO:0005506; GO:0016491; GO:0051537; GO:0071949"
"g41900",185.635601919047,0.708702516988226,0.118616311124048,5.97474757284494,2.30446725827012e-09,3.49645294761034e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3440",31.5847803611611,-2.96755513433179,0.498165697367765,-5.95696401822109,2.56966790654086e-09,3.80373524995036e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59432",46.7230762700507,4.62221070029207,0.786386839935031,5.87778236557716,4.15799074871272e-09,6.00829663188989e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108640",23.2345077288521,4.08685668519444,0.702483457628395,5.8177265824761,5.96533712555233e-09,8.41944907325048e-06,0,5474,"sp|B2D0J5|EST6_APIME","B2D0J5","EST6",2.96e-07,"Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)",NA,"GO:0005576; GO:0080030"
"g32791",31.1467463182319,5.05323037323141,0.870539400598393,5.80471184849062,6.44767915461231e-09,8.89340108848684e-06,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125331",20.2461823690416,4.04354466233187,0.710221438316731,5.69335765464265,1.24565071150968e-08,1.6541661015099e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139790",33.5016146491814,4.59113152776343,0.806558590152478,5.6922480075446,1.2537755918513e-08,1.6541661015099e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120970",48.7087280323703,2.71350324594221,0.477351499131223,5.6844971700744,1.31198095064858e-08,1.69413029563537e-05,0,4405,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",8.79e-20,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g146361",102.741640210692,3.8123865688647,0.672224967732021,5.67129569990099,1.41721537327279e-08,1.79189168758179e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88412",20.9378262112898,3.61520815802368,0.638611344874948,5.66104593511662,1.50453143586993e-08,1.82620025685892e-05,0,4914,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.7e-10,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g117059",34.6446306841816,2.6530514928626,0.468494280915114,5.66293250726641,1.48807700932765e-08,1.82620025685892e-05,0,4763,"sp|Q8S8Q4|GUN14_ARATH","Q8S8Q4","GUN14",2.83e-09,"Endoglucanase 14 (EC 3.2.1.4) (Endo-1,4-beta glucanase 14)","cellulose catabolic process [GO:0030245]; cell wall organization [GO:0071555]","GO:0005576; GO:0008810; GO:0030245; GO:0071555"
"g87617",96.9535585393511,4.36508270822919,0.776188844371533,5.62373801154476,1.86868990842295e-08,2.22374099102331e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154026",445.915959831858,1.01231867125624,0.180122843116559,5.62015707580834,1.90783921840419e-08,2.22666850317212e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56507",34.8586381608233,2.92864007650638,0.52489803983477,5.57944563372397,2.41286344418609e-08,2.76295627221988e-05,625,5588,"sp|P04323|POL3_DROME","P04323","POL3",4.37e-82,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g86828",43.2033264858173,3.22734632837782,0.57905814562604,5.57344085866994,2.49756466066861e-08,2.80698517140699e-05,0,8116,"sp|P21328|RTJK_DROME","P21328","RTJK",1.54e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g79937",27.4512061013853,4.58104595546504,0.824688819389015,5.55487821316529,2.77805381816094e-08,3.06545611316704e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18751",27.7541551795686,1.83256672686282,0.332373890955045,5.51357003884123,3.51627011855092e-08,3.81075774097956e-05,436,32054,"sp|O02467|ASPG_SPOFR","O02467","ASPG",2.52e-75,"N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] (Fragment)",NA,"GO:0003948; GO:0005764; GO:0008233"
"g140341",25.670013432466,2.3127479889187,0.420254852387177,5.50320353419259,3.72951435941535e-08,3.97095134163013e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149788",73.5817583186908,2.79033528368931,0.507804026898447,5.49490578231932,3.90919064640713e-08,4.09049621259395e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11932",72.5876365163577,1.80482088836608,0.329605674813793,5.47569725365224,4.35792207312848e-08,4.48275068844352e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89290",354.627077532519,1.93562553086536,0.353846138458728,5.47024630336932,4.49410583303383e-08,4.54578805011372e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144112",263.492084529082,1.88034987968728,0.349188978713643,5.38490615200455,7.24824569650933e-08,7.21141034952707e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162225",28.2996865803044,5.02725490743249,0.936000340687784,5.37099687777721,7.83025652060696e-08,7.66481077799413e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21471",61.0053093902623,3.85781595167322,0.719839313529753,5.35927377008114,8.35571536874605e-08,8.04933913855869e-05,24355,27804,"sp|O19015|BGAL_FELCA","O19015","BGAL",7.75e-11,"Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005764; GO:0005773; GO:0005975"
"g11930",48.6255644914053,1.75191261770911,0.327168945516372,5.35476438616158,8.5667973717787e-08,8.12373332020702e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65912",35.2173247274741,0.848490245743505,0.159036640303227,5.33518718784383,9.54460412623754e-08,8.91172345263625e-05,6578,11850,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.59e-69,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g57249",48.4943919743002,3.31564280541118,0.621877996011216,5.33166123689538,9.73183582230446e-08,8.94886539478269e-05,2725,13679,"sp|Q9R0J8|LGMN_RAT","Q9R0J8","LGMN",1.05e-07,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)","activation of cysteine-type endopeptidase activity [GO:0097202]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]","GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0032801; GO:0035729; GO:0040015; GO:0043524; GO:0045177; GO:0045931; GO:0048471; GO:0051603; GO:0071277; GO:0090026; GO:0097061; GO:0097202; GO:0097264; GO:1900273; GO:1901185; GO:1904646; GO:2001028"
"g32185",28.3690628414639,2.68909614219894,0.505498066434066,5.31969619818455,1.03940669709497e-07,9.41091337591736e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69228",20.1897766490498,7.55247609286055,1.42041738817287,5.3170822574733,1.05444407573304e-07,9.41091337591736e-05,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124730",1005.67590303041,0.942824888551702,0.177698812806806,5.30574669385518,1.12212694578574e-07,9.86983831010679e-05,0,4064,"sp|Q6GMC7|AK1A1_XENLA","Q6GMC7","AK1A1",6.14e-11,"Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase)","aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; lipid metabolic process [GO:0006629]","GO:0005829; GO:0006629; GO:0008106; GO:0016324; GO:0046185; GO:0110095"
"g38625",43.3036367642699,1.8935782053883,0.357727795171408,5.29334938729313,1.2009615673696e-07,0.000104123367890944,615,25586,"sp|P21329|RTJK_DROFU","P21329","RTJK",3.44e-10,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g31622",49.1638614374158,3.39877619188151,0.649856801704267,5.23003865308192,1.69474601361075e-07,0.000142852966063939,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120971",47.1194364841266,2.63115926434232,0.503034632742071,5.23057279376516,1.68985617348693e-07,0.000142852966063939,0,4405,"sp|Q54K67|MANG_DICDI","Q54K67","MANG",8.79e-20,"Alpha-mannosidase G (EC 3.2.1.24)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g155721",260.38965042894,0.843426139350521,0.161911446441362,5.2091816723778,1.89675324761384e-07,0.000157690348763951,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27859",1591.57643031481,1.12240936434756,0.216130459263394,5.19320306898393,2.06706505699913e-07,0.000169261419711046,23825,37860,"sp|C5FK77|DPEP1_ARTOC","C5FK77","DPEP1",3.83e-14,"Putative dipeptidase MCYG_02918 (EC 3.4.13.19)",NA,"GO:0046872; GO:0070573"
"g135902",20.0950624628229,5.9498208813197,1.14618081950439,5.19099672588519,2.09171304635499e-07,0.000169261419711046,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145502",58.5053404397319,2.22804235882935,0.434207384379895,5.13128619867046,2.87768966459698e-07,0.000229798665453146,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148980",227.803645017519,-0.980871645168519,0.192629863970911,-5.09200196142297,3.54302437753109e-07,0.000279254739574496,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153882",34.72799407135,2.89693289614931,0.569225179525333,5.08925641442112,3.59470276652571e-07,0.000279695526795442,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139265",27.9820781488664,1.63961746977355,0.323947866739757,5.06136214531933,4.16271669670274e-07,0.000319791489016316,0,2902,"sp|Q9H0J4|QRIC2_HUMAN","Q9H0J4","QRIC2",1.22e-12,"Glutamine-rich protein 2","cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]","GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059"
"g11892",30.301969824922,1.87203413556178,0.370299820705019,5.05545514982316,4.29365527531391e-07,0.000325727423323501,1015,30236,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.2e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g18128",285.365939868482,0.911360884059057,0.18143455501477,5.02308330397628,5.08484760358627e-07,0.000380986914890927,9862,56101,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.99e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g5581",52.5806090466652,2.10060452041706,0.418965022038187,5.01379449338756,5.33669850866609e-07,0.000393774915559274,71535,112204,"sp|P21328|RTJK_DROME","P21328","RTJK",9.87e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g20234",984.676666205862,2.10845827611035,0.420706722358452,5.01170569438606,5.39496727405087e-07,0.000393774915559274,0,49764,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.71e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g104316",85.2781133960429,3.34144393481809,0.666988598052831,5.00974671017303,5.45017184165085e-07,0.000393774915559274,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46895",61.3271172938925,2.51380796221974,0.504969420899835,4.97813898857527,6.41985505197749e-07,0.000458377650711192,0,6164,"sp|Q9NTJ4|MA2C1_HUMAN","Q9NTJ4","MA2C1",3.49e-09,"Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g56502",95.0585987562763,0.628704681636977,0.126535394393823,4.96860727900546,6.74354887240803e-07,0.000475890675658655,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17476",120.208900047595,0.893859703147387,0.18013126350922,4.96226854646826,6.96745701754508e-07,0.000486040191258403,162,12244,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.42e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g97904",130.621948238928,1.47809678243335,0.298141469763974,4.9577027429411,7.13315893867719e-07,0.000491944790895817,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88617",217.875922702572,1.91016846026398,0.385861790509603,4.95039547124176,7.4062827937856e-07,0.000505041913207695,2775,7875,"sp|C4N147|FABP1_DORPE","C4N147","FABP1",8.72e-08,"Sodium/calcium exchanger regulatory protein 1 (ReP1-NCXSQ) (Fatty acid-binding protein 1) (Na(+)/Ca(2+) exchanger regulatory protein 1)",NA,"GO:0005737; GO:0008289; GO:0016020"
"g99049",118.898887922721,2.80341037748679,0.566872537954892,4.9453981094245,7.59884082038519e-07,0.000512415165987975,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95701",21.251491886555,2.54790438289052,0.524145619649442,4.86106205484385,1.16757643035574e-06,0.000770219712590108,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145649",34.732989570026,0.942681354818156,0.193903568893867,4.86159878436344,1.16441447141521e-06,0.000770219712590108,0,2373,"sp|M1RIR6|GSTM_TYRPU","M1RIR6","GSTM",7.86e-09,"Glutathione S-transferase (EC 2.5.1.18) (GST class-mu) (allergen Tyr p 8)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0043295"
"g41645",705.536939396888,0.568517222563212,0.1170997087543,4.85498408673313,1.20396411422051e-06,0.000785683678409064,0,9889,"sp|P30104|GSTT1_DROER","P30104","GSTT1",2.76e-23,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (EC 4.5.1.1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g58313",135.437791807927,0.816603167328126,0.168535583360999,4.84528638429419,1.26429176537127e-06,0.000816275183408323,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20154",533.62469464498,1.94490730715848,0.402762773752247,4.82891526701734,1.37278803050285e-06,0.000876994795486506,0,49874,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.73e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g119843",25.400425320493,1.98963948350838,0.412605337726063,4.82213704377556,1.42028308254465e-06,0.000897885211246199,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27050",91.9829875929691,-0.660726809009349,0.137093775559273,-4.81952449200496,1.43900787260471e-06,0.000900344204003919,9731,16074,"sp|Q32LE3|CETN1_BOVIN","Q32LE3","CETN1",2.44e-69,"Centrin-1","cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair [GO:0006289]","GO:0000278; GO:0000922; GO:0005509; GO:0005737; GO:0005813; GO:0005814; GO:0006289; GO:0007099; GO:0051301"
"g69922",96.134464531928,1.09676898558207,0.227685749770956,4.81702955360791,1.45711113692791e-06,0.000902368111226071,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99050",42.480315125773,2.67582138615626,0.558000507409729,4.79537446762832,1.62371225306249e-06,0.000995384814528913,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111234",28.453001860754,7.55876327733466,1.58578887302387,4.76656344732775,1.87394736286979e-06,0.00113729865452568,0,2734,"sp|Q6DCX5|PCFT_XENLA","Q6DCX5","PCFT",2.11e-13,"Proton-coupled folate transporter (Heme carrier protein 1) (Solute carrier family 46 member 1)",NA,"GO:0005542; GO:0016021; GO:0022857"
"g28922",35.7107666142029,1.85651777036169,0.390666866561037,4.75217616150623,2.01238920927743e-06,0.00120922674367373,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10833",103.358939096305,-0.635011978355879,0.133830791967031,-4.74488695032389,2.08622815233524e-06,0.00122231972272272,12575,20351,"sp|Q9BY12|SCAPE_HUMAN","Q9BY12","SCAPE",2.5e-13,"S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291)","antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]","GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0072520; GO:1990917"
"g70960",30.9362985753563,-1.15188000145663,0.2428038557112,-4.7440762342206,2.09459962371335e-06,0.00122231972272272,0,10700,"sp|O00255|MEN1_HUMAN","O00255","MEN1",3.26e-15,"Menin","brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; chromatin organization [GO:0006325]; decidualization [GO:0046697]; DNA repair [GO:0006281]; histone H3-K4 methylation [GO:0051568]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; type B pancreatic cell differentiation [GO:0003309]","GO:0000122; GO:0000165; GO:0000278; GO:0000400; GO:0000403; GO:0000781; GO:0000785; GO:0000976; GO:0001933; GO:0002076; GO:0003309; GO:0003682; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0005788; GO:0005829; GO:0006281; GO:0006325; GO:0006357; GO:0006974; GO:0007420; GO:0008285; GO:0009411; GO:0010332; GO:0010812; GO:0016363; GO:0017053; GO:0030511; GO:0030674; GO:0032092; GO:0032154; GO:0032925; GO:0032991; GO:0035097; GO:0043433; GO:0044665; GO:0045668; GO:0045736; GO:0045786; GO:0045892; GO:0045944; GO:0046329; GO:0046697; GO:0047485; GO:0050680; GO:0051219; GO:0051568; GO:0051974; GO:0061469; GO:0070412; GO:0071333; GO:0071339; GO:0071375; GO:0071559; GO:1902807"
"g143434",110.530495825215,3.17683200687325,0.669394965436524,4.7458259636022,2.07657204707169e-06,0.00122231972272272,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122571",102.529206137668,1.65096116447106,0.350617427133911,4.70872534193946,2.49270687147086e-06,0.00142719226442987,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142948",77.9559602866173,0.654577441656981,0.138988339908011,4.70958529391897,2.48221323288531e-06,0.00142719226442987,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133012",194.064356410737,0.579339548581781,0.123113078603512,4.70575145348736,2.52932526520667e-06,0.00143462383500367,0,1861,"sp|O00370|LORF2_HUMAN","O00370","LORF2",5.92e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g83832",45.1182538579225,3.22711719874688,0.687106662219427,4.69667575092773,2.64429716532809e-06,0.00148594810151631,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146559",41.3576375925708,2.49102308553618,0.531145278689625,4.68990911805093,2.73326420730494e-06,0.00152185141964529,0,2024,"sp|Q9NTJ4|MA2C1_HUMAN","Q9NTJ4","MA2C1",5.66e-13,"Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"g9739",39.5443840507402,2.50651389365734,0.534736549196727,4.6873809120072,2.76723627786294e-06,0.00152675972457729,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44466",245.816667976063,-0.445219358771492,0.0950966641235997,-4.68175579947609,2.84428187622621e-06,0.00155513033394747,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11934",26.8422198285114,1.47557239404494,0.315399030923912,4.67843033544675,2.89079351135474e-06,0.00156644873396535,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91763",27.6872040527906,1.95153873868393,0.419444949915253,4.65266953167092,3.27665148803201e-06,0.0017598228213156,0,7472,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.72e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g41649",626.711693967805,0.568487747985404,0.122288295833638,4.64875026763625,3.33952248833912e-06,0.00177785631418685,14645,18044,"sp|Q93113|GST1D_ANOGA","Q93113","GST1D",1.86e-19,"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g58503",71.009694054905,0.527412138756763,0.113747795695435,4.63668008274142,3.54049742991856e-06,0.0018275950074903,3734,10726,"sp|Q9UT21|YFY7_SCHPO","Q9UT21","YFY7",4.54e-25,"Uncharacterized GTP-binding protein C9.07c","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829"
"g90986",29.6523764834271,2.72423060515094,0.587634435089929,4.6359274448136,3.55340601225663e-06,0.0018275950074903,0,3881,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",2.91e-54,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g149135",530.089756278356,0.900764274759328,0.194262154090429,4.63684899911087,3.53760650935982e-06,0.0018275950074903,0,2065,"sp|Q28FD1|AK1A1_XENTR","Q28FD1","AK1A1",9.99e-10,"Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase)","aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; lipid metabolic process [GO:0006629]","GO:0004032; GO:0005829; GO:0006629; GO:0016324; GO:0046185; GO:0110095"
"g153811",728.546048700778,4.06073914776432,0.874964134098641,4.64103497447648,3.46668437703431e-06,0.0018275950074903,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21443",881.33594545253,-0.563049085237615,0.121564798944488,-4.63167866130993,3.62712806253414e-06,0.00184887432117413,4525,35798,"sp|P06171|MYC1_XENLA","P06171","MYC1",6.17e-06,"Transcriptional regulator Myc-A (c-Myc I)",NA,"GO:0000981; GO:0003677; GO:0005634; GO:0046983"
"g99309",81.2973779623384,2.7921055763395,0.603039558182687,4.63005376422362,3.65570800034429e-06,0.00184887432117413,0,5224,"sp|O46108|LIP3_DROME","O46108","LIP3",9.99e-15,"Lipase 3 (DmLip3) (EC 3.1.1.-)","lipid catabolic process [GO:0016042]","GO:0004806; GO:0016042"
"g18004",469.834512439127,1.24062880242823,0.268125494637563,4.62704527260732,3.70919456071474e-06,0.00186042163545271,41025,51234,"sp|F4KHQ8|NCER3_ARATH","F4KHQ8","NCER3",6.14e-19,"Neutral ceramidase 3 (AtNCER3) (N-CDase 3) (NCDase 3) (EC 3.5.1.23) (Acylsphingosine deacylase 3) (N-acylsphingosine amidohydrolase 3)","cellular response to oxidative stress [GO:0034599]; ceramide catabolic process [GO:0046514]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512]","GO:0005576; GO:0005783; GO:0005794; GO:0017040; GO:0034599; GO:0042759; GO:0046512; GO:0046514; GO:0102121"
"g41593",1647.48987703658,0.536160607987659,0.116283530721001,4.61080433887126,4.0111393921806e-06,0.00197987087277193,0,18081,"sp|P30104|GSTT1_DROER","P30104","GSTT1",6.13e-23,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (EC 4.5.1.1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g102257",27.7705527592355,0.87851978290854,0.190538145600443,4.61072915420722,4.01259049845027e-06,0.00197987087277193,0,1560,"sp|Q28452|QOR_LAMGU","Q28452","QOR",2.6e-10,"Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin)","xenobiotic catabolic process [GO:0042178]","GO:0003730; GO:0003960; GO:0005829; GO:0008270; GO:0042178; GO:0070402"
"g55151",67.2422039443832,7.44076439075988,1.6145051343789,4.60869664166311,4.05201032589386e-06,0.00198319763450402,7525,13689,"sp|O89017|LGMN_MOUSE","O89017","LGMN",7.42e-10,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)","activation of cysteine-type endopeptidase activity [GO:0097202]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]","GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0032801; GO:0035729; GO:0040015; GO:0043524; GO:0045177; GO:0045931; GO:0048471; GO:0051603; GO:0071277; GO:0090026; GO:0097061; GO:0097202; GO:0097264; GO:1900273; GO:1901185; GO:1904646; GO:2001028"
"g16072",995.752539347937,0.849308307244776,0.184537040006871,4.60237309113202,4.17704086492911e-06,0.00202803688074038,9950,60394,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.45e-26,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g105347",263.134798544405,1.34744900007386,0.293412127648038,4.59234255541813,4.38298154149019e-06,0.00209451299018141,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g135071",176.685444281915,4.89139396714066,1.06478401655021,4.593789811936,4.3526780728376e-06,0.00209451299018141,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21054",105.141325383012,1.3561327108315,0.295424989631091,4.59044684244537,4.42298094645867e-06,0.00209711495031701,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75956",41.3212630016891,6.7706116527623,1.47797003443609,4.5810209239767,4.62711540884369e-06,0.00214366132948644,4775,9762,"sp|P04323|POL3_DROME","P04323","POL3",6.08e-70,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g105743",92.0160949581307,0.571571793911239,0.124717763928666,4.58292207867163,4.58522938410844e-06,0.00214366132948644,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109772",65.016699159182,2.49225987024296,0.5439691866481,4.58161956856434,4.61388676185387e-06,0.00214366132948644,1325,5466,"sp|Q2KHZ8|GLCM_BOVIN","Q2KHZ8","GLCM",2.49e-08,"Lysosomal acid glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase)","autophagy [GO:0006914]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; lipid glycosylation [GO:0030259]; lysosome organization [GO:0007040]; regulation of TOR signaling [GO:0032006]","GO:0004348; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0030259; GO:0032006; GO:0046527; GO:0050295"
"g26334",176.849184536521,0.562598910030156,0.122882694197821,4.57834126849842,4.68677613454285e-06,0.0021548518454955,0,3300,"sp|T1SH39|TXD17_EPICO","T1SH39","TXD17",4.52e-09,"Thioredoxin domain-containing protein 17 (14 kDa thioredoxin-related protein) (TRP14)",NA,"GO:0004601; GO:0005829; GO:0047134"
"g100996",137.512838152028,1.12296881467565,0.245531781947609,4.57361896601745,4.79371284946955e-06,0.00218744686341584,0,1944,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.93e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g125421",98.9661054294018,0.648906952884354,0.141966294738268,4.57085221587765,4.85744759064834e-06,0.00219998876325707,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19223",95.4205122827934,0.688914818796793,0.151072077440011,4.56017306752371,5.11114791511541e-06,0.00229774494050633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15143",84.9414867718319,1.3972494100464,0.306605118618852,4.55716269950259,5.18492606207233e-06,0.00229899426000059,1587,8924,"sp|Q9H3S4|TPK1_HUMAN","Q9H3S4","TPK1",5.25e-10,"Thiamin pyrophosphokinase 1 (hTPK1) (EC 2.7.6.2) (Placental protein 20) (PP20) (Thiamine pyrophosphokinase 1)","thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772]","GO:0004788; GO:0005524; GO:0005829; GO:0006772; GO:0009229; GO:0016301; GO:0030975; GO:0042802"
"g28258",387.104559413999,2.3172272315707,0.509674144071796,4.54648770890814,5.45485538705033e-06,0.00229899426000059,34446,37594,"sp|Q2KIG3|CBPB2_BOVIN","Q2KIG3","CBPB2",2.62e-15,"Carboxypeptidase B2 (EC 3.4.17.20) (Carboxypeptidase U) (CPU) (Plasma carboxypeptidase B) (pCPB) (Thrombin-activable fibrinolysis inhibitor) (TAFI)","blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; proteolysis [GO:0006508]","GO:0004181; GO:0005615; GO:0006508; GO:0007596; GO:0008270; GO:0042730"
"g31320",141.062975932186,0.44284841649681,0.0972050191911992,4.55581841536126,5.21820015911633e-06,0.00229899426000059,9550,15004,"sp|P87115|NAT10_SCHPO","P87115","NAT10",2.51e-11,"RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase)","rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]","GO:0000049; GO:0005524; GO:0005634; GO:0005730; GO:0030686; GO:0051391; GO:0051392; GO:1904812; GO:1990883"
"g43487",79.6959112641429,2.28483614480933,0.502457285196998,4.54732414500372,5.43322848796208e-06,0.00229899426000059,0,21467,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3e-06,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g61350",24.1398550817952,3.01260728209358,0.661937118931636,4.55119858961213,5.33411709925807e-06,0.00229899426000059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85374",172.533145947374,0.882986295813836,0.193910396646017,4.55357892658909,5.27408711205669e-06,0.00229899426000059,0,5524,"sp|Q8BQ86|CHST8_MOUSE","Q8BQ86","CHST8",4.87e-10,"Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1)","carbohydrate biosynthetic process [GO:0016051]; hormone biosynthetic process [GO:0042446]; peptide hormone processing [GO:0016486]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790]","GO:0000139; GO:0001537; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0016486; GO:0030166; GO:0042446"
"g99410",140.299030959715,1.67274205928429,0.36770936058035,4.54908750934224,5.38790355973905e-06,0.00229899426000059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103134",45.8603514236137,6.15104091708009,1.35249176192637,4.54793226120585,5.41755659143225e-06,0.00229899426000059,0,4523,"sp|F6R2G2|NLRC4_XENTR","F6R2G2","NLRC4",1.39e-06,"NLR family CARD domain-containing protein 4 (Ice protease-activating factor) (Ipaf)","apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of apoptotic process [GO:0042981]","GO:0005524; GO:0005829; GO:0006915; GO:0006954; GO:0016045; GO:0042742; GO:0042981; GO:0045087"
"g153068",55.4015084890075,1.66205929337332,0.36516429778964,4.55153831695446,5.32550963310539e-06,0.00229899426000059,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50644",177.961591973664,2.34594982852569,0.516597983847974,4.54115173089034,5.59477469411154e-06,0.00232566353551801,5890,9804,"sp|G5ECR8|GLCM3_CAEEL","G5ECR8","GLCM3",5.06e-09,"Putative glucosylceramidase 3 (EC 3.2.1.45)","glucosylceramide catabolic process [GO:0006680]","GO:0004348; GO:0006680"
"g131580",92.0236968507816,0.760882370149251,0.167547157403493,4.54130277075883,5.59076732355418e-06,0.00232566353551801,0,3502,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.85e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g59682",28.2531337673756,1.35219283168962,0.298203415184117,4.53446460649939,5.77497844602371e-06,0.00238424110128693,0,13531,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.62e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g68955",107.088793739061,1.0004352018865,0.22070806901189,4.53284379844128,5.81948497771939e-06,0.00238638204930939,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87960",98.434263493637,0.48972551210419,0.108336936617948,4.52039283546678,6.17249850281286e-06,0.00251415392037391,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21070",433.310442819946,0.491711941269952,0.109082815541836,4.50769389135694,6.55360334118699e-06,0.0026340277269976,30746,43654,"sp|P46087|NOP2_HUMAN","P46087","NOP2",9.93e-22,"Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)","maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]","GO:0000027; GO:0000470; GO:0001510; GO:0003723; GO:0005654; GO:0005730; GO:0008284; GO:0009383; GO:0070475; GO:1901796"
"g68623",3330.84297032461,0.336590925997025,0.0746599820162706,4.50831780167951,6.53436485949822e-06,0.0026340277269976,3875,11232,"sp|Q08473|SQD_DROME","Q08473","SQD",4.68e-45,"RNA-binding protein squid (Heterogeneous nuclear ribonucleoprotein 40) (HNRNP 40)","dorsal/ventral axis specification, ovarian follicular epithelium [GO:0008069]; dorsal/ventral pattern formation [GO:0009953]; germarium-derived egg chamber formation [GO:0007293]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of RNA splicing [GO:0033119]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oocyte microtubule cytoskeleton organization [GO:0016325]; oogenesis [GO:0048477]; ovarian follicle cell migration [GO:0007297]; pole plasm mRNA localization [GO:0019094]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; RNA export from nucleus [GO:0006405]","GO:0000184; GO:0000381; GO:0000398; GO:0000785; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005703; GO:0005737; GO:0006405; GO:0006406; GO:0007293; GO:0007297; GO:0007314; GO:0008069; GO:0008298; GO:0009953; GO:0010468; GO:0016325; GO:0017148; GO:0019094; GO:0030720; GO:0033119; GO:0035062; GO:0045451; GO:0048477; GO:0071011; GO:0071013"
"g87964",23.6567761401522,2.08703100358688,0.463568856652179,4.5020949393777,6.72869104158053e-06,0.00268660696916791,5318,7664,"sp|Q9Y4A0|JERKL_HUMAN","Q9Y4A0","JERKL",4.13e-41,"Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG)","central nervous system development [GO:0007417]","GO:0003677; GO:0005634; GO:0007417"
"g4918",39.9820217136645,1.99967220144519,0.444389745210416,4.49981626038278,6.80122237130965e-06,0.00269781820728616,0,7370,"sp|O04847|DV4H_CATRO","O04847","DV4H",5.87e-07,"Deacetoxyvindoline 4-hydroxylase (EC 1.14.11.20)","alkaloid metabolic process [GO:0009820]","GO:0005634; GO:0005737; GO:0009820; GO:0031418; GO:0046872; GO:0050590"
"g10773",296.195834727462,-0.870512100064467,0.193659239187866,-4.49507136202262,6.95466194545859e-06,0.00274076904850573,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14600",101.795987467053,-0.512296890904292,0.114012122229455,-4.49335457393968,7.01099050121509e-06,0.00274514202270157,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132823",53.2723599107722,1.0297919910372,0.229508175641738,4.48695123020239,7.22496047855123e-06,0.00281078750925176,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35215",71.2610070784883,0.46520258163733,0.103779369247848,4.48261138036333,7.3735135495321e-06,0.00285030915491149,6805,12034,"sp|A4FUY7|MOC2B_BOVIN","A4FUY7","MOC2B",2.2e-22,"Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B)","Mo-molybdopterin cofactor biosynthetic process [GO:0006777]","GO:0005829; GO:0006777; GO:0016607; GO:0019008; GO:0030366"
"g116231",140.56663510262,1.38896332098422,0.310118916580595,4.47880876245498,7.50607404088107e-06,0.00288318755405742,20,4288,"sp|Q64581|CP3AI_RAT","Q64581","CP3AI",3.78e-14,"Cytochrome P450 3A18 (EC 1.14.14.1) (CYPIIIA18) (Cytochrome P450(6)beta-2)","oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]","GO:0005506; GO:0005789; GO:0008202; GO:0008390; GO:0008395; GO:0020037; GO:0050649; GO:0070330; GO:0070989"
"g50646",63.6879618685926,2.72673549169918,0.610672188485574,4.46513783190504,8.00172218181369e-06,0.00305424225920926,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5778",53.1628603933642,1.71867913295655,0.385206063165569,4.46171360552502,8.13068439602107e-06,0.00308407022496574,107866,116500,"sp|O76082|S22A5_HUMAN","O76082","S22A5",5.74e-07,"Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2)","(R)-carnitine transmembrane transport [GO:1902270]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; sodium-dependent organic cation transport [GO:0070715]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]","GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006814; GO:0009609; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042910; GO:0060731; GO:0070062; GO:0070715; GO:0150104; GO:1901235; GO:1902270; GO:1902603; GO:1990961"
"g28257",100.464804782037,1.78750209695565,0.401109344024437,4.4563960515633,8.33489868669981e-06,0.0031418944179864,30686,36144,"sp|Q2KIG3|CBPB2_BOVIN","Q2KIG3","CBPB2",5.24e-15,"Carboxypeptidase B2 (EC 3.4.17.20) (Carboxypeptidase U) (CPU) (Plasma carboxypeptidase B) (pCPB) (Thrombin-activable fibrinolysis inhibitor) (TAFI)","blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; proteolysis [GO:0006508]","GO:0004181; GO:0005615; GO:0006508; GO:0007596; GO:0008270; GO:0042730"
"g26893",106.464987198686,0.708906937541473,0.159196332134993,4.45303561981783,8.4664702544539e-06,0.00317179061569634,0,4706,"sp|Q8BTV1|TUSC3_MOUSE","Q8BTV1","TUSC3",2.1e-15,"Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33)","cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0005739; GO:0008250; GO:0015095; GO:0015693; GO:0016021; GO:0018279; GO:0050890; GO:0062062"
"g5019",1796.70560858437,0.372420138413972,0.0836797925957001,4.45053849754772,8.56552365098561e-06,0.00318921245630869,4411,11874,"sp|G4WAW9|SELM_ERISI","G4WAW9","SELM",9.44e-11,"Selenoprotein M",NA,"GO:0005783"
"g104479",60.3501771098582,3.08761853721635,0.695036476924668,4.44238344277721,8.89678299738595e-06,0.00329235219580093,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g582",150.011776773892,0.444390207524425,0.100559385267978,4.41918182316035,9.90752680718422e-06,0.00364416849653339,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138378",222.097527029799,3.43281120022189,0.779283457549031,4.40508670749745,1.05741573685009e-05,0.0038659374138212,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27724",45.1668666627764,1.39846432759142,0.317798532566642,4.40047446505487,1.0801443842989e-05,0.00392538698701201,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7372",49.300939014903,2.00183373155789,0.455214248475118,4.39756386858202,1.09472676222969e-05,0.00394548067350878,67786,78254,"sp|P21328|RTJK_DROME","P21328","RTJK",6.07e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g147186",25.5354249571954,4.32616039580614,0.983937875121644,4.3967820582893,1.09867562007412e-05,0.00394548067350878,0,2234,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.98e-13,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g11933",24.9520946823488,1.56561597548239,0.357385966224123,4.38074273599363,1.18275450871183e-05,0.00422243359610124,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160502",122.616405134112,1.32760625228315,0.30363825577536,4.37232867410934,1.22928275683271e-05,0.00436287546854838,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53609",218.774834148431,0.50499719972646,0.115557184165848,4.37010648339859,1.24185963162341e-05,0.00438188726995494,3834,9714,"sp|A7YW45|ANM5_BOVIN","A7YW45","ANM5",5.08e-14,"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog)","chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; peptidyl-arginine methylation [GO:0018216]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0003714; GO:0005634; GO:0005794; GO:0005829; GO:0006325; GO:0006353; GO:0006355; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035243; GO:0042118; GO:0043985; GO:0044020; GO:0070888; GO:0090161"
"g10279",853.40227218515,-0.832758361163938,0.190713573500447,-4.36653954870174,1.26230440584444e-05,0.00438701284121502,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45295",26.6911383323589,2.52390277002606,0.578400584083719,4.36358959426768,1.27945505502564e-05,0.00438701284121502,7505,12128,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",4.46e-72,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g68959",455.873246343339,0.414884709218308,0.0950148325882866,4.36652570884448,1.2623843543822e-05,0.00438701284121502,100,4131,"sp|A7YW45|ANM5_BOVIN","A7YW45","ANM5",4.9e-17,"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (Histone-arginine N-methyltransferase PRMT5) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog)","chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; peptidyl-arginine methylation [GO:0018216]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]","GO:0000387; GO:0003714; GO:0005634; GO:0005794; GO:0005829; GO:0006325; GO:0006353; GO:0006355; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035243; GO:0042118; GO:0043985; GO:0044020; GO:0070888; GO:0090161"
"g82079",31.4523426780422,2.05347871424061,0.47049961896344,4.36446413870565,1.27434751813183e-05,0.00438701284121502,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104459",321.79796500165,0.568073057615906,0.130148808525861,4.36479645146369,1.27241184201899e-05,0.00438701284121502,0,4484,"sp|Q7ZT42|SND1_DANRE","Q7ZT42","SND1",6.41e-20,"Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (4SNc-Tudor domain protein) (p100 co-activator)","gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]","GO:0003723; GO:0004518; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0016442; GO:0031047"
"g120101",137.129292418824,-0.553698718978365,0.126963995691024,-4.36106878934269,1.29428664201386e-05,0.00441293574740569,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35652",272.748768509971,0.438710406999671,0.100762933060523,4.35388682796839,1.33744770900871e-05,0.00453462019328148,10178,20854,"sp|Q3KPW1|RNP1B_XENLA","Q3KPW1","RNP1B",1.94e-09,"RNA-binding protein with serine-rich domain 1-B","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0003723; GO:0005737; GO:0006397; GO:0008380; GO:0016607"
"g5463",361.973521710032,-0.839058146927996,0.193187794523752,-4.34322545581333,1.40405911362431e-05,0.0047185755821046,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86267",56.6883496247424,0.810193037463421,0.186563224576067,4.34272638299669,1.40725355142681e-05,0.0047185755821046,0,5514,"sp|P0C2X9|AL4A1_RAT","P0C2X9","AL4A1",1.2e-29,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0004029; GO:0005759; GO:0010133; GO:0042802"
"g33590",421.225104933483,0.378088304147836,0.0871889779119602,4.33642317185567,1.44820012837144e-05,0.00482919042806937,6934,19994,"sp|Q0P5L5|SUMF1_BOVIN","Q0P5L5","SUMF1",3.56e-19,"Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)","post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158]","GO:0005783; GO:0005788; GO:0018158; GO:0042802; GO:0043687; GO:0120147; GO:1903135"
"g2800",30.4410746675619,-0.794242308533783,0.183383123390415,-4.33105453680639,1.48396917617374e-05,0.00491371733895721,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10915",457.772854245651,0.67423555556862,0.155748348870898,4.32900612081289,1.4978377124849e-05,0.00491371733895721,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19705",340.22372363186,0.486451179906041,0.112357850454568,4.32948101034328,1.49461157278095e-05,0.00491371733895721,0,14836,"sp|Q2KJJ9|F16P2_BOVIN","Q2KJJ9","F16P2",3.87e-12,"Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)","fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]","GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030018; GO:0030054; GO:0030388; GO:0042132; GO:0042802; GO:0046872"
"g41895",46.3087673063491,0.871368511609684,0.201358433676706,4.32744979040075,1.50845717107774e-05,0.00492194976950045,0,15346,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.03e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g4920",108.603254986274,2.33268140644699,0.539198301698301,4.32620317812536,1.51701504032797e-05,0.00492340335815531,14296,26864,"sp|Q7LHG5|YI31B_YEAST","Q7LHG5","YI31B",2.51e-64,"Transposon Ty3-I Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-2 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p52 (IN); Integrase p49 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g90822",118.321081206812,0.760954603841196,0.176212981565844,4.31837993477715,1.57178688470647e-05,0.00507402904429978,322,7345,"sp|Q4FAT7|BGLR_PIG","Q4FAT7","BGLR",1.99e-10,"Beta-glucuronidase (EC 3.2.1.31)","glucuronoside catabolic process [GO:0019391]","GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0019391; GO:0019904; GO:0030246"
"g33909",392.299816485621,-1.16246061055502,0.269315862329781,-4.31634661433932,1.58632820786483e-05,0.00509387613414374,10185,30381,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.56e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g113402",875.772971012844,0.711021742228893,0.164809184442241,4.31421188470281,1.6017327122981e-05,0.00511627148996694,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105245",564.572205488292,4.04372349595077,0.937966873411823,4.3111581129106,1.62401723706775e-05,0.00516029351401267,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151147",984.601876330389,0.377434737132123,0.0875832826450952,4.30943812258743,1.63669842984225e-05,0.00517350144307949,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18003",122.69235737486,1.32090379566562,0.306934789062423,4.30353235519673,1.68096286123996e-05,0.00528588787816855,38106,43224,"sp|Q9JHE3|ASAH2_MOUSE","Q9JHE3","ASAH2",7.87e-15,"Neutral ceramidase (N-CDase) (NCDase) (EC 3.5.1.-) (EC 3.5.1.23) (Acylsphingosine deacylase 2) (N-acylsphingosine amidohydrolase 2) [Cleaved into: Neutral ceramidase soluble form]","apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; ceramide metabolic process [GO:0006672]; lipid digestion [GO:0044241]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of apoptotic signaling pathway [GO:2001234]; regulation of mitotic cell cycle [GO:0007346]; response to organic substance [GO:0010033]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]","GO:0000139; GO:0005509; GO:0005576; GO:0005615; GO:0005739; GO:0005794; GO:0005886; GO:0005887; GO:0005901; GO:0006670; GO:0006672; GO:0006915; GO:0007346; GO:0008270; GO:0010033; GO:0016020; GO:0017040; GO:0042759; GO:0044241; GO:0046512; GO:0046513; GO:0046514; GO:0070062; GO:0070774; GO:0071633; GO:0102121; GO:2001234"
"g2451",232.264931918198,-0.589656081745694,0.13730764603215,-4.2944154880321,1.75154185035107e-05,0.00547943685040239,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118985",32.929643683645,1.74534191477725,0.406543962854076,4.29311974656899,1.76179923855282e-05,0.00548326132244977,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109418",25.5870689782362,-1.06527538795713,0.2489131339824,-4.27970742609528,1.87139156246146e-05,0.00579463030233602,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44",237.736128247569,0.393199397183589,0.0919880050960124,4.27446379311289,1.91597836214267e-05,0.0058432526029366,359715,370168,"sp|Q15269|PWP2_HUMAN","Q15269","PWP2",4.89e-09,"Periodic tryptophan protein 2 homolog","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]","GO:0000028; GO:0000462; GO:0003723; GO:0005654; GO:0032040; GO:0034388"
"g86270",64.0253869799972,0.753153537046575,0.176145869874107,4.27573770298936,1.90505413614491e-05,0.0058432526029366,3724,8087,"sp|P0C2X9|AL4A1_RAT","P0C2X9","AL4A1",8.73e-30,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0004029; GO:0005759; GO:0010133; GO:0042802"
"g146509",337.034861177162,1.54097832982974,0.360429702819912,4.27539217154833,1.90801131224729e-05,0.0058432526029366,0,1792,"sp|Q8N0N3|BGBP_PENMO","Q8N0N3","BGBP",7.49e-22,"Beta-1,3-glucan-binding protein (GBP)","carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]","GO:0001872; GO:0004553; GO:0005576; GO:0005975; GO:0045087"
"g4291",381.241957811532,0.766982346795002,0.179592182926873,4.27068892584988,1.94870060980774e-05,0.00588391243827022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140128",23.5879910157443,1.06980227758264,0.250438922221329,4.27170931776008,1.93980328480093e-05,0.00588391243827022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54424",185.706896310777,0.856972452105748,0.200906304969468,4.2655328922404,1.9942562946691e-05,0.00598293533689706,6586,10644,"sp|Q03278|PO21_NASVI","Q03278","PO21",1.24e-09,"Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)",NA,"GO:0003964; GO:0004519; GO:0046872"
"g73940",201.06366827752,2.46232685958039,0.577366481398712,4.26475546972388,2.00121251176488e-05,0.00598293533689706,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113851",83.8346835590263,2.37145906505656,0.556209626186172,4.26360665729074,2.0115341627664e-05,0.00598431413423005,0,5074,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.83e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g143206",129.195418921353,0.855756253507029,0.200800318839221,4.26172756325266,2.0285264739438e-05,0.00600542788798288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18404",340.564919077667,0.446556226506047,0.104825614344851,4.25999150395613,2.04434674437911e-05,0.00602288368526059,48225,55293,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.91e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g9964",1045.33856666321,0.390522811345177,0.0917221170030865,4.25767333010898,2.06565492173302e-05,0.0060278939324471,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39021",311.055853539249,0.304829137614949,0.071613748531033,4.25657284903687,2.07584417841727e-05,0.0060278939324471,14005,24645,"sp|P17027|ZNF23_HUMAN","P17027","ZNF23",9.85e-38,"Zinc finger protein 23 (Zinc finger protein 359) (Zinc finger protein 612) (Zinc finger protein KOX16)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837"
"g99013",103.073643970368,0.618603205334005,0.145315384175607,4.256969823556,2.07216312142879e-05,0.0060278939324471,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18907",895.724661013001,-0.647287053014386,0.15215436299896,-4.25414717170358,2.09847255445852e-05,0.00606458568238511,2233,22804,"sp|P20482|CNC_DROME","P20482","CNC",5.28e-19,"Segmentation protein cap'n'collar","blastoderm segmentation [GO:0007350]; dendrite morphogenesis [GO:0048813]; determination of adult lifespan [GO:0008340]; head development [GO:0060322]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pharynx development [GO:0060465]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bicoid mRNA localization [GO:0008359]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]","GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005703; GO:0006357; GO:0006979; GO:0007310; GO:0007317; GO:0007350; GO:0008103; GO:0008340; GO:0008359; GO:0034976; GO:0036335; GO:0045944; GO:0046982; GO:0048813; GO:0051663; GO:0060322; GO:0060465; GO:2000378"
"g9144",111.555535211302,-0.450478518766272,0.106054031962782,-4.24763217794831,2.16041706788368e-05,0.00621081420755597,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87028",69.8042118618379,-0.731606817350496,0.17227703741311,-4.24668794133106,2.16953799967353e-05,0.00621081420755597,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91166",40.0309618571944,-0.674851743693099,0.159242025411218,-4.23789977520318,2.25620440061548e-05,0.00639855350810064,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111963",90.4005335256274,1.03943859269735,0.245264493847015,4.23803126328469,2.25488375702409e-05,0.00639855350810064,2926,5252,"sp|Q93112|GST1C_ANOGA","Q93112","GST1C",1.29e-13,"Glutathione S-transferase 1, isoform C (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-5) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g85761",285.596476152626,0.472501957697331,0.11153580032206,4.23632552358058,2.2720731870142e-05,0.00641358705673915,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87705",153.15985208079,-0.463886823905168,0.109565441597633,-4.23387901459605,2.29694548927582e-05,0.00645377878445135,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17510",1946.41733501649,-0.375437866789522,0.0887713843271814,-4.22926678045016,2.34454187716747e-05,0.00652707552868319,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88738",104.291166525753,0.734744741411211,0.173691843983679,4.23016259462505,2.33522461127484e-05,0.00652707552868319,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21400",458.659758123519,-0.549040461182076,0.130001702440352,-4.22333285546001,2.4071590555834e-05,0.00667079831430853,4125,32665,"sp|P06171|MYC1_XENLA","P06171","MYC1",5.62e-06,"Transcriptional regulator Myc-A (c-Myc I)",NA,"GO:0000981; GO:0003677; GO:0005634; GO:0046983"
"g146477",2449.09038087012,0.500515261599697,0.118707831461777,4.2163626058729,2.48274434904808e-05,0.00684898884289673,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38948",47.2988626493614,1.93523175485243,0.459475664895907,4.21182644197456,2.5331414599871e-05,0.00695639616319533,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140076",191.666646619756,0.659597447233217,0.156657143648147,4.21045240499646,2.54859813443024e-05,0.00696731625128699,0,2071,"sp|O61661|CHK1_DROME","O61661","CHK1",5.8e-06,"Serine/threonine-protein kinase grp (EC 2.7.11.1) (Chk1 homolog) (Protein grapes)","centrosome separation [GO:0051299]; DNA damage checkpoint signaling [GO:0000077]; intracellular signal transduction [GO:0035556]; mitotic DNA replication checkpoint signaling [GO:0033314]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of syncytial blastoderm mitotic cell cycle [GO:0007348]; spindle assembly [GO:0051225]; wound healing [GO:0042060]","GO:0000077; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0007348; GO:0033314; GO:0035556; GO:0042060; GO:0051225; GO:0051299; GO:0051726; GO:0106310"
"g61855",56.4931971049333,-0.745098646493873,0.177183307176859,-4.20524178245604,2.60803197479943e-05,0.00706613663172222,10537,12484,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",3.13e-35,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g143857",28.1324272116582,0.942863539369651,0.224208083492881,4.20530573510562,2.60729458741229e-05,0.00706613663172222,0,2527,"sp|Q642M9|DHDH_DANRE","Q642M9","DHDH",4.79e-09,"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase)",NA,"GO:0000166; GO:0047115; GO:0047837"
"g2450",927.184622203478,-0.35759588036239,0.0851468965575475,-4.19975236702496,2.67207057121822e-05,0.00717011763387811,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31679",111.879423172938,0.56738606069465,0.135137639552329,4.19857903818826,2.68595105259826e-05,0.00717011763387811,6685,11420,"sp|Q7ZT42|SND1_DANRE","Q7ZT42","SND1",8.05e-11,"Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (4SNc-Tudor domain protein) (p100 co-activator)","gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]","GO:0003723; GO:0004518; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0016442; GO:0031047"
"g46650",3010.88414917954,-0.518195998580306,0.123427733023631,-4.19837572874399,2.68836316255853e-05,0.00717011763387811,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101034",20.743859563112,-0.6469050467781,0.154173661015178,-4.19595047894993,2.71729618683797e-05,0.00717011763387811,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103355",77.4542905785473,-0.700391828915471,0.166896790405159,-4.1965566097179,2.71003747097407e-05,0.00717011763387811,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137245",39.0612946804957,2.87922782178461,0.68614881216973,4.19621483083233,2.71412817198655e-05,0.00717011763387811,0,3057,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.1e-10,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g126551",21.1224248279002,-0.943253366560329,0.225028822561463,-4.19170022676849,2.76871681257665e-05,0.0072741741712241,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44922",127.011972852789,-0.713215068269289,0.170404551634861,-4.18542263939962,2.84635998109808e-05,0.00744593048503631,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90212",562.09173929994,-0.434343722723966,0.103835336388491,-4.18300491750619,2.87681166799198e-05,0.00749329185109156,0,5734,"sp|Q8IUZ5|AT2L2_HUMAN","Q8IUZ5","AT2L2",1.3e-07,"5-phosphohydroxy-L-lysine phospho-lyase (EC 4.2.3.134) (Alanine--glyoxylate aminotransferase 2-like 2)",NA,"GO:0005759; GO:0008483; GO:0016829; GO:0030170; GO:0042802"
"g39943",35.2320989455795,1.57074705820287,0.375625271812602,4.18168631365812,2.89354999916347e-05,0.00750468160039449,8795,24330,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.86e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g73734",199.853103035935,2.39313234481639,0.572762580886681,4.1782274622613,2.93789762161223e-05,0.00758727687896367,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134669",54.2968357876439,-1.1471218748269,0.274616777717216,-4.17717331170543,2.95154134914665e-05,0.00759021374914027,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17462",224.586338174296,0.719648868808499,0.172481143484041,4.17233359120838,3.01495783938819e-05,0.00768814249043988,482,13744,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.67e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g17631",310.046806700805,2.36382842961692,0.566450236692348,4.17305577171251,3.00541335104544e-05,0.00768814249043988,10075,44675,"sp|P21328|RTJK_DROME","P21328","RTJK",3.95e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g6770",73.8390884065304,1.22245875650152,0.293741571783707,4.16168113038377,3.15913275263351e-05,0.00782562313295215,0,4854,"sp|P21328|RTJK_DROME","P21328","RTJK",5.56e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g38673",50.9640202450072,0.464188269348633,0.111487284071437,4.16359832616604,3.13271026511367e-05,0.00782562313295215,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38947",45.7841910382859,2.29976391836343,0.552012102048144,4.16614764392041,3.09790109628949e-05,0.00782562313295215,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57992",23.988146800477,1.50885102918996,0.362548627231925,4.16178938728884,3.15763514966028e-05,0.00782562313295215,0,14087,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.43e-25,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g66310",180.817008199262,0.512277119981222,0.122979056743805,4.16556390612443,3.10583903631455e-05,0.00782562313295215,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124501",28.6938209492849,2.32225122224572,0.55781967695542,4.16308588273646,3.13975204241806e-05,0.00782562313295215,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140086",32.0215604704437,0.640111975169882,0.153769779325635,4.16279439287176,3.14376427897773e-05,0.00782562313295215,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129274",281.748708906163,-0.943027941371724,0.226715685745838,-4.15951784839853,3.18920100099614e-05,0.00786799222562829,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4292",30.4365112708447,1.04878053169295,0.252342378820258,4.15618072793071,3.2361186829465e-05,0.00792218391041047,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41024",45.2181513979322,1.07829332301269,0.259505855771261,4.1551791569711,3.25032755592718e-05,0.00792218391041047,0,17758,"sp|P04323|POL3_DROME","P04323","POL3",8.46e-89,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g86262",54.0712795764267,0.682346827413499,0.164192344864479,4.15577734745609,3.24183416295729e-05,0.00792218391041047,0,3664,"sp|A7YWE4|AL4A1_BOVIN","A7YWE4","AL4A1",5.9e-17,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0005759; GO:0010133; GO:0016620"
"g4638",123.094866227415,4.01679303909394,0.967845890178117,4.15024032220121,3.32126376141316e-05,0.00800999872437668,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4979",284.423380618067,-1.02399995254491,0.246931005763979,-4.1469071467018,3.36996648987708e-05,0.00800999872437668,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41311",23.440726688713,-0.679415798947287,0.163797059187117,-4.14791207069928,3.35521205839525e-05,0.00800999872437668,13517,14374,"sp|B3LYS5|FOXO_DROAN","B3LYS5","FOXO",3.37e-34,"Forkhead box protein O","cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]","GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0007049; GO:0008285; GO:0010259; GO:0019216; GO:0030154; GO:0030308; GO:0042593; GO:0043565; GO:0046627"
"g55668",146.168411440566,0.465262763876069,0.112127022042564,4.14942585115167,3.33310230769449e-05,0.00800999872437668,2086,14916,"sp|Q91W96|APC4_MOUSE","Q91W96","APC4",1.27e-64,"Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]","GO:0005634; GO:0005680; GO:0007049; GO:0019903; GO:0031145; GO:0034399; GO:0045842; GO:0051301; GO:0070979"
"g63839",406.464956119249,0.575118706732687,0.138639351040491,4.14830783912656,3.34941819048909e-05,0.00800999872437668,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79278",2286.63144230807,0.467618516346606,0.112657138228743,4.15081124639556,3.31298905574318e-05,0.00800999872437668,2216,7571,"sp|P60060|SC61G_MOUSE","P60060","SC61G",4.72e-14,"Protein transport protein Sec61 subunit gamma","posttranslational protein targeting to membrane, translocation [GO:0031204]","GO:0008320; GO:0016020; GO:0016021; GO:0031204; GO:0043022; GO:0071261"
"g120969",20.3530175677644,0.732583636657602,0.176683221294816,4.14631129820304,3.378743900874e-05,0.00800999872437668,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10906",1528.35097992054,0.555983839495451,0.13414020883898,4.14479628671852,3.40115935319135e-05,0.00803176502510439,40406,62154,"sp|Q02253|MMSA_RAT","Q02253","MMSA",1.33e-34,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)","beta-alanine catabolic process [GO:0019484]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]","GO:0000062; GO:0004491; GO:0005739; GO:0006210; GO:0006573; GO:0006574; GO:0016790; GO:0018478; GO:0019484; GO:0019859; GO:0050873; GO:0102662"
"g2955",252.001113260487,-0.546125725126098,0.131859095730204,-4.14173722413144,3.44685117086394e-05,0.00810811618448576,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4154",2105.44667885651,0.363395020514449,0.087775785993787,4.14003721413752,3.47249483953558e-05,0.00813690006993877,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142209",56.0533946349891,3.02389477499279,0.730724457454897,4.13821481427483,3.5001858686585e-05,0.00817024155264939,0,2667,"sp|P04746|AMYP_HUMAN","P04746","AMYP",5.01e-14,"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate catabolic process [GO:0016052]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245]","GO:0004556; GO:0005509; GO:0005576; GO:0005615; GO:0005975; GO:0016052; GO:0031404; GO:0044245; GO:0070062"
"g4000",139.078470014759,0.74073386183904,0.179100697240895,4.13585135764565,3.53641058677506e-05,0.00819809766599823,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23704",41.8292996693529,-0.825603553792378,0.199632685200869,-4.13561312848975,3.54008161329473e-05,0.00819809766599823,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69215",57.40863243448,0.764177649636585,0.184855093739302,4.13392800911558,3.56615222248069e-05,0.00819809766599823,4345,11096,"sp|Q5R8G6|MCM3_PONAB","Q5R8G6","MCM3",7.13e-20,"DNA replication licensing factor MCM3 (EC 3.6.4.12)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]","GO:0003677; GO:0003678; GO:0005524; GO:0006270; GO:0007049; GO:0016887; GO:0042555; GO:0071162"
"g155268",497.055676032997,1.11184813026291,0.268937421967942,4.13422617844326,3.56152598581168e-05,0.00819809766599823,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33907",104.650997061793,-0.856909456458817,0.207723123243162,-4.12524827799606,3.70335033227569e-05,0.00846748200240835,0,8050,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.21e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g69936",30.9951801422885,1.87189213457886,0.453818589191164,4.12475861316107,3.71123778652269e-05,0.00846748200240835,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13019",769.249051582718,0.520892379567732,0.126506563649832,4.11751267712521,3.82983468569214e-05,0.00861449786580531,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17629",121.668672134931,2.37510451183865,0.577052672111519,4.11592325384752,3.85632617754486e-05,0.00861449786580531,0,6370,"sp|Q04519|ASM_MOUSE","Q04519","ASM",1.14e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g18607",155.675920973357,-0.66901352314805,0.162551152805319,-4.11571072614478,3.85988160914181e-05,0.00861449786580531,40349,50884,"sp|Q05B92|TFE3_BOVIN","Q05B92","TFE3",9.3e-07,"Transcription factor E3","adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell adhesion [GO:0045785]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0002250; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006959; GO:0045670; GO:0045785; GO:0045893; GO:0045944; GO:0046983; GO:0090336"
"g27178",74.8711978137261,1.23053242302893,0.299049845561334,4.11480708414728,3.87503364205775e-05,0.00861449786580531,35810,37004,"sp|Q5U3U0|PHYD1_DANRE","Q5U3U0","PHYD1",2.07e-11,"Phytanoyl-CoA dioxygenase domain-containing protein 1 (Protein PHYHD1) (EC 1.14.11.-)",NA,"GO:0046872; GO:0051213"
"g63143",35.5945301861913,1.13553188029609,0.27595342611312,4.11494032268551,3.87279599008438e-05,0.00861449786580531,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83009",27.2904463704307,-0.648299689074229,0.157406790558101,-4.11862592951435,3.8113826748323e-05,0.00861449786580531,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94956",108.376612644886,1.49776090547563,0.363686187538195,4.11827822116102,3.81713681271965e-05,0.00861449786580531,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33519",105.227243842236,-0.809063009097387,0.196902931152868,-4.10894344924333,3.97473382369477e-05,0.00871700028298141,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61516",46.6872172347304,-0.713408229280216,0.173617013332237,-4.10909170471113,3.97218328894397e-05,0.00871700028298141,0,11684,"sp|P31396|HR3_DROME","P31396","HR3",1.25e-20,"Probable nuclear hormone receptor HR3 (dHR3) (Nuclear receptor subfamily 1 group F member 4)","metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000977; GO:0000978; GO:0004879; GO:0005634; GO:0006357; GO:0007552; GO:0008270; GO:0016319; GO:0040034; GO:0045944"
"g80973",103.544608587859,1.00838422143036,0.245425440761842,4.10871920327481,3.97859462577995e-05,0.00871700028298141,0,7681,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.17e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g112406",30.7726891077255,-0.724004409826259,0.176150098528524,-4.11015614452819,3.95391659992515e-05,0.00871700028298141,1306,5212,"sp|Q9VS29|DSCL_DROME","Q9VS29","DSCL",8.45e-19,"Down syndrome cell adhesion molecule-like protein Dscam2","axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron projection morphogenesis [GO:0048812]","GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0042802; GO:0048812; GO:0070593; GO:0098632"
"g4714",1517.47892886586,0.285533867026554,0.069532786657602,4.10646373821604,4.0176249862779e-05,0.00877085109414409,48571,57994,"sp|Q94613|RS19_MYAAR","Q94613","RS19",3.68e-17,"40S ribosomal protein S19","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g158393",25.0624209098599,1.89658927273253,0.462162384196334,4.10372920338499,4.06543293301138e-05,0.00884340948761508,0,1311,"sp|P21328|RTJK_DROME","P21328","RTJK",5.3e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g132561",500.343857628726,4.95831074353609,1.20863018945071,4.10242172238765,4.08848195863965e-05,0.00886178464535145,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75936",23.2940901590379,-0.886216935251325,0.216141617604216,-4.10016795966665,4.12850394307544e-05,0.00891668698595191,0,6411,"sp|P21328|RTJK_DROME","P21328","RTJK",9.63e-41,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g36577",23.2596127090515,3.08899297417104,0.754703709701053,4.09298766451622,4.25850383497854e-05,0.00910030273749463,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117546",32.2184707020255,0.721699991326869,0.176275042544629,4.09417000222338,4.23683370564032e-05,0.00910030273749463,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133107",38.4208047920068,1.83818182963472,0.449093801057535,4.09309107653264,4.2566042900156e-05,0.00910030273749463,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151635",34.457538960457,0.584965526468511,0.142950726084512,4.09207803619465,4.27524721385097e-05,0.00910402643539,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8055",222.145450875607,0.355584793370958,0.0870807392721848,4.0833919916495,4.43830626095313e-05,0.00912943052349254,51255,60352,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.43e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g10524",227.889468024002,0.768361964075449,0.188086543661611,4.08515117093023,4.40481293003241e-05,0.00912943052349254,4159,13604,"sp|Q99NB1|ACS2L_MOUSE","Q99NB1","ACS2L",5.16e-30,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)","acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]","GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218"
"g17577",116.948285817288,2.50069856331984,0.611744481090187,4.08781548607248,4.35454271269777e-05,0.00912943052349254,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33250",128.475107581857,-0.550169521779046,0.134652462192088,-4.08584821118387,4.39160828782696e-05,0.00912943052349254,11530,16604,"sp|Q6UB98|ANR12_HUMAN","Q6UB98","ANR12",4.09e-08,"Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein)",NA,"GO:0005654; GO:0005829"
"g52019",552.861701572003,1.07656632654048,0.263286230296428,4.08895795776482,4.33315372834692e-05,0.00912943052349254,1429,16384,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.44e-53,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g62055",115.264863704864,0.651445133059348,0.159548719984003,4.0830483198152,4.44487763350305e-05,0.00912943052349254,0,12822,"sp|P21328|RTJK_DROME","P21328","RTJK",4.66e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g64959",370.171617497212,0.556018451752338,0.136190821411259,4.08264261857496,4.45264695164573e-05,0.00912943052349254,0,11564,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",6.5e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g74523",6197.79050672389,-0.260999111034042,0.0638155287828151,-4.08989968448442,4.31559799647927e-05,0.00912943052349254,0,6289,"sp|Q9NL83|ORCKA_PROCL","Q9NL83","ORCKA",9.52e-50,"Orcokinin peptides type A [Cleaved into: Orcomyotropin-like peptide; Orcokinin; Orcokinin-like peptide 1; Orcokinin-like peptide 2; Orcokinin-like peptide 3; Orcokinin-like peptide 4]","neuropeptide signaling pathway [GO:0007218]","GO:0005184; GO:0005576; GO:0007218"
"g86110",1573.69213895224,0.278458784041501,0.0682018943208201,4.08285996766654,4.4484830414596e-05,0.00912943052349254,0,8212,"sp|P21328|RTJK_DROME","P21328","RTJK",1.37e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g86841",35.0252524386966,-0.531269419731474,0.130107119846378,-4.0833231906045,4.43962107225899e-05,0.00912943052349254,0,8114,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.27e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g143778",422.722128282768,0.444849602657197,0.108841915175795,4.08711664011702,4.36767560681206e-05,0.00912943052349254,0,1564,"sp|Q2KJJ9|F16P2_BOVIN","Q2KJJ9","F16P2",1.98e-12,"Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)","fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]","GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030018; GO:0030054; GO:0030388; GO:0042132; GO:0042802; GO:0046872"
"g41210",148.9064248888,-0.330562270990521,0.0809988982984299,-4.08107119892678,4.48286191440471e-05,0.00916043399276841,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73630",212.537420057668,2.88902327218472,0.70866657971366,4.0767031420503,4.56787494353613e-05,0.00925792252285576,3116,8914,"sp|P00688|AMYP_MOUSE","P00688","AMYP",2.2e-23,"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate catabolic process [GO:0016052]","GO:0004556; GO:0005509; GO:0005615; GO:0016052; GO:0016160; GO:0031404"
"g84103",103.186689609589,-0.556446027126203,0.136461830636067,-4.07766790561533,4.54896776621605e-05,0.00925792252285576,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134094",26.1635609519318,3.03763183243043,0.745198373505352,4.07627276230041,4.57633342701718e-05,0.00925792252285576,314,3224,"sp|O42563|CP3AR_ONCMY","O42563","CP3AR",7.86e-14,"Cytochrome P450 3A27 (EC 1.14.14.1) (CYPIIIA27)","progesterone metabolic process [GO:0042448]","GO:0005506; GO:0005737; GO:0005789; GO:0016020; GO:0020037; GO:0042448; GO:0050649; GO:0070330"
"g34469",193.561553715244,1.22983587054077,0.301981473987364,4.07255403552415,4.65004075132089e-05,0.00937577984045398,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27179",75.0379414765829,1.18004860937087,0.290055247565276,4.06835807756004,4.73455844892062e-05,0.00945198527187475,37067,39249,"sp|Q5U3U0|PHYD1_DANRE","Q5U3U0","PHYD1",2.1e-13,"Phytanoyl-CoA dioxygenase domain-containing protein 1 (Protein PHYHD1) (EC 1.14.11.-)",NA,"GO:0046872; GO:0051213"
"g128634",99.6259533513754,1.45504520682128,0.357627381622987,4.06860682819638,4.72950760636048e-05,0.00945198527187475,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134663",20.8540818578078,3.18694980858486,0.783136050881815,4.06947146028629,4.71199110054041e-05,0.00945198527187475,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2444",41.1391692085656,-0.79959979477814,0.196797483068638,-4.063059050909,4.84337705922785e-05,0.00954365434170578,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9804",23.3416302866608,-2.49674305013532,0.614468601481264,-4.06325570438678,4.8392966466536e-05,0.00954365434170578,3785,7410,"sp|Q09575|YRD6_CAEEL","Q09575","YRD6",1.89e-16,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0008270; GO:0015074"
"g24136",165.500671650954,1.39463923413277,0.343056267034059,4.06533670464707,4.7963166950175e-05,0.00954365434170578,13175,35182,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.45e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g89158",141.03197587309,0.37578558535936,0.0924551503910209,4.06451759334173,4.81319084531214e-05,0.00954365434170578,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32960",829.012834324846,0.420603100646333,0.103665552075836,4.05730825934004,4.96415423232641e-05,0.00965623462691955,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65208",93.9606043854802,2.09454805218823,0.516180705975305,4.05778059493846,4.95412769476108e-05,0.00965623462691955,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70399",35.8913006085421,1.11051890150719,0.273676703206859,4.05777652425097,4.95421402350364e-05,0.00965623462691955,0,10825,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.45e-31,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g95295",186.598775750652,0.864856514634114,0.21310824816334,4.05829676743076,4.94319255939646e-05,0.00965623462691955,0,4768,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.9e-22,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g41209",187.603632741726,1.61407832982324,0.397985991487887,4.05561593710609,5.00023627353328e-05,0.00967913826884703,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83162",228.370580561551,0.572313988063432,0.141128752101872,4.055261451262,5.00782569849723e-05,0.00967913826884703,0,4510,"sp|Q18515|C1GLT_CAEEL","Q18515","C1GLT",6.95e-19,"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Ce-T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)","O-glycan processing, core 1 [GO:0016267]","GO:0016021; GO:0016263; GO:0016267; GO:0046872"
"g21562",161.97677204061,-0.78888668990143,0.194957736132339,-4.0464497872807,5.20002726306167e-05,0.00984200834778591,0,30170,"sp|P47736|RPGP1_HUMAN","P47736","RPGP1",2.84e-11,"Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1)","activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]","GO:0000139; GO:0002250; GO:0003924; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0007165; GO:0016020; GO:0030424; GO:0030425; GO:0031267; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0051056; GO:0090630; GO:1903697; GO:1904425; GO:1904442; GO:1990792"
"g22396",33.6711063264072,0.997835026613444,0.246654911156986,4.04546993178806,5.22182680505365e-05,0.00984200834778591,16969,27844,"sp|A1ZAY1|DLISH_DROME","A1ZAY1","DLISH",2.66e-26,"SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)","establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251]","GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219"
"g68472",34.8126019201355,0.901063154052221,0.222501082974671,4.04970232956032,5.12828227941853e-05,0.00984200834778591,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93508",2043.35521844549,0.646738460627536,0.159866670906079,4.04548651049031,5.22145724769254e-05,0.00984200834778591,0,3733,"sp|P54985|PPIA_BLAGE","P54985","PPIA",1.09e-17,"Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)","protein folding [GO:0006457]","GO:0003755; GO:0005737; GO:0006457"
"g103969",104.120015001288,1.18571344690925,0.29296112864578,4.04734052053335,5.18028534587428e-05,0.00984200834778591,0,5382,"sp|Q9WUW8|ST1C2_RAT","Q9WUW8","ST1C2",2.98e-07,"Sulfotransferase 1C2 (ST1C2) (rSULT1C2) (EC 2.8.2.1) (Sulfotransferase K1)","sulfation [GO:0051923]","GO:0004062; GO:0005737; GO:0005764; GO:0008146; GO:0051923"
"g109499",576.540823528687,0.396000887690351,0.0978216569811877,4.04819239329085,5.16147118501138e-05,0.00984200834778591,152,3654,"sp|Q66HV4|COPB_DANRE","Q66HV4","COPB",4.6e-11,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; notochord development [GO:0030903]; somite development [GO:0061053]","GO:0000139; GO:0005198; GO:0006886; GO:0006888; GO:0006891; GO:0030126; GO:0030903; GO:0061053"
"g138964",361.949318768605,0.620932822622816,0.153367765725877,4.04865272493208,5.15133143291689e-05,0.00984200834778591,0,2924,"sp|P20000|ALDH2_BOVIN","P20000","ALDH2",2.21e-34,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)","aldehyde catabolic process [GO:0046185]; ethanol catabolic process [GO:0006068]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627]","GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0008957; GO:0018547; GO:0043878; GO:0046185; GO:0051287; GO:0052689; GO:1903179; GO:1905627"
"g143783",165.229919882137,0.608989815751814,0.150429898745709,4.04832962615542,5.15844637141573e-05,0.00984200834778591,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114187",25.5007328053502,1.59653673350909,0.394972932839604,4.0421421337179,5.29651099527553e-05,0.00995186539638613,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72805",10377.523026437,0.384036961108064,0.0950623869282739,4.03984134542957,5.34873708494689e-05,0.0100189769655996,0,5886,"sp|Q01768|NDKB_MOUSE","Q01768","NDKB",4.29e-33,"Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3) (P18) (nm23-M2)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; CTP biosynthetic process [GO:0006241]; dTMP biosynthetic process [GO:0006231]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228]","GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006165; GO:0006183; GO:0006228; GO:0006231; GO:0006241; GO:0007189; GO:0007229; GO:0010976; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0042802; GO:0042981; GO:0043066; GO:0043209; GO:0045618; GO:0045893; GO:0045944; GO:0046777; GO:0046872; GO:0048471; GO:0050679; GO:0051880; GO:0071944; GO:1901363"
"g118452",26.089094002735,1.53206042539092,0.379405424900066,4.0380561922499,5.3895944374713e-05,0.0100644457356964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49826",131.660925286681,0.398445743645729,0.0987237946235218,4.03596463411057,5.43784076309643e-05,0.0101233912856541,7108,17442,"sp|P21328|RTJK_DROME","P21328","RTJK",1.36e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g94365",58.8829256030163,0.905924035182894,0.224579331416791,4.0338709242197,5.48654634885563e-05,0.0101828286823256,0,4474,"sp|O96553|C1TC_DROME","O96553","C1TC",9.07e-23,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]","cellular amino acid biosynthetic process [GO:0008652]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]","GO:0000105; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005737; GO:0005829; GO:0006164; GO:0008652; GO:0009086; GO:0035999"
"g22455",327.405788539066,0.347541423122531,0.0861802562378072,4.03272673225198,5.51333782838767e-05,0.0102013558781966,0,10750,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.19e-31,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g18683",157.78014345895,0.510561349441785,0.126671224989583,4.03060244727065,5.56340735464661e-05,0.0102430083129954,46,4414,"sp|Q6DJ55|FAKD4_XENTR","Q6DJ55","FAKD4",4.38e-45,"FAST kinase domain-containing protein 4 (Protein TBRG4) (Transforming growth factor beta regulator 4)","mitochondrial mRNA processing [GO:0090615]; mitochondrial RNA processing [GO:0000963]; mRNA metabolic process [GO:0016071]; regulation of mitochondrial mRNA stability [GO:0044528]","GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0016071; GO:0035770; GO:0044528; GO:0090615"
"g107688",130.242407645969,2.41118891027481,0.598259311150322,4.03034079927418,5.56960412471327e-05,0.0102430083129954,0,5676,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.54e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g54019",164.806159530141,-0.378663642381324,0.0941157438533631,-4.02338255936542,5.73681970356038e-05,0.0105186582419662,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160643",48.0375120460106,0.731721041313249,0.182146364613572,4.01721463321881,5.88900828331871e-05,0.0107651780938136,0,1153,"sp|Q7ZVM1|WASC5_DANRE","Q7ZVM1","WASC5",1.29e-13,"WASH complex subunit 5 (WASH complex subunit strumpellin)","actin filament polymerization [GO:0030041]; axonogenesis [GO:0007409]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]","GO:0005768; GO:0005769; GO:0007032; GO:0007409; GO:0015031; GO:0030041; GO:0048666; GO:0051125; GO:0060047; GO:0071203; GO:0140285"
"g56253",748.727394455911,-0.471390032024131,0.11743620407357,-4.01400944234218,5.96959567545497e-05,0.0108797225688697,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3678",877.442523332595,-0.552433372011111,0.137730358602187,-4.01097751881073,6.04678685355114e-05,0.0108895992327009,0,51393,"sp|P21328|RTJK_DROME","P21328","RTJK",1.1e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g17573",93.8813651777377,2.33309922312861,0.581481325897951,4.01233731715413,6.0120509419801e-05,0.0108895992327009,0,7989,"sp|Q04519|ASM_MOUSE","Q04519","ASM",1.48e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g50088",77.5123899761126,1.57079489575263,0.391574645973307,4.01148264297917,6.03386138217319e-05,0.0108895992327009,3755,7349,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.94e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g127088",43.5888556112035,-0.635755534683012,0.158501303188212,-4.01104294977365,6.04511108336576e-05,0.0108895992327009,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18913",54.5053198051647,-0.40148399795165,0.100197475731713,-4.00692727056972,6.15137946741633e-05,0.0110451840200443,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145242",40.3897932459167,0.779694383501991,0.194658301676782,4.00545148491343,6.18991378881934e-05,0.0110815890219305,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90811",101.262859603515,0.780711011623524,0.195001720026169,4.00361089901542,6.23829372300661e-05,0.0111026992976326,3478,7345,"sp|Q4FAT7|BGLR_PIG","Q4FAT7","BGLR",9.77e-11,"Beta-glucuronidase (EC 3.2.1.31)","glucuronoside catabolic process [GO:0019391]","GO:0004566; GO:0005102; GO:0005615; GO:0005764; GO:0019391; GO:0019904; GO:0030246"
"g120975",183.348903308752,-1.0638220530888,0.265694497154636,-4.00392956753504,6.22989195386647e-05,0.0111026992976326,0,4404,"sp|Q9C0D7|ZC12C_HUMAN","Q9C0D7","ZC12C",1.66e-06,"Probable ribonuclease ZC3H12C (EC 3.1.-.-) (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C)","RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]","GO:0003729; GO:0004521; GO:0005634; GO:0036464; GO:0046872; GO:0090502"
"g574",431.302659285318,0.349885443043233,0.0874315432206587,4.00182165560313,6.28566708907933e-05,0.0111543022115855,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60891",1428.91638567219,-0.213502026994278,0.0533618006924364,-4.00102740581879,6.30680521006228e-05,0.0111591839124979,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8962",356.330564017778,0.508013213427283,0.127011657282609,3.99973690837621,6.34129399546603e-05,0.0111696964424065,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87501",1162.7820695129,0.488336057769829,0.122101451616854,3.99942876438681,6.34955556538184e-05,0.0111696964424065,455,6717,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.24e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g945",300.033059071039,0.296235051179478,0.074128049528894,3.99626124067935,6.4350719646201e-05,0.0112225436072642,55990,61154,"sp|P21328|RTJK_DROME","P21328","RTJK",1.13e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g69555",1123.43151096336,0.576069296523307,0.144105997871059,3.99753865233808,6.40045421905008e-05,0.0112225436072642,6266,11014,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",6.07e-07,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g146918",123.810105753028,0.347202445171495,0.0868675646297852,3.99691699256463,6.41727906799208e-05,0.0112225436072642,0,2257,"sp|Q71U00|SKP1_XENLA","Q71U00","SKP1",1.23e-11,"S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (S-phase kinase-associated protein 1A) (p19A) (p19skp1)","protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0006511; GO:0016567; GO:0019005; GO:0031467"
"g29962",3745.09627099716,0.362681903195454,0.0907837649916146,3.99500839416556,6.46919608468011e-05,0.0112497280910956,8955,35418,"sp|P29775|ETS4_DROME","P29775","ETS4",4.28e-43,"DNA-binding protein D-ETS-4","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565"
"g49628",57.8528504561871,0.743967115113782,0.186488782658792,3.98933975817182,6.62574612541424e-05,0.0114890437814683,15998,17522,"sp|P09488|GSTM1_HUMAN","P09488","GSTM1",2.16e-07,"Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GST HB subunit 4) (GST class-mu 1) (GSTM1-1) (GSTM1a-1a) (GSTM1b-1b) (GTH4)","cellular detoxification of nitrogen compound [GO:0070458]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; nitrobenzene metabolic process [GO:0018916]; prostaglandin metabolic process [GO:0006693]; xenobiotic catabolic process [GO:0042178]","GO:0004364; GO:0005737; GO:0005829; GO:0006693; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042803; GO:0043295; GO:0045171; GO:0051122; GO:0070458; GO:1901687"
"g53190",25.5377459618268,0.629647110884209,0.15795080046206,3.98634960406834,6.70976252303927e-05,0.0116015808411183,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44283",189.392828590562,0.606689277344775,0.152342566158428,3.98240158770761,6.82223770517988e-05,0.011737243155391,15729,20872,"sp|Q3T0R7|THIM_BOVIN","Q3T0R7","THIM",4.96e-12,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)","fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]","GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0006635; GO:0016290; GO:0047617; GO:0102991; GO:1901029"
"g81992",6965.69150785336,0.49521051087157,0.124375782466293,3.98156699842896,6.84624168233387e-05,0.011737243155391,0,1274,"sp|Q4R6V2|TCPE_MACFA","Q4R6V2","TCPE",0,"T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998]","GO:0003730; GO:0005524; GO:0005813; GO:0005832; GO:0005874; GO:0007339; GO:0009615; GO:0016887; GO:0031681; GO:0032212; GO:0044183; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0061077; GO:1901998; GO:1904851"
"g144353",33.4576776138662,-0.684461230911213,0.171899876707578,-3.98174358248996,6.84115621740929e-05,0.011737243155391,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23925",1424.31073295628,0.788239314644351,0.198017383636532,3.98065715326889,6.87250116311792e-05,0.0117490731152007,2288,4934,"sp|P70691|UD12_MOUSE","P70691","UD12",3.24e-12,"UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2)","flavonoid glucuronidation [GO:0052696]; xenobiotic glucuronidation [GO:0052697]","GO:0001972; GO:0005783; GO:0005789; GO:0015020; GO:0016021; GO:0019899; GO:0042803; GO:0046982; GO:0052696; GO:0052697"
"g8449",33.7557543435534,-0.826767669654611,0.207794035021514,-3.97878442260872,6.92685119050553e-05,0.0118087246840388,58405,65230,"sp|Q95RI5|FAXC_DROME","Q95RI5","FAXC",5.17e-10,"Failed axon connections","axonogenesis [GO:0007409]; female germ-line stem cell population maintenance [GO:0036099]","GO:0005737; GO:0005886; GO:0007409; GO:0036099"
"g161980",104.333787645796,0.770628232378441,0.193785157940503,3.97671442213878,6.98739942788414e-05,0.011878579027403,0,1065,"sp|Q5JJ64|Y1782_THEKO","Q5JJ64","Y1782",4.03e-06,"Uncharacterized serpin-like protein TK1782",NA,"GO:0004867; GO:0005615"
"g10302",171.39730278878,0.755068096077595,0.18990690745405,3.97599069038757,7.00868671711998e-05,0.0118814859458662,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17579",296.072511596577,2.1330060678993,0.536819339569982,3.97341509642321,7.08494201019663e-05,0.0119440314055231,34425,50323,"sp|P21328|RTJK_DROME","P21328","RTJK",1.79e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g22016",134.816948623314,0.862864386739755,0.217135774742422,3.9738471827746,7.07209472927734e-05,0.0119440314055231,0,13202,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.21e-30,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g24354",26.7774040340689,-0.642896383650294,0.161860199908413,-3.97192382076676,7.12945210742259e-05,0.0119857741938913,34024,43614,"sp|Q9VUC6|FRL_DROME","Q9VUC6","FRL",1.96e-20,"Formin-like protein (Formin related in leukocytes)","axon extension [GO:0048675]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; mushroom body development [GO:0016319]; ommatidial rotation [GO:0016318]; regulation of cell shape [GO:0008360]","GO:0005829; GO:0008360; GO:0016318; GO:0016319; GO:0016477; GO:0030866; GO:0031267; GO:0048675; GO:0051015; GO:0051020"
"g31820",288.299460252534,-0.642452482288715,0.161845987760005,-3.96952986713136,7.20145800624939e-05,0.0120733836021899,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17401",450.567053299384,-0.598730830452242,0.150935376802063,-3.96680250275203,7.28433047964995e-05,0.0121786781490346,0,31413,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.61e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g40515",256.898630594322,0.510416194608462,0.12873418352343,3.96488469991782,7.34314323786484e-05,0.0122062247270894,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41621",459.760712218423,-0.485206326220029,0.122389394321005,-3.96444748265869,7.35661398660872e-05,0.0122062247270894,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65016",252.127729304324,0.540328130527657,0.136320861178808,3.9636496267356,7.3812563434533e-05,0.0122062247270894,777,11544,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.53e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g68935",454.806023031114,0.556264981614845,0.140340397898406,3.9636839423637,7.38019487580458e-05,0.0122062247270894,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40161",41.5585642015414,0.939521537648577,0.237112133615234,3.9623511598658,7.42152741261433e-05,0.0122394700725968,2285,22522,"sp|P04323|POL3_DROME","P04323","POL3",1.77e-100,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g82215",27.7961594869865,0.792120514203317,0.199995554365733,3.96069060992607,7.47333107122285e-05,0.0122915030545397,5425,8777,"sp|Q1LW01|HE12_DANRE","Q1LW01","HE12",4.13e-13,"Hatching enzyme 1.2 (EC 3.4.24.67) (Choriolysin H homolog 1) (High choriolytic enzyme 1 homolog) (zHCE-1)","hatching [GO:0035188]; proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0008270; GO:0035188"
"g22384",297.482662304539,0.7175994566318,0.181253404913849,3.95909504140284,7.52342952715297e-05,0.012337641218608,385,5520,"sp|D0E8I5|PHNZ_UNCHF","D0E8I5","PHNZ",6.46e-10,"2-amino-1-hydroxyethylphosphonate dioxygenase (glycine-forming) (EC 1.13.11.78) (Di-iron oxygenase) (Nonheme iron-dependent oxygenase)",NA,"GO:0016491; GO:0016787; GO:0046872"
"g32416",71.9127097531786,1.72186979829161,0.435050515861279,3.95786175516373,7.5623702971201e-05,0.012337641218608,22096,32145,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.19e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g111224",542.968574214224,0.493979073931398,0.124806088034535,3.95797257738508,7.55886332857762e-05,0.012337641218608,0,5322,"sp|Q5ZIK9|COPE_CHICK","Q5ZIK9","COPE",6.62e-26,"Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005198; GO:0005654; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0099612"
"g13564",113.660416066111,-0.514569582584066,0.130119730830995,-3.9545853599437,7.66674966673134e-05,0.0124743977821428,0,35840,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.4e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g67413",275.966735043818,0.918013775106515,0.232328724924145,3.95135717895514,7.77092426820424e-05,0.0126100907443133,0,7879,"sp|Q9DCU9|HOGA1_MOUSE","Q9DCU9","HOGA1",8.35e-10,"4-hydroxy-2-oxoglutarate aldolase, mitochondrial (EC 4.1.3.16) (Dihydrodipicolinate synthase-like) (DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase) (Probable KHG-aldolase)","4-hydroxyproline catabolic process [GO:0019470]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; oxalate metabolic process [GO:0033609]; pyruvate biosynthetic process [GO:0042866]","GO:0005739; GO:0008700; GO:0009436; GO:0019470; GO:0033609; GO:0042803; GO:0042866; GO:0046487"
"g117608",828.871271482905,0.91658037952525,0.232080273260691,3.94941098029333,7.83437395734781e-05,0.0126791508125717,678,4711,"sp|Q93112|GST1C_ANOGA","Q93112","GST1C",1.42e-08,"Glutathione S-transferase 1, isoform C (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-5) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g119583",57.4663848626886,1.40899592160298,0.356911212106144,3.94774911465641,7.88894123783844e-05,0.0126997306027696,0,3627,"sp|Q5WN23|GCP2_CAEBR","Q5WN23","GCP2",9.1e-07,"Glutamate carboxypeptidase 2 homolog (EC 3.4.17.21) (Glutamate carboxypeptidase II homolog)","proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0006508; GO:0016021; GO:0046872"
"g127988",620.308551500476,0.513278123050661,0.13001761881381,3.94775821718203,7.88864138058943e-05,0.0126997306027696,0,3790,"sp|Q90YV8|RL10A_ICTPU","Q90YV8","RL10A",1.36e-19,"60S ribosomal protein L10a","hemoglobin biosynthetic process [GO:0042541]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015934; GO:0042541"
"g8760",122.369787354504,-0.597950174529962,0.151564932830641,-3.94517493830919,7.97417405101777e-05,0.012749880827468,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32321",7464.8985526044,3.53211538974274,0.895079324715133,3.9461478912686,7.9418570595686e-05,0.012749880827468,5250,13374,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.93e-25,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g109848",86.7772568990601,1.34437198436564,0.340786796998455,3.94490630566222,7.98311865947904e-05,0.012749880827468,3209,5014,"sp|Q6TLF6|RGN_DANRE","Q6TLF6","RGN",3.12e-14,"Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)","cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]","GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848"
"g3491",38.384591007724,-0.699856635437119,0.177501320318328,-3.94282495579191,8.05274307768184e-05,0.0127978896836005,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17924",231.489584309289,-0.504404059335532,0.127932131092649,-3.9427472600315,8.05535320338669e-05,0.0127978896836005,41776,52524,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g159718",6094.58529605535,0.589881052715958,0.149662191043174,3.94141665710208,8.10017803535338e-05,0.0128355040460991,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17387",177.754128556224,-0.703560289252153,0.178578525012064,-3.93978105264686,8.15560069326071e-05,0.0128694496951982,0,27002,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.42e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g17633",154.975901676516,2.02238325839682,0.513450784595457,3.93880644274454,8.18879568732551e-05,0.0128694496951982,43915,53258,"sp|Q04519|ASM_MOUSE","Q04519","ASM",3.3e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g41501",63.7698457867313,0.95670833737084,0.242924777713585,3.93829047154187,8.20642120949368e-05,0.0128694496951982,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89746",35.8735345871314,2.67272008356486,0.67848616303066,3.9392403695108,8.17400049879302e-05,0.0128694496951982,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120709",64.2782117251314,2.40969532729868,0.611999593034662,3.93741328380622,8.23646817361758e-05,0.0128832797282694,0,4428,"sp|Q93789|LIPL1_CAEEL","Q93789","LIPL1",1.85e-07,"Lipase lipl-1 (EC 3.1.1.-) (Lipase-like 1)","lipid catabolic process [GO:0016042]","GO:0005576; GO:0005764; GO:0016042; GO:0016788; GO:0043202"
"g19215",85.6715727567014,0.503895821899654,0.128071481156744,3.93448890688589,8.33739191572349e-05,0.0129742644965451,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34468",68.8511692088235,1.23134271971198,0.312942353267754,3.93472697720287,8.32913232432967e-05,0.0129742644965451,0,9068,"sp|Q960A1|GAD3_CAEEL","Q960A1","GAD3",3.53e-08,"Probable aldehyde oxidase gad-3 (EC 1.2.3.1)","endoplasmic reticulum unfolded protein response [GO:0030968]","GO:0004031; GO:0005506; GO:0016491; GO:0030968; GO:0051537; GO:0071949; GO:0102797; GO:0102798"
"g70822",305.401843802145,0.311780468411233,0.0792628518136972,3.93350051476895,8.37176595917399e-05,0.0129944367279353,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47305",36.9382037718954,2.79228881775923,0.710234773563928,3.93150113412167,8.44170979752095e-05,0.0130695757043762,2322,4874,"sp|Q9VZ49|ENDOU_DROME","Q9VZ49","ENDOU",8.24e-17,"Endoribonuclease CG2145 (EC 4.6.1.-) (Poly(U)-specific endoribonuclease homolog) (Uridylate-specific endoribonuclease homolog)","RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]","GO:0003723; GO:0004521; GO:0005576; GO:0016829; GO:0046872; GO:0090502"
"g146346",67.3030714248129,2.70981043131632,0.690370853764873,3.92515184634262,8.66750456822276e-05,0.0133850089629883,0,1844,"sp|Q55C09|SGMA_DICDI","Q55C09","SGMA",2.16e-06,"Sphingomyelin phosphodiesterase A (EC 3.1.4.-) (Acid sphingomyelinase A) (aSMase A)","ceramide biosynthetic process [GO:0046513]; sphingomyelin catabolic process [GO:0006685]","GO:0004767; GO:0005615; GO:0006685; GO:0008081; GO:0016798; GO:0046513; GO:0046872"
"g137728",150.641230168128,0.470162032638241,0.119857793056486,3.92266552427397,8.75746884555256e-05,0.0134896138131113,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9950",434.011241037318,-0.437100074032243,0.111542372837301,-3.91869083392917,8.90312252202702e-05,0.0136389803522473,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77463",122.67264202065,0.344800431743819,0.0879958261929327,3.91837257130624,8.91488377452746e-05,0.0136389803522473,0,7571,"sp|Q99PT0|DDX52_RAT","Q99PT0","DDX52",2.31e-06,"Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (rROK1L) (DEAD box protein 52)","maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364; GO:0016887; GO:0030490"
"g156417",229.453297227622,0.982702379509382,0.250805568660926,3.91818405291446,8.92185730736891e-05,0.0136389803522473,0,1340,"sp|P42860|GSTT1_LUCCU","P42860","GSTT1",3.51e-19,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749"
"g122431",265.812178858018,-0.429006029117221,0.109526484539258,-3.91691590323482,8.96890185860051e-05,0.0136764485879011,135,4267,"sp|Q94HW2|POLR1_ARATH","Q94HW2","POLR1",3.02e-19,"Retrovirus-related Pol polyprotein from transposon RE1 (Retro element 1) (AtRE1) [Includes: Protease RE1 (EC 3.4.23.-); Reverse transcriptase RE1 (EC 2.7.7.49); Endonuclease RE1]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0006310; GO:0015074; GO:0046872"
"g137545",34.2384199724641,1.85137524222881,0.472944731518758,3.91456996736918,9.05654737384664e-05,0.0137754852160088,0,2714,"sp|Q6K332|ODD33_ORYSJ","Q6K332","ODD33",3.95e-07,"2-oxoglutarate-dependent dioxygenase 33 (EC 1.14.11.-) (Melatonin 2-hydroxylase)",NA,"GO:0005737; GO:0031418; GO:0046872; GO:0051213"
"g18111",766.031791016159,0.266664217017804,0.0681479987211829,3.91301611231197,9.11504502195762e-05,0.0138083943065268,2566,16454,"sp|A2AKG8|FOCAD_MOUSE","A2AKG8","FOCAD",9.63e-27,"Focadhesin","regulation of posttranscriptional gene silencing [GO:0060147]","GO:0005925; GO:0016021; GO:0060147"
"g113228",744.326989715858,0.483294238282266,0.123524181603915,3.91254758385665,9.13275352471124e-05,0.0138083943065268,0,5132,"sp|Q2T9X2|TCPD_BOVIN","Q2T9X2","TCPD",1.86e-31,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","protein folding [GO:0006457]","GO:0005524; GO:0005815; GO:0005832; GO:0005929; GO:0006457; GO:0016887; GO:0042470; GO:0051082"
"g134850",273.065911400495,0.523786540198408,0.133885897297146,3.91218605374036,9.14644012394756e-05,0.0138083943065268,0,3243,"sp|Q91VD9|NDUS1_MOUSE","Q91VD9","NDUS1",1.66e-53,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g20932",177.055025057653,-0.532825077274604,0.13623154717005,-3.91117247321216,9.1849150413775e-05,0.0138320718079702,0,19030,"sp|Q2LZZ7|TRC_DROPS","Q2LZZ7","TRC",1.32e-32,"Serine/threonine-protein kinase tricornered (EC 2.7.11.1) (NDR protein kinase) (Serine/threonine-protein kinase 38-like) (Serine/threonine-protein kinase tricorner)","antennal morphogenesis [GO:0048800]; chaeta development [GO:0022416]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; imaginal disc-derived wing hair organization [GO:0035317]; intracellular signal transduction [GO:0035556]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; signal transduction [GO:0007165]","GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005938; GO:0006468; GO:0007165; GO:0018105; GO:0022416; GO:0030424; GO:0030425; GO:0035317; GO:0035556; GO:0044297; GO:0046872; GO:0048800; GO:0048813; GO:0048814; GO:0050773; GO:0051012; GO:0070451; GO:0070593; GO:0106310; GO:0150013"
"g145678",250.883526517752,-1.03234677249141,0.26400352177743,-3.91035227689781,9.21616105413532e-05,0.0138447726330563,0,2371,"sp|Q86V86|PIM3_HUMAN","Q86V86","PIM3",1.46e-07,"Serine/threonine-protein kinase pim-3 (EC 2.7.11.1)","apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]","GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0007346; GO:0043066; GO:0046777; GO:0061179; GO:0106310"
"g16100",686.474917982188,-0.892019780071398,0.228286492659093,-3.90745755336247,9.32724207906236e-05,0.0138709871050406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21282",22.157212590681,1.49072257595733,0.381526672879397,3.90725650897954,9.3350036524294e-05,0.0138709871050406,39505,44304,"sp|Q8R0M8|MOT5_MOUSE","Q8R0M8","MOT5",1.71e-10,"Monocarboxylate transporter 5 (MCT 5)","monocarboxylic acid transport [GO:0015718]","GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016021"
"g28103",555.198087709326,-0.434416416810984,0.111253850807272,-3.90473150959543,9.43300528311356e-05,0.0138709871050406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30962",154.81432367289,0.459560940998812,0.117594392987586,3.90801746004442,9.3056582810853e-05,0.0138709871050406,11636,26574,"sp|Q7ZVM1|WASC5_DANRE","Q7ZVM1","WASC5",2.61e-33,"WASH complex subunit 5 (WASH complex subunit strumpellin)","actin filament polymerization [GO:0030041]; axonogenesis [GO:0007409]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]","GO:0005768; GO:0005769; GO:0007032; GO:0007409; GO:0015031; GO:0030041; GO:0048666; GO:0051125; GO:0060047; GO:0071203; GO:0140285"
"g33312",1195.7125377144,0.466611456733687,0.119458728668831,3.90604740175368,9.38181157565568e-05,0.0138709871050406,0,5414,"sp|Q9SF16|TCPH_ARATH","Q9SF16","TCPH",4.42e-17,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (Chaperonin CCT7)","protein folding [GO:0006457]","GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0016887; GO:0051082"
"g41347",364.950114531961,0.458840224231384,0.117518385522012,3.90441225169351,9.44546545557393e-05,0.0138709871050406,5510,11304,"sp|Q28104|COPE_BOVIN","Q28104","COPE",4.17e-11,"Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0005198; GO:0005654; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0099612"
"g55172",1382.6507584079,0.490174111173361,0.125477071651662,3.906483509068,9.36490314438832e-05,0.0138709871050406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68075",20.4952798287629,0.927982103653279,0.237678212930371,3.90436334997661,9.44737539072912e-05,0.0138709871050406,0,11352,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.91e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g69919",50.338093093418,0.99045483948181,0.253363701220323,3.90922154480416,9.2594018034881e-05,0.0138709871050406,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119744",1142.03250905203,0.566896877880782,0.145209800521295,3.90398496413917,9.46216619127833e-05,0.0138709871050406,0,4512,"sp|Q7YRU4|MDHC_FELCA","Q7YRU4","MDHC",1.13e-18,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase)","malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005813; GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0030060"
"g84127",53.8413903447116,1.7803370636056,0.456262270936997,3.90200368737357,9.53997040221768e-05,0.0139513446677251,0,6481,"sp|O97396|AMY_PHACE","O97396","AMY",1.28e-17,"Alpha-amylase (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate metabolic process [GO:0005975]; digestion [GO:0007586]","GO:0004556; GO:0005576; GO:0005975; GO:0007586; GO:0046872"
"g29989",3451.23164388931,0.358385469261273,0.0919196153984944,3.89890087885576,9.6630318101626e-05,0.0140973413595858,9085,35022,"sp|P29775|ETS4_DROME","P29775","ETS4",4.19e-43,"DNA-binding protein D-ETS-4","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565"
"g584",650.874442613254,0.278244989594311,0.0713773009129002,3.89822795252297,9.68991799856116e-05,0.0141026648281218,204136,213662,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",8.14e-70,"PiggyBac transposable element-derived protein 4",NA,NA
"g27152",175.027407982735,-0.620202965615589,0.159179491916381,-3.89624918479693,9.76938775180916e-05,0.0141504568653293,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44751",144.953553365119,1.47854655530415,0.379474349196308,3.89630170902348,9.76727038726183e-05,0.0141504568653293,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13459",5046.84702808212,0.558832113291942,0.143480366060548,3.89483333946973,9.82662707845559e-05,0.0141994761283683,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30758",367.134508133405,0.346512419292349,0.0890097554574714,3.89297125367243,9.90238900412912e-05,0.0142749641012018,14135,23177,"sp|Q9DE26|RUVB1_XENLA","Q9DE26","RUVB1",6.39e-09,"RuvB-like 1 (EC 3.6.4.12) (Pontin)","DNA recombination [GO:0006310]; DNA repair [GO:0006281]","GO:0000812; GO:0003678; GO:0005524; GO:0006281; GO:0006310; GO:0016887; GO:0031011; GO:0035267; GO:0071339; GO:0097255; GO:0120293"
"g22467",72.2016785209132,-0.563073951573659,0.144810374145973,-3.88835368249282,0.000100926483842889,0.0144850006033373,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137406",585.389195233428,-0.211031439931605,0.0542749393937006,-3.88819300931542,0.000100993303779155,0.0144850006033373,0,3045,"sp|E9Q5F9|SETD2_MOUSE","E9Q5F9","SETD2",1.68e-11,"Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2)","angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]; vasculogenesis [GO:0001570]","GO:0001525; GO:0001570; GO:0001763; GO:0001843; GO:0005634; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010452; GO:0010468; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0018024; GO:0018026; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0046872; GO:0046975; GO:0048332; GO:0048568; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:1902850; GO:1905634"
"g156269",582.864955049868,0.538067240334268,0.13840231492945,3.88770405038777,0.000101196906505438,0.0144850006033373,0,1307,"sp|P80317|TCPZ_MOUSE","P80317","TCPZ",8.57e-22,"T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:0071987; GO:1901998; GO:1904851"
"g53304",298.422249012491,0.438316027919744,0.112766977211694,3.88691830496535,0.000101524903040083,0.0144977561541238,2128,15634,"sp|Q16U49|MED14_AEDAE","Q16U49","MED14",4.95e-12,"Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0006357; GO:0016592"
"g131016",121.838781402185,-0.382753686709638,0.0984937848859024,-3.88606943222894,0.000101880378540617,0.0145143666047653,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123234",177.684198024829,0.546114929967943,0.140607298431158,3.88397285248548,0.000102763386726982,0.0146058780807039,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30756",125.810578066336,0.41554398773466,0.107084724785633,3.88051599858444,0.00010423508782503,0.0147804380376194,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3492",53.3099571696138,-0.583800428397245,0.150470846073936,-3.87982418940071,0.000104531993471305,0.0147858856700376,133311,135634,"sp|Q9C0G0|ZN407_HUMAN","Q9C0G0","ZN407",1.95e-09,"Zinc finger protein 407","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]","GO:0003677; GO:0005634; GO:0008270; GO:0010468; GO:0045944"
"g34568",177.602154261358,-0.571087080552921,0.147214239506662,-3.87929240042759,0.000104760765169158,0.0147858856700376,11276,29636,"sp|Q8TDY8|IGDC4_HUMAN","Q8TDY8","IGDC4",4.99e-08,"Immunoglobulin superfamily DCC subclass member 4 (Neighbor of punc e11) (Protein DDM36) (hDDM36)","cell-cell adhesion [GO:0098609]","GO:0005886; GO:0016021; GO:0098609"
"g3892",121.738875284185,-0.550221621073072,0.142012624028283,-3.87445570306123,0.000106863278642118,0.014959818591358,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9302",182.453379746341,-0.516764647555175,0.133386435666031,-3.87419189196295,0.000106979094886297,0.014959818591358,31635,66674,"sp|A2RSJ4|UH1BL_MOUSE","A2RSJ4","UH1BL",1.76e-07,"UHRF1-binding protein 1-like (Syntaxin-6 Habc-interacting protein of 164 kDa)",NA,"GO:0005769; GO:0005829; GO:0042803; GO:0062069"
"g54362",25.6765796350003,1.38014924520297,0.356114346901189,3.87557888979385,0.000106371509019394,0.014959818591358,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98021",57.0011254002037,0.963578442544308,0.248683929448795,3.87471134415508,0.000106751162007784,0.014959818591358,4665,6354,"sp|O96553|C1TC_DROME","O96553","C1TC",2.96e-09,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]","cellular amino acid biosynthetic process [GO:0008652]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999]","GO:0000105; GO:0004329; GO:0004477; GO:0004488; GO:0005524; GO:0005737; GO:0005829; GO:0006164; GO:0008652; GO:0009086; GO:0035999"
"g55718",3318.98698685236,0.285077615699122,0.0737085488266839,3.86763299830315,0.000109896893265725,0.0152898949413201,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87800",111.526350854663,0.695610928060002,0.17989479910051,3.86676508458344,0.000110288572200302,0.0152898949413201,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104685",147.116507643425,-1.08253660302417,0.279942334810769,-3.866998550812,0.000110183082439181,0.0152898949413201,0,5364,"sp|Q91822|PIM3_XENLA","Q91822","PIM3",2.49e-08,"Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Pim-1)","apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]","GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0006915; GO:0043066; GO:0106310"
"g123940",192.648710494383,0.496875819892764,0.128503408491282,3.86663533462984,0.000110347239813778,0.0152898949413201,0,4138,"sp|P48605|TCPG_DROME","P48605","TCPG",2.9e-20,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (Chaperonin containing TCP1 subunit 3)","lumen formation, open tracheal system [GO:0035149]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]","GO:0005524; GO:0005832; GO:0006457; GO:0007430; GO:0016887; GO:0035149; GO:0051082"
"g32170",108.236172068051,0.633068352908908,0.163825277794261,3.8642898179849,0.000111412876398859,0.0154023860333639,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3881",837.244234556368,0.349396210617756,0.0904689595142541,3.86205625104714,0.000112436668730227,0.0154651423461066,105965,115318,"sp|Q5R664|COPB2_PONAB","Q5R664","COPB2",7.35e-29,"Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0016192; GO:0030117; GO:0030663"
"g25703",174.623713136457,-0.910680769838356,0.235827841413899,-3.8616338273649,0.000112631288795174,0.0154651423461066,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66174",28.7591242861383,2.25678091062133,0.584383036256083,3.86181796973378,0.000112546411240001,0.0154651423461066,0,11792,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.17e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g25658",69.1283654391432,-0.492322263508699,0.127574100619034,-3.85910824469685,0.000113801526797671,0.0155554384264655,14200,20344,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.82e-15,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g26579",133.296252037657,0.352174807747081,0.0912544847915609,3.85926027144311,0.000113730761492651,0.0155554384264655,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33314",238.895201187739,0.51042526397981,0.132343900847278,3.85680987723665,0.000114876442234607,0.0156624681803242,6495,10395,"sp|P80313|TCPH_MOUSE","P80313","TCPH",1.25e-20,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0005524; GO:0005739; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:1901998; GO:1904851"
"g75088",530.027229143387,-0.818174391543243,0.21218649505066,-3.85592113837359,0.000115294655023773,0.0156624681803242,2761,9912,"sp|Q292F9|GDAP2_DROPS","Q292F9","GDAP2",8.31e-15,"Protein GDAP2 homolog","response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]","GO:0006979; GO:0042594"
"g76268",115.200066116879,0.356112038109406,0.0923578524349141,3.85578517387423,0.000115358762178364,0.0156624681803242,2575,8258,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.28e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g1039",287.072244029918,0.534366085372804,0.1387792689082,3.85047485533505,0.000117889033561394,0.0159347114628976,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45918",513.933919561849,-0.40482391772556,0.10513118666082,-3.85065488732305,0.0001178024011876,0.0159347114628976,0,12193,"sp|Q99315|YG31B_YEAST","Q99315","YG31B",1.56e-90,"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g45625",248.593514344932,-0.661269282700291,0.171836733573979,-3.84824169400078,0.000118968649595984,0.0160449052088451,16286,19654,"sp|Q9NJB5|ONEC_DROME","Q9NJB5","ONEC",3.61e-19,"Homeobox protein onecut","positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0045944"
"g13396",2438.51737596901,0.455732886444937,0.118481695683392,3.84644129049901,0.000119845830807721,0.0160561666042397,0,2024,"sp|P12261|EF1G_ARTSA","P12261","EF1G",1.17e-28,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]","GO:0003746; GO:0006749"
"g97861",10877.8594925792,0.490979056235613,0.127643871286645,3.84647575544807,0.000119828981910955,0.0160561666042397,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160291",21.3544359926671,1.0437793225173,0.271295394387517,3.84739049799855,0.000119382606723092,0.0160561666042397,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49350",2760.09466880682,-0.699497356850167,0.181934270857261,-3.84478060980037,0.000120660340703575,0.0160804232204384,0,10729,"sp|P18444|MYCN_CHICK","P18444","MYCN",5.79e-09,"N-myc proto-oncogene protein",NA,"GO:0003677; GO:0003700; GO:0005634; GO:0046983"
"g82025",93.0024074260068,0.430040214066208,0.111833406049027,3.84536454051736,0.000120373348540637,0.0160804232204384,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115973",72.8040194390901,-0.510349917532373,0.132749692119403,-3.84445273947102,0.000120821766164441,0.0160804232204384,745,4870,"sp|Q99NI3|GT2D2_MOUSE","Q99NI3","GT2D2",1.64e-08,"General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2)","transition between fast and slow fiber [GO:0014883]","GO:0003677; GO:0005634; GO:0005654; GO:0014883"
"g24981",823.764714340518,0.516471670921251,0.13438948541324,3.84309582950727,0.000121492002182546,0.0161342442285749,0,7124,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.37e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g55724",61.4726982488481,-0.510332874108363,0.132846441359973,-3.84152461205579,0.00012227247309417,0.0162024375373039,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56778",211.580046224693,0.375773659808728,0.097869960290921,3.83951989652117,0.000123275139451209,0.0162997128829931,0,7244,"sp|Q23381|MUTA_CAEEL","Q23381","MUTA",2.9e-28,"Probable methylmalonyl-CoA mutase, mitochondrial (EC 5.4.99.2) (MethylmalonylCoA mutase homolog 1) (MCM)","cellular amino acid metabolic process [GO:0006520]; fatty acid metabolic process [GO:0006631]","GO:0004494; GO:0005739; GO:0005759; GO:0006520; GO:0006631; GO:0031419; GO:0046872"
"g79416",119.565649314063,0.762185562223416,0.198651445072687,3.83679847858409,0.000124648675173007,0.0164454958614126,6300,9217,"sp|Q9QZU7|BODG_RAT","Q9QZU7","BODG",4.98e-07,"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)","carnitine biosynthetic process [GO:0045329]","GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0042802; GO:0045329"
"g148463",260.858151449716,-0.408398704400932,0.106482744808465,-3.83535102457713,0.00012538508869289,0.0165067701361638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22739",106.037259031025,0.434535859961906,0.113444667714405,3.83037712319669,0.000127947014009981,0.016568379276532,20136,39984,"sp|P53034|RFC2_DROME","P53034","RFC2",4.42e-32,"Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40) (Replication factor C subunit 4) (DmRfc4)","DNA damage checkpoint signaling [GO:0000077]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA strand elongation involved in DNA replication [GO:0006271]; leading strand elongation [GO:0006272]; sister chromatid cohesion [GO:0007062]","GO:0000076; GO:0000077; GO:0003677; GO:0005524; GO:0005634; GO:0005663; GO:0006260; GO:0006261; GO:0006271; GO:0006272; GO:0006281; GO:0007062; GO:0016887; GO:0031391"
"g27170",2051.93012920013,0.528233759617924,0.137860305401558,3.83165957800027,0.000127281775659758,0.016568379276532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41854",294.508477079207,-0.740890019995305,0.193351187311454,-3.8318358955917,0.00012719057104917,0.016568379276532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68625",95.4862066179886,3.83348460939534,1.00068713766133,3.83085228651428,0.000127700154813863,0.016568379276532,3367,7754,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.6e-07,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g70400",35.1193202365015,1.19994230693147,0.313243003997423,3.83070744316237,0.000127775356945639,0.016568379276532,0,10825,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.16e-31,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g95785",324.888071042001,-0.363630144359294,0.0948499321920992,-3.83374174293383,0.000126208648024082,0.016568379276532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101476",2186.78188448475,0.421360382089727,0.109989373272477,3.83091902020289,0.000127665520968749,0.016568379276532,0,6329,"sp|P12261|EF1G_ARTSA","P12261","EF1G",1.31e-16,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]","GO:0003746; GO:0006749"
"g153196",22.3737415741592,-0.686813015497141,0.179314996516859,-3.83020399207139,0.000128037071687156,0.016568379276532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4290",258.390015394928,0.635385003244215,0.166001987908101,3.82757466492488,0.000129412134059763,0.0165888185710265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64090",68.6459918095206,2.57583114613978,0.67270067399376,3.82908958727113,0.000128618183447313,0.0165888185710265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64675",775.3311237336,0.443512668321779,0.11584705416509,3.82843285501021,0.000128961802742794,0.0165888185710265,0,5904,"sp|Q963B6|RL10A_SPOFR","Q963B6","RL10A",1.38e-20,"60S ribosomal protein L10a","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015934"
"g68509",158.836634224027,1.54842310005423,0.404683891583396,3.82625336035927,0.000130108380949228,0.0165888185710265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70588",316.598473409719,0.309068225830652,0.0807665023307661,3.82668825455525,0.000129878829453277,0.0165888185710265,0,10781,"sp|Q19749|ODP2_CAEEL","Q19749","ODP2",2.86e-13,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]","GO:0004742; GO:0005967; GO:0006086; GO:0006096"
"g89400",177.392243874212,0.679822652508286,0.177612683671929,3.82755689770443,0.000129421472966869,0.0165888185710265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111725",90.9814502346292,0.460445535169775,0.120317215500057,3.82692978104664,0.000129751508703361,0.0165888185710265,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87001",87.8264826591415,1.16301845147632,0.304017892281248,3.82549343642056,0.000130510411857475,0.0166051926533127,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29610",155.610398329565,0.845330608729377,0.22117229012142,3.82204573757998,0.0001323491338318,0.0168039099001086,25796,33754,"sp|P11586|C1TC_HUMAN","P11586","C1TC",1.69e-26,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) (Epididymis secretory sperm binding protein) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]","10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]","GO:0000105; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009257; GO:0016020; GO:0035999; GO:0048702; GO:0048703; GO:0061053; GO:0070062"
"g23932",946.018685214599,0.789351537219995,0.206566145771639,3.82130157035815,0.000132749202119449,0.0168195179052805,28766,40034,"sp|A0A291PQH4|UGT2_DACCO","A0A291PQH4","UGT2",1.46e-13,"UDP-glucosyltransferase 2 (DcUGT2) (EC 2.4.1.-)","organic acid biosynthetic process [GO:0016053]","GO:0005783; GO:0005789; GO:0016021; GO:0016053; GO:0035251"
"g10916",161.435405855638,-0.428815239149463,0.112249949033587,-3.82018203875669,0.000133353215488422,0.0168490599425474,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132716",56.0442042255605,3.2032824344292,0.838590469908266,3.81984120899873,0.000133537614637754,0.0168490599425474,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134670",20.9592227168676,0.748729351068463,0.196172115778766,3.81669610941468,0.000135250582229179,0.0170297880404333,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32947",192.996000953919,-0.934330255971807,0.244877577064826,-3.81549943106659,0.000135907769221881,0.0170771066544016,23721,30164,"sp|Q80U96|XPO1_RAT","Q80U96","XPO1",1.26e-35,"Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)","mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to xenobiotic stimulus [GO:0009410]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]","GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0006611; GO:0006913; GO:0009410; GO:0010824; GO:0015030; GO:0019904; GO:0031267; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0046825; GO:0051028; GO:1990904"
"g105175",88.5653484642267,0.400744845826619,0.105207107094511,3.8091043171315,0.000139471109729995,0.0174166700607271,0,5934,"sp|O35156|UGPA_CRIGR","O35156","UGPA",4.28e-14,"UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase)","brain development [GO:0007420]; glycogen biosynthetic process [GO:0005978]; UDP-glucose metabolic process [GO:0006011]","GO:0003983; GO:0005737; GO:0005978; GO:0006011; GO:0007420; GO:0042802; GO:0046872"
"g120072",72.6546767474296,1.26403604646094,0.331838739908888,3.80918770004974,0.000139424087957267,0.0174166700607271,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161927",156.995450849449,3.26909522941589,0.85803606025423,3.80997417340162,0.000138981309451567,0.0174166700607271,0,594,"sp|P28622|GUN4_BACS5","P28622","GUN4",2.14e-06,"Endoglucanase 4 (EC 3.2.1.4) (Cellulase 4) (EG-IV) (Endo-1,4-beta-glucanase 4)","cellulose catabolic process [GO:0030245]","GO:0005576; GO:0008810; GO:0030245; GO:0030248"
"g1504",163.038165668851,-0.623813257814399,0.163837440411444,-3.80751344898835,0.000140371107444679,0.0174890374739294,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6043",96.4857562066483,0.362007048080476,0.0950882749259557,3.80706294611367,0.000140626961398542,0.0174890374739294,93682,96554,"sp|Q0VFM6|GMPPA_XENTR","Q0VFM6","GMPPA",1.03e-06,"Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A) (GTP-mannose-1-phosphate guanylyltransferase alpha)","biosynthetic process [GO:0009058]","GO:0005737; GO:0009058; GO:0016779"
"g2637",457.962445973371,-0.527451829810964,0.138612495904452,-3.80522568596229,0.000141674951310309,0.0175833390491261,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28331",465.681590786666,-0.380660997034261,0.100140125740834,-3.80128339382581,0.000143948546613922,0.0176133816411268,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34301",138.112519529715,-0.477302637361209,0.12556103902588,-3.80135941104175,0.000143904382985341,0.0176133816411268,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39067",145.452729925745,-0.361164277137687,0.0949664622629865,-3.80307182695224,0.000142912897578675,0.0176133816411268,6745,24934,"sp|Q96IR2|ZN845_HUMAN","Q96IR2","ZN845",1.22e-114,"Zinc finger protein 845","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g46920",184.292886222642,-0.777522418915908,0.204408127978561,-3.80377447122581,0.000142507932381872,0.0176133816411268,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53749",71.105844119441,-1.16027486321019,0.305147112579822,-3.80234586983575,0.000143332437159557,0.0176133816411268,11533,14844,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.25e-39,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g129575",127.05618702142,0.486417308830844,0.127881422003017,3.80365889909614,0.00014257446740401,0.0176133816411268,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138000",33.9050663480579,1.51476345280968,0.398408893967146,3.80203222304217,0.000143514056089522,0.0176133816411268,0,3001,"sp|Q964T2|CP9E2_BLAGE","Q964T2","CP9E2",3.27e-10,"Cytochrome P450 9e2 (EC 1.14.-.-) (CYPIXE2)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g2860",260.38202091259,0.440763418693939,0.116009528497705,3.79937255501093,0.000145062886200741,0.0176784469147048,0,4319,"sp|P23927|CRYAB_MOUSE","P23927","CRYAB",1.31e-07,"Alpha-crystallin B chain (Alpha(B)-crystallin) (P23)","apoptotic process involved in morphogenesis [GO:0060561]; camera-type eye development [GO:0043010]; cellular response to gamma radiation [GO:0071480]; lens development in camera-type eye [GO:0002088]; microtubule polymerization or depolymerization [GO:0031109]; multicellular organism aging [GO:0010259]; muscle organ development [GO:0007517]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular transport [GO:0032387]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell death [GO:0010941]; response to estradiol [GO:0032355]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; stress-activated MAPK cascade [GO:0051403]; tubulin complex assembly [GO:0007021]","GO:0001540; GO:0001666; GO:0002088; GO:0005198; GO:0005212; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006457; GO:0007021; GO:0007517; GO:0008017; GO:0008092; GO:0009986; GO:0010259; GO:0010629; GO:0010941; GO:0014069; GO:0015630; GO:0030018; GO:0030308; GO:0030424; GO:0031109; GO:0031333; GO:0031430; GO:0031674; GO:0032355; GO:0032387; GO:0032432; GO:0032991; GO:0042542; GO:0042802; GO:0042803; GO:0043010; GO:0043066; GO:0043154; GO:0043197; GO:0043204; GO:0043209; GO:0043292; GO:0044877; GO:0045202; GO:0045892; GO:0046872; GO:0050821; GO:0051082; GO:0051403; GO:0060561; GO:0071480; GO:0097060; GO:0097512; GO:1905907; GO:2000378"
"g56736",182.37289090459,0.635294958327873,0.167204351455549,3.79951211076444,0.000144981227603725,0.0176784469147048,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125315",43.4690674062284,0.6196368745974,0.163172528611419,3.79743379520097,0.000146201807042995,0.0177815384157101,0,1684,"sp|P21328|RTJK_DROME","P21328","RTJK",1.34e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g15055",135.196916605012,-0.431603819407164,0.113716140326642,-3.79544907316949,0.000147376446453735,0.017817283934815,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20119",256.834575829356,0.523359723394032,0.137883059278253,3.79567820828428,0.000147240382621443,0.017817283934815,22295,46064,"sp|O43102|CBF5_ASPFU","O43102","CBF5",8.59e-29,"H/ACA ribonucleoprotein complex subunit cbf5 (EC 5.4.99.-) (Centromere-binding factor 5) (H/ACA snoRNP protein cbf5) (Small nucleolar RNP protein cbf5)","box H/ACA RNA 3'-end processing [GO:0000495]; mRNA pseudouridine synthesis [GO:1990481]; rRNA pseudouridine synthesis [GO:0031118]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]","GO:0000454; GO:0000495; GO:0003677; GO:0003723; GO:0005874; GO:0009982; GO:0031118; GO:0031120; GO:0031429; GO:1990481"
"g55089",540.035071485917,1.23303235616838,0.324867655830357,3.79549128403308,0.000147351372123879,0.017817283934815,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25704",1008.43132218173,-0.70918808512205,0.186957863483069,-3.79330439442188,0.00014865574109959,0.0179362165553362,13205,20660,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",7.44e-48,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g150244",622.319726703686,0.513809178011609,0.135476405671608,3.79261005238853,0.000149072149549162,0.0179507713415449,0,1204,"sp|Q3T084|TCPW_BOVIN","Q3T084","TCPW",2.91e-23,"T-complex protein 1 subunit zeta-2 (TCP-1-zeta-2) (CCT-zeta-2)","protein folding [GO:0006457]","GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g2359",1799.41092708802,-0.401769026738409,0.105967447015992,-3.79143820156179,0.000149777419672572,0.0179999833661949,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48755",64.4570288082513,0.441427817053602,0.116454249693821,3.79056855558467,0.000150302839306224,0.0180274294812149,10778,16204,"sp|O75564|JERKY_HUMAN","O75564","JERKY",8.96e-55,"Jerky protein homolog","positive regulation of canonical Wnt signaling pathway [GO:0090263]","GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904"
"g2954",154.66267014544,-0.565981727539042,0.149417960103973,-3.78790961371177,0.000151920093376386,0.0180678541072112,3695,16900,"sp|Q640T2|WIPI3_XENTR","Q640T2","WIPI3",8.23e-24,"WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45-like) (WDR45-like protein) (WD repeat-containing protein 45B)","autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]","GO:0000045; GO:0000407; GO:0000422; GO:0005764; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0080025"
"g3911",2102.98977941336,0.272184305720338,0.0719182892441735,3.7846326515948,0.000153935784563875,0.0180678541072112,58846,71244,"sp|A6QL88|SAC1_BOVIN","A6QL88","SAC1",0,"Phosphatidylinositol-3-phosphatase SAC1 (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein)","phosphatidylinositol dephosphorylation [GO:0046856]","GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0005794; GO:0016021; GO:0016791; GO:0043812; GO:0046856; GO:0140268"
"g5442",86.6152175924924,-0.608270747151458,0.160623637623585,-3.78693171285858,0.000152518993655618,0.0180678541072112,48662,54264,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.1e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g7875",97.8464742235492,-0.925134567192797,0.244150740002142,-3.78919419693211,0.000151136733911483,0.0180678541072112,58775,81940,"sp|Q5RDF5|JAZF1_PONAB","Q5RDF5","JAZF1",4.25e-09,"Juxtaposed with another zinc finger protein 1","lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000122; GO:0001650; GO:0003714; GO:0005654; GO:0005829; GO:0006629; GO:0017053; GO:0046872"
"g17339",41.9864626368568,0.67908078095188,0.179543067632337,3.78227235340816,0.000155403194001718,0.0180678541072112,0,5072,"sp|P19971|TYPH_HUMAN","P19971","TYPH",2.35e-16,"Thymidine phosphorylase (TP) (EC 2.4.2.4) (Gliostatin) (Platelet-derived endothelial cell growth factor) (PD-ECGF) (TdRPase)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; dTMP catabolic process [GO:0046074]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]","GO:0000002; GO:0001525; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0006935; GO:0008083; GO:0009032; GO:0016154; GO:0030154; GO:0031641; GO:0042803; GO:0046074; GO:0051969; GO:1905333"
"g21027",42.4002991162281,-0.604981290730245,0.159894852111005,-3.78361956462641,0.000154564021038647,0.0180678541072112,45005,49701,"sp|Q9BLY8|GBRB_DROSI","Q9BLY8","GBRB",3.78e-08,"Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor) (Protein cyclodiene resistance)","chloride transport [GO:0006821]; ion transport [GO:0006811]","GO:0004890; GO:0005230; GO:0005254; GO:0006811; GO:0006821; GO:0030594; GO:0034707; GO:0045211"
"g26429",113.361921131761,0.333389542480386,0.0880860125118146,3.78481819046662,0.00015382098874057,0.0180678541072112,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28255",24.9548376436779,1.88123793686787,0.497219771718803,3.7835139386448,0.000154629660668652,0.0180678541072112,28044,33514,"sp|P04069|CBPB_ASTAS","P04069","CBPB",2.75e-12,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g28943",75.700920490579,1.633250323639,0.431496065029796,3.78508741099694,0.00015365456104176,0.0180678541072112,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63887",247.677442200353,2.00712146457897,0.530587948781597,3.7828252020951,0.000155058309077058,0.0180678541072112,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88041",228.814664304503,0.693834901269514,0.183216048290635,3.78697667449353,0.000152491408922702,0.0180678541072112,0,7324,"sp|Q6NVG7|GT252_MOUSE","Q6NVG7","GT252",1.35e-103,"Procollagen galactosyltransferase 2 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 2) (Glycosyltransferase 25 family member 2) (Hydroxylysine galactosyltransferase 2)",NA,"GO:0005788; GO:0050211"
"g103853",37.304787795696,0.98320355258579,0.259844956803344,3.78380848595764,0.000154446684204248,0.0180678541072112,974,6073,"sp|Q99LB7|SARDH_MOUSE","Q99LB7","SARDH",1.32e-06,"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)","sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:0035999; GO:0050660; GO:1901053"
"g108963",636.291550986907,3.00982906455734,0.795635365241487,3.78292518915849,0.00015499601088717,0.0180678541072112,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132349",756.393346414094,0.443085235289771,0.117144253035149,3.78238986386146,0.000155329826805315,0.0180678541072112,0,3278,"sp|O16797|RL3_DROME","O16797","RL3",1.66e-20,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g139361",61.9776048293927,-0.520012554097233,0.137416627423874,-3.78420402134604,0.000154201293264775,0.0180678541072112,0,2650,"sp|Q5RBN1|FND3A_PONAB","Q5RBN1","FND3A",1.28e-13,"Fibronectin type-III domain-containing protein 3A",NA,"GO:0000139; GO:0016021"
"g157842",75.3049413815321,0.993949182974363,0.262448765463639,3.7872122630048,0.000152346948094388,0.0180678541072112,0,1264,"sp|Q3LSM4|AGT_AEDAE","Q3LSM4","AGT",2.1e-21,"Alanine--glyoxylate aminotransferase (EC 2.6.1.44)","glyoxylate catabolic process [GO:0009436]","GO:0005777; GO:0008453; GO:0009436; GO:0030170"
"g25646",34.2604076104385,-0.505279806799377,0.133642309153947,-3.78083714654561,0.000156301895711516,0.0181375947432733,0,15571,"sp|P32866|GPRK2_DROME","P32866","GPRK2",2.81e-26,"G protein-coupled receptor kinase 2 (EC 2.7.11.16)","apical constriction involved in gastrulation [GO:0003384]; defense response to Gram-positive bacterium [GO:0050830]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of smoothened signaling pathway [GO:0045879]; oocyte morphogenesis [GO:0048601]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Toll signaling pathway [GO:0045752]; protein phosphorylation [GO:0006468]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]","GO:0003384; GO:0004672; GO:0004674; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0006963; GO:0007165; GO:0007476; GO:0009898; GO:0009966; GO:0010739; GO:0045752; GO:0045879; GO:0045880; GO:0048260; GO:0048601; GO:0050830; GO:0070273"
"g81364",31.4090309431491,-0.611518936161511,0.161779295767974,-3.77995795604499,0.00015685484325003,0.0181448253192748,0,3326,"sp|P97471|SMAD4_MOUSE","P97471","SMAD4",1.13e-27,"Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4 homolog) (SMAD family member 4) (SMAD 4) (Smad4)","adrenal gland development [GO:0030325]; aging [GO:0007568]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac septum development [GO:0003279]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; cellular response to glucose stimulus [GO:0071333]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; female gonad development [GO:0008585]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation [GO:0007369]; gastrulation with mouth forming second [GO:0001702]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; male gonad development [GO:0008584]; mesendoderm development [GO:0048382]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of binding [GO:0051098]; regulation of cell population proliferation [GO:0042127]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; tissue morphogenesis [GO:0048729]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; wound healing [GO:0042060]","GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001822; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003279; GO:0003360; GO:0003677; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006357; GO:0006879; GO:0007179; GO:0007183; GO:0007283; GO:0007338; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0007568; GO:0008283; GO:0008285; GO:0008584; GO:0008585; GO:0009653; GO:0009952; GO:0010614; GO:0010666; GO:0010718; GO:0010862; GO:0014033; GO:0017015; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0030513; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032991; GO:0033686; GO:0035556; GO:0036302; GO:0042060; GO:0042118; GO:0042127; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048663; GO:0048729; GO:0048733; GO:0048859; GO:0051098; GO:0051571; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060548; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0072133; GO:0072134; GO:0072520; GO:0090575; GO:1902895; GO:1905305; GO:2000617"
"g138965",60.7715832823018,0.605563645475375,0.16021102219598,3.77978766488744,0.000156962156741131,0.0181448253192748,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129732",27.2516951790657,1.2535743421325,0.331714367632923,3.77907761752338,0.000157410357089418,0.0181478604863511,0,3650,"sp|A8Y9I2|NINAB_GALME","A8Y9I2","NINAB",4.79e-07,"Carotenoid isomerooxygenase (EC 1.13.11.65) (Beta-carotene 15,15'-monooxygenase and retinoid isomerase) (Beta-carotene dioxygenase and retinoid isomerase) (Neither inactivation nor afterpotential mutant B)","retinol metabolic process [GO:0042572]","GO:0004497; GO:0016702; GO:0042572; GO:0046872"
"g157956",20.2586952675345,0.703701334170073,0.186223534731719,3.77879914686323,0.00015758646360697,0.0181478604863511,0,1124,"sp|O00462|MANBA_HUMAN","O00462","MANBA",3.21e-07,"Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase)","cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; oligosaccharide catabolic process [GO:0009313]","GO:0004567; GO:0005537; GO:0005886; GO:0006464; GO:0006516; GO:0009313; GO:0035577; GO:0043202"
"g22402",39.852094322866,1.18087584893976,0.312576242095587,3.77788100919916,0.000158168413797187,0.0181803807449834,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115718",107.230220058794,1.27311324388227,0.337038605111707,3.77735139112719,0.000158505024854563,0.0181846313013675,406,4834,"sp|Q6TLF6|RGN_DANRE","Q6TLF6","RGN",7.61e-14,"Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17)","cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848]","GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0008270; GO:0019853; GO:0030234; GO:0032781; GO:0050848"
"g62001",383.224409431669,0.30764151250293,0.0814659102005944,3.77632204372874,0.000159161179829657,0.0182254566110602,4893,12474,"sp|Q9VAH9|INT11_DROME","Q9VAH9","INT11",2.3e-35,"Integrator complex subunit 11 (EC 3.1.27.-)","snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]","GO:0004521; GO:0005634; GO:0005737; GO:0016180; GO:0032039; GO:0034472"
"g30332",2902.95630104339,-0.993093091389787,0.263108946070464,-3.77445581467923,0.000160357326055067,0.018259122678985,9354,31614,"sp|A2SXS5|MEN1_CANLF","A2SXS5","MEN1",3.4e-25,"Menin","chromatin organization [GO:0006325]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000403; GO:0000785; GO:0000976; GO:0003682; GO:0006325; GO:0006357; GO:0008285; GO:0035097; GO:0045786"
"g79538",1773.4600728191,0.956363044247755,0.253377774629364,3.7744551417215,0.000160357758904251,0.018259122678985,85,5342,"sp|Q93113|GST1D_ANOGA","Q93113","GST1D",4.02e-22,"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g156734",20.5149929694814,-0.840412732080526,0.222603039913757,-3.77538748979405,0.00015975912205682,0.018259122678985,0,1429,"sp|Q6UX65|DRAM2_HUMAN","Q6UX65","DRAM2",1.9e-14,"DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77)","apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601]","GO:0001917; GO:0005737; GO:0005764; GO:0005765; GO:0005794; GO:0006914; GO:0006915; GO:0007601; GO:0010506; GO:0016021; GO:0016324; GO:0043231; GO:0045494"
"g116634",92.8796117550123,2.93551171014095,0.778493948706944,3.77075726152625,0.000162752924629332,0.0184971441868056,0,4534,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.32e-15,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g28131",659.301989968533,-0.637137277787327,0.16905056183029,-3.76891547054986,0.000163958396561581,0.0185993179202288,10785,15610,"sp|Q9VVI3|NEDD4_DROME","Q9VVI3","NEDD4",1.22e-06,"E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4)","axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]","GO:0000209; GO:0002092; GO:0004842; GO:0005112; GO:0005737; GO:0005886; GO:0007219; GO:0007411; GO:0007528; GO:0008586; GO:0016199; GO:0016567; GO:0017022; GO:0019871; GO:0019904; GO:0031623; GO:0043161; GO:0045732; GO:0045746; GO:0045807; GO:0045879; GO:0048814; GO:0051965; GO:0061630; GO:0071212; GO:1905062; GO:1905306; GO:2000650"
"g38725",1902.92351859067,-0.393920016742208,0.1045721770851,-3.7669677319775,0.000165242348855486,0.0187099965523124,8941,25494,"sp|P21521|SY65_DROME","P21521","SY65",2.79e-28,"Synaptotagmin 1 (p65)","calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; larval locomotory behavior [GO:0008345]; neurotransmitter secretion [GO:0007269]; positive regulation of vesicle fusion [GO:0031340]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of pole plasm oskar mRNA localization [GO:0007317]; regulation of synapse structure or activity [GO:0050803]; rhythmic synaptic transmission [GO:0060024]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle-mediated transport [GO:0016192]","GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0007268; GO:0007269; GO:0007317; GO:0008021; GO:0008345; GO:0014059; GO:0016021; GO:0016079; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030285; GO:0030424; GO:0030672; GO:0031045; GO:0031340; GO:0031594; GO:0042803; GO:0043195; GO:0048488; GO:0048791; GO:0050803; GO:0060024; GO:0070382; GO:0071277; GO:0150007; GO:1900073"
"g4622",30.1182676964593,0.652081641129789,0.173162339090328,3.76572437491525,0.000166066912051883,0.0187654436910288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20414",365.927834941831,-0.43975262649637,0.116836203045016,-3.76383873350399,0.000167324812269443,0.0187654436910288,21735,43649,"sp|Q24210|CSKP_DROME","Q24210","CSKP",6.88e-24,"Peripheral plasma membrane protein CASK (dCASK) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase) (CAKI) (Camguk)","adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; anesthesia-resistant memory [GO:0007615]; behavioral response to ethanol [GO:0048149]; border follicle cell migration [GO:0007298]; cellular protein localization [GO:0034613]; locomotion [GO:0040011]; long-term memory [GO:0007616]; male courtship behavior [GO:0008049]; medium-term memory [GO:0072375]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; regulation of locomotion [GO:0040012]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of terminal button organization [GO:2000331]; synaptic vesicle docking [GO:0016081]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]","GO:0004674; GO:0004683; GO:0004712; GO:0005102; GO:0005516; GO:0005524; GO:0005886; GO:0005911; GO:0007269; GO:0007274; GO:0007298; GO:0007615; GO:0007616; GO:0007628; GO:0008049; GO:0008344; GO:0008582; GO:0016080; GO:0016081; GO:0031594; GO:0034613; GO:0040011; GO:0040012; GO:0042043; GO:0046928; GO:0048149; GO:0048488; GO:0061174; GO:0072375; GO:0106310; GO:1900073; GO:1900244; GO:2000331"
"g69532",419.456089469188,-0.589793952405802,0.156695768389014,-3.76394307561374,0.000167254972641869,0.0187654436910288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93463",211.604326405684,1.34141934733631,0.356387169095787,3.76393838964436,0.000167258108528065,0.0187654436910288,0,6382,"sp|H9J9M0|CDA1_BOMMO","H9J9M0","CDA1",2.26e-15,"Chitin deacetylase 1 (BmCDA1) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0008061; GO:0008270"
"g94306",41.8162010983297,0.65448070676238,0.173842820089617,3.76478422534212,0.000166692964044074,0.0187654436910288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102901",52.6524617896464,0.864674902915119,0.229756099117399,3.76344700417853,0.000167587254581276,0.0187654436910288,1045,5981,"sp|Q9V7S5|PICO_DROME","Q9V7S5","PICO",1.8e-06,"Putative inorganic phosphate cotransporter","anion transport [GO:0006820]; sodium ion transport [GO:0006814]","GO:0005886; GO:0006814; GO:0006820; GO:0015114; GO:0015293; GO:0016021; GO:0022857"
"g22677",219.555757387924,0.420480789681775,0.111781316719584,3.76163747235684,0.000168804599052878,0.0187977084706774,38695,43923,"sp|Q92665|RT31_HUMAN","Q92665","RT31",2.97e-18,"28S ribosomal protein S31, mitochondrial (MRP-S31) (S31mt) (Imogen 38) (Mitochondrial small ribosomal subunit protein mS31)","mitochondrial translation [GO:0032543]","GO:0003723; GO:0003735; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0019904; GO:0032543"
"g63943",249.055507058507,1.94211522868811,0.516240653140349,3.76203465742964,0.000168536686381692,0.0187977084706774,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147631",126.01241987587,-0.993188994132545,0.263977337082161,-3.76240250436128,0.000168288919928794,0.0187977084706774,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31152",26.1455101442753,-1.03107326366635,0.274163794724901,-3.76079294022371,0.000169375592188798,0.0188267485163703,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32261",9030.64699092201,0.356081606420128,0.0947000114660703,3.76010098528559,0.000169844780565471,0.0188443870795584,24369,27074,"sp|P60868|RS20_RAT","P60868","RS20",2.12e-43,"40S ribosomal protein S20","positive regulation of signal transduction by p53 class mediator [GO:1901798]; translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015935; GO:0022626; GO:0022627; GO:0045202; GO:0097371; GO:1901798; GO:1990948"
"g24134",25.8737898711551,1.53479958981384,0.408271596523586,3.75926124394297,0.000170415819383255,0.0188732410189229,0,14005,"sp|Q6AZB8|HARB1_DANRE","Q6AZB8","HARB1",1.67e-06,"Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)",NA,"GO:0004518; GO:0005634; GO:0005737; GO:0046872"
"g45973",30.8321897284138,-0.511885829304733,0.136212007128942,-3.75800812347012,0.000171271322332114,0.0189250549871538,0,11714,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.85e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g116298",103.653749684293,1.05007121818968,0.279466821855622,3.75740923812476,0.000171681605275398,0.0189250549871538,0,3054,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.38e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g130772",13616.3923294188,0.819084061014926,0.218003341710309,3.75720874087957,0.000171819167868212,0.0189250549871538,0,1214,"sp|Q5UPS7|COLL4_MIMIV","Q5UPS7","COLL4",3.13e-12,"Collagen-like protein 4",NA,NA
"g153403",52.0122838115784,0.717409494592076,0.190997692058468,3.75611603920567,0.00017257070222876,0.0189733984026512,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33176",1920.62033446508,0.315530213526944,0.0840159868448823,3.75559730208852,0.000172928558577332,0.0189783620615882,3955,8552,"sp|P62282|RS11_RAT","P62282","RS11",2.08e-10,"40S ribosomal protein S11","osteoblast differentiation [GO:0001649]; translation [GO:0006412]","GO:0001649; GO:0003735; GO:0006412; GO:0016020; GO:0019843; GO:0022626; GO:0022627"
"g69696",366.935646550272,0.548277290151373,0.146074098012835,3.75341896756534,0.000174438938846567,0.0191095653404298,0,10980,"sp|O62742|SCP2_RABIT","O62742","SCP2",2.52e-23,"Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X)","bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; regulation of phospholipid biosynthetic process [GO:0071071]","GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032367; GO:0033814; GO:0050632; GO:0050633; GO:0071071; GO:0120019; GO:0120020"
"g3418",104.726538400642,1.25214619288365,0.333684551480973,3.75248475641535,0.000175090481618755,0.0191126994267827,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113123",81.3938024051767,0.763072985335127,0.203351924649795,3.7524748617416,0.000175097394649715,0.0191126994267827,0,2414,"sp|Q640T1|ALLC_XENTR","Q640T1","ALLC",4.1e-16,"Allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase)","allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144]","GO:0000256; GO:0004037; GO:0006144"
"g5498",72889.3091588588,0.305899404950434,0.0815376682325837,3.75163297628117,0.000175686528836586,0.0191425770827512,56627,94494,"sp|P13607|ATNA_DROME","P13607","ATNA",0,"Sodium/potassium-transporting ATPase subunit alpha (Na(+)/K(+) ATPase alpha subunit) (EC 7.2.2.13) (Sodium pump subunit alpha)","adult locomotory behavior [GO:0008344]; cation transport [GO:0006812]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; jump response [GO:0007630]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of tube diameter, open tracheal system [GO:0035158]; regulation of tube length, open tracheal system [GO:0035159]; response to mechanical stimulus [GO:0009612]; response to temperature stimulus [GO:0009266]; sensory perception of sound [GO:0007605]; septate junction assembly [GO:0019991]; sodium ion export across plasma membrane [GO:0036376]; synaptic assembly at neuromuscular junction [GO:0051124]; tissue homeostasis [GO:0001894]; trachea morphogenesis [GO:0060439]","GO:0001894; GO:0005391; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005890; GO:0005918; GO:0006812; GO:0006883; GO:0007268; GO:0007605; GO:0007626; GO:0007630; GO:0008340; GO:0008344; GO:0009266; GO:0009612; GO:0016323; GO:0016887; GO:0019991; GO:0030007; GO:0035158; GO:0035159; GO:0036376; GO:0045202; GO:0050905; GO:0051124; GO:0060439; GO:1902600; GO:1990573"
"g22734",250.294484154879,1.40876545646235,0.375597841784508,3.75072830495817,0.000176321676791448,0.0191773522660807,35513,44524,"sp|O45228|PROD_CAEEL","O45228","PROD",2.36e-07,"Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase)","proline catabolic process to glutamate [GO:0010133]","GO:0004657; GO:0005739; GO:0005759; GO:0010133; GO:0071949"
"g24983",836.306662398907,0.512228816666883,0.136602277174081,3.74978241405241,0.000176988072748122,0.0192153955904893,0,7334,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.45e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g5333",565.864636688661,0.259728727204416,0.0692926200475804,3.74828844725558,0.00017804542369393,0.0192956727928297,15196,16404,"sp|Q5TTG1|VATA_ANOGA","Q5TTG1","VATA",7.96e-115,"V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 7.1.2.2) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha)","proton transmembrane transport [GO:1902600]","GO:0005524; GO:0033180; GO:0046933; GO:0046961; GO:1902600"
"g4116",170.127926594774,-0.707560722032421,0.188875505491165,-3.74617513368094,0.000179551263024812,0.0193296420395674,0,14784,"sp|Q8MQJ9|BRAT_DROME","Q8MQJ9","BRAT",2.14e-109,"Brain tumor protein","asymmetric cell division [GO:0008356]; asymmetric neuroblast division resulting in ganglion mother cell formation [GO:0055060]; brain development [GO:0007420]; ganglion mother cell fate determination [GO:0007402]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of translation [GO:0017148]; neuroblast development [GO:0014019]; neuroblast differentiation [GO:0014016]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; oogenesis [GO:0048477]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of translation [GO:0006417]; rRNA transcription [GO:0009303]; segmentation [GO:0035282]; ventral cord development [GO:0007419]","GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007400; GO:0007402; GO:0007405; GO:0007406; GO:0007419; GO:0007420; GO:0008270; GO:0008285; GO:0008356; GO:0008582; GO:0009303; GO:0010629; GO:0014016; GO:0014019; GO:0017148; GO:0030182; GO:0030371; GO:0035282; GO:0043025; GO:0045179; GO:0045180; GO:0045182; GO:0048477; GO:0050767; GO:0055060; GO:0099738; GO:1900242; GO:1902692"
"g7284",1202.10353087892,0.480739794272292,0.128392150634129,3.74430829219635,0.00018089143243432,0.0193296420395674,0,10835,"sp|Q66X93|SND1_RAT","Q66X93","SND1",7.37e-18,"Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (SND p102) (p100 co-activator) (p105 coactivator)","gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; regulation of cell cycle process [GO:0010564]","GO:0003713; GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0010564; GO:0010587; GO:0016442; GO:0031047; GO:0042470; GO:0097433; GO:1905172"
"g10731",1465.65570515521,0.416872275763989,0.111352101829387,3.74373064284603,0.000181308017318735,0.0193296420395674,34875,57870,"sp|P21328|RTJK_DROME","P21328","RTJK",7.78e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g38063",53.0368347102732,-0.474123684880081,0.126670500683334,-3.74296842850059,0.000181859085850006,0.0193296420395674,15986,26149,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.15e-71,"PiggyBac transposable element-derived protein 4",NA,NA
"g42194",63.8416463395587,0.660861419498258,0.176469573033167,3.74490292087946,0.000180463542631372,0.0193296420395674,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45313",162.503926655983,0.713838499176893,0.190617946721225,3.74486511608935,0.0001804907182878,0.0193296420395674,56,6564,"sp|O18835|BGLR_CANLF","O18835","BGLR",1.2e-10,"Beta-glucuronidase (EC 3.2.1.31)","carbohydrate metabolic process [GO:0005975]","GO:0004566; GO:0005764; GO:0005975"
"g57008",200.300626612194,-0.348770692278987,0.0931880941061794,-3.74265291745954,0.000182087655685667,0.0193296420395674,2495,6278,"sp|Q8BVI5|STX16_MOUSE","Q8BVI5","STX16",5.14e-08,"Syntaxin-16","Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]","GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0016021; GO:0019905; GO:0030285; GO:0031201; GO:0031985; GO:0042147; GO:0043231; GO:0048278; GO:0048471; GO:0090161"
"g57552",617.07179780098,0.894408542301241,0.23898536072592,3.74252439389788,0.000182180841104507,0.0193296420395674,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73504",99.4675513648349,0.382343128380556,0.102037343220467,3.74709019573793,0.000178897772454217,0.0193296420395674,1582,5204,"sp|O00370|LORF2_HUMAN","O00370","LORF2",3.13e-06,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g85684",2680.35783928357,-0.368259528573361,0.0983194064919716,-3.74554263204824,0.000180004274546947,0.0193296420395674,1745,8145,"sp|P48613|TIPE_DROME","P48613","TIPE",2.29e-16,"Protein tipE (Temperature-induced paralytic E)","cellular response to heat [GO:0034605]; male courtship behavior, veined wing generated song production [GO:0045433]; regulation of sodium ion transport [GO:0002028]; sodium ion transport [GO:0006814]","GO:0002028; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0017080; GO:0034605; GO:0045433"
"g95442",284.72560835292,0.31200726527399,0.08333440521457,3.74403902530571,0.000181085508237048,0.0193296420395674,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124562",22.8265390845758,2.36042535970461,0.63024816193275,3.74523164409716,0.000180227404810128,0.0193296420395674,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40784",75.0872082781606,-0.488525343116624,0.13059574917205,-3.74074459707741,0.00018347589265956,0.0194330749136277,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18709",49.5921164802874,1.99687222088468,0.534001742346061,3.73944888664915,0.000184424141950324,0.0194927495777211,8493,11194,"sp|Q8IW92|GLBL2_HUMAN","Q8IW92","GLBL2",1.72e-07,"Beta-galactosidase-1-like protein 2 (EC 3.2.1.-)","carbohydrate metabolic process [GO:0005975]","GO:0004565; GO:0005576; GO:0005773; GO:0005975"
"g28589",53.3171254068962,-0.552993728808927,0.147946726588456,-3.73778955141869,0.000185645234073535,0.0194927495777211,0,4650,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.52e-27,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g73030",75.2768369990089,1.46817811179945,0.392758684313252,3.73811750175962,0.000185403296943704,0.0194927495777211,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91021",678.37701656345,0.288049849943963,0.0770464531529649,3.73865165956544,0.000185009869857182,0.0194927495777211,0,7562,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.79e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g111757",43.4230333406941,1.53958441088449,0.411876122059429,3.73797928169856,0.000185505229166256,0.0194927495777211,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g782",22.7886164020425,-0.918005799695178,0.245679594127081,-3.73659767290371,0.000186527014056017,0.0194991519338613,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7179",16176.3218161559,0.317343090897178,0.0849772483652434,3.73444771397158,0.00018812756876982,0.0194991519338613,1455,18689,"sp|P82013|VDAC2_MELGA","P82013","VDAC2",7.11e-36,"Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin 2)",NA,"GO:0000166; GO:0005741; GO:0008308; GO:0015288; GO:0046930"
"g32412",69.5586253194643,2.07977855099249,0.556791075885868,3.73529433402558,0.000187495760772916,0.0194991519338613,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46846",22.6517303607494,-0.693778999009871,0.185703712804579,-3.73594576291511,0.000187010976582403,0.0194991519338613,0,14444,"sp|P21328|RTJK_DROME","P21328","RTJK",1.54e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g63142",202.51073419838,1.42125697260847,0.380651614579546,3.73374739045396,0.000188651711651661,0.0194991519338613,1399,8094,"sp|Q9CPP7|LIPG_MOUSE","Q9CPP7","LIPG",3.19e-13,"Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3)","lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]","GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0016042; GO:0016615; GO:0043231"
"g84518",21.6898653181079,-1.25056293298552,0.334785303209433,-3.73541765721778,0.000187403894844376,0.0194991519338613,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89184",347.290652207896,2.43933848167451,0.653457999569983,3.73296904051943,0.000189235862166625,0.0194991519338613,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g111967",532.56050359764,0.23373944740512,0.0626149919146357,3.7329629894991,0.000189240410101241,0.0194991519338613,2080,5014,"sp|Q32PI5|2AAA_BOVIN","Q32PI5","2AAA",3.41e-10,"Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)","chromosome segregation [GO:0007059]; protein-containing complex assembly [GO:0065003]","GO:0000775; GO:0005634; GO:0005737; GO:0007059; GO:0016328; GO:0019888; GO:0030425; GO:0065003"
"g116942",25.2531031770439,-0.947801605764307,0.253697403924014,-3.7359531122683,0.000187005514024641,0.0194991519338613,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131223",1066.77454939501,0.5534650497216,0.148217085943977,3.73415147246113,0.000188349117437293,0.0194991519338613,0,1034,"sp|P38377|S61A1_CANLF","P38377","S61A1",3.26e-26,"Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)","cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein insertion into ER membrane [GO:0045048]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0005048; GO:0005784; GO:0005789; GO:0006613; GO:0006616; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047; GO:0045048"
"g137244",36.6326471510472,2.73524766619629,0.732455140843192,3.73435520303334,0.000188196728149614,0.0194991519338613,0,3057,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.1e-10,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g113678",221.693271401837,0.345024967271384,0.092487436640445,3.73050632393139,0.000191095346432853,0.0196569094491692,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64976",253.685507361741,0.475313321883146,0.127431152249539,3.72996173614107,0.000191508851714316,0.0196661120313737,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87119",235.674992277648,-0.774031184832912,0.207555430448756,-3.72927455166737,0.000192031830660573,0.0196865064236321,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23737",394.342533915154,-0.373955815655372,0.100332873234688,-3.72715146690412,0.00019365608742565,0.0198195412240517,2324,21644,"sp|Q9UQ26|RIMS2_HUMAN","Q9UQ26","RIMS2",1.3e-17,"Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 3)","adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium-ion regulated exocytosis [GO:0017156]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; spontaneous neurotransmitter secretion [GO:0061669]","GO:0006886; GO:0007188; GO:0017156; GO:0017157; GO:0030073; GO:0030154; GO:0031267; GO:0042391; GO:0042734; GO:0042995; GO:0044325; GO:0046872; GO:0048167; GO:0048786; GO:0048788; GO:0048791; GO:0050806; GO:0061669; GO:0070062; GO:0097151; GO:1903861; GO:2000463"
"g37758",26.1456717191257,1.83980513796924,0.493886339943846,3.725158987346,0.0001951921610122,0.0198965343227811,25127,26435,"sp|O18345|AMY2_DROAN","O18345","AMY2",7.4e-08,"Alpha-amylase 2 (EC 3.2.1.1)","carbohydrate metabolic process [GO:0005975]","GO:0004556; GO:0005975; GO:0046872"
"g48146",860.844289064497,2.31610446761716,0.621789539648767,3.72490098325788,0.000195391900747694,0.0198965343227811,15250,18064,"sp|P55115|NAS15_CAEEL","P55115","NAS15",1.27e-13,"Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)",NA,"GO:0004222; GO:0005576; GO:0008270"
"g99169",83.8693531337369,-0.49965462280214,0.134132583755521,-3.72508013200465,0.000195253188300572,0.0198965343227811,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15756",45.079150699866,-0.447257673656386,0.120190671725778,-3.72123449544263,0.000198251234487776,0.019986490732663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41714",548.751178504148,-0.773848517152201,0.207864494544219,-3.72285088345177,0.00019698587220525,0.019986490732663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70052",307.561259851328,0.438939795310112,0.117938032619057,3.72178325822932,0.000197820790935915,0.019986490732663,425,10902,"sp|Q91VD9|NDUS1_MOUSE","Q91VD9","NDUS1",1.04e-52,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g86709",81.2710759043206,0.577546925432036,0.155170657717193,3.7220111967602,0.000197642256685958,0.019986490732663,1601,8131,"sp|Q9NZK5|ADA2_HUMAN","Q9NZK5","ADA2",1.83e-07,"Adenosine deaminase 2 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1)","adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]","GO:0004000; GO:0005576; GO:0005615; GO:0006154; GO:0008083; GO:0008201; GO:0008270; GO:0031685; GO:0035578; GO:0042803; GO:0043394; GO:0046103"
"g99007",60.8621346818399,0.93457257460413,0.251051172504048,3.72263776059067,0.00019715227646361,0.019986490732663,0,6618,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.06e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g105377",632.789671141449,2.74343441091458,0.737173481386016,3.72155873778373,0.000197996796079466,0.019986490732663,0,5915,"sp|Q8S8Q4|GUN14_ARATH","Q8S8Q4","GUN14",4.56e-10,"Endoglucanase 14 (EC 3.2.1.4) (Endo-1,4-beta glucanase 14)","cellulose catabolic process [GO:0030245]; cell wall organization [GO:0071555]","GO:0005576; GO:0008810; GO:0030245; GO:0071555"
"g97015",90.0050865422764,0.76008185151079,0.204283157385118,3.72072696173317,0.000198650121581708,0.0199934923363082,156,6838,"sp|P31335|PUR9_CHICK","P31335","PUR9",1.28e-21,"Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (IMP synthase) (Inosinicase)]","'de novo' IMP biosynthetic process [GO:0006189]","GO:0003937; GO:0004643; GO:0005829; GO:0006189; GO:0042803"
"g19281",1861.30517435221,0.796487546741993,0.214102012001083,3.72013106881949,0.000199119415406019,0.0200075452334293,6098,10686,"sp|Q9CY50|SSRA_MOUSE","Q9CY50","SSRA",1.17e-26,"Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha)",NA,"GO:0005783; GO:0005789; GO:0016021"
"g82313",32.2293567424404,0.72011833298602,0.193617387731217,3.71928544963999,0.00019978716861506,0.0200414599392528,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90287",64.8939800931131,1.5976415705182,0.4296505510145,3.71846740739845,0.000200435146983702,0.0200732822944569,0,7655,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.74e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g10775",1305.76146579557,-0.624482027389477,0.168065877187718,-3.71569790274545,0.000202643583416531,0.0201466218120537,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27721",1363.98737252661,0.479799410268775,0.12910413848303,3.71637513643176,0.000202101447436198,0.0201466218120537,35909,38234,"sp|Q9TZH6|PHS_CAEEL","Q9TZH6","PHS",7.37e-21,"Putative pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Pterin carbinolamine dehydratase) (PCD)","tetrahydrobiopterin biosynthetic process [GO:0006729]","GO:0006729; GO:0008124"
"g48123",280.912198082073,0.254705496461564,0.0685337058549003,3.71649968850111,0.000202001890045342,0.0201466218120537,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75461",57.5760713791092,0.758303494373602,0.204075857375957,3.7157922751079,0.000202567955051792,0.0201466218120537,4485,8448,"sp|Q16851|UGPA_HUMAN","Q16851","UGPA",2.89e-14,"UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase)","brain development [GO:0007420]; glucose 1-phosphate metabolic process [GO:0019255]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011]","GO:0003983; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0005977; GO:0005978; GO:0006011; GO:0007420; GO:0019255; GO:0032557; GO:0042802; GO:0046872; GO:0070062"
"g100360",31.3187115361261,1.6241995168296,0.437145238485777,3.71546885070885,0.000202827252054125,0.0201466218120537,0,6458,"sp|O75093|SLIT1_HUMAN","O75093","SLIT1",5.08e-07,"Slit homolog 1 protein (Slit-1) (Multiple epidermal growth factor-like domains protein 4) (Multiple EGF-like domains protein 4)","axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]","GO:0005509; GO:0005615; GO:0007097; GO:0007411; GO:0008045; GO:0008201; GO:0021510; GO:0022028; GO:0031290; GO:0033563; GO:0043395; GO:0048495; GO:0048843; GO:0048846; GO:0048853; GO:0050919; GO:0051964"
"g85988",2628.00440233575,0.286465687248605,0.0771202016849857,3.7145349855118,0.000203577704934579,0.0201881224060124,1975,4788,"sp|Q567C6|ZN367_DANRE","Q567C6","ZN367",5.46e-20,"Zinc finger protein 367","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872"
"g89205",229.491626940942,0.282797009434096,0.0761459490338751,3.71388121130762,0.000204104628390656,0.0202073570914011,1615,7714,"sp|E1C231|LTN1_CHICK","E1C231","LTN1",1.27e-09,"E3 ubiquitin-protein ligase listerin (EC 2.3.2.27) (RING finger protein 160) (Zfp-294) (RING-type E3 ubiquitin transferase listerin)","rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]","GO:0005829; GO:0008270; GO:0043023; GO:0061630; GO:0072344; GO:1990112; GO:1990116"
"g41689",3154.41061915486,-0.331408923034052,0.08927447802854,-3.71224710972944,0.00020542727637884,0.0202721648836289,3139,22741,"sp|P21328|RTJK_DROME","P21328","RTJK",6.48e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g70142",81.1698035769516,0.54260164800223,0.146155958486836,3.71248393578905,0.000205235090885864,0.0202721648836289,0,3400,"sp|P51570|GALK1_HUMAN","P51570","GALK1",3.5e-11,"Galactokinase (EC 2.7.1.6) (Galactose kinase)","galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]","GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0016020; GO:0019388; GO:0019402; GO:0061623; GO:0070062"
"g1940",501.397765511988,0.309151009616316,0.0833173386489581,3.71052429937622,0.000206830441472207,0.0203699709890009,128075,133860,"sp|Q24562|U2AF2_DROME","Q24562","U2AF2",5.94e-20,"Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit)","mRNA splicing, via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]","GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701"
"g50670",248.5329613188,0.319062298099383,0.0859958162048943,3.71020721914172,0.000207089670459936,0.0203699709890009,12200,17004,"sp|Q9U516|ASTER_MANSE","Q9U516","ASTER",2.14e-10,"Protein Asterix","protein insertion into ER membrane [GO:0045048]","GO:0030176; GO:0044183; GO:0045048"
"g50117",1752.20285043471,-0.337823442915182,0.0911119632931214,-3.70778359619309,0.000209081208228433,0.0205325866138894,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4941",290.502409709903,-0.473441140654469,0.127777006952808,-3.70521388741971,0.000211212426009093,0.0205635841295086,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10917",908.151715054475,-0.445973819284426,0.120372324475652,-3.70495312130186,0.000211429831880266,0.0205635841295086,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85683",162.798536959914,-0.60526688030763,0.163338416175178,-3.70560027751518,0.000210890670923849,0.0205635841295086,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100286",168.750680175702,0.377822329698845,0.101932166766555,3.70660549740039,0.000210055758578155,0.0205635841295086,0,1904,"sp|Q8R2N1|AQP3_MOUSE","Q8R2N1","AQP3",3.34e-11,"Aquaporin-3 (AQP-3) (Aquaglyceroporin-3)","cellular response to hypoxia [GO:0071456]; cellular response to oxygen-glucose deprivation [GO:0090650]; glycerol transport [GO:0015793]; odontogenesis [GO:0042476]; positive regulation of immune system process [GO:0002684]; renal water absorption [GO:0070295]; response to retinoic acid [GO:0032526]; urea transport [GO:0015840]; water transport [GO:0006833]","GO:0002684; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0006833; GO:0015166; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0015840; GO:0016323; GO:0032526; GO:0042476; GO:0042802; GO:0070295; GO:0071456; GO:0090650"
"g131232",597.721270477634,2.99741628856091,0.808818131887592,3.70592123295461,0.000210623754687143,0.0205635841295086,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142014",3410.75402346725,0.417715051032871,0.112697363885379,3.70652015833944,0.000210126518460449,0.0205635841295086,0,2684,"sp|P35979|RL12_MOUSE","P35979","RL12",1.78e-13,"60S ribosomal protein L12","cytoplasmic translation [GO:0002181]; translation [GO:0006412]","GO:0002181; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0014069; GO:0015934; GO:0022625; GO:0022626; GO:0070180"
"g28038",2501.00855906078,0.24799317932059,0.0669494740324137,3.70418413146194,0.000212072178229759,0.0205930567948225,0,3470,"sp|P31410|VATB_HELVI","P31410","VATB",4.19e-85,"V-type proton ATPase subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B)","ATP metabolic process [GO:0046034]","GO:0005524; GO:0016787; GO:0033180; GO:0046034; GO:0046961"
"g60598",634.014106349067,0.52130532544056,0.140832615307523,3.70159514756036,0.000214248284397179,0.0207711315975476,6565,11007,"sp|Q54TH8|TCPG_DICDI","Q54TH8","TCPG",2.59e-12,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0005856; GO:0006457; GO:0016887; GO:0045335; GO:0051082"
"g98919",83.8651866237696,2.34042847914706,0.632394877649393,3.70089727457378,0.000214838441953059,0.0207951276589014,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34741",468.679028501229,-0.49979859481763,0.135087943821261,-3.69980163055061,0.000215768055672139,0.0208187015878253,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69950",446.457044715612,0.653254993924709,0.176556738185236,3.69997203527481,0.000215623225910983,0.0208187015878253,0,3160,"sp|Q3T0R7|THIM_BOVIN","Q3T0R7","THIM",2.55e-17,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-) (EC 3.1.2.1) (EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)","fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]","GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0006635; GO:0016290; GO:0047617; GO:0102991; GO:1901029"
"g96285",812.743981488419,0.257947294483085,0.0697351720276306,3.69895544791774,0.000216488594086976,0.0208220170762893,0,2323,"sp|Q8MQI6|ELOF1_DROME","Q8MQI6","ELOF1",1.96e-15,"Transcription elongation factor 1 homolog","transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0000993; GO:0006368; GO:0008023; GO:0046872"
"g138627",91.2691438421518,0.643073884041316,0.173851728974018,3.69897893933181,0.000216468560308499,0.0208220170762893,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g313",11288.6926416692,-0.434880727899097,0.117830150924116,-3.69074234810379,0.000223600538726011,0.020978436944082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3883",2743.14242597482,-0.376435441742112,0.101962280492886,-3.69190881100758,0.000222577273838346,0.020978436944082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14626",799.096927498412,-0.320464674262641,0.0867707608193006,-3.69323342606164,0.000221420602887317,0.020978436944082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17345",602.568956341148,0.775718012397749,0.210069094564339,3.69268032504498,0.000221902889948887,0.020978436944082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28697",696.644937828642,0.445598074049223,0.120722620785685,3.69109012999542,0.000223294990329572,0.020978436944082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28958",93.3314597426012,-0.397612819628229,0.10762548703524,-3.69441133862685,0.000220396776856331,0.020978436944082,28715,33252,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.12e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g34302",112.713571457807,-0.481825156597133,0.13050043228556,-3.6921345635301,0.000222379743684633,0.020978436944082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45411",678.156492353779,0.569462810245202,0.154224636071684,3.6924244060496,0.000222126376993125,0.020978436944082,16400,20038,"sp|Q21217|GABT_CAEEL","Q21217","GABT",3.96e-20,"Probable 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (L-AIBAT)","gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]","GO:0003867; GO:0005739; GO:0005759; GO:0009450; GO:0030170; GO:0034386; GO:0042135; GO:0047298"
"g61199",603.621027286281,0.491148268205212,0.132972018205187,3.69362122072427,0.000221083044907212,0.020978436944082,0,13063,"sp|Q4R963|TCPG_MACFA","Q4R963","TCPG",2.93e-34,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","protein folding [GO:0006457]","GO:0005524; GO:0005832; GO:0006457; GO:0016887; GO:0051082"
"g74862",41.7317646903473,1.52399521133377,0.412911097051747,3.6908555430342,0.000223501046761207,0.020978436944082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88006",405.307477077483,0.966721843484431,0.261739948197869,3.69344400860664,0.000221237240175458,0.020978436944082,1809,7804,"sp|P30039|PBLD_HUMAN","P30039","PBLD",7.36e-15,"Phenazine biosynthesis-like domain-containing protein (EC 5.1.-.-) (MAWD-binding protein) (MAWDBP) (Unknown protein 32 from 2D-page of liver tissue)","biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]","GO:0005737; GO:0009058; GO:0016853; GO:0030277; GO:0030512; GO:0042802; GO:0060392; GO:0070062"
"g94486",49.7575023123939,-0.480813076006661,0.13008303786636,-3.69620116421804,0.000218849587990037,0.020978436944082,0,4228,"sp|Q9P255|ZN492_HUMAN","Q9P255","ZN492",9.92e-53,"Zinc finger protein 492 (Zinc finger protein 115)","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g102578",262.389110250846,-0.702347395670765,0.190199790214771,-3.69268228360128,0.000221901180409547,0.020978436944082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116616",43.4513278184262,0.550323497003405,0.149111230107011,3.69069114786634,0.00022364555450356,0.020978436944082,1864,4806,"sp|P0C6T1|CTF8_RAT","P0C6T1","CTF8",1.95e-12,"Chromosome transmission fidelity protein 8 homolog","DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]","GO:0003677; GO:0005634; GO:0006260; GO:0007064; GO:0031390; GO:0032508; GO:1900264"
"g122595",32.7155288663843,-0.995169894798977,0.269421234505861,-3.69373222056604,0.00022098651345834,0.020978436944082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147236",53.691464144175,1.31846667009383,0.357130237950115,3.69183712267456,0.000222640034529617,0.020978436944082,0,1489,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.38e-16,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g35076",1384.53521389077,0.552591464012104,0.149770037163973,3.6895995652796,0.00022460731168926,0.0210361384975635,0,22254,"sp|P80147|GABT_PIG","P80147","GABT",1.12e-23,"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)","behavioral response to cocaine [GO:0048148]; gamma-aminobutyric acid catabolic process [GO:0009450]; neurotransmitter catabolic process [GO:0042135]","GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042135; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0048148; GO:0051537"
"g50521",218.00451339996,2.49682625114505,0.676896053589515,3.68864057916222,0.000225455444766789,0.0210830368919822,0,17117,"sp|Q05487|ESTS_DROVI","Q05487","ESTS",1.86e-06,"Esterase S (Est-S) (EC 3.1.1.1) (Carboxylic-ester hydrolase S) (Carboxylesterase-S)",NA,"GO:0005576; GO:0080030"
"g15413",160.554815986654,-0.36849756688338,0.0999231224126747,-3.68781076877796,0.000226191759164896,0.0210896815356661,47084,51764,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.27e-20,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g89230",24.8714470666029,1.83501351560037,0.497632800466689,3.68748505701284,0.000226481388876767,0.0210896815356661,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110840",30.6080986387996,1.49043887518649,0.404199242347692,3.68738661292298,0.000226568995901373,0.0210896815356661,0,5355,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.17e-19,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g35214",205.553386810703,0.407362975504935,0.110500131633083,3.68653837316312,0.000227325177398439,0.0211242171277911,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140395",43.4916204178979,0.988384002221608,0.268131571945672,3.68619030966586,0.000227636150956919,0.0211242171277911,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42134",411.055145928104,-0.634221845588657,0.172101027851539,-3.68517174770021,0.000228548469511741,0.0211764986483474,0,14130,"sp|Q66KB0|UBE2Z_XENTR","Q66KB0","UBE2Z",1.03e-30,"Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z)","apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]","GO:0004869; GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0043066; GO:0061631"
"g114788",22.3617195253975,2.78453688564741,0.755839332003923,3.68403279340451,0.000229572686305622,0.0212066458628435,1445,4748,"sp|Q9V774|C6A21_DROME","Q9V774","C6A21",7.41e-30,"Probable cytochrome P450 6a21 (EC 1.14.-.-) (CYPVIA21)",NA,"GO:0004497; GO:0005506; GO:0005789; GO:0016705; GO:0020037"
"g122495",973.988737292293,0.56081473513257,0.152227159040392,3.68406491106994,0.000229543745222187,0.0212066458628435,455,4140,"sp|O88989|MDHC_RAT","O88989","MDHC",2.06e-21,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase)","malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; NAD metabolic process [GO:0019674]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0016615; GO:0019674; GO:0030060; GO:0051287"
"g571",4509.22195287225,0.311106484135327,0.0845614136143109,3.67905964243101,0.000234095522273685,0.0215915763629027,107645,124308,"sp|P81021|VIGLN_CHICK","P81021","VIGLN",3.62e-14,"Vigilin",NA,"GO:0003729; GO:0005634; GO:0005737; GO:0005844"
"g111412",1317.41554426161,2.41413158414834,0.656285369359164,3.67847844376851,0.00023462951696466,0.0216079899614343,0,4944,"sp|Q95029|CATL_DROME","Q95029","CATL",2.01e-24,"Cathepsin L (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain]","digestion [GO:0007586]; immune response [GO:0006955]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0007586; GO:0008233; GO:0008234; GO:0045169; GO:0051603"
"g98071",463.766694761765,0.426658252114236,0.116020325613809,3.67744401558079,0.000235582759300594,0.0216629055484137,2707,6718,"sp|Q9YHT1|SDHA_CHICK","Q9YHT1","SDHA",4.81e-32,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp)","mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]","GO:0000104; GO:0005743; GO:0005749; GO:0006099; GO:0006105; GO:0006121; GO:0008177; GO:0009055; GO:0022904; GO:0050660"
"g34419",409.890255380315,0.396490594693524,0.107846766290536,3.67642543519004,0.000236524947595729,0.021683835452545,0,28565,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.62e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g57575",57.9830756070488,0.92447056325173,0.251443504954519,3.67665318465453,0.000236313972628122,0.021683835452545,889,11704,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.42e-52,"PiggyBac transposable element-derived protein 4",NA,NA
"g311",61.8178454289428,-0.697046534319985,0.189675134231946,-3.67494947159281,0.000237896491437491,0.0217438826285261,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82311",502.72134978272,0.46469458702976,0.126449111682514,3.67495335353962,0.000237892874358585,0.0217438826285261,5855,8766,"sp|P80317|TCPZ_MOUSE","P80317","TCPZ",3.39e-15,"T-complex protein 1 subunit zeta (TCP-1-zeta) (CCT-zeta-1)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0001669; GO:0002199; GO:0005524; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:0071987; GO:1901998; GO:1904851"
"g92451",48.7266461215634,0.491058544504891,0.13365183273075,3.67416244485147,0.000238630885482497,0.02177820818035,4856,7105,"sp|P57740|NU107_HUMAN","P57740","NU107",3.82e-10,"Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107)","female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]","GO:0000776; GO:0000973; GO:0005635; GO:0005643; GO:0005829; GO:0006355; GO:0006406; GO:0006606; GO:0006913; GO:0008585; GO:0016020; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0051292; GO:0072006"
"g20451",2282.18499194956,-0.620377218744268,0.16888909139738,-3.67328175911954,0.00023945519668679,0.0218206244548367,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19117",108.094265745672,-0.459948926497253,0.125232576562742,-3.67275783283767,0.000239946851980965,0.0218280909507496,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g156625",27.3012199106344,-0.922015497239922,0.251064253071483,-3.67242841607326,0.000240256463257551,0.0218280909507496,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121506",109.620953830492,-0.488570276617413,0.133070435271945,-3.67151633357901,0.000241115665418225,0.0218734076744874,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15116",142.343074677894,1.03081660054631,0.280833547141554,3.67056076825013,0.000242018920966537,0.021922579572327,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4295",30.1155248079123,0.814020966466215,0.221842796906054,3.66935946453531,0.000243158966774695,0.0219602941868396,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28285",289.969700994289,0.276984894620115,0.0754801031671488,3.66964117691703,0.000242891168419013,0.0219602941868396,13745,32303,"sp|Q95TS5|INT9_DROME","Q95TS5","INT9",2.77e-18,"Integrator complex subunit 9","snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]","GO:0005634; GO:0016180; GO:0032039; GO:0034472"
"g11801",989.508938075336,0.378715032417804,0.103245101509987,3.66811622904132,0.000244344109588445,0.0220345379062744,42670,60244,"sp|P84104|SRSF3_MOUSE","P84104","SRSF3",2.45e-06,"Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Protein X16) (Splicing factor, arginine/serine-rich 3)","cellular response to leukemia inhibitory factor [GO:1990830]; insulin receptor signaling pathway [GO:0008286]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]","GO:0000398; GO:0003723; GO:0005634; GO:0005737; GO:0006406; GO:0008286; GO:0008380; GO:0016607; GO:0043274; GO:0048024; GO:1990825; GO:1990830"
"g65173",294.354204845834,1.02271253293218,0.278866305610881,3.66739370212489,0.00024503536240492,0.0220640892349475,3634,8384,"sp|Q6ZQX7|LIAT1_HUMAN","Q6ZQX7","LIAT1",1.61e-09,"Protein LIAT1 (Ligand of ATE1 protein)","protein arginylation [GO:0016598]","GO:0016598"
"g78298",157.430913239595,-1.2202246226323,0.332969398611662,-3.66467497529836,0.000247652883082459,0.022266745887814,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8261",909.391721404955,0.721661086152398,0.196946611997292,3.66424727409031,0.000248067042594176,0.0222671224363407,6445,16804,"sp|Q24319|OST48_DROME","Q24319","OST48",1.99e-14,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit) (DmOST50) (DrOST) (OST5OP)","protein N-linked glycosylation via asparagine [GO:0018279]","GO:0008250; GO:0012505; GO:0016021; GO:0018279"
"g95735",150.102997088539,-0.499898261455215,0.136438342587197,-3.66391332506646,0.000248390869820442,0.0222671224363407,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108699",274.923074295232,0.417886175116949,0.11409150981854,3.66272806610753,0.000249543408060508,0.0223374475445313,0,5575,"sp|P00765|TRYP_ASTAS","P00765","TRYP",4.75e-10,"Trypsin-1 (EC 3.4.21.4) (Trypsin I)","digestion [GO:0007586]","GO:0004252; GO:0005615; GO:0007586; GO:0046872"
"g27858",106.943644671748,3.09378108880401,0.844757288543115,3.66233133559535,0.000249930305383476,0.0223391314193272,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5108",126.885146706163,-0.371077568887842,0.1014287876556,-3.65850344330082,0.000253692333108373,0.0224113358025432,43095,53844,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.01e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g52791",39.4327104856251,-0.639118942072098,0.174688290848093,-3.65862496546988,0.000253572090117091,0.0224113358025432,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53974",12817.4072691161,-0.479164732634801,0.130884330621044,-3.66097859355029,0.000251253752797705,0.0224113358025432,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67045",510.16814352979,0.692159609931822,0.189095667389259,3.66036736583176,0.000251853897247008,0.0224113358025432,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70521",53.5574338567209,-0.403727437142864,0.110351936065652,-3.65854421351223,0.000253651986096855,0.0224113358025432,0,1627,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.55e-06,"PiggyBac transposable element-derived protein 4",NA,NA
"g74991",4367.71226167938,0.542055230049208,0.148143741977539,3.65898162698895,0.000253219491475327,0.0224113358025432,0,654,"sp|P52174|NDKA1_BOVIN","P52174","NDKA1",3.6e-15,"Nucleoside diphosphate kinase A 1 (NDK A 1) (NDP kinase A 1) (EC 2.7.4.6) (Nucleoside diphosphate kinase NBR-A) (NDK NBR-A)","cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; nervous system development [GO:0007399]; UTP biosynthetic process [GO:0006228]","GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006183; GO:0006228; GO:0006241; GO:0006897; GO:0007399; GO:0030154; GO:0046872"
"g83623",154.868761952917,2.73071079449315,0.746169711515096,3.65963768342788,0.000252572108921939,0.0224113358025432,2180,8566,"sp|Q04519|ASM_MOUSE","Q04519","ASM",1.08e-12,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g98203",69.5822792871028,1.23602727986132,0.337738173802922,3.65972038619055,0.000252490609851187,0.0224113358025432,0,4671,"sp|Q8BX37|ACP7_MOUSE","Q8BX37","ACP7",2.55e-08,"Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form)",NA,"GO:0003993; GO:0005576; GO:0046872"
"g20915",365.023646963581,-0.429711173441449,0.117501733032008,-3.65706243093787,0.000255122259382349,0.022504898142318,0,49280,"sp|Q8K4P8|HECW1_MOUSE","Q8K4P8","HECW1",4.93e-66,"E3 ubiquitin-protein ligase HECW1 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECW1) (NEDD4-like E3 ubiquitin-protein ligase 1) (mNEDL1)","negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]","GO:0000209; GO:0005737; GO:0005829; GO:0016567; GO:0043161; GO:0045732; GO:0048814; GO:0061630; GO:2000650"
"g85079",105.769068762502,0.400787368589112,0.109609458163739,3.65650351076821,0.000255678911173101,0.0225212672265537,0,6785,"sp|P21328|RTJK_DROME","P21328","RTJK",4.85e-31,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g28644",102.569030012963,-0.609679289469852,0.166772940732628,-3.65574467171683,0.00025643649351918,0.0225552620169262,6188,17364,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.96e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g45629",44.5543141382089,1.31576757451454,0.360148213823442,3.6534058035328,0.000258784751548583,0.0226852597277507,0,19867,"sp|P21328|RTJK_DROME","P21328","RTJK",1.57e-11,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g58981",156.604377896696,0.356458332507471,0.0975754237347376,3.65315690021,0.000259035837721721,0.0226852597277507,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69921",126.407098857404,0.994380266536892,0.272190498852469,3.65325119991003,0.00025894068416018,0.0226852597277507,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20349",340.156056420665,-0.436374151656409,0.119488155975784,-3.65202850519215,0.000260176996410705,0.0227186045402269,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132828",211.898956665622,0.389371398991389,0.106623616647622,3.65183072225185,0.000260377501406458,0.0227186045402269,0,2878,"sp|Q6ZW76|ANKS3_HUMAN","Q6ZW76","ANKS3",1.6e-09,"Ankyrin repeat and SAM domain-containing protein 3",NA,"GO:0005737; GO:0005929"
"g157688",53.8607386369585,1.4758386055965,0.404154327508003,3.65167092159188,0.000260539607184016,0.0227186045402269,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1566",44.8170650909861,-0.509415914835414,0.13954931015339,-3.65043663974743,0.000261794885298034,0.0227953107442435,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38662",93.1791473864057,0.337701915413839,0.0925380430578744,3.64933063478159,0.000262924519273314,0.022860872599853,16354,24624,"sp|P10394|POL4_DROME","P10394","POL4",2.03e-39,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g1344",58.2042845841162,-0.754067292227818,0.206838287834251,-3.64568523614974,0.000266680236952167,0.0231211765437529,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54638",50.5717228967093,0.720029789207552,0.197489189560561,3.64592001622828,0.00026643684459008,0.0231211765437529,12851,15024,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.03e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g86473",404.345678192101,2.68298563622703,0.736882673498506,3.64099433019504,0.000271587118037047,0.0235130131150762,0,8160,"sp|P28622|GUN4_BACS5","P28622","GUN4",1.59e-10,"Endoglucanase 4 (EC 3.2.1.4) (Cellulase 4) (EG-IV) (Endo-1,4-beta-glucanase 4)","cellulose catabolic process [GO:0030245]","GO:0005576; GO:0008810; GO:0030245; GO:0030248"
"g92129",238.529842333736,-0.321405592180012,0.0883226770343872,-3.63899287218023,0.000273706374251598,0.0236627348338026,0,7363,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.19e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g10117",249.416346564579,0.525286757900853,0.144422513639089,3.63715285563816,0.000275668352221472,0.0237118028739071,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25873",146.916768055866,-0.320247962693375,0.0880528896673219,-3.63699549104321,0.000275836757768634,0.0237118028739071,0,41218,"sp|P21329|RTJK_DROFU","P21329","RTJK",6.02e-30,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g106122",50.7425132954691,-0.727583782484493,0.200025780922681,-3.63745002833278,0.000275350592178983,0.0237118028739071,0,5393,"sp|Q62101|KPCD1_MOUSE","Q62101","KPCD1",7.82e-29,"Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)","angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; nervous system development [GO:0007399]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","GO:0000421; GO:0001525; GO:0001938; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006468; GO:0006915; GO:0006954; GO:0007030; GO:0007265; GO:0007399; GO:0010508; GO:0010595; GO:0010837; GO:0010976; GO:0016301; GO:0018105; GO:0018107; GO:0030154; GO:0031647; GO:0032793; GO:0033138; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0038033; GO:0042307; GO:0042802; GO:0043123; GO:0043536; GO:0045087; GO:0045669; GO:0045766; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0048193; GO:0050829; GO:0051092; GO:0051279; GO:0060548; GO:0071447; GO:0089700; GO:0106310; GO:1901727; GO:2001028"
"g111336",556.161228993525,0.686123527003385,0.188632672115261,3.63735252917447,0.000275454807968116,0.0237118028739071,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128201",27.8091990509242,-1.40785587692245,0.387216703320847,-3.63583457234257,0.000277082110921195,0.0237551270254249,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143303",75.0311234711109,1.35265733294012,0.37203884170692,3.63579600112211,0.000277123577755822,0.0237551270254249,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49495",32.1432212001451,0.441736487085596,0.121517263072073,3.6351747555703,0.000277792263073317,0.0237788609956553,0,6926,"sp|P08548|LIN1_NYCCO","P08548","LIN1",4.07e-25,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g11337",149.59535139797,-0.473275812001007,0.130239505758517,-3.63388826796172,0.000279181800401249,0.0237971116100446,15568,18984,"sp|Q9VSH9|PHAF1_DROME","Q9VSH9","PHAF1",4.24e-13,"PHAF1 protein CG7083","Golgi to plasma membrane protein transport [GO:0043001]","GO:0000407; GO:0005802; GO:0043001"
"g11411",44.6344434926789,1.69373906608975,0.466029789670245,3.63440085512174,0.000278627375436107,0.0237971116100446,36336,38204,"sp|P44836|HGP3_HAEIN","P44836","HGP3",2.84e-07,"Probable hemoglobin and hemoglobin-haptoglobin-binding protein 3","siderophore transmembrane transport [GO:0044718]","GO:0015344; GO:0016021; GO:0031230; GO:0044718"
"g151869",27.4730816833161,-0.803123469093914,0.221001839903747,-3.6340125921291,0.000279047233904344,0.0237971116100446,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101291",2010.53889626684,0.38449219732761,0.10582818498124,3.63317387892241,0.000279956223096115,0.0238296538284758,382,4391,"sp|Q9NB32|TCPD_OCHTR","Q9NB32","TCPD",1.62e-19,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","protein folding [GO:0006457]","GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g27607",695.93196634872,-0.268074743988922,0.0738096290705205,-3.63197522280993,0.000281260132187128,0.0238736747166948,10892,38204,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",8.7e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g30501",321.705933761608,-0.47423118577075,0.130571131665721,-3.63197576463413,0.000281259541502342,0.0238736747166948,16559,25354,"sp|E9Q9R9|DLG5_MOUSE","E9Q9R9","DLG5",5.92e-09,"Disks large homolog 5","apical protein localization [GO:0045176]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; protein localization to adherens junction [GO:0071896]; regulation of apoptotic process [GO:0042981]; zonula adherens assembly [GO:0045186]","GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0008013; GO:0008092; GO:0014069; GO:0030011; GO:0030054; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205"
"g30496",380.018381688902,-0.575088668317915,0.158392448328769,-3.63078337626441,0.000282562274267413,0.023950704504594,1865,5553,"sp|Q641Z2|PTN9_RAT","Q641Z2","PTN9",1.76e-12,"Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48)","negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]","GO:0004725; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:1903078"
"g119460",154.456753585801,1.59680076101186,0.439961389531771,3.62941112335165,0.000284068513110791,0.0240447950637293,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10048",106.047622849367,-0.575616514739727,0.158636851065787,-3.62851702408677,0.000285053955839597,0.024061091209882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102393",450.406875384196,0.31880277647687,0.0878529614947439,3.62882219395579,0.000284717249559801,0.024061091209882,1566,3314,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.68e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g51992",25147.2703859385,0.40444122042907,0.111484414223573,3.62778262096794,0.000285865782397251,0.0240626828483899,11136,16394,"sp|A2I3Z2|RSSA_MACHI","A2I3Z2","RSSA",4.49e-24,"40S ribosomal protein SA","ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]","GO:0000028; GO:0003735; GO:0006412; GO:0022627"
"g67644",96.4040252674735,0.657422925280617,0.181214237410774,3.62787678647114,0.000285761568691096,0.0240626828483899,0,11114,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.01e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g130704",223.300118667995,0.472272900238414,0.130202797444357,3.62721008694335,0.000286500177124375,0.0240826810937373,0,3576,"sp|Q91VD9|NDUS1_MOUSE","Q91VD9","NDUS1",2.25e-53,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0043209; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g132443",42.2494884700443,0.583343484212255,0.16084495641935,3.62674402230791,0.000287017572372787,0.0240928028593422,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53816",1310.81096295117,-0.365661084721947,0.100836062093513,-3.62629278782069,0.000287519338078976,0.0241015865027805,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51289",58.6322739357144,0.717371866021187,0.197907245077682,3.62478829786958,0.000289198251642174,0.0241498441978163,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g72884",22.539828899249,1.03307844347902,0.285010162264523,3.62470739734608,0.000289288791099233,0.0241498441978163,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142290",510.304687088751,0.304271611012632,0.0839405718080945,3.62484558370962,0.00028913415650651,0.0241498441978163,0,2480,"sp|P33731|SRP72_CANLF","P33731","SRP72",9.85e-12,"Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005047; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0008312; GO:0030911; GO:0043022"
"g140450",33.2535805491483,-0.859900481484783,0.2372861749224,-3.62389625845668,0.000290198042555596,0.0241772127898564,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158120",775.696032770888,3.21699423802264,0.887763953760763,3.62370450432769,0.000290413381509398,0.0241772127898564,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3453",173.078834258566,-0.465848346430995,0.128592777437057,-3.62266338526684,0.000291585168211562,0.0242278864630927,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61803",204.414719223462,0.639954285990067,0.17666315357119,3.62245478501652,0.000291820481208119,0.0242278864630927,3173,10464,"sp|Q8NDH3|PEPL1_HUMAN","Q8NDH3","PEPL1",3.51e-09,"Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1)",NA,"GO:0005634; GO:0005737; GO:0008233; GO:0030145; GO:0070006"
"g108822",75.2239220496671,0.431967947134758,0.119274670172322,3.62162348896602,0.0002927599987685,0.0242726835044539,0,1024,"sp|Q5XJD3|FIP1_DANRE","Q5XJD3","FIP1",1.42e-06,"Pre-mRNA 3'-end-processing factor FIP1 (FIP1-like 1 protein)","mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]","GO:0005847; GO:0006378; GO:0098789"
"g78621",197.788590921626,0.4139823825141,0.114335270888629,3.62077580519618,0.000293720954651303,0.0243170664082182,2455,7480,"sp|Q2TBL4|RPC3_BOVIN","Q2TBL4","RPC3",9.16e-47,"DNA-directed RNA polymerase III subunit RPC3 (RNA polymerase III subunit C3) (DNA-directed RNA polymerase III subunit C)","defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]","GO:0003697; GO:0003899; GO:0005654; GO:0005666; GO:0006351; GO:0032728; GO:0045087; GO:0045089; GO:0051607"
"g101166",265.239145718343,0.568205864773462,0.156943649562007,3.6204450856036,0.000294096667385601,0.0243170664082182,0,4064,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.14e-34,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g37542",62.4574341349654,0.82261817569676,0.227258469699271,3.61974705182747,0.000294891144269337,0.0243495830553824,17028,26464,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",5.89e-70,"PiggyBac transposable element-derived protein 4",NA,NA
"g34754",33.1581268031419,0.967348148417213,0.267314378264567,3.61876586922611,0.000296011290286616,0.0243559719554874,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75544",29.2933967880876,0.908355062500373,0.250987256999671,3.61912821136398,0.000295597166864683,0.0243559719554874,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92677",991.002615804764,0.556683066534505,0.153838286956659,3.61862497007225,0.000296172471628765,0.0243559719554874,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5619",123.022966048867,0.510203146528496,0.141172169526516,3.61404905966728,0.000301451982396154,0.0244775715991766,66756,79944,"sp|Q96EZ8|MCRS1_HUMAN","Q96EZ8","MCRS1",2.53e-23,"Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2)","cellular protein modification process [GO:0006464]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleosome mobilization [GO:0042766]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]","GO:0000123; GO:0000723; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0006464; GO:0008266; GO:0010521; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0042766; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051571; GO:0051726; GO:0051974; GO:0060382; GO:0071339; GO:1900095; GO:1904357; GO:1904507; GO:1904751"
"g65174",28.0893624668627,1.04159269958824,0.288141642635694,3.61486347499294,0.000300505939730179,0.0244775715991766,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76938",2750.8201496832,0.652170602314798,0.180464245486131,3.6138493836161,0.000301684355844194,0.0244775715991766,5325,9603,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.26e-13,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g87840",134.052141608464,0.86312472142519,0.238658830153716,3.61656311174101,0.000298540553815531,0.0244775715991766,0,1974,"sp|P42860|GSTT1_LUCCU","P42860","GSTT1",1.1e-16,"Glutathione S-transferase 1-1 (EC 2.5.1.18) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749"
"g95860",242.30743684515,0.399815315783799,0.110612436096533,3.61456026006764,0.000300857835459572,0.0244775715991766,0,6976,"sp|Q7ZVF3|SDHA_DANRE","Q7ZVF3","SDHA",1.57e-18,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp)","mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; tricarboxylic acid cycle [GO:0006099]","GO:0000104; GO:0005749; GO:0006099; GO:0006121; GO:0008177; GO:0009055; GO:0050660"
"g125769",73.9968814648254,0.484332085131569,0.133937054621801,3.61611718653348,0.000299055034098127,0.0244775715991766,0,3953,"sp|Q498P2|RT35_DANRE","Q498P2","RT35",8.96e-18,"28S ribosomal protein S35, mitochondrial (MRP-S35) (S35mt)","mitochondrial translation [GO:0032543]","GO:0003735; GO:0005763; GO:0032543"
"g131151",38.9582464022233,0.585578509359578,0.161969123897068,3.61537122181211,0.000299917537799172,0.0244775715991766,0,3461,"sp|P21328|RTJK_DROME","P21328","RTJK",2.15e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g139279",35.7747698020795,1.2774568681825,0.353444044885015,3.61431147778453,0.000301146847624712,0.0244775715991766,0,2774,"sp|Q71R50|DHR11_CHICK","Q71R50","DHR11",2.51e-10,"Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)","estrogen biosynthetic process [GO:0006703]","GO:0000166; GO:0000253; GO:0005576; GO:0006703; GO:0044594; GO:0072555; GO:0072582; GO:0102176"
"g152185",22.9134690391855,1.10291081750655,0.305118984918374,3.61469089772177,0.00030070617679181,0.0244775715991766,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159612",510.421753594533,0.530328970913072,0.146647579896416,3.61634996832317,0.00029878636169635,0.0244775715991766,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1798",122.791837259036,-0.593985086080927,0.164498933174565,-3.61087500458494,0.000305165716970004,0.0245630071126122,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16039",384.315261448318,0.712095840799157,0.197153479803168,3.61188573242578,0.000303978512852454,0.0245630071126122,26206,36094,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.35e-21,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g48218",183.694616632467,-0.519860758424891,0.143963474926278,-3.61106008792233,0.00030494799326962,0.0245630071126122,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51206",123.19710233297,-0.462098081261581,0.127939983459225,-3.61183477414511,0.000304038264929636,0.0245630071126122,2470,6444,"sp|P21328|RTJK_DROME","P21328","RTJK",9.99e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g73253",542.937909809346,0.362641841284229,0.100429124464459,3.61092305860504,0.000305109174399422,0.0245630071126122,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89536",42213.6200850853,0.690084371187383,0.191107680969346,3.61097140464006,0.00030505229813062,0.0245630071126122,3932,7064,"sp|H6VGI3|KARG0_SCYPA","H6VGI3","KARG0",0,"Arginine kinase Scy p 2.0101 (AK) (EC 2.7.3.3) (allergen Scy p 2.0101)","phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]","GO:0004054; GO:0004111; GO:0005524; GO:0016310; GO:0019863; GO:0046314"
"g65388",552.869558042791,0.454957930013717,0.126018377009871,3.61025066985333,0.000305901230381547,0.0245895969163657,4326,11975,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",8.22e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g53303",27.7192914718973,0.567043233116641,0.15709410258473,3.60957683189158,0.000306696924770599,0.024620947571862,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64613",5839.27873196163,0.528418304786057,0.146418977528871,3.60894682987293,0.000307442608583368,0.0246482059642333,8105,12153,"sp|Q26365|ADT_DROME","Q26365","ADT",1.7e-16,"ADP,ATP carrier protein (ADP/ATP translocase) (Adenine nucleotide translocator) (ANT) (Stress-sensitive protein B)","action potential [GO:0001508]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; determination of adult lifespan [GO:0008340]; locomotion [GO:0040011]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial transport [GO:0006839]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagy [GO:0010507]; neuron cellular homeostasis [GO:0070050]; oogenesis [GO:0048477]; positive regulation of ATP biosynthetic process [GO:2001171]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitochondrial depolarization [GO:0051900]; synaptic assembly at neuromuscular junction [GO:0051124]; synaptic vesicle transport [GO:0048489]","GO:0001508; GO:0005471; GO:0005739; GO:0005743; GO:0006839; GO:0007268; GO:0008340; GO:0010507; GO:0016021; GO:0034599; GO:0040011; GO:0045202; GO:0046716; GO:0048477; GO:0048489; GO:0051124; GO:0051480; GO:0051560; GO:0051900; GO:0070050; GO:0140021; GO:1990544; GO:2001171"
"g9806",34.2179151700814,-2.49757448374568,0.692285591347844,-3.6077227591622,0.000308896300739636,0.0246669953840638,8585,10271,"sp|Q09575|YRD6_CAEEL","Q09575","YRD6",6.37e-16,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0008270; GO:0015074"
"g146288",9337.24350036606,0.993289507207426,0.275289704889548,3.60816074689737,0.000308375413762441,0.0246669953840638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g158129",43.3104684691335,0.569804058040756,0.15793857564206,3.60775735582241,0.000308855125919097,0.0246669953840638,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81248",329.04032120817,2.35595607638514,0.653134588109663,3.60715252150996,0.000309575703509287,0.0246887640551624,0,8671,"sp|P32138|SQASE_ECOLI","P32138","SQASE",9.26e-10,"Sulfoquinovosidase (SQase) (EC 3.2.1.199)","6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde [GO:0061720]; carbohydrate metabolic process [GO:0005975]","GO:0004553; GO:0005975; GO:0030246; GO:0061720; GO:1990929"
"g89346",20.1428692736602,-0.640782057623496,0.177669968355028,-3.60658620900443,0.000310251814218435,0.0247102133922793,0,5560,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",8.21e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g101760",53.0297874891342,2.532255859905,0.702246327953645,3.60593677617942,0.000311028862561405,0.0247396352147466,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55699",542.0515457923,0.538494133803523,0.14942347381272,3.60381217263391,0.000313583707193438,0.0249102031277091,11145,14783,"sp|P20136|GSTM2_CHICK","P20136","GSTM2",2.06e-10,"Glutathione S-transferase 2 (EC 2.5.1.18) (GST class-mu) (GST-CL2) (GSTM1-1)","glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178]","GO:0004364; GO:0004464; GO:0005829; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042759; GO:0042803; GO:0043295; GO:0045171"
"g12517",202.258510013605,-0.21898065529788,0.0607766517231854,-3.60303914561226,0.00031451814025037,0.0249403030828992,38735,57230,"sp|P21328|RTJK_DROME","P21328","RTJK",3.08e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g159849",118.059476383464,0.480882464605388,0.133473938329381,3.60281917671962,0.000314784514112717,0.0249403030828992,0,544,"sp|P0C2B8|RM55_BOVIN","P0C2B8","RM55",1.46e-09,"39S ribosomal protein L55, mitochondrial (L55mt) (MRP-L55)","translation [GO:0006412]","GO:0003735; GO:0005743; GO:0005762; GO:0006412"
"g80998",63.2908031421745,0.669983048983693,0.185993150187195,3.60219206088709,0.000315545087054717,0.0249420397771482,0,8000,"sp|Q55F21|AATM_DICDI","Q55F21","AATM",2.53e-13,"Aspartate aminotransferase, mitochondrial (EC 2.6.1.1) (EC 2.6.1.7) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Transaminase A)","2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; glutamate metabolic process [GO:0006536]","GO:0004069; GO:0005739; GO:0005759; GO:0005886; GO:0006103; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0016212; GO:0030170"
"g130275",85.0452481788905,0.567310953464363,0.157493478127262,3.60212346701716,0.000315628382745919,0.0249420397771482,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113759",290.736360176202,0.393330773953164,0.109225672136683,3.60108357548908,0.000316893679789132,0.0250094634933711,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68271",21.896066881883,0.925758447904854,0.257137127424183,3.60025196352796,0.000317908966186997,0.025033598146946,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117226",226.625478114502,0.409365152864594,0.113707566958746,3.60015752525175,0.000318024454956259,0.025033598146946,0,4747,"sp|P53451|TCPD_TAKRU","P53451","TCPD",9.3e-34,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","protein folding [GO:0006457]; response to hypoxia [GO:0001666]","GO:0001666; GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g43008",1805.45924675807,0.340489781003587,0.0946040667431471,3.59910300608986,0.000319316699093092,0.0250378946614467,17605,19730,"sp|Q17237|SGF3_BOMMO","Q17237","SGF3",3.77e-108,"Silk gland factor 3 (SGF-3) (POU domain protein M1)","cell differentiation [GO:0030154]; nervous system development [GO:0007399]","GO:0000981; GO:0003677; GO:0005634; GO:0007399; GO:0030154"
"g63431",33.5602940369163,0.556228901147016,0.154540273702454,3.59924884187767,0.00031913769449043,0.0250378946614467,3096,8004,"sp|Q24134|NELFD_DROME","Q24134","NELFD",4.61e-15,"Negative elongation factor D","negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]","GO:0000122; GO:0003723; GO:0005634; GO:0005703; GO:0005705; GO:0008023; GO:0017053; GO:0032021; GO:0034244"
"g69150",38.1297283142889,5.31013867567784,1.47533136102155,3.59928543239329,0.000319092796589871,0.0250378946614467,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42491",1623.82710094929,0.297202165997578,0.0826068557699008,3.59779056142056,0.000320931879591317,0.0251320719643832,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48892",269.929925526799,0.33697716434933,0.0936844833283785,3.59693678587279,0.000321986693798424,0.0251821809879205,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6771",87.9603423054767,1.10982380257539,0.308812379516375,3.59384492394206,0.000325833812401206,0.0254079038644479,4925,24051,"sp|P21328|RTJK_DROME","P21328","RTJK",6.35e-15,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g55207",26.6513007134072,0.582693269062859,0.162162162955459,3.59327514164268,0.000326547454510947,0.0254079038644479,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124459",515.222414474683,0.42621641466889,0.118613322944883,3.59332665241109,0.000326482878103098,0.0254079038644479,0,4088,"sp|P50991|TCPD_HUMAN","P50991","TCPD",2.84e-14,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]","GO:0002199; GO:0003723; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0042470; GO:0042995; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0061077; GO:0070062; GO:0090666; GO:1901998; GO:1904851; GO:1904871; GO:1904874"
"g151506",25.1133942326915,0.6653880045881,0.185138766920395,3.59399609091164,0.000325644723625859,0.0254079038644479,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4132",1975.83845354331,-0.370795868669438,0.103223548941474,-3.59216353702074,0.000327943932005415,0.0254838889032121,5397,14164,"sp|Q80T69|RSBN1_MOUSE","Q80T69","RSBN1",6.46e-19,"Lysine-specific demethylase 9 (KDM9) (EC 1.14.11.-) (Round spermatid basic protein 1) (Rosbin)","chromatin organization [GO:0006325]","GO:0005634; GO:0006325; GO:0035575; GO:0046872"
"g2464",321.47701949721,0.908833847706504,0.253078742971148,3.59111096031528,0.000329271404263274,0.0255118092514073,48821,69124,"sp|O00370|LORF2_HUMAN","O00370","LORF2",6.22e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g15142",31.7042512616271,1.29739579061045,0.361279531948987,3.59111346167723,0.00032926824368239,0.0255118092514073,0,2074,"sp|Q9H3S4|TPK1_HUMAN","Q9H3S4","TPK1",1.5e-06,"Thiamin pyrophosphokinase 1 (hTPK1) (EC 2.7.6.2) (Placental protein 20) (PP20) (Thiamine pyrophosphokinase 1)","thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772]","GO:0004788; GO:0005524; GO:0005829; GO:0006772; GO:0009229; GO:0016301; GO:0030975; GO:0042802"
"g83627",75.0046792297346,2.74241657208881,0.763717293118088,3.59087923869333,0.000329564317895919,0.0255118092514073,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17568",633.867766455663,-0.435426278384833,0.121291058922386,-3.5899289053405,0.000330768163635485,0.0255225513313692,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55782",111.192595418061,0.398146532942312,0.110903001028336,3.59004291363209,0.000330623525400088,0.0255225513313692,0,3886,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.16e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g65099",10165.9777468175,1.16944992496462,0.325772570964599,3.58977406078702,0.00033096470419818,0.0255225513313692,0,5129,"sp|H9J9M0|CDA1_BOMMO","H9J9M0","CDA1",1.38e-117,"Chitin deacetylase 1 (BmCDA1) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0008061; GO:0008270"
"g53653",129.569638044437,0.43493534938492,0.121262850806421,3.58671552328282,0.000334869303136095,0.0255959924525562,0,11794,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.44e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g92323",45.9543254029533,-0.42583416021265,0.118677741829613,-3.58815523153471,0.000333025999993984,0.0255959924525562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94305",316.741695498126,0.467400264736681,0.130268861894767,3.58796613356654,0.000333267565200782,0.0255959924525562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98731",2058.23259184708,0.672008630830093,0.187337031606276,3.58716386753925,0.000334294253015463,0.0255959924525562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121585",2007.105991773,2.75832088862454,0.768762245075649,3.58800254082861,0.000333221043616301,0.0255959924525562,1436,4284,"sp|P04069|CBPB_ASTAS","P04069","CBPB",3.01e-12,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g123676",90.0950998350892,-0.486821912574796,0.135719684677125,-3.58696613341636,0.000334547754480294,0.0255959924525562,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124743",48.2896564604241,0.648888774454745,0.180904955759587,3.58690435942,0.000334626987585168,0.0255959924525562,0,4063,"sp|Q588U8|CFDP2_TRAJA","Q588U8","CFDP2",2.47e-20,"Craniofacial development protein 2 (p97 bucentaur protein)",NA,"GO:0003824; GO:0005634; GO:0005737"
"g65359",111.641664542978,0.405639818172494,0.113139817837861,3.58529672333228,0.000336695172745596,0.0257031824326166,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147471",32.1000643037447,0.549704628166801,0.153349115174351,3.58466123225954,0.000337516010140983,0.0257334756978093,0,1754,"sp|Q8R2K1|FUCM_MOUSE","Q8R2K1","FUCM",3.4e-06,"Fucose mutarotase (EC 5.1.3.29)","female mating behavior [GO:0060180]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; negative regulation of neuron differentiation [GO:0045665]","GO:0006004; GO:0016857; GO:0036065; GO:0036373; GO:0042806; GO:0045665; GO:0060180"
"g15081",467.146981484756,-0.630067094519886,0.176004386638813,-3.57983744923857,0.00034380800839717,0.0258985551590015,15285,44351,"sp|Q9P281|BAHC1_HUMAN","Q9P281","BAHC1",4.43e-18,"BAH and coiled-coil domain-containing protein 1 (Bromo adjacent homology domain-containing protein 2) (BAH domain-containing protein 2)",NA,"GO:0003682"
"g19173",77.2386292879505,0.556389037651521,0.155372065709419,3.58101075062034,0.000342267568988931,0.0258985551590015,48075,53406,"sp|Q5RBL1|GARS_PONAB","Q5RBL1","GARS",7.56e-18,"Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1)","diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; tRNA aminoacylation for protein translation [GO:0006418]","GO:0004081; GO:0004820; GO:0005524; GO:0005739; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030424; GO:0046983; GO:0070062"
"g60596",460.902927787817,0.504306133429239,0.140868754276942,3.57997155591932,0.000343631610641654,0.0258985551590015,0,4147,"sp|P50143|TCPG_XENLA","P50143","TCPG",2.18e-13,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","protein folding [GO:0006457]","GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g64376",54.2391333952984,0.542649259273306,0.151547945384579,3.58071010396241,0.00034266167461202,0.0258985551590015,10477,11614,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.52e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g85786",21.900455495618,-0.60891512342784,0.169999220832888,-3.58187008413652,0.00034114344013094,0.0258985551590015,0,7789,"sp|P21328|RTJK_DROME","P21328","RTJK",5.9e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g98137",39.4049157890495,0.480689559072819,0.134267208700092,3.58009646380986,0.000343467388707817,0.0258985551590015,4065,6710,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.97e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g101830",32.7110213084304,-0.902738564292679,0.252215530013895,-3.57923464999537,0.000344601949397194,0.0258985551590015,0,6287,"sp|Q9M2U3|ALPL_ARATH","Q9M2U3","ALPL",7.14e-25,"Protein ALP1-like (EC 3.1.-.-)",NA,"GO:0000118; GO:0004518; GO:0046872"
"g107245",404.18151577082,0.831045620051407,0.232084338711873,3.58079146858388,0.000342554975121249,0.0258985551590015,201,5723,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.03e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g128451",67.1670949107723,-0.591185160416486,0.165050071248868,-3.58185340935163,0.000341165220190061,0.0258985551590015,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130746",86.4251402988931,-0.792561352419054,0.221384893227817,-3.58001551444373,0.000343573808048814,0.0258985551590015,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152272",48.6277560066743,1.39138473225412,0.38875453329547,3.57908297675493,0.000344801986628328,0.0258985551590015,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153549",238.868131778827,0.673065711504091,0.188023427418754,3.57969068399696,0.000344001153718331,0.0258985551590015,0,1674,"sp|Q5E947|PRDX1_BOVIN","Q5E947","PRDX1",4.82e-28,"Peroxiredoxin-1 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 1)","cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; leukocyte activation [GO:0045321]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]","GO:0004601; GO:0005829; GO:0006979; GO:0008283; GO:0019430; GO:0032872; GO:0034101; GO:0042267; GO:0042802; GO:0045321; GO:0045454; GO:0051920; GO:1901222"
"g1849",342.991624294143,-0.370446886043926,0.103525897022366,-3.57830162982208,0.000345834203626282,0.0258992892643116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13457",251.337620180496,0.285599828552599,0.0798416260287568,3.57707931010491,0.000347454777893475,0.0258992892643116,7971,12944,"sp|O08609|MLX_MOUSE","O08609","MLX",9.02e-18,"Max-like protein X (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4)","negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006913; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:0061629; GO:1990837"
"g26658",869.922985415782,0.91642641955177,0.256156493278732,3.57760370553861,0.000346758656560647,0.0258992892643116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51514",79.853832758886,1.4896579629913,0.416354492958851,3.57785970413085,0.000346419299161074,0.0258992892643116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55974",3170.93965512928,0.440619150607696,0.123175120447171,3.57717653539194,0.000347325615216018,0.0258992892643116,0,12200,"sp|Q9M888|TCPZA_ARATH","Q9M888","TCPZA",6.91e-35,"T-complex protein 1 subunit zeta 1 (TCP-1-zeta 1) (CCT-zeta 1) (Chaperonin CCT6A)","protein folding [GO:0006457]; response to zinc ion [GO:0010043]","GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0006457; GO:0010043; GO:0016887; GO:0051082"
"g74970",108.509028267286,0.445934773527467,0.124666264688061,3.57702843382116,0.000347522384357693,0.0258992892643116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142289",116.420764769329,0.534948187474326,0.149559701506781,3.57682037397,0.0003477989907796,0.0258992892643116,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16506",482.478716361023,-0.348069521609103,0.0973305842638903,-3.57615773337381,0.000348681315297583,0.0259331728252577,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g74524",5224.65580778237,-0.257202561323938,0.0719329196050962,-3.57558907293005,0.000349440171485583,0.0259578017227173,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32447",3722.60521991129,1.01667581005891,0.284518939650266,3.57331505350265,0.000352490232594888,0.026152362122474,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117047",32.9199579138024,0.934645667865789,0.261659366856005,3.57199392131884,0.000354273636461132,0.0262525848557095,0,4764,"sp|Q01415|GALK2_HUMAN","Q01415","GALK2",5.23e-19,"N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2)","carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012]","GO:0004335; GO:0005524; GO:0005829; GO:0005975; GO:0006012; GO:0033858"
"g33793",201.173277443234,-0.336412088298873,0.0942131934801797,-3.57075347806406,0.00035595579600012,0.0263450698283504,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73664",446.777952730445,0.308440439225688,0.0864165794452163,3.56922758579242,0.000358035297500765,0.0264667018335218,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14787",949.739818633506,-0.682463445090479,0.191268809961114,-3.56808538323226,0.000359599331656687,0.0265458771089524,9645,22910,"sp|Q28298|RRBP1_CANLF","Q28298","RRBP1",1.68e-19,"Ribosome-binding protein 1 (180 kDa ribosome receptor) (RRp)","protein transport [GO:0015031]; signal transduction [GO:0007165]","GO:0007165; GO:0015031; GO:0030176"
"g84552",24.158139749852,0.917675204724832,0.257232808894005,3.56748895551254,0.000360418565460154,0.0265458771089524,0,642,"sp|Q9XYU1|MCM3_DROME","Q9XYU1","MCM3",8.09e-06,"DNA replication licensing factor Mcm3 (EC 3.6.4.12) (Minichromosome maintenance 3 protein) (DmMCM3)","DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000727; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0006271; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975"
"g104222",188.091864446315,-0.556822443308995,0.156071252215625,-3.56774508696642,0.000360066538009395,0.0265458771089524,1949,4644,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.76e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g44720",54.6445145661397,0.560774576537658,0.157213556296807,3.56696069821713,0.000361145619674099,0.0265671850400255,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60890",449.903776264558,-0.326536232585526,0.0915626808794508,-3.56625897635562,0.000362113538685574,0.0265972311621285,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117162",3475.7372276656,0.53386613810687,0.149708838265306,3.56602952967133,0.000362430551508984,0.0265972311621285,95,4282,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",3.12e-52,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g37757",24.0087315358331,1.77956275643112,0.499251131122434,3.5644641453896,0.000364600284158681,0.0266621141418518,20086,25014,"sp|P91778|AMY_PECMA","P91778","AMY",2.68e-07,"Alpha-amylase (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate metabolic process [GO:0005975]","GO:0004556; GO:0005975; GO:0046872"
"g73581",482.279894770854,0.55385580278293,0.155363953613199,3.56489256292895,0.000364005263330188,0.0266621141418518,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153583",46.8426766001582,0.5233445242897,0.146823735722145,3.56444086997008,0.000364632636970456,0.0266621141418518,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6027",87.3915036115508,0.551843380898544,0.154866600817808,3.56334663500336,0.000366156655520545,0.0267413326396412,51719,71298,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",8.71e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g78945",226.041041161525,0.338328359244991,0.0949873052430221,3.56182711341677,0.000368282880235244,0.0268642884633136,0,9290,"sp|P21328|RTJK_DROME","P21328","RTJK",1.16e-14,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g7723",23.2870100355446,-0.854241129147657,0.239864259988518,-3.56135227977919,0.000368949665437642,0.0268806184818853,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12631",84.3814430574889,-0.353309224647625,0.0992310067969496,-3.56047203441743,0.000370188736577239,0.0269296707338224,47415,71514,"sp|Q9VB11|UNC80_DROME","Q9VB11","UNC80",1.82e-15,"Protein unc-80 homolog","cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475]","GO:0005261; GO:0030424; GO:0034703; GO:0045475; GO:0055080"
"g71918",30.4680453947783,0.472085438670809,0.132610888541401,3.55992968498528,0.000370954106664616,0.0269296707338224,0,9204,"sp|P21328|RTJK_DROME","P21328","RTJK",3.21e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g78785",407.235590057294,0.659578276266038,0.185275513440903,3.55998622816621,0.000370874243221741,0.0269296707338224,6121,7924,"sp|P28765|SODM_PALVU","P28765","SODM",7.93e-19,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) (Fragment)",NA,"GO:0004784; GO:0005759; GO:0046872"
"g87745",261.340323704411,1.24584420425753,0.350144043851557,3.55809052341242,0.000373560582125388,0.0270864895211348,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35569",32.9477037152113,1.13062126097157,0.317937470067941,3.55611202646219,0.000376383634006942,0.0271937175570015,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89937",51.2244427225208,1.02625565634428,0.288587969286968,3.55612764759359,0.000376361266834827,0.0271937175570015,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143666",54.1672170494481,0.782373870311941,0.219974974886859,3.5566494357567,0.00037561485611123,0.0271937175570015,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g117619",292.47966445576,0.898107117596804,0.252583547270412,3.55568336616677,0.000376997897854653,0.0272057103695587,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145866",22.4459404679617,-0.76100379335125,0.214124925288045,-3.55401778810913,0.000379393551713367,0.0273460744103138,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9411",382.661355937965,0.384426806604605,0.108200424877784,3.55291402079825,0.000380988966419067,0.0274284939169314,0,8348,"sp|Q9CQJ8|NDUB9_MOUSE","Q9CQJ8","NDUB9",1.24e-08,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit)","aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]","GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0009060; GO:0032981; GO:0042776"
"g9079",191.021093174487,-0.495733474955674,0.139609398910442,-3.55086032046941,0.000383974140117863,0.0276106523267217,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63233",77.6818764631507,1.28185862445297,0.361045215894461,3.55041022016387,0.000384631301137773,0.0276251759361556,0,12502,"sp|Q4V8V2|NUD17_DANRE","Q4V8V2","NUD17",1.11e-13,"Nucleoside diphosphate-linked moiety X motif 17 (Nudix motif 17) (EC 3.6.1.-)","NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]","GO:0005777; GO:0006734; GO:0006742; GO:0019677; GO:0035529; GO:0046872"
"g11410",21.679039909551,1.00705111910321,0.283683178720395,3.5499148156958,0.000385355822777108,0.027629367432289,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11996",102.94817297833,0.534321273582863,0.150546565699863,3.54920931672472,0.000386389806226777,0.027629367432289,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12158",87.5879048874555,1.25563288512055,0.353810861633767,3.54888168023588,0.000386870873312217,0.027629367432289,31558,46724,"sp|Q9GKT2|FXDC2_MACFA","Q9GKT2","FXDC2",5.85e-24,"Fatty acid hydroxylase domain-containing protein 2","lipid biosynthetic process [GO:0008610]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]","GO:0001934; GO:0005506; GO:0005737; GO:0008610; GO:0016021; GO:0016491; GO:0045654"
"g15806",605.298587998971,-0.300213477236133,0.0845770947123266,-3.54958370534308,0.000385840777622715,0.027629367432289,0,24344,"sp|O75182|SIN3B_HUMAN","O75182","SIN3B",3.57e-12,"Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)","histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]","GO:0000118; GO:0000122; GO:0000785; GO:0000805; GO:0000806; GO:0001741; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0016575; GO:0016580; GO:0030336; GO:0030849"
"g109628",127.997663344651,1.18479141166719,0.333855314744702,3.54881698550524,0.000386965930424216,0.027629367432289,0,3434,"sp|B2D0J5|EST6_APIME","B2D0J5","EST6",5.95e-17,"Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)",NA,"GO:0005576; GO:0080030"
"g48064",74.2348532083155,0.843571964322494,0.237739534617237,3.54830325415019,0.000387721540193763,0.0276321511561336,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123344",42.4179143323602,0.587519069066121,0.165583615530715,3.54817152157871,0.000387915517960551,0.0276321511561336,0,4187,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",4.45e-28,"PiggyBac transposable element-derived protein 4",NA,NA
"g43508",136.22819956252,0.919359118754994,0.259186979087405,3.54708836837425,0.000389513915837202,0.0276558148173581,0,16314,"sp|Q9W3Z3|AGT_DROME","Q9W3Z3","AGT",7.06e-18,"Alanine--glyoxylate aminotransferase (AGT) (EC 2.6.1.44)","glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]","GO:0004760; GO:0005777; GO:0008453; GO:0009436; GO:0019265"
"g56551",31.8123480617592,0.512433737573162,0.144481342303176,3.54671218722404,0.000390070480864369,0.0276558148173581,0,9034,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.85e-14,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g104480",50.8667156432715,2.65930662627655,0.749773586861905,3.54681289508582,0.000389921409441743,0.0276558148173581,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154993",51.9721839104554,0.721080902301419,0.20327048513063,3.54739598244194,0.000389059348337488,0.0276558148173581,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g45248",189.959314687925,0.485005070137722,0.136763909391463,3.54629428403863,0.000390689645496658,0.0276673915813211,10798,12764,"sp|P51688|SPHM_HUMAN","P51688","SPHM",0,"N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase)","glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]","GO:0005539; GO:0005764; GO:0006027; GO:0008449; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0070062"
"g19650",1451.12972491323,0.509496275724564,0.143747928850715,3.54437298539225,0.00039354807328922,0.0277081584314649,0,5931,"sp|Q5EA68|S61A1_BOVIN","Q5EA68","S61A1",1.22e-37,"Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1)","cotranslational protein targeting to membrane [GO:0006613]; posttranslational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein insertion into ER membrane [GO:0045048]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0005048; GO:0005784; GO:0005789; GO:0006613; GO:0006616; GO:0008320; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047; GO:0045048"
"g31803",8082.42656173814,0.473584588116322,0.13361381083054,3.54442841778506,0.000393465330250073,0.0277081584314649,23519,32887,"sp|Q7PQV7|ADT2_ANOGA","Q7PQV7","ADT2",5.54e-70,"ADP,ATP carrier protein 2 (ADP/ATP translocase 2) (Adenine nucleotide translocator 2) (ANT 2)","mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]","GO:0005471; GO:0005743; GO:0016021; GO:0140021; GO:1990544"
"g95498",172.911951559946,0.732195607845658,0.206565209445655,3.54462210655221,0.000393176341761579,0.0277081584314649,0,5243,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.13e-19,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g105330",862.917013168831,0.575556945968662,0.162383923235404,3.54442074375979,0.000393476784174394,0.0277081584314649,0,5919,"sp|Q04820|MDHC_ECHGR","Q04820","MDHC",1.13e-18,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37)","malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099]","GO:0005737; GO:0006099; GO:0006108; GO:0030060"
"g109650",22.9385517035921,-0.845537761700158,0.238512631613444,-3.54504395000143,0.000392547626993672,0.0277081584314649,0,5478,"sp|O60308|CE104_HUMAN","O60308","CE104",4.86e-13,"Centrosomal protein of 104 kDa (Cep104)",NA,"GO:0000922; GO:0005737; GO:0005814; GO:0005929; GO:0016594; GO:0016595; GO:0016596"
"g55020",1274.22868441479,0.86617736060455,0.244402158318186,3.54406592218747,0.000394006716141981,0.0277083054491968,6045,13768,"sp|P29413|CALR_DROME","P29413","CALR",7.44e-26,"Calreticulin","olfactory behavior [GO:0042048]; protein folding [GO:0006457]; sleep [GO:0030431]; ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0005509; GO:0005615; GO:0005788; GO:0005789; GO:0006457; GO:0012505; GO:0030246; GO:0030431; GO:0030433; GO:0042048; GO:0045169; GO:0051082"
"g15197",799.878873133594,0.548923247931621,0.15496712789904,3.54219153038212,0.000396817235436228,0.0278736551141489,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139455",29.9168968698131,1.14906311622812,0.324445513116603,3.54162122690584,0.000397676075159153,0.02790168901897,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6683",4206.62799184195,-0.577480456479165,0.163084626131525,-3.54098648154265,0.000398634002127623,0.027914845936513,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54439",76.9882857879974,0.523256548802039,0.147775534476091,3.54088754039796,0.000398783513378758,0.027914845936513,0,11924,"sp|P21328|RTJK_DROME","P21328","RTJK",1.04e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g13368",168.715523118052,-0.446475913501878,0.126136233932933,-3.53963250353003,0.000400684568617294,0.0279258294192264,15465,19689,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.72e-06,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g38276",109.261792111376,-0.438503520777433,0.123896735627655,-3.53926613607692,0.000401241114739914,0.0279258294192264,14560,18224,"sp|P21328|RTJK_DROME","P21328","RTJK",6.48e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g39918",251.255828290549,0.272345891470519,0.0769252020532573,3.54039877960888,0.000399522855106957,0.0279258294192264,0,13561,"sp|Q05913|T2FA_DROME","Q05913","T2FA",1.7e-16,"General transcription factor IIF subunit 1 (Transcription factor 5 large chain) (TF5A) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha)","positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]","GO:0001096; GO:0003677; GO:0005634; GO:0005674; GO:0006366; GO:0006367; GO:0006368; GO:0016251; GO:0016740; GO:0032968"
"g44065",70.4655850345117,0.335684537753791,0.0948438393791211,3.53933940202434,0.000401129759236169,0.0279258294192264,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54121",77.7319306737607,0.527360887012405,0.148969964819529,3.54004840943126,0.000400053643099973,0.0279258294192264,2470,13014,"sp|Q7ZUC7|PGES2_DANRE","Q7ZUC7","PGES2",8.6e-15,"Prostaglandin E synthase 2 (EC 5.3.99.3) (Microsomal prostaglandin E synthase 2) (mPGES-2)","prostaglandin biosynthetic process [GO:0001516]","GO:0000139; GO:0001516; GO:0004362; GO:0005739; GO:0016021; GO:0016829; GO:0020037; GO:0036134; GO:0043295; GO:0050220; GO:0097573"
"g15564",479.363317516218,-0.401049926652681,0.113327793919412,-3.5388487923613,0.00040187597840985,0.0279379760935782,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84000",53.9834590340854,-0.539644118654938,0.152508367461251,-3.53845580828245,0.000402474643931992,0.0279475813961472,0,6146,"sp|Q6ZQT0|YD023_HUMAN","Q6ZQT0","YD023",1.29e-13,"Putative uncharacterized protein FLJ45035",NA,NA
"g35295",144.457608835891,0.40179738575631,0.113561398825738,3.53815107872065,0.000402939437349012,0.0279478793745275,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43630",138.145141744299,0.298844672731847,0.0844734941706447,3.53773305657454,0.000403577847780094,0.027960205002025,8966,21370,"sp|O00370|LORF2_HUMAN","O00370","LORF2",9.19e-12,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g26714",2377.48824211568,-0.236474272736999,0.0668602027528437,-3.5368464796787,0.000404934971346527,0.0279903227915954,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148584",124.380957523256,2.66400706297463,0.753180578859188,3.53700976598426,0.000404684701730227,0.0279903227915954,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2494",292.76457326429,0.439662594409582,0.124358628609418,3.53544100096553,0.000407095140570333,0.0280151039129671,3115,6079,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.59e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g16066",123.48907363892,0.596506710616717,0.168834515519819,3.53308509684855,0.000410740239484073,0.0280151039129671,26295,37559,"sp|Q3UDW8|HGNAT_MOUSE","Q3UDW8","HGNAT",3.64e-19,"Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)","lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]","GO:0005765; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0051259"
"g17239",3575.66544833347,-0.233248375951524,0.0660278316408417,-3.53257664465309,0.000411530915479123,0.0280151039129671,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18256",134.691103950259,-0.606936034235677,0.171738641725057,-3.53406797759204,0.000409215817469534,0.0280151039129671,44555,55668,"sp|Q99315|YG31B_YEAST","Q99315","YG31B",1.9e-43,"Transposon Ty3-G Gag-Pol polyprotein (Gag3-Pol3) (Transposon Ty3-1 TYA-TYB polyprotein) [Cleaved into: Capsid protein (CA) (p24); Spacer peptide p3; Nucleocapsid protein p11 (NC); Ty3 protease (PR) (EC 3.4.23.-) (p16); Spacer peptide J; Reverse transcriptase/ribonuclease H (RT) (RT-RH) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p55); Integrase p61 (IN); Integrase p58 (IN)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, RNA-mediated [GO:0032197]","GO:0000943; GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0004540; GO:0005524; GO:0005634; GO:0005737; GO:0006310; GO:0008233; GO:0008270; GO:0015074; GO:0032197"
"g24123",43.9509250733138,-0.408033117398159,0.115439356736084,-3.53461010988653,0.000408377247615225,0.0280151039129671,37395,44050,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.91e-08,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g35164",1407.11829754164,-0.378403861253395,0.107078634309319,-3.53388763028389,0.000409495134895917,0.0280151039129671,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37575",828.562846112267,-0.370657060579918,0.104856528303255,-3.53489731710305,0.000407933646387849,0.0280151039129671,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63602",83.6618816113913,-1.16543381056535,0.329783531889924,-3.53393574229277,0.000409420602801143,0.0280151039129671,0,12409,"sp|P04323|POL3_DROME","P04323","POL3",2.6e-31,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g85707",1383.77063090032,0.501748371959606,0.14203759188039,3.53250407386609,0.000411643883603292,0.0280151039129671,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90145",2507.42421234754,0.189697548037579,0.0537016834151284,3.53243205750491,0.00041175601730708,0.0280151039129671,0,7034,"sp|P30153|2AAA_HUMAN","P30153","2AAA",1.55e-31,"Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)","apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; female meiotic nuclear division [GO:0007143]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein-containing complex assembly [GO:0065003]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]","GO:0000159; GO:0000775; GO:0004722; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006275; GO:0006355; GO:0006470; GO:0006672; GO:0006915; GO:0007059; GO:0007143; GO:0008380; GO:0010033; GO:0015630; GO:0016020; GO:0016328; GO:0019888; GO:0019932; GO:0030111; GO:0030155; GO:0030308; GO:0030425; GO:0040008; GO:0042532; GO:0043005; GO:0043025; GO:0043409; GO:0045595; GO:0046982; GO:0051232; GO:0051306; GO:0051754; GO:0065003; GO:0070062; GO:0070262; GO:0098978; GO:1903538; GO:1990405; GO:2001241"
"g94376",23.2694346377515,0.741829810020268,0.209931234347732,3.53368002777278,0.000409816884983587,0.0280151039129671,0,6960,"sp|P11369|LORF2_MOUSE","P11369","LORF2",7.38e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g110926",38.9289978007641,0.467549132088628,0.132327365671224,3.53327620267364,0.000410443424639752,0.0280151039129671,1268,1814,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.7e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g130292",163.143500003484,0.313320369744889,0.0886941333486715,3.53259407263357,0.000411503790331433,0.0280151039129671,0,3608,"sp|Q6DEU3|VPS29_XENTR","Q6DEU3","VPS29",1.34e-29,"Vacuolar protein sorting-associated protein 29 (Vesicle protein sorting 29)","endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005768; GO:0005829; GO:0006886; GO:0010008; GO:0030904; GO:0032456; GO:0042147; GO:0046872"
"g150994",146.444353053122,0.415472299361768,0.11754815714318,3.5344858605967,0.000408569294426886,0.0280151039129671,0,1824,"sp|Q9HD20|AT131_HUMAN","Q9HD20","AT131",9.2e-14,"Endoplasmic reticulum transmembrane helix translocase (EC 7.4.2.-) (Endoplasmic reticulum P5A-ATPase)","cellular calcium ion homeostasis [GO:0006874]; extraction of mislocalized protein from ER membrane [GO:0140569]; ion transmembrane transport [GO:0034220]; protein transport [GO:0015031]","GO:0005524; GO:0005789; GO:0006874; GO:0015031; GO:0015410; GO:0016020; GO:0016021; GO:0016887; GO:0034220; GO:0046872; GO:0140567; GO:0140569"
"g87382",1209.52831299701,0.424853688096863,0.120310894316506,3.53129856203367,0.00041352469898262,0.0280755423047133,4459,8041,"sp|Q2NKZ1|TCPH_BOVIN","Q2NKZ1","TCPH",3.8e-22,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998]","GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:1901998; GO:1904851"
"g113463",232.160109170287,0.442205990248515,0.1252257697871,3.53126988957881,0.000413569530736756,0.0280755423047133,0,3911,"sp|P40313|CTRL_HUMAN","P40313","CTRL",1.53e-06,"Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-)","protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004252; GO:0005615; GO:0006508; GO:0008236; GO:0030163"
"g8065",963.338239571382,-0.331135497228376,0.0937854252964944,-3.53077779603302,0.00041433966755488,0.0280934436198134,40375,52312,"sp|P21328|RTJK_DROME","P21328","RTJK",1.94e-27,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g8446",39.9293637875539,-0.647603114321764,0.183457690523269,-3.52998619177332,0.000415581355909817,0.0280934436198134,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12048",677.306171194611,0.606767227333145,0.171866137941433,3.53046408443712,0.000414831331743986,0.0280934436198134,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93160",20.2071952227642,5.37123147489094,1.52162966350176,3.5299203240623,0.000415684830624361,0.0280934436198134,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142349",833.308884595023,0.582441664850893,0.165016908077752,3.529587795794,0.000416207582533958,0.0280974840756239,0,2544,"sp|A0A291PQF1|UGT5_DACCO","A0A291PQF1","UGT5",5e-15,"UDP-glycosyltransferase UGT5 (EC 2.4.1.-) (UDP-glucosyltransferase 5) (DcUGT5)",NA,"GO:0005783; GO:0008194; GO:0016021"
"g16166",159.47085415781,-0.507003952146207,0.143729204300771,-3.52749432248465,0.000419512758027858,0.0282714211090209,21556,46034,"sp|Q95YM8|MBLK1_APIME","Q95YM8","MBLK1",4.32e-16,"Mushroom body large-type Kenyon cell-specific protein 1","memory [GO:0007613]; positive regulation of transcription, DNA-templated [GO:0045893]","GO:0005634; GO:0007613; GO:0043565; GO:0045893"
"g43824",96.8704168673779,0.390044135563456,0.11059277791707,3.52684997076334,0.000420534983307257,0.0282714211090209,0,13687,"sp|Q9D3U0|PUS10_MOUSE","Q9D3U0","PUS10",5.54e-15,"tRNA pseudouridine synthase Pus10 (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase)","primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119]","GO:0005634; GO:0005737; GO:0005739; GO:0009982; GO:0031053; GO:0031119; GO:0046872; GO:0070878; GO:0106029"
"g95880",36.0370375501352,0.643224186539419,0.182382892453976,3.52677917256815,0.00042064744210654,0.0282714211090209,625,6974,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.47e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g154269",217.785728307473,0.556008607595671,0.157651929089804,3.52681131658687,0.000420596379729304,0.0282714211090209,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g119056",55.3603059586365,0.894534588692895,0.253691026206881,3.52607895544329,0.000421761209564453,0.0283149201421091,0,4575,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",2.3e-17,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g5684",1704.15402020347,-0.3511565366118,0.0997091869011207,-3.52180724289763,0.000428615672311123,0.0283671593812018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10838",106.787961029706,-0.539346513480323,0.153092008382865,-3.52302199949902,0.000426655943749752,0.0283671593812018,63365,69712,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",7.11e-36,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g13983",748.575784692287,-0.502502528101077,0.142671317415928,-3.52209916612838,0.000428143956061495,0.0283671593812018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g35255",230.408530893902,-0.514729072817934,0.146011623708597,-3.52526093295973,0.000423065846133151,0.0283671593812018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36533",84.7301964154003,-0.706617148352344,0.200539268680993,-3.52358494672877,0.000425750598566893,0.0283671593812018,4109,17324,"sp|A6NP11|ZN716_HUMAN","A6NP11","ZN716",4.85e-45,"Zinc finger protein 716","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g36879",112.992610519647,-0.678784167141904,0.192724043917261,-3.52205232593249,0.000428219612070429,0.0283671593812018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38678",87.7309145735172,-0.308963172972121,0.0876565265731035,-3.52470243860795,0.000423958733672824,0.0283671593812018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51338",407.13877903291,-0.614877104100913,0.174520855005793,-3.52322995484123,0.00042632129583542,0.0283671593812018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85383",53.7235069809759,-0.438264930391402,0.124397218323088,-3.52310876641251,0.000426516286046556,0.0283671593812018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90552",195.664341565373,0.648460184324994,0.184105900090151,3.52221294378651,0.000427960235030468,0.0283671593812018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91849",505.975047626203,2.15872791537946,0.61293108731565,3.52197491700686,0.000428344669872433,0.0283671593812018,0,1650,"sp|P80067|CATC_RAT","P80067","CATC",3.7e-11,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043621; GO:0051087; GO:0051603; GO:1903052; GO:1903980; GO:2001235"
"g123307",66.4150051633808,0.622259619521258,0.1766486728419,3.52258304299959,0.000427363131036373,0.0283671593812018,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157640",22.4072250455881,-0.69216154801335,0.19643493873917,-3.5236172976968,0.000425698625510553,0.0283671593812018,0,1365,"sp|Q8TDM6|DLG5_HUMAN","Q8TDM6","DLG5",9.04e-11,"Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG)","apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; protein localization to adherens junction [GO:0071896]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186]","GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609"
"g7863",301.952125243283,0.914185067571612,0.259702380949189,3.52012586188215,0.000431342061319465,0.0284194261292469,58975,62999,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.7e-37,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g83299",43.9599387096029,2.36404118947107,0.671558885949151,3.52022918456338,0.000431174055947899,0.0284194261292469,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91720",207.734634427577,1.48566462385064,0.422070772858236,3.51994196089393,0.00043164124032621,0.0284194261292469,0,7480,"sp|Q9FR44|PEAM1_ARATH","Q9FR44","PEAM1",2.5e-08,"Phosphoethanolamine N-methyltransferase 1 (AtNMT1) (PEAMT 1) (EC 2.1.1.103) (Protein XIPOTL 1)","choline biosynthetic process [GO:0042425]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]; pollen development [GO:0009555]; pollen tube growth [GO:0009860]; pollen tube guidance [GO:0010183]; post-embryonic root development [GO:0048528]; unidimensional cell growth [GO:0009826]","GO:0000234; GO:0005737; GO:0006656; GO:0008168; GO:0009555; GO:0009826; GO:0009860; GO:0010183; GO:0032259; GO:0042425; GO:0048528; GO:0052667"
"g112760",40.1961824085674,0.844424771802571,0.239862721489093,3.52045022486318,0.000430814843795327,0.0284194261292469,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121505",177.7007023014,-0.351732198474252,0.099927408180321,-3.51987712759991,0.000431746760441022,0.0284194261292469,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95074",60.0298198343119,1.49765194469582,0.425632742261075,3.51864834631823,0.000433751235853821,0.028519767786555,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128260",160.501062096935,1.089626441992,0.309721489898487,3.51808472298493,0.000434673561835625,0.028519767786555,1716,3324,"sp|Q924Z4|CERS2_MOUSE","Q924Z4","CERS2",1.54e-53,"Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24) (Translocating chain-associating membrane protein homolog 3) (TRAM homolog 3) (Tumor metastasis-suppressor gene 1 protein) (Very-long-chain ceramide synthase CERS2) (EC 2.3.1.297)","ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; regulation of lipid metabolic process [GO:0019216]; sphingolipid biosynthetic process [GO:0030148]","GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0016410; GO:0019216; GO:0030148; GO:0046513; GO:0048681; GO:0050291; GO:1900148; GO:1905045"
"g132516",193.430231153741,0.960128893500811,0.272934978808397,3.51779349679775,0.000435150848086174,0.028519767786555,0,3426,"sp|B2D0J5|EST6_APIME","B2D0J5","EST6",2.23e-18,"Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)",NA,"GO:0005576; GO:0080030"
"g146181",45.1151337544519,2.48367806562054,0.705983583284748,3.51803940548399,0.00043474779988959,0.028519767786555,1014,2326,"sp|O61866|LIPL5_CAEEL","O61866","LIPL5",4.16e-17,"Lipase lipl-5 (EC 3.1.1.-) (Lipase-like 5)","defense response to Gram-negative bacterium [GO:0050829]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; triglyceride catabolic process [GO:0019433]","GO:0005576; GO:0005764; GO:0006629; GO:0016788; GO:0019433; GO:0043202; GO:0050829; GO:0055088"
"g114986",41.6469145772224,1.06183130254215,0.301964085727452,3.51641586774841,0.000437415262285415,0.0286372516376503,0,4963,"sp|P51910|APOD_MOUSE","P51910","APOD",6.74e-06,"Apolipoprotein D (Apo-D) (ApoD)","aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]","GO:0000302; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405"
"g31396",1003.73884477774,0.360704392990674,0.102615862870509,3.51509389387338,0.000439598534008493,0.028687349493522,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31447",164.639854759206,0.471537933064925,0.134133365801573,3.51544099595983,0.000439024303836389,0.028687349493522,1876,17854,"sp|A8PB32|CLP1_BRUMA","A8PB32","CLP1",1.21e-25,"Protein CLP1 homolog","mRNA 3'-end processing [GO:0031124]","GO:0005524; GO:0005849; GO:0031124; GO:0051731"
"g101781",410.727514197537,0.448406097916513,0.127563758012416,3.51515277460601,0.000439501075004501,0.028687349493522,1842,3664,"sp|Q5RFK0|ETFB_PONAB","Q5RFK0","ETFB",1.13e-07,"Electron transfer flavoprotein subunit beta (Beta-ETF)","cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]","GO:0000166; GO:0005759; GO:0009055; GO:0009063; GO:0022904; GO:0033539; GO:0045251"
"g4131",1318.02598546034,-0.360122266291099,0.102473990861621,-3.51427970417783,0.00044094824527564,0.028744520951427,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g20655",189.405348300816,-0.442645544078453,0.126006177138229,-3.51288765464942,0.000443264859765481,0.0288407373044185,0,13589,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.24e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g75090",176.247235560392,1.75460257641422,0.499485215308575,3.51282184664917,0.000443374656533572,0.0288407373044185,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4102",590.874712243702,-0.547659868486454,0.155984404789433,-3.5109911739302,0.000446439220649074,0.0290089896158376,32745,48476,"sp|Q9V5M3|LOLA6_DROME","Q9V5M3","LOLA6",9.9e-07,"Longitudinals lacking protein, isoforms N/O/W/X/Y","axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; gonad development [GO:0008406]; larval lymph gland hemopoiesis [GO:0035167]; larval somatic muscle development [GO:0007526]; nurse cell apoptotic process [GO:0045476]; positive regulation of transcription, DNA-templated [GO:0045893]; R3/R4 cell fate commitment [GO:0007464]; R7 cell development [GO:0045467]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007409; GO:0007411; GO:0007464; GO:0007526; GO:0008406; GO:0016199; GO:0035167; GO:0045467; GO:0045476; GO:0045893; GO:0046872; GO:0048813"
"g6614",21.2558076845089,0.673839642010553,0.19201029544697,3.50939328769824,0.000449130245301928,0.029122022324979,101676,105144,"sp|Q3SYU1|NOC2L_BOVIN","Q3SYU1","NOC2L",8.16e-14,"Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)","apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]","GO:0000122; GO:0002903; GO:0003714; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0140297; GO:2001243"
"g51107",101.017416957307,-0.416480579040909,0.118685717606087,-3.50910444357921,0.000449618304803185,0.029122022324979,10556,13894,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.35e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g128648",847.339624950405,2.99839304018396,0.854442629284092,3.509180063612,0.000449490481932457,0.029122022324979,1802,3740,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.72e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g120270",141.152361552396,0.478919688308084,0.136559427275151,3.5070423028585,0.000453117108684099,0.0293173532260533,0,2144,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.28e-09,"PiggyBac transposable element-derived protein 4",NA,NA
"g73628",363.4948168961,2.65943723823463,0.75845940557161,3.5063672738429,0.000454267929339825,0.0293287300640887,0,5254,"sp|H2N0D4|AMY_ORYLA","H2N0D4","AMY",1.01e-26,"Alpha-amylase (EC 3.2.1.1)","carbohydrate metabolic process [GO:0005975]","GO:0004556; GO:0005576; GO:0005975; GO:0046872"
"g94751",438.679546499922,-0.467614131315443,0.133371998795526,-3.50608925065557,0.00045474270868854,0.0293287300640887,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133688",1448.31831800004,1.02522407539814,0.292371557880031,3.50657937739216,0.00045390603186564,0.0293287300640887,0,1000,"sp|Q5UQ13|COLL2_MIMIV","Q5UQ13","COLL2",1.8e-06,"Collagen-like protein 2",NA,NA
"g33297",267.077438516697,0.405312012214431,0.115660387931333,3.50432865965368,0.000457760031716149,0.029398366481326,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120826",28.4440794327978,-0.632526312665796,0.180486211096798,-3.50456862506001,0.000457347679209316,0.029398366481326,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131071",211.775381176399,0.473712498877127,0.135174448351647,3.50445298393078,0.000457546351686468,0.029398366481326,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140552",215.920930326773,-0.540280995135082,0.15416844373818,-3.50448497782481,0.000457491377838492,0.029398366481326,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g443",92.3334276029419,0.345271960842235,0.0985418117369813,3.50381178056482,0.0004586494067213,0.029424347245154,63305,72215,"sp|O94805|ACL6B_HUMAN","O94805","ACL6B",4.53e-24,"Actin-like protein 6B (53 kDa BRG1-associated factor B) (Actin-related protein Baf53b) (ArpNalpha) (BRG1-associated factor 53B) (BAF53B)","chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite development [GO:0016358]; histone H4 acetylation [GO:0043967]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]","GO:0000776; GO:0000785; GO:0003682; GO:0003713; GO:0005200; GO:0005634; GO:0006325; GO:0006338; GO:0006357; GO:0007399; GO:0008284; GO:0016358; GO:0016363; GO:0016514; GO:0016586; GO:0021510; GO:0030071; GO:0035060; GO:0035267; GO:0042551; GO:0043967; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0070316; GO:0071565; GO:0140092; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819"
"g6379",3491.31239064203,-0.795053836903795,0.226930215653238,-3.50351686140678,0.000459157585548853,0.0294258435765152,82789,91334,"sp|P08548|LIN1_NYCCO","P08548","LIN1",7.97e-09,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g15718",92.808068105522,0.901527142585472,0.257490427297729,3.50120644113524,0.000463156917391345,0.0295884140173481,55349,57004,"sp|P08548|LIN1_NYCCO","P08548","LIN1",9e-24,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g67990",121.662532497891,0.388555176845264,0.110959756783232,3.50176665945956,0.000462184206783639,0.0295884140173481,5635,11196,"sp|Q24134|NELFD_DROME","Q24134","NELFD",4.65e-15,"Negative elongation factor D","negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]","GO:0000122; GO:0003723; GO:0005634; GO:0005703; GO:0005705; GO:0008023; GO:0017053; GO:0032021; GO:0034244"
"g107812",135.591237082989,0.594808752075598,0.169878773835391,3.50137182325059,0.000462869564860441,0.0295884140173481,955,5663,"sp|Q8JJC0|ZIC1_CHICK","Q8JJC0","ZIC1",8.29e-66,"Zinc finger protein ZIC 1 (Zinc finger protein of the cerebellum 1)","cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; pattern specification process [GO:0007389]; regulation of smoothened signaling pathway [GO:0008589]; spinal cord development [GO:0021510]","GO:0003677; GO:0005634; GO:0005737; GO:0007389; GO:0008589; GO:0021510; GO:0030154; GO:0042472; GO:0046872"
"g82474",93.1959119372708,0.972582213059737,0.277845178151825,3.50044661393506,0.000464479262515385,0.0296416892135213,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69777",28.5507333908376,-0.717703839199376,0.205052714396732,-3.50009431141096,0.000465093577363429,0.0296497155569186,2105,5011,"sp|P08548|LIN1_NYCCO","P08548","LIN1",4.51e-14,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g103063",30.4775855626763,0.823434165744015,0.235282797724812,3.49976357688125,0.000465670973571016,0.0296553739622507,0,5236,"sp|Q99758|ABCA3_HUMAN","Q99758","ABCA3",2.49e-14,"Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form]","cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908]","GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016021; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0044267; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140"
"g90460",130.445912472712,1.28312498244704,0.366678284396238,3.4993208953178,0.000466444853538053,0.0296729377423752,1128,7574,"sp|P08548|LIN1_NYCCO","P08548","LIN1",4.4e-22,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g142416",1570.94003330002,0.749682817473774,0.214253441362748,3.49904679572685,0.000466924625868649,0.0296729377423752,0,2649,"sp|Q5UPS7|COLL4_MIMIV","Q5UPS7","COLL4",1.55e-16,"Collagen-like protein 4",NA,NA
"g94469",3761.27529705426,-1.17893423131605,0.337025457127782,-3.49805691642178,0.000468661105013151,0.0297210475060064,3865,5762,"sp|Q24133|DNAJ1_DROME","Q24133","DNAJ1",7.77e-121,"DnaJ protein homolog 1 (DROJ1)","chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]","GO:0000122; GO:0005829; GO:0006457; GO:0008134; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087"
"g143740",137.931537642634,0.837429366631609,0.23938296615017,3.49828302363949,0.000468263930135287,0.0297210475060064,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6078",68.6172251337129,-0.461301621595489,0.13189971648679,-3.497366286164,0.000469876197561609,0.0297670004488664,5425,37790,"sp|Q24UI6|IF2_DESHY","Q24UI6","IF2",5.74e-20,"Translation initiation factor IF-2",NA,"GO:0003743; GO:0003924; GO:0005525; GO:0005737"
"g35163",3390.17130692681,-0.296120421804643,0.0847304252586397,-3.49485348268625,0.000474322059536235,0.0299116198735375,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76182",71.9588174264704,0.362304231350592,0.103653264722196,3.49534799817076,0.000473444032038465,0.0299116198735375,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77598",34.5107887687896,2.05595074751215,0.588186032043808,3.49540899563393,0.000473335834265272,0.0299116198735375,0,3464,"sp|Q9GV46|LUCB_OPLGR","Q9GV46","LUCB",5.94e-22,"Oplophorus-luciferin 2-monooxygenase non-catalytic subunit",NA,"GO:0005576"
"g92576",1224.90632404715,-0.29252036106085,0.0837043810151505,-3.49468399996774,0.000474623330667599,0.0299116198735375,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147306",6578.63845907559,0.31967465694209,0.0914652743786183,3.49503851722791,0.000473993347305185,0.0299116198735375,0,2223,"sp|B0WN96|RS3A_CULQU","B0WN96","RS3A",4.22e-32,"40S ribosomal protein S3a","translation [GO:0006412]","GO:0003735; GO:0006412; GO:0022627"
"g61741",713.700118292889,0.311142547765662,0.089069890955474,3.49324047024153,0.000477196581879362,0.0300425939359528,0,12913,"sp|Q562C7|PUM3_RAT","Q562C7","PUM3",1.14e-83,"Pumilio homolog 3","regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417]","GO:0003677; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0005783; GO:0006417; GO:0010835"
"g70278",1012.33872771907,0.52288627082573,0.149705911773917,3.49275632892429,0.000478062527374425,0.0300659220583977,0,374,"sp|Q6DIY9|MDHC_XENTR","Q6DIY9","MDHC",1.88e-20,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase)","malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0030060"
"g9293",11148.3580246705,0.213436239906753,0.0611172980108155,3.49223946171479,0.000478988624642213,0.0300929809829564,57916,72634,"sp|Q5REX3|ZFR_PONAB","Q5REX3","ZFR",6.75e-26,"Zinc finger RNA-binding protein",NA,"GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0008270"
"g8262",174.522727568489,0.80593910161773,0.230864722293848,3.49095822700845,0.000481291498103459,0.0301493074601088,2466,10744,"sp|P45971|OST48_CAEEL","P45971","OST48",7.64e-14,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (Oligosaccharyl transferase 48 kDa subunit) (Oligosaccharyl transferase beta subunit 1)","protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0006487; GO:0008250; GO:0016021; GO:0018279"
"g31589",85.8988451664285,0.489769040339811,0.140298322129972,3.49091160111016,0.000481375497262242,0.0301493074601088,714,5232,"sp|Q9W3K5|GSH1_DROME","Q9W3K5","GSH1",1.28e-12,"Glutamate--cysteine ligase (EC 6.3.2.2) (Gamma-ECS) (GCS) (Gamma-glutamylcysteine synthetase)","axonogenesis [GO:0007409]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; imaginal disc-derived wing morphogenesis [GO:0007476]; response to copper ion [GO:0046688]","GO:0004357; GO:0005524; GO:0005634; GO:0006749; GO:0006750; GO:0007409; GO:0007476; GO:0017109; GO:0046688; GO:0048471"
"g48875",84.0175448350301,0.392206985401226,0.112334435098919,3.49142259945365,0.000480455651013149,0.0301493074601088,0,8214,"sp|B1P1W2|SDHF2_ARTSF","B1P1W2","SDHF2",1.01e-18,"Succinate dehydrogenase assembly factor 2, mitochondrial (SDH assembly factor 2) (SDHAF2)","mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; protein-FAD linkage [GO:0018293]","GO:0005739; GO:0005759; GO:0006121; GO:0018293"
"g29333",352.864058236388,-0.661096972855889,0.189435754402445,-3.4898215225592,0.000483343235677586,0.0302413412095595,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8401",37.8454383658303,-0.699796278967972,0.200563621758915,-3.48914859450012,0.000484561703637987,0.0302863540615751,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75000",207.180876400749,0.292727928935728,0.0839181472763375,3.48825538261459,0.000486183463773435,0.0303564551609154,3015,9414,"sp|Q80WQ9|ZBED4_MOUSE","Q80WQ9","ZBED4",3.1e-30,"Zinc finger BED domain-containing protein 4","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000976; GO:0000977; GO:0001228; GO:0001917; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0042802; GO:0045944; GO:0046872; GO:0046983"
"g123197",40.9969388319341,-0.541813577355901,0.155339765028683,-3.48792582025508,0.000486783111011617,0.0303626587947534,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122654",279.219433893565,0.270712610536442,0.0776249705301958,3.48744236149032,0.000487664024921552,0.0303863754337669,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68362",58.5621676125285,0.583571324681459,0.167379294678295,3.48652039550704,0.000489348068517753,0.0304600351572743,3126,8804,"sp|Q5PRA2|DHTK1_DANRE","Q5PRA2","DHTK1",9.92e-17,"2-oxoadipate dehydrogenase complex component E1 (E1a) (OADC-E1) (OADH-E1) (EC 1.2.4.-) (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase) (Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)","glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005739; GO:0006096; GO:0006099; GO:0030976"
"g818",569.670955146202,-0.450499189793231,0.129259057910436,-3.48524271394105,0.000491690821526,0.0305728913634023,88745,155139,"sp|Q9VX32|RG190_DROME","Q9VX32","RG190",3.93e-17,"Rho GTPase-activating protein 190 (Rho GTPase-activating protein of 190 kDa)","defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266]","GO:0003924; GO:0005096; GO:0005525; GO:0005829; GO:0007266; GO:0007415; GO:0016319; GO:0030215; GO:0045792; GO:0050770"
"g83424",382.614109974942,0.455720148290299,0.130787364787852,3.48443558771534,0.000493176151668658,0.0305728913634023,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103417",171.524921951688,0.595218701491348,0.170795874823632,3.48497118039874,0.000492190050282287,0.0305728913634023,0,1920,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.17e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g104525",44.1424888226393,-0.504492148626814,0.144775757783847,-3.48464519439803,0.000492790017107293,0.0305728913634023,0,5997,"sp|Q8VI56|LRP4_MOUSE","Q8VI56","LRP4",2.75e-19,"Low-density lipoprotein receptor-related protein 4 (LRP-4) (LDLR dan)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; anatomical structure development [GO:0048856]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of protein phosphorylation [GO:0001932]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001932; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0048699; GO:0048813; GO:0048856; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"g23999",281.876020389304,0.445780095266037,0.127956247020388,3.48384784366962,0.000494260390948918,0.0306088399251937,33015,35277,"sp|Q6NV04|HACL2_DANRE","Q6NV04","HACL2",1.06e-22,"2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein)","embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]","GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016021; GO:0016829; GO:0030976; GO:0048701; GO:0050660"
"g84416",117.219636606227,0.35829687814329,0.102867256699027,3.4830993810947,0.000495644332889234,0.0306632564353187,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29753",258.176195220655,-0.2316276373193,0.0665186150359668,-3.48214762430122,0.000497409394099335,0.0307098434668247,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g36397",656.401307462933,0.439020428298589,0.126075076294034,3.48221425838919,0.000497285628660463,0.0307098434668247,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33792",286.047541327836,-0.334659624488431,0.096142178294149,-3.48088248494363,0.000499764706588457,0.0308239024825746,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97485",28.2509883040409,-0.793671242054502,0.228106558165492,-3.47938809141423,0.000502560216723107,0.0309648523379953,0,6785,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.6e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g1700",429.12306282908,0.390307943668686,0.112198091319924,3.47873960311636,0.000503777851383563,0.0309769785212446,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151260",41.9738997224973,0.472752572204304,0.135892385086976,3.478874639677,0.000503524073349784,0.0309769785212446,0,1813,"sp|A2RRV9|NARFL_DANRE","A2RRV9","NARFL",8.56e-14,"Cytosolic Fe-S cluster assembly factor narfl (Nuclear prelamin A recognition factor-like protein)","iron-sulfur cluster assembly [GO:0016226]; sprouting angiogenesis [GO:0002040]","GO:0002040; GO:0016226; GO:0046872; GO:0051539; GO:0097361"
"g123941",190.046465789313,0.444239333969248,0.127712321127922,3.47843755438662,0.000504345931852614,0.0309805208543878,0,4138,"sp|P48605|TCPG_DROME","P48605","TCPG",2.9e-20,"T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (Chaperonin containing TCP1 subunit 3)","lumen formation, open tracheal system [GO:0035149]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]","GO:0005524; GO:0005832; GO:0006457; GO:0007430; GO:0016887; GO:0035149; GO:0051082"
"g126175",176.822849186518,2.15891475711554,0.620784762767404,3.47771866611431,0.000505700389573552,0.0310010577634765,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g135363",3759.62015817152,0.820783922862529,0.236012221893566,3.4777178752746,0.000505701881460566,0.0310010577634765,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g98366",169.756679850784,0.514045713119332,0.147835244043699,3.47715266710951,0.000506769173738112,0.0310038519699254,0,5744,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.1e-39,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g154457",56.1293225554336,0.441949470903464,0.127096211761109,3.47728279843742,0.000506523258600138,0.0310038519699254,0,1319,"sp|Q9VFR0|BCCIP_DROME","Q9VFR0","BCCIP",3.75e-10,"Protein BCCIP homolog","regulation of protein kinase activity [GO:0045859]","GO:0005634; GO:0019887; GO:0045859"
"g89993",76.897819392884,-0.862155768191672,0.247994720084841,-3.47650856395943,0.000507988004684511,0.0310471218573041,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g307",114.920589941687,-0.6131652561795,0.176396142958672,-3.47606952110715,0.000508820367384616,0.0310667083466522,0,14702,"sp|Q01617|CPO_DROME","Q01617","CPO",4.49e-06,"Protein couch potato","chemical synaptic transmission [GO:0007268]; dormancy process [GO:0022611]; regulation of hemocyte proliferation [GO:0035206]","GO:0003729; GO:0005634; GO:0007268; GO:0022611; GO:0035206; GO:0045202"
"g70961",23.65082557368,-0.767730072280354,0.220908614263648,-3.47532881340739,0.000510227526176489,0.031109935598919,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162538",22.4317611727348,-0.874714462358344,0.251704986503621,-3.47515746314291,0.000510553564945186,0.031109935598919,0,448,"sp|Q641Z2|PTN9_RAT","Q641Z2","PTN9",3.23e-17,"Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48)","negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470]","GO:0004725; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:1903078"
"g33515",101.179036695813,-0.78268068593573,0.225254136368002,-3.47465621966226,0.000511508427335702,0.031136857026082,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g102625",88.3669741169736,1.98843841060586,0.572351063873801,3.47415866958936,0.000512457899957494,0.0311633967419041,0,5548,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.77e-08,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g29023",1661.99633787032,2.49652655517837,0.718724828247633,3.47354989984875,0.000513621847317014,0.0311717099136696,1135,6799,"sp|Q6L6Q6|LYS_CRAGI","Q6L6Q6","LYS",3.97e-08,"Lysozyme (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase) (Invertebrate-type lysozyme)","cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152]","GO:0003796; GO:0005576; GO:0008152; GO:0019835; GO:0042742"
"g107663",43.8462839105429,0.492025707626448,0.141644813475694,3.47365848104899,0.000513414063296305,0.0311717099136696,0,5678,"sp|Q9N5X6|ODD2_CAEEL","Q9N5X6","ODD2",5.68e-19,"Protein odd-skipped-related 2","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g65981",1859.21270617558,0.393242566577749,0.113252272983275,3.47227085354678,0.000516075373287734,0.0312893250797528,3735,11502,"sp|P55884|EIF3B_HUMAN","P55884","EIF3B",3.6e-09,"Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116)","formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]","GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0045202; GO:0060090; GO:0070062; GO:0071541; GO:0075522; GO:0075525"
"g97521",288.100886629838,0.494043327567784,0.142307495972008,3.47166060503912,0.000517249825774171,0.0313292334593158,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19146",45.3041677866875,1.49187639830001,0.429995272645748,3.46951813939845,0.000521392858564997,0.03136151536572,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26436",185.732767444728,-0.360705432522396,0.103945228076909,-3.47014903132937,0.00052016965797634,0.03136151536572,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29311",133.89997883386,0.463380185797274,0.133545269156755,3.46983602431742,0.000520776194830909,0.03136151536572,3235,5415,"sp|Q5BU09|EAPP_MOUSE","Q5BU09","EAPP",1.28e-09,"E2F-associated phosphoprotein (EAPP)","negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]","GO:0005634; GO:0005737; GO:0008284; GO:0032968; GO:0034244"
"g55280",5371.47827725571,0.395204033422039,0.113901109921027,3.46971187283471,0.000521016954872889,0.03136151536572,4125,8400,"sp|B4LYI3|EI3D1_DROVI","B4LYI3","EI3D1",1.95e-119,"Eukaryotic translation initiation factor 3 subunit D-1 (eIF3d-1) (Eukaryotic translation initiation factor 3 subunit 7-1) (Eukaryotic translation initiation factor 3 subunit p66)","cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]","GO:0001732; GO:0002191; GO:0003743; GO:0005634; GO:0005852; GO:0006446; GO:0016282; GO:0033290; GO:0098808"
"g62876",34.9862097402488,1.82873138416539,0.526897363122289,3.47075448115491,0.000518998301082818,0.03136151536572,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104290",83.6531997100636,0.642882585229961,0.18529468527889,3.46951443460102,0.000521400049497635,0.03136151536572,0,6023,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.29e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g136703",52.732140934105,0.408750244179222,0.117771558095375,3.47070422425933,0.000519095438881035,0.03136151536572,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3891",191.072199407508,-0.405117903877107,0.116801550803342,-3.4684291526163,0.000523510542693701,0.0313707151933813,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12557",314.662584229542,-0.330150065077961,0.0952307850190554,-3.46684178873354,0.000526611751304646,0.0313707151933813,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14151",469.957141469197,0.710873173211393,0.205063067201841,3.46660753158291,0.000527070862971399,0.0313707151933813,33745,56447,"sp|Q9GMB0|RPN1_PIG","Q9GMB0","RPN1",9.43e-29,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1)","protein N-linked glycosylation via asparagine [GO:0018279]","GO:0008250; GO:0016021; GO:0018279; GO:0042470"
"g21025",26.7229892777393,-0.596439449857306,0.171952832982302,-3.46862240948769,0.000523134144111706,0.0313707151933813,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21999",96.9839152864293,0.885144891124841,0.255307155626173,3.4669803474717,0.000526340370750134,0.0313707151933813,4205,13200,"sp|P21328|RTJK_DROME","P21328","RTJK",2.32e-12,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g23634",42.0360842572809,0.430147092108961,0.124051104027967,3.46749910433675,0.000525325492740421,0.0313707151933813,40466,41994,"sp|P14735|IDE_HUMAN","P14735","IDE",5.24e-26,"Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin)","amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]","GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008286; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0019885; GO:0030163; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0045732; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715"
"g47235",86.8257021301445,0.701278138692816,0.202174590987479,3.46867593631608,0.000523029936687254,0.0313707151933813,0,18679,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.42e-39,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g84692",75.3204297791251,0.699152843552693,0.201597272292031,3.4680669812829,0.000524216608932816,0.0313707151933813,6803,8408,"sp|Q94529|GS1_DROME","Q94529","GS1",3.06e-19,"Probable pseudouridine-5'-phosphatase (EC 3.1.3.96) (GS1-like protein) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase)","nucleotide metabolic process [GO:0009117]; wound healing [GO:0042060]","GO:0009117; GO:0016791; GO:0042060; GO:0046872; GO:1990738"
"g99918",160.540603372436,-0.532900047978034,0.153726979517915,-3.46653560519565,0.00052721190358746,0.0313707151933813,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131584",20.58598775049,-1.08052104597026,0.31170178570707,-3.4665218343847,0.000527238910813131,0.0313707151933813,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g142790",70.6683199576875,0.452806986348478,0.130594430690787,3.46727639113958,0.000525760977536776,0.0313707151933813,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6440",29.5154098447896,-0.672227999896779,0.194069702865368,-3.46384824612796,0.000532506827715449,0.0314706824893765,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6670",127.561807469313,0.365291880256422,0.105488533212752,3.46285865516484,0.000534469078596689,0.0314706824893765,66745,73635,"sp|Q3UGY8|BIG3_MOUSE","Q3UGY8","BIG3",1.01e-16,"Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3)","actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012]","GO:0005085; GO:0016021; GO:0030036; GO:0030658; GO:0032012"
"g10432",25.3652210362978,-0.691110334260161,0.199532696635993,-3.46364453501549,0.000532910215075357,0.0314706824893765,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25662",296.41100244497,0.270818754017717,0.0781701338462831,3.46447857630979,0.000531260453710401,0.0314706824893765,11345,34402,"sp|Q8BHY2|NOC4L_MOUSE","Q8BHY2","NOC4L",5.25e-09,"Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein)","ribosome biogenesis [GO:0042254]","GO:0005654; GO:0005730; GO:0016021; GO:0030692; GO:0031965; GO:0032040; GO:0042254"
"g39834",53.4515289386503,0.378181593134072,0.109138305897148,3.46515909354933,0.000529917895057624,0.0314706824893765,0,24449,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.35e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g43117",377.283176579784,-0.440992538797887,0.127352125551262,-3.46278114235619,0.000534623062226844,0.0314706824893765,2915,11501,"sp|P17019|ZN708_HUMAN","P17019","ZN708",1.53e-61,"Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8)","regulation of transcription, DNA-templated [GO:0006355]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872"
"g49299",40.0544550270964,0.725417009323181,0.209429895678102,3.46377009344531,0.000532661551474928,0.0314706824893765,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68614",92.9464005309776,0.915427524933861,0.264312221258909,3.46343245338303,0.000533330480197721,0.0314706824893765,2221,11234,"sp|P29291|TNNCB_HOMAM","P29291","TNNCB",1.46e-20,"Troponin C, isoform 2B",NA,"GO:0005509"
"g112547",356.433240352211,2.50980098004787,0.724671079742878,3.46336572578331,0.00053346277277413,0.0314706824893765,926,4814,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.02e-14,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g121256",29.4428413264746,-0.646805811256744,0.186672759080653,-3.4649180439728,0.00053039308777167,0.0314706824893765,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g159355",52.4445427870534,1.39977950330265,0.404201469924413,3.46307375765954,0.000534041981616118,0.0314706824893765,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18736",45.1889916908,0.846090091026759,0.244560216526585,3.45963911483037,0.000540899791109235,0.0317477836773883,0,3991,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.59e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g19177",96.4174014000055,0.531665388173845,0.1536656232413,3.45988502151177,0.000540406085557744,0.0317477836773883,44285,51157,"sp|Q04451|GARS_BOMMO","Q04451","GARS",1.84e-36,"Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase)","diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]","GO:0004820; GO:0005524; GO:0005739; GO:0006426; GO:0015966; GO:0016740; GO:0030424; GO:0046983"
"g142735",619.486041106536,0.457502955089135,0.132235369740498,3.45976236151454,0.000540652296885391,0.0317477836773883,0,2625,"sp|O16797|RL3_DROME","O16797","RL3",1.2e-20,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g17414",975.119192837446,0.593750384900726,0.171695235625958,3.45816459458564,0.000543869003051836,0.0317981604183022,36066,42324,"sp|P28765|SODM_PALVU","P28765","SODM",1.42e-25,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) (Fragment)",NA,"GO:0004784; GO:0005759; GO:0046872"
"g22595",536.967056215369,-0.36006888346458,0.104121465610501,-3.45816188192673,0.00054387447944519,0.0317981604183022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25600",144.452462688447,-0.730090950070347,0.211178820906904,-3.45721671773231,0.000545785734400904,0.0317981604183022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51876",20.3229875238934,1.04441413831918,0.302051293195677,3.45773768180024,0.000544731499227769,0.0317981604183022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60478",137.810080249478,0.422042874495918,0.122078766269,3.45713580989136,0.000545949631831782,0.0317981604183022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86924",412.323304320487,1.43847996091047,0.416064461181698,3.45734878875482,0.000545518292662153,0.0317981604183022,0,3784,"sp|P04040|CATA_HUMAN","P04040","CATA",1.91e-27,"Catalase (EC 1.11.1.6)","aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to growth factor stimulus [GO:0071363]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]","GO:0000268; GO:0000302; GO:0001649; GO:0001657; GO:0001666; GO:0004046; GO:0004096; GO:0005576; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005778; GO:0005782; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006641; GO:0007568; GO:0008203; GO:0009060; GO:0009410; GO:0009642; GO:0009650; GO:0010193; GO:0010288; GO:0014068; GO:0014823; GO:0014854; GO:0016020; GO:0016209; GO:0016684; GO:0019899; GO:0020027; GO:0020037; GO:0032088; GO:0032355; GO:0032868; GO:0032991; GO:0033189; GO:0033197; GO:0033591; GO:0034774; GO:0042542; GO:0042744; GO:0042802; GO:0042803; GO:0043066; GO:0043231; GO:0045471; GO:0046686; GO:0046872; GO:0050661; GO:0051092; GO:0051781; GO:0055093; GO:0061692; GO:0062151; GO:0070062; GO:0070542; GO:0071363; GO:0080184; GO:1904813"
"g101950",62.8026642857564,0.707528783551779,0.204627683954889,3.45763960123674,0.000544929832295424,0.0317981604183022,0,6276,"sp|Q58D68|ENPP6_PIG","Q58D68","ENPP6",6.1e-10,"Glycerophosphocholine cholinephosphodiesterase ENPP6 (GPC-Cpde) (EC 3.1.4.-) (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 6) (E-NPP 6) (NPP-6)","choline metabolic process [GO:0019695]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]","GO:0005886; GO:0006629; GO:0008081; GO:0008889; GO:0016042; GO:0019695; GO:0031225; GO:0046872; GO:0047390"
"g144102",191.756565625696,0.501519827153086,0.145009667745905,3.45852683444444,0.000543138164167126,0.0317981604183022,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31954",51.3332040205634,1.96012037948581,0.567076938118879,3.45653340442299,0.000547171384958511,0.0318387644804718,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118276",1618.98836273445,0.541621050269478,0.156707472495656,3.45625541426873,0.000547736041978096,0.0318410923253359,1125,4644,"sp|Q4U3L0|G3P_GLOMM","Q4U3L0","G3P",9.78e-06,"Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12)","glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]","GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0015630; GO:0050661; GO:0051287"
"g84238",26.9873538041485,-1.00496290953044,0.290807582664096,-3.45576583775413,0.000548731795813256,0.0318684523329249,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9921",421.716111013263,1.22120916294388,0.353511148066764,3.4545138664573,0.000551285866127985,0.0319499365030166,89,22211,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.06e-54,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g73423",31.8431739405684,0.647268566096334,0.187368711698268,3.45451788737637,0.000551277645599867,0.0319499365030166,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113172",90.4511592937967,-1.24822601990746,0.361353795107325,-3.45430444292616,0.000551714177873808,0.0319499365030166,0,464,"sp|P41383|TBA2_PATVU","P41383","TBA2",4.13e-35,"Tubulin alpha-2/alpha-4 chain","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g15094",34.5968817371266,0.572066554141799,0.165649765370154,3.45347035574414,0.000553423125593021,0.0319769686565428,36525,42787,"sp|Q27640|ALDH_ENCBU","Q27640","ALDH",3.96e-16,"Aldehyde dehydrogenase (EC 1.2.1.3) (Aldehyde dehydrogenase [NAD(+)])","ethanol catabolic process [GO:0006068]","GO:0004029; GO:0006068; GO:0043878"
"g37753",181.966107568988,1.74014011311111,0.503905650155171,3.4533054205192,0.000553761642083152,0.0319769686565428,5136,15554,"sp|P29957|AMY_PSEHA","P29957","AMY",2.78e-06,"Alpha-amylase (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)","carbohydrate metabolic process [GO:0005975]","GO:0004556; GO:0005576; GO:0005975; GO:0046872"
"g95950",217.461716714095,-0.585798374918711,0.16961653388656,-3.45366316299386,0.000553027648349796,0.0319769686565428,1526,6966,"sp|Q96GN5|CDA7L_HUMAN","Q96GN5","CDA7L",1.64e-38,"Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2)","positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]","GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0008284"
"g26666",30.1536699542689,-0.647919456351675,0.187657148927725,-3.45267665023098,0.000555053913257432,0.0319907141458628,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118463",177.381421647798,0.975522886915479,0.282523297064089,3.452893609316,0.000554607694125294,0.0319907141458628,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6376",94.1734820936743,0.417457193251805,0.120945745614074,3.45160709152903,0.000557258563406339,0.0320474299971143,32035,39627,"sp|Q9VZU4|NDUS3_DROME","Q9VZU4","NDUS3",7.57e-26,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (NADH dehydrogenase (Ubiquinone) 30 kDa subunit)","reactive oxygen species metabolic process [GO:0072593]","GO:0005739; GO:0005747; GO:0008137; GO:0072593"
"g132705",71.1366844815535,-1.54486477034802,0.44760122000215,-3.45143109829011,0.000557622113642325,0.0320474299971143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139469",28.0318971653827,1.04043398337314,0.301420737601915,3.45176643004317,0.000556929607358254,0.0320474299971143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22306",165.372072989359,-0.366043961615944,0.106109827199551,-3.44967069758353,0.000561270759286415,0.0321529245371085,16322,33184,"sp|P11369|LORF2_MOUSE","P11369","LORF2",6.41e-19,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g29363",77.0417992409023,0.498743910008875,0.144626063035266,3.44850644165887,0.000563696024179988,0.0321529245371085,11725,15030,"sp|Q93XX8|NOP10_ARATH","Q93XX8","NOP10",2.46e-06,"H/ACA ribonucleoprotein complex subunit 3-like protein (Nucleolar protein 10)","polar nucleus fusion [GO:0010197]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]","GO:0005730; GO:0005739; GO:0010197; GO:0015030; GO:0031118; GO:0031120; GO:0031429; GO:0034513; GO:0070034; GO:0090661"
"g30961",120.675823353234,0.472673467737718,0.13705094788329,3.44888871648109,0.000562898632280249,0.0321529245371085,3432,15824,"sp|P21328|RTJK_DROME","P21328","RTJK",7.53e-26,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g52514",385.508634687019,0.737776234587215,0.213867880065591,3.44968227281696,0.000561246695747979,0.0321529245371085,715,16145,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.53e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g83621",118.248131939246,2.61272981668381,0.757590267462829,3.44873730418138,0.000563214339392608,0.0321529245371085,0,3514,"sp|Q04519|ASM_MOUSE","Q04519","ASM",5.12e-13,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (ASMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; ceramide metabolic process [GO:0006672]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006672; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g84387",35.0464778776022,0.44395971627528,0.128677319899636,3.45017845119524,0.000560216102604922,0.0321529245371085,0,8455,"sp|P21328|RTJK_DROME","P21328","RTJK",2.33e-29,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g110234",5579.14917513621,0.394626761888538,0.114409312069102,3.44925386536881,0.000562137944662894,0.0321529245371085,0,2975,"sp|Q5UAP0|RS4_BOMMO","Q5UAP0","RS4",2.78e-20,"40S ribosomal protein S4","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:0019843"
"g120176",410.499675654228,0.432266511360606,0.125336910336243,3.44883650156173,0.000563007486063664,0.0321529245371085,0,3381,"sp|Q5ZIA5|COPB_CHICK","Q5ZIA5","COPB",1.18e-21,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]","GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0030126"
"g76736",183.25527674756,2.16950882382116,0.62921301977746,3.44797191988886,0.000564812753890095,0.0321863718625257,0,8774,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.01e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g94706",153.858693277583,0.993191865635085,0.288080417516792,3.44762019645848,0.000565548702513176,0.0321980776318243,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76145",53.1298254618086,-0.508661433017717,0.147624262624621,-3.4456492718351,0.000569689229107783,0.0324029613904644,0,9733,"sp|Q96JN8|NEUL4_HUMAN","Q96JN8","NEUL4",1.6e-29,"Neuralized-like protein 4",NA,"GO:0005737; GO:0005814; GO:0061630"
"g120640",43.1838628147178,-0.508233256386914,0.147510674964269,-3.44539984316404,0.0005702152375188,0.0324029613904644,0,4174,"sp|Q5JCS6|SI1L2_RAT","Q5JCS6","SI1L2",6.17e-10,"Signal-induced proliferation-associated 1-like protein 2 (SIPA1-like protein 2) (Serine-rich synapse-associated protein)","activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]","GO:0005096; GO:0005737; GO:0051056; GO:0090630"
"g109645",129.068937362965,-0.500976848712758,0.145437215953796,-3.44462622876329,0.000571849554663469,0.0324350929649775,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146426",33.2622528637342,2.39231558504195,0.694485091400897,3.44473281667752,0.000571624121086951,0.0324350929649775,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128841",983.840194195327,0.534008576545813,0.155064070296433,3.44379310774545,0.000573614461231794,0.0325048194698017,0,1454,"sp|A0A1L5YRA2|TPIS_SCYPA","A0A1L5YRA2","TPIS",3.89e-12,"Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Allergen Scy p 8) (Methylglyoxal synthase) (EC 4.2.3.3) (Triose-phosphate isomerase) (allergen Scy p 8.0101)","gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242]","GO:0004807; GO:0005737; GO:0006094; GO:0006096; GO:0008929; GO:0019242; GO:0019863; GO:0042803"
"g100394",26.3378800211248,1.35714622789795,0.394120932124255,3.44347665216137,0.000574286177663958,0.032512526233606,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37455",80.8588249544063,0.483190776634493,0.140345143245365,3.44287494003075,0.000575565407456585,0.0325242686951026,0,4019,"sp|Q96IR7|HPDL_HUMAN","Q96IR7","HPDL",4.02e-08,"4-hydroxyphenylpyruvate dioxygenase-like protein (HPD-like protein) (EC 1.13.-.-) (Glyoxalase domain-containing protein 1)","aromatic amino acid family metabolic process [GO:0009072]","GO:0003868; GO:0005739; GO:0009072; GO:0046872"
"g76888",93.7642793631302,0.482236239971995,0.140067783951821,3.44287762943312,0.000575559683934447,0.0325242686951026,5271,9414,"sp|P37227|MDHM_SCHMA","P37227","MDHM",3.72e-19,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37) (Fragment)","tricarboxylic acid cycle [GO:0006099]","GO:0005759; GO:0006099; GO:0030060"
"g34290",105.491323996752,-0.695402279515035,0.202084415409687,-3.44114749326533,0.000579252687709724,0.0326717896069732,11126,13554,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.2e-07,"PiggyBac transposable element-derived protein 4",NA,NA
"g124869",39.3124996373813,0.540566270068637,0.157077953386941,3.44138854888835,0.000578736831087003,0.0326717896069732,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38786",18184.695729553,0.384759738898113,0.111823080831228,3.44079000540883,0.000580018496418292,0.0326846077508135,0,3768,"sp|Q5E973|RL18_BOVIN","Q5E973","RL18",4.42e-23,"60S ribosomal protein L18","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0005791; GO:0022625; GO:0042788"
"g21591",898.819563520346,-0.485282276363004,0.141069924771702,-3.44001229991689,0.000581687750355234,0.0327408654030881,5617,13164,"sp|P80363|CCB23_FAXLI","P80363","CCB23",2.93e-19,"Crustacean calcium-binding protein 23 (CCBP-23)",NA,"GO:0005509"
"g71365",631.351387615039,-0.367155104612022,0.106736642294558,-3.43982250817665,0.000582095794528457,0.0327408654030881,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108434",42.5351382341339,0.486453680527091,0.141433787744941,3.4394446212835,0.0005829090289321,0.03275624904249,2288,5304,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.37e-59,"PiggyBac transposable element-derived protein 4",NA,NA
"g34724",22.6769584600052,1.01759537176486,0.29588656205303,3.43914020530099,0.000583564918836134,0.032762770512641,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41343",32.222872566905,1.41815254300574,0.412438673402729,3.43845675602049,0.000585039971672776,0.0327849269444328,13805,16795,"sp|Q9FY48|KEG_ARATH","Q9FY48","KEG",1.22e-06,"E3 ubiquitin-protein ligase KEG (EC 2.3.2.27) (EC 2.7.11.1) (Protein KEEP ON GOING) (RING finger protein KEG) (RING-type E3 ubiquitin transferase KEG)","abscisic acid-activated signaling pathway [GO:0009738]; defense response [GO:0006952]; developmental growth [GO:0048589]; endosomal transport [GO:0016197]; late endosome to vacuole transport [GO:0045324]; negative regulation of abscisic acid-activated signaling pathway [GO:0009788]; positive regulation of histone ubiquitination [GO:0033184]; protein ubiquitination [GO:0016567]; response to abscisic acid [GO:0009737]; secretion by cell [GO:0032940]","GO:0004672; GO:0004674; GO:0004712; GO:0004842; GO:0005524; GO:0005769; GO:0005802; GO:0006952; GO:0009737; GO:0009738; GO:0009788; GO:0016197; GO:0016567; GO:0032940; GO:0033184; GO:0043621; GO:0045324; GO:0046872; GO:0048589; GO:0106310"
"g133536",42.1676365018394,-0.542623076341796,0.15780575970932,-3.43855051514796,0.000584837411027587,0.0327849269444328,0,3345,"sp|O61366|GPRS_DROME","O61366","GPRS",1.3e-08,"Serine-enriched protein",NA,NA
"g25355",33.4887223831075,-0.752736148218225,0.218986326415417,-3.43736597868803,0.000587401331778285,0.0328868882155204,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54728",120.076432467737,0.529824034498518,0.154173624945177,3.43654133245502,0.000589192446587349,0.0329567645929827,11648,15301,"sp|P08548|LIN1_NYCCO","P08548","LIN1",9.01e-13,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g37965",303.654013013574,0.502979761687346,0.14642557503789,3.43505403039866,0.000592435696370413,0.0329594205869248,18374,21904,"sp|Q25008|TBA1_HOMAM","Q25008","TBA1",1.04e-27,"Tubulin alpha-1 chain (Alpha-I tubulin)","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g64436",76.0746394144506,2.12547800084233,0.618716149075484,3.43530390150367,0.000591889662015251,0.0329594205869248,0,12054,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",8.08e-69,"PiggyBac transposable element-derived protein 4",NA,NA
"g72797",37.5858898368601,0.704619380586783,0.20513816245013,3.4348527459296,0.000592875897058233,0.0329594205869248,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73585",608.428586790564,0.547279317660938,0.159304311357212,3.43543318444007,0.000591607328590768,0.0329594205869248,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100350",272.831140348337,-0.582233455852481,0.169510889598966,-3.43478497003908,0.000593024188593567,0.0329594205869248,0,6294,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.55e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g101322",999.366069246643,2.38106393716901,0.693222264274101,3.4347770691732,0.000593041477688612,0.0329594205869248,0,1363,"sp|P25784|CYSP3_HOMAM","P25784","CYSP3",3.78e-29,"Digestive cysteine proteinase 3 (EC 3.4.22.-)",NA,"GO:0008234"
"g121890",100.978694465248,1.25948920153,0.366617724938287,3.43542910191267,0.000591616242265755,0.0329594205869248,0,4223,"sp|Q17058|MAL1_APIME","Q17058","MAL1",9.3e-12,"Alpha-glucosidase (EC 3.2.1.20) (Maltase)",NA,"GO:0032450"
"g13866",287.606589180898,-0.466834157672206,0.135989237544373,-3.43287576356826,0.000597215684827999,0.0331264597739317,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21419",347.617683943236,0.255613250505371,0.0744695518975415,3.4324531837798,0.000598147141420657,0.0331264597739317,17485,23790,"sp|P14604|ECHM_RAT","P14604","ECHM",4.33e-24,"Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH)","fatty acid beta-oxidation [GO:0006635]","GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0043956; GO:0120092"
"g46997",1236.92007822689,-0.448938974600334,0.13080791666681,-3.43204743290773,0.000599042775795942,0.0331264597739317,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113121",87.5495301570884,1.06153670870092,0.309325467680565,3.43177920867852,0.000599635525807701,0.0331264597739317,0,2824,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.07e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g119235",4236.69640286079,0.94715002957186,0.275961825395948,3.43217772317926,0.000598755043540515,0.0331264597739317,0,4538,"sp|P21329|RTJK_DROFU","P21329","RTJK",6.66e-07,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g131415",21.4431855054229,-0.850702639116258,0.247884074044138,-3.43185677577973,0.000599464053814723,0.0331264597739317,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144556",58.4870417259804,0.744672943552369,0.216999898801353,3.43167415130485,0.00059986784135032,0.0331264597739317,0,1950,"sp|Q0IG34|HKT_AEDAE","Q0IG34","HKT",6.48e-11,"3-hydroxykynurenine transaminase (EC 2.6.1.63) (3-hydroxykynurenine transaminase and alanine--glyoxylate aminotransferase) (Ae-HKT/AGT) (Alanine--glyoxylate aminotransferase) (EC 2.6.1.44)","glyoxylate catabolic process [GO:0009436]; L-kynurenine catabolic process [GO:0097053]","GO:0005777; GO:0008453; GO:0009436; GO:0036137; GO:0047315; GO:0097053"
"g33553",49.238516533229,-0.522675682364893,0.152342036413838,-3.43093537849948,0.000601503872267427,0.0331596659335927,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69741",342.128504843362,0.582072001027581,0.169667500008486,3.43066292011416,0.000602108285694829,0.0331596659335927,3075,7330,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",8.56e-68,"PiggyBac transposable element-derived protein 4",NA,NA
"g99034",20.9118268048035,1.53417540641651,0.447168699035213,3.43086492799376,0.000601660103381996,0.0331596659335927,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85762",263.231973487451,0.521509010958938,0.15202607867837,3.43039178207218,0.000602710331226972,0.033162728923087,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87527",246.432687641056,0.489148799765189,0.142608289971645,3.43001658502776,0.000603544357545467,0.0331785390031108,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21412",207.370154490591,-0.470320576046487,0.137131369252331,-3.42970815948803,0.000604230761613375,0.0331862125993808,12873,48184,"sp|Q13136|LIPA1_HUMAN","Q13136","LIPA1",1.72e-81,"Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1)","cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0005737; GO:0005829; GO:0005925; GO:0007160; GO:0007165; GO:0030424; GO:0030425; GO:0032991; GO:0048786; GO:0050808; GO:0051497; GO:1903077"
"g28675",44.5738466341848,-0.428359869600279,0.124919394503856,-3.42909018492766,0.000605608256802503,0.0332317948511247,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122831",90.0994411326698,0.910006955207715,0.265402218339844,3.42878428409541,0.000606291205443813,0.0332340133917487,602,3684,"sp|Q5RB59|PUR6_PONAB","Q5RB59","PUR6",1.68e-17,"Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS) [Includes: Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC); Phosphoribosylaminoimidazole succinocarboxamide synthetase (EC 6.3.2.6) (SAICAR synthetase)]","'de novo' IMP biosynthetic process [GO:0006189]","GO:0004638; GO:0004639; GO:0005524; GO:0006189; GO:0043727"
"g147477",32.2615098038194,1.68355814634115,0.491036322073529,3.4285816968323,0.000606743892536785,0.0332340133917487,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9628",1591.21969302959,-0.670915941677452,0.19571744392711,-3.42798234135592,0.000608085012259357,0.0332774385879354,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88734",26.4917642381571,0.668135693888297,0.194938317940788,3.42742104757076,0.000609343466009604,0.033286278084719,0,5121,"sp|P58742|AAAS_MOUSE","P58742","AAAS",1.72e-06,"Aladin (Adracalin)","fertilization [GO:0009566]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]","GO:0000922; GO:0001578; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006913; GO:0007612; GO:0009566; GO:0015031; GO:0031965; GO:0051028; GO:0072686; GO:0090307"
"g103595",852.689944757223,1.18200743529766,0.344848634330586,3.42761234241843,0.000608914299688634,0.033286278084719,0,3215,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.68e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g36598",23.1602514755103,0.57178467017329,0.166841162594629,3.4271199102259,0.00061001963224426,0.033293247734626,23361,24474,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.45e-15,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g17274",680.005013387284,-0.530514492354921,0.154821215312728,-3.42662658527335,0.00061112884076666,0.03332381792105,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57002",335.972847688843,2.45149131001953,0.71551232582613,3.4262041638333,0.00061208011875886,0.0333457292706241,4396,14144,"sp|P81182|BGBP_PENVA","P81182","BGBP",0,"Beta-1,3-glucan-binding protein (BGBP) (Beta-1,3-glucan recognition protein) (BetaGRP) (BetaGBP-HDL) (High density lipoprotein)","cell surface pattern recognition receptor signaling pathway [GO:0002752]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; regulation of innate immune response [GO:0045088]","GO:0002752; GO:0005576; GO:0006869; GO:0038187; GO:0045087; GO:0045088"
"g9883",20.7997587368184,0.878450208900778,0.256416684604602,3.42586992829799,0.000612833781515645,0.033356845022587,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29242",94.1516203284313,1.6495516806011,0.481541399548953,3.42556565675598,0.000613520629713342,0.0333643073631745,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25702",577.606896386319,-0.721932454751471,0.210867209428165,-3.42363545621544,0.000617894485759649,0.0334224744569992,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38205",39.0092219301168,1.01423293786403,0.296198069561517,3.42417133023678,0.000616677288787815,0.0334224744569992,0,20571,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.96e-17,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g44068",41.0381166892802,0.439081791674254,0.128228180333749,3.42422227728274,0.000616561682675347,0.0334224744569992,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80510",79.7343972369291,0.423049520097576,0.123552145612044,3.4240564419331,0.000616938060762138,0.0334224744569992,4335,9039,"sp|P08548|LIN1_NYCCO","P08548","LIN1",3.07e-27,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g126147",60.0451660037973,0.432407774046543,0.126273362256207,3.42437839874092,0.000616207546393104,0.0334224744569992,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147545",30.6733524920018,-0.718839465357193,0.209954085884066,-3.42379364674107,0.000617534935692057,0.0334224744569992,0,2202,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",3.81e-23,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g11116",309.332502529282,0.348723461787905,0.101874085462152,3.42308311486597,0.000619151426301097,0.0334606411952035,38465,44451,"sp|P15505|GCSP_CHICK","P15505","GCSP",1.78e-20,"Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))","glycine catabolic process [GO:0006546]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255]","GO:0004375; GO:0005739; GO:0006546; GO:0016829; GO:0036255; GO:0042803; GO:0047960; GO:0070280; GO:1903442"
"g67890",1021.40006222286,-0.373710175915529,0.109199435772738,-3.42227204079408,0.000621001466603843,0.0335009591183886,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80553",34.8321114550037,0.564890806210136,0.165062980345631,3.42227436477453,0.000620996158320927,0.0335009591183886,0,9032,"sp|P08548|LIN1_NYCCO","P08548","LIN1",8.56e-17,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g5170",95.3088199840801,0.711104568613949,0.207807303584417,3.42194213749122,0.00062175543850429,0.0335118450824382,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25685",2804.85954627528,-0.581716059049867,0.170009604551165,-3.42166585579462,0.000622387517038707,0.0335161476566807,0,20200,"sp|A6QQJ8|ZC12A_BOVIN","A6QQJ8","ZC12A",4.02e-64,"Ribonuclease ZC3H12A (EC 3.1.-.-) (Zinc finger CCCH domain-containing protein 12A)","3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response-activating signal transduction [GO:0002757]; miRNA catabolic process [GO:0010587]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor production [GO:0032720]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852]","GO:0000294; GO:0000932; GO:0001525; GO:0001933; GO:0002230; GO:0002757; GO:0003677; GO:0003682; GO:0003729; GO:0003730; GO:0004518; GO:0004521; GO:0004532; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005791; GO:0005856; GO:0006915; GO:0006974; GO:0010508; GO:0010587; GO:0010595; GO:0010656; GO:0010884; GO:0010942; GO:0016579; GO:0030154; GO:0030867; GO:0032088; GO:0032689; GO:0032691; GO:0032715; GO:0032720; GO:0032991; GO:0034599; GO:0035198; GO:0035613; GO:0035925; GO:0036464; GO:0042149; GO:0042307; GO:0042406; GO:0043022; GO:0043124; GO:0044828; GO:0045019; GO:0045600; GO:0045766; GO:0045944; GO:0046872; GO:0050852; GO:0051259; GO:0055118; GO:0061014; GO:0061158; GO:0071222; GO:0071347; GO:0071356; GO:0090501; GO:0090502; GO:0098586; GO:1900016; GO:1900119; GO:1900745; GO:1901223; GO:1903003; GO:1903799; GO:1903936; GO:1904637; GO:1990869; GO:2000320; GO:2000379; GO:2000627"
"g102327",167.756758373203,0.288015354897829,0.0841867066422453,3.42115004120261,0.000623569200370322,0.0335500130943926,0,6240,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.84e-32,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g5792",3182.66432015551,-0.368564963484048,0.107758147989537,-3.42029786480588,0.000625526031381348,0.0335660255035668,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9290",2110.35587570935,0.271912783310083,0.0794969511795788,3.42041775534068,0.00062525038487387,0.0335660255035668,50798,60474,"sp|Q562A2|ZFR_RAT","Q562A2","ZFR",6.02e-12,"Zinc finger RNA-binding protein",NA,"GO:0003677; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0008270"
"g69569",84.4343135533738,-0.387313455021788,0.113239445655608,-3.42030511346472,0.000625509362405576,0.0335660255035668,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9822",196.783272021164,-1.00530628010256,0.293954879826934,-3.4199339731813,0.00062636336587471,0.0335683837002528,0,10062,"sp|P18700|TBB_STRPU","P18700","TBB",3.69e-62,"Tubulin beta chain (Beta-tubulin) (Fragment)","microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]","GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874"
"g46559",39.727717491757,-0.645711626105305,0.188815713818124,-3.41979813569587,0.000626676202543853,0.0335683837002528,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27727",5737.12132754929,0.261174023900472,0.0763791151340089,3.41944291240133,0.000627494976715186,0.033582601531609,5341,17844,"sp|Q6GPM1|ZFR_XENLA","Q6GPM1","ZFR",4.17e-30,"Zinc finger RNA-binding protein",NA,"GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0008270"
"g68114",28.6251450818717,-0.503296160587136,0.147230963678203,-3.41841245899315,0.000629875761195012,0.0336803171338549,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61871",24.0794681500829,1.58923319800976,0.464971193779344,3.41791753827215,0.000631022222838682,0.0336822679895159,4085,12868,"sp|Q8I7P9|POL5_DROME","Q8I7P9","POL5",4.31e-68,"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074"
"g131915",67.4079355317742,1.21639940528122,0.35588466562004,3.41795958857049,0.000630924739800372,0.0336822679895159,0,3329,"sp|B2D0J5|EST6_APIME","B2D0J5","EST6",2.71e-18,"Venom carboxylesterase-6 (EC 3.1.1.1) (allergen Api m 8)",NA,"GO:0005576; GO:0080030"
"g88193",198.030619216967,0.454676693944749,0.133053230278314,3.41725407939123,0.0006325621411058,0.0337347946781292,4037,7564,"sp|Q84WW2|6PGL3_ARATH","Q84WW2","6PGL3",1.02e-10,"6-phosphogluconolactonase 3, chloroplastic (6PGL3) (EC 3.1.1.31) (Protein EMBRYO DEFECTIVE 2024)","carbohydrate metabolic process [GO:0005975]; cellular response to redox state [GO:0071461]; defense response to bacterium [GO:0042742]; defense response to oomycetes [GO:0002229]; nitrate assimilation [GO:0042128]; pentose-phosphate shunt, oxidative branch [GO:0009051]","GO:0002229; GO:0005737; GO:0005777; GO:0005975; GO:0009051; GO:0009507; GO:0009536; GO:0009570; GO:0017057; GO:0042128; GO:0042742; GO:0071461"
"g39914",125.903281355633,0.268011747569705,0.078442079246005,3.4166833687463,0.000633889582719985,0.0337492643862499,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68703",70.0909104378302,0.702672329626461,0.205660638138062,3.41665928875874,0.000633945648382351,0.0337492643862499,0,11216,"sp|Q09326|MGAT2_RAT","Q09326","MGAT2",2.02e-18,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)","oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0000139; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016021; GO:0018279; GO:0030145; GO:0030246; GO:0042803"
"g112759",63.20180971532,0.592033167534809,0.173358500062917,3.4150801219435,0.000637632524388548,0.0339157913279062,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52112",89.3943691263221,-0.450542495015623,0.131937245845312,-3.41482416226768,0.000638231987718434,0.0339179503805882,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g51339",333.840319027568,-0.557353582824846,0.163283405035491,-3.41341229810647,0.000641548036996611,0.0340367189175139,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65681",25.1312945783781,1.59246667992295,0.466554650227333,3.41324789956976,0.000641935200207737,0.0340367189175139,0,6670,"sp|P82968|MCPI_MELCP","P82968","MCPI",1.79e-06,"Four-domain proteases inhibitor (McaPI)",NA,"GO:0004867"
"g137528",826.798861100516,0.792624522641898,0.232226211615921,3.41315701240832,0.000642149335319714,0.0340367189175139,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31680",151.230010823673,0.468105711520012,0.137226070743886,3.41120101291589,0.000646773908715056,0.0341994081264049,10475,15570,"sp|Q9W0S7|SND1_DROME","Q9W0S7","SND1",2.29e-16,"Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (Tudor staphylococcal nuclease)","gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of transposition [GO:0010529]; spermatogenesis [GO:0007283]","GO:0003723; GO:0004518; GO:0004519; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0007283; GO:0010529; GO:0016442; GO:0031047"
"g124341",25.3251117532348,-1.30226185082271,0.381766896712358,-3.41114397826875,0.000646909219461408,0.0341994081264049,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134738",82.7610337426587,0.809143146732058,0.237179677315655,3.41151972162942,0.000646018278777652,0.0341994081264049,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48748",69.0498788693987,-0.374954789413196,0.109938167182426,-3.41059705671657,0.00064820809031622,0.0342084773924273,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g71757",65.960205406428,0.827845142812996,0.242710735880467,3.41083034423621,0.000647653765037684,0.0342084773924273,3557,10529,"sp|Q91Z53|GRHPR_MOUSE","Q91Z53","GRHPR",2.56e-06,"Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81)","dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487]","GO:0005737; GO:0005829; GO:0008465; GO:0016618; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0050661; GO:0051287; GO:0070402; GO:1902494"
"g87909",49.7225292110512,0.631718471283842,0.185254758577095,3.40999862101221,0.000649632079507213,0.0342538409255367,4450,7674,"sp|Q9UJM8|HAOX1_HUMAN","Q9UJM8","HAOX1",1.32e-06,"2-Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GO) (GOX) (Glyoxylate oxidase) (EC 1.2.3.5)","fatty acid alpha-oxidation [GO:0001561]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979]","GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0005829; GO:0006979; GO:0010181; GO:0046296; GO:0047969"
"g6015",207.778462348306,0.342677207149415,0.100548629667879,3.40807436442751,0.000654230626415446,0.0344559814187694,82075,86310,"sp|Q6GMK8|GMPAA_DANRE","Q6GMK8","GMPAA",1.04e-22,"Mannose-1-phosphate guanyltransferase alpha-A (EC 2.7.7.13) (GDP-mannose pyrophosphorylase A-A) (GTP-mannose-1-phosphate guanylyltransferase subunit alpha-A)","GDP-mannose biosynthetic process [GO:0009298]","GO:0004475; GO:0005525; GO:0005737; GO:0009298"
"g26983",127.581516370931,0.518685364424148,0.15221512572718,3.4075809611313,0.000655414617433216,0.0344559814187694,32730,36234,"sp|P51659|DHB4_HUMAN","P51659","DHB4",4.89e-15,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]","androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]","GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033989; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009; GO:0106386"
"g91593",43.9334804583577,-0.508566565857912,0.149261847858906,-3.40721070489927,0.00065630440797656,0.0344559814187694,0,7495,"sp|Q7TT49|MRCKB_RAT","Q7TT49","MRCKB",8.85e-26,"Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta)","actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]","GO:0000287; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0006468; GO:0016477; GO:0018107; GO:0030027; GO:0030036; GO:0031032; GO:0031252; GO:0031267; GO:0031532; GO:0042641; GO:0044877; GO:0106310"
"g97119",38.8531677097397,-0.442323949601146,0.12980346071354,-3.40764373437856,0.000655263873595783,0.0344559814187694,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101642",286.57941304447,3.45114857323866,1.01287382469424,3.40728379892775,0.00065612866128876,0.0344559814187694,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27191",428.626340739196,-0.53376138037401,0.156715201650955,-3.40593238403785,0.000659385078249269,0.034460388678402,10036,28194,"sp|P21328|RTJK_DROME","P21328","RTJK",4.28e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g50250",299.282159901729,0.214956455456091,0.0631082680909048,3.40615361439575,0.00065885096708302,0.034460388678402,0,17229,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.28e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g55000",77.9381347533468,0.492752764334252,0.144661424104101,3.40624853782484,0.000658621919079956,0.034460388678402,2368,4524,"sp|Q4ZQC3|TPMT_PSEU2","Q4ZQC3","TPMT",4.09e-07,"Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase)","methylation [GO:0032259]; response to metal ion [GO:0010038]","GO:0005737; GO:0008119; GO:0010038; GO:0032259"
"g82321",467.075137594035,0.25781585816123,0.0757007029331635,3.40572607877706,0.000659883518881154,0.034460388678402,2502,8764,"sp|P31410|VATB_HELVI","P31410","VATB",1e-25,"V-type proton ATPase subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B)","ATP metabolic process [GO:0046034]","GO:0005524; GO:0016787; GO:0033180; GO:0046034; GO:0046961"
"g100759",845.486329340482,-1.82389477576616,0.535575290082607,-3.40548716406398,0.000660461182867314,0.034460388678402,1853,5104,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.9e-20,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g112723",29920.087846558,0.315056994468601,0.0925197886037821,3.40529306457712,0.000660930835749876,0.034460388678402,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138234",274.611215241227,0.393806959111026,0.115639567511289,3.40546897213691,0.000660505187786129,0.034460388678402,0,2983,"sp|Q00725|SGS4_DROME","Q00725","SGS4",1.61e-11,"Salivary glue protein Sgs-4","puparial adhesion [GO:0007594]","GO:0005576; GO:0007594; GO:0062130"
"g148175",23.1839138841889,1.35354017896295,0.397402698972415,3.40596624648717,0.000659303298858233,0.034460388678402,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44756",310.628829195012,0.44464909790767,0.13060799106546,3.40445553354247,0.000662960931135786,0.0345365655885244,0,3307,"sp|Q8CIE6|COPA_MOUSE","Q8CIE6","COPA",2.77e-12,"Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin]","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005794; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030137; GO:0030157; GO:0030424; GO:0030426; GO:0044297; GO:0099612; GO:1902463"
"g6558",4000.00105226926,-0.472769040166588,0.138954304365744,-3.4023346187406,0.000668127787207786,0.0346884782828604,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21071",536.795901721852,0.342795393520252,0.100760342673915,3.40208642034518,0.000668734875448124,0.0346884782828604,38938,45824,"sp|P46087|NOP2_HUMAN","P46087","NOP2",2.25e-13,"Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)","maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475]","GO:0000027; GO:0000470; GO:0001510; GO:0003723; GO:0005654; GO:0005730; GO:0008284; GO:0009383; GO:0070475; GO:1901796"
"g32118",749.190158187812,-0.303011369817338,0.0890512990616699,-3.40266085964109,0.000667330587989563,0.0346884782828604,0,25448,"sp|Q9ESJ0|XPO4_MOUSE","Q9ESJ0","XPO4",1.94e-08,"Exportin-4 (Exp4)","positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611]","GO:0005049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0046827"
"g60018",55.2213918183596,0.764702611827511,0.224771049964707,3.40214014192479,0.000668603430079902,0.0346884782828604,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77507",37.149183695631,0.948168921801948,0.278689766940582,3.40223802334337,0.000668363996659261,0.0346884782828604,0,9509,"sp|Q8JFR5|KITA_DANRE","Q8JFR5","KITA",5.98e-18,"Mast/stem cell growth factor receptor kita (SCFR) (EC 2.7.10.1) (Tyrosine-protein kinase Kit)","B cell differentiation [GO:0030183]; developmental pigmentation [GO:0048066]; Fc receptor signaling pathway [GO:0038093]; gastro-intestinal system smooth muscle contraction [GO:0014831]; hematopoietic progenitor cell differentiation [GO:0002244]; Kit signaling pathway [GO:0038109]; melanocyte apoptotic process [GO:1902362]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; stem cell fate commitment [GO:0048865]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0002244; GO:0004712; GO:0004714; GO:0005524; GO:0005887; GO:0007169; GO:0014831; GO:0019955; GO:0030183; GO:0030318; GO:0030335; GO:0033674; GO:0038093; GO:0038109; GO:0043235; GO:0043406; GO:0043473; GO:0046427; GO:0046872; GO:0048066; GO:0048865; GO:0097324; GO:1902362"
"g44718",93.7828022084969,0.490957952575522,0.144357404876124,3.40098904518839,0.000671425184537548,0.0347785099952801,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g66006",38.1289158229261,1.54888128499766,0.455460607628933,3.40069208852316,0.000672154927163226,0.0347785099952801,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121440",53.5784467849618,1.03562188321594,0.304533948337511,3.40067795025654,0.000672189688984406,0.0347785099952801,2135,4360,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.28e-28,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g70772",59.284903223582,2.54305753256457,0.747921153891763,3.40016794461812,0.000673444760345627,0.0348137670403544,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73930",67.41262032636,0.4578833237728,0.134695620710872,3.39939280398476,0.000675356474094003,0.0348236061280927,6926,10120,"sp|Q29RY4|RNZ1_BOVIN","Q29RY4","RNZ1",8.84e-08,"Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1)",NA,"GO:0005634; GO:0005654; GO:0005829; GO:0042781; GO:0046872"
"g121029",78.6413197013939,-0.388658262111852,0.11432929655944,-3.39946342545533,0.000675182093123934,0.0348236061280927,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132534",34.1441917679064,-0.521961764931278,0.153543183359249,-3.39944602887404,0.00067522504547621,0.0348236061280927,0,3425,"sp|P21328|RTJK_DROME","P21328","RTJK",2.91e-13,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g13982",287.476231752392,-0.632010855956615,0.185959060890273,-3.3986558811971,0.000677178608867815,0.0348681357392475,2465,40489,"sp|Q9BX70|BTBD2_HUMAN","Q9BX70","BTBD2",4.06e-09,"BTB/POZ domain-containing protein 2","neurogenesis [GO:0022008]","GO:0000932; GO:0005829; GO:0022008"
"g113594",349.074367761653,-0.930338787441406,0.273743468738413,-3.39857893862823,0.00067736912236897,0.0348681357392475,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g84847",48.7273260995282,1.58105063246013,0.465277471218682,3.39808121016252,0.00067860272614858,0.0348724804826057,0,8386,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.29e-35,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g140532",919.8639574977,-0.689579424947513,0.202931722054623,-3.39808590774142,0.000678591073596266,0.0348724804826057,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154442",44.7611562986608,2.66134623686458,0.783627126077967,3.39618952470999,0.000683310284378702,0.0350846879517288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5151",101.524231337314,1.67371600314909,0.492968313693393,3.39517968327286,0.000685835738090661,0.035095591015786,109046,124074,"sp|Q93113|GST1D_ANOGA","Q93113","GST1D",1.57e-19,"Glutathione S-transferase 1, isoform D (EC 2.5.1.18) (EC 4.5.1.1) (AgGst1-alpha) (Aggst1-1) (Aggst1-6) (Aggst2-1) (DDT-dehydrochlorinase) (GST class-theta)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0006749; GO:0018833"
"g8314",177.413040915553,-0.718717788178037,0.211685544205371,-3.3952143065601,0.000685749007287337,0.035095591015786,0,65240,"sp|G5ECJ6|CSK1_CAEEL","G5ECJ6","CSK1",2.07e-16,"Tyrosine-protein kinase csk-1 (EC 2.7.10.2) (C-terminal src kinase)","embryo development ending in birth or egg hatching [GO:0009792]; larval feeding behavior [GO:0030536]; muscle cell development [GO:0055001]; nematode larval development [GO:0002119]; pharyngeal pumping [GO:0043050]","GO:0002119; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005886; GO:0005911; GO:0009792; GO:0030536; GO:0043050; GO:0046872; GO:0055001"
"g52339",160.603333392439,0.750534847521537,0.22104884817661,3.39533480365339,0.000685447243391126,0.035095591015786,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151421",22.1956583948762,0.591696932588732,0.17427386739381,3.39521318621835,0.000685751813566632,0.035095591015786,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82061",303.11619478377,0.859951345379879,0.253312725899931,3.39482093655095,0.000686734993465982,0.0351120023196718,0,8384,"sp|P15144|AMPN_HUMAN","P15144","AMPN",4.12e-11,"Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]","GO:0001525; GO:0001618; GO:0004177; GO:0005615; GO:0005737; GO:0005765; GO:0005793; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0030667; GO:0038023; GO:0042277; GO:0043171; GO:0070006; GO:0070062"
"g113888",1236.18050058126,0.435271127687722,0.128234494322504,3.39433730360439,0.000687949030615174,0.0351149088881706,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124428",21.2945889758997,1.09094243041418,0.321395733251665,3.39438989863605,0.000687816907595022,0.0351149088881706,0,4090,"sp|Q93789|LIPL1_CAEEL","Q93789","LIPL1",1.69e-07,"Lipase lipl-1 (EC 3.1.1.-) (Lipase-like 1)","lipid catabolic process [GO:0016042]","GO:0005576; GO:0005764; GO:0016042; GO:0016788; GO:0043202"
"g62138",384.823577979607,0.399957574990734,0.117847766409551,3.39384943114475,0.000689175730909459,0.0351479622763824,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g882",348.132031291261,0.256809236167279,0.0756770897644362,3.39348720949315,0.00069008781115191,0.0351649280090759,153005,157028,"sp|Q7KRI2|LOLAL_DROME","Q7KRI2","LOLAL",5.23e-24,"Longitudinals lacking protein-like (Lola-like protein) (Protein Batman)","dorsal/ventral pattern formation [GO:0009953]; embryonic development via the syncytial blastoderm [GO:0001700]; heterochromatin assembly [GO:0031507]; larval lymph gland hemopoiesis [GO:0035167]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland morphogenesis [GO:0007435]; tracheal outgrowth, open tracheal system [GO:0007426]","GO:0000794; GO:0001700; GO:0003677; GO:0005634; GO:0005700; GO:0006357; GO:0007426; GO:0007435; GO:0009953; GO:0031208; GO:0031507; GO:0031519; GO:0035167; GO:0042803; GO:0045892; GO:0045893; GO:0045944"
"g27569",470.306421578323,-0.257927022186396,0.0760145045753308,-3.39312903014172,0.000690990815914076,0.0351814032028735,11917,27594,"sp|P17192|DPOL_HPBDB","P17192","DPOL",5.08e-08,"Protein P [Includes: DNA-directed DNA polymerase (EC 2.7.7.7); RNA-directed DNA polymerase (EC 2.7.7.49); Ribonuclease H (EC 3.1.26.4)]","DNA replication [GO:0006260]","GO:0003677; GO:0003887; GO:0003964; GO:0004523; GO:0006260; GO:0046872"
"g31638",36.4126586950028,1.32863884513879,0.391662451928442,3.392305896562,0.000693070178810109,0.0352576941760147,0,2914,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.89e-67,"PiggyBac transposable element-derived protein 4",NA,NA
"g115345",82.4195849038556,0.431327362396156,0.127163358364053,3.3919154695594,0.000694058489951536,0.0352784001299487,0,2394,"sp|Q6DCD7|ZCHC4_XENLA","Q6DCD7","ZCHC4",5.87e-09,"rRNA N6-adenosine-methyltransferase ZCCHC4 (EC 2.1.1.-) (Zinc finger CCHC domain-containing protein 4)","positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]","GO:0003676; GO:0005730; GO:0005737; GO:0008270; GO:0008988; GO:0031167; GO:0045727; GO:1904047"
"g16922",48.303506979203,0.82140511561494,0.242190580174936,3.39156508490807,0.000694946554545059,0.0352939802471462,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6058",1323.63400244287,-0.540012223515223,0.159258195020831,-3.39079708547864,0.000696896776753886,0.0353609866671934,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16460",37.0346893656375,-0.680720428632795,0.200767724015587,-3.39058696795281,0.000697431224923884,0.0353609866671934,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48950",40.8874621663108,-0.6773912913316,0.199812097795118,-3.39014153200163,0.000698565481376625,0.0353889307719093,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6353",56.3591436860291,1.57862647103059,0.465760758828385,3.38935052193234,0.000700583932717972,0.0354114173522705,106125,110714,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.52e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g22202",30.6268489983184,0.485790506435329,0.143332197871078,3.38926294057305,0.000700807750456255,0.0354114173522705,4785,6984,"sp|O16129|SYFM_DROME","O16129","SYFM",4.92e-11,"Probable phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)","phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA processing [GO:0008033]","GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006432; GO:0008033"
"g88384",20.6002151810768,-1.39526910720872,0.411698756422562,-3.38905348982068,0.000701343279904913,0.0354114173522705,1803,7240,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.73e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g155444",430.434076570191,0.419749418527362,0.123831128119498,3.38969227609961,0.000699711201182003,0.0354114173522705,0,1523,"sp|Q94511|NDUS1_DROME","Q94511","NDUS1",8.92e-07,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]","GO:0005747; GO:0008137; GO:0042773; GO:0045333; GO:0046872; GO:0051537; GO:0051539; GO:0072593"
"g12506",26332.8643706614,2.03926282441904,0.601905161105827,3.3880135213868,0.000704007936255186,0.0354410430326306,58930,68894,"sp|P04069|CBPB_ASTAS","P04069","CBPB",4.45e-24,"Carboxypeptidase B (EC 3.4.17.2)",NA,"GO:0004181; GO:0005576; GO:0008270"
"g58304",48.4130307638453,1.06791245962288,0.315233630878209,3.38768568774779,0.000704849875438872,0.0354410430326306,0,13992,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.4e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g84395",9851.73240651369,0.938766573723495,0.277103727365956,3.38778039056731,0.000704606564519078,0.0354410430326306,4076,7935,"sp|H9J9M0|CDA1_BOMMO","H9J9M0","CDA1",5.47e-119,"Chitin deacetylase 1 (BmCDA1) (EC 3.5.1.41)","chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272]","GO:0000272; GO:0004099; GO:0005615; GO:0006032; GO:0008061; GO:0008270"
"g89787",643.183139982189,0.451891796576689,0.133376090753346,3.38810197558104,0.000703780929195932,0.0354410430326306,2730,7723,"sp|P36967|SUCA_DICDI","P36967","SUCA",9.87e-23,"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) (p36)","succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099]","GO:0000166; GO:0004775; GO:0004776; GO:0005739; GO:0006099; GO:0006104; GO:0009361; GO:0016020"
"g119114",248.773348495587,-0.386045226246396,0.113946523002496,-3.38795090955026,0.000704168663134735,0.0354410430326306,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15593",96.0020958045344,0.429474015890539,0.126815130959266,3.38661493026798,0.000707606307582277,0.035461502514133,31524,44598,"sp|P55786|PSA_HUMAN","P55786","PSA",1.1e-16,"Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S)","cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]","GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955"
"g20571",134.256994417969,-0.240957815234466,0.0711547063542794,-3.38639322091692,0.000708178300331673,0.035461502514133,19086,45444,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.5e-32,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g34752",29.8316075546508,0.840988538140251,0.248296815615618,3.38702909280224,0.000706538950533623,0.035461502514133,18052,20594,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.38e-14,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g84094",491.770343111755,0.195958083711768,0.0578641914927518,3.3865172683924,0.000707858214645219,0.035461502514133,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g161641",815.625348645357,0.416820011215687,0.123074590591891,3.38672677447972,0.000707317921214162,0.035461502514133,0,1086,"sp|B4MQL8|EIF3B_DROWI","B4MQL8","EIF3B",3.15e-10,"Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9)","formation of cytoplasmic translation initiation complex [GO:0001732]; ovarian follicle cell development [GO:0030707]; regulation of translational initiation [GO:0006446]","GO:0001732; GO:0003743; GO:0005852; GO:0006446; GO:0016282; GO:0030707; GO:0031369; GO:0033290"
"g10730",431.92154321422,-0.370913637937052,0.109598623069999,-3.38429103894997,0.000713623154761065,0.03567527945836,26725,35112,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.24e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g35476",504.180303979794,-0.684160119352134,0.20215300846731,-3.38436773481295,0.000713423823314711,0.03567527945836,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43182",272.1865812031,0.382599388488811,0.113068748946525,3.38377661425932,0.000714961475252831,0.0356833979712946,1975,19334,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.24e-22,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g82359",353.502069608289,0.550218004741305,0.162595514832017,3.38396791147502,0.000714463526822427,0.0356833979712946,0,5534,"sp|P21328|RTJK_DROME","P21328","RTJK",3.06e-12,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g138715",45.5093554181343,0.431745765292562,0.127611160841753,3.38329157453523,0.000716225483801293,0.0357171114313069,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145272",24.4848522543761,0.870510956941562,0.257329707190993,3.38286226819299,0.000717345983503166,0.035743618833175,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53091",515.949625812543,0.745823326428814,0.220545765405399,3.38171682896685,0.000720343581705858,0.0357754926135258,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57792",80.8351180374189,-0.461563621022942,0.136483405849119,-3.38182959423798,0.000720047960975582,0.0357754926135258,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64525",161.460179703754,0.474136736071124,0.140186579677673,3.38218349546222,0.000719120920068804,0.0357754926135258,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136554",110.289182181149,0.581194043760004,0.171852269583749,3.38193987875599,0.000719758952706631,0.0357754926135258,0,3108,"sp|P47738|ALDH2_MOUSE","P47738","ALDH2",6.04e-08,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (AHD-M1) (ALDH class 2) (ALDH-E2) (ALDHI)","acetaldehyde metabolic process [GO:0006117]; aldehyde catabolic process [GO:0046185]; behavioral response to ethanol [GO:0048149]; cellular detoxification of aldehyde [GO:0110095]; ethanol catabolic process [GO:0006068]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of apoptotic process [GO:0043066]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of inflammatory response [GO:0050727]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of serotonin biosynthetic process [GO:1905627]; response to organic cyclic compound [GO:0014070]","GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0006117; GO:0008631; GO:0008957; GO:0014070; GO:0018547; GO:0042802; GO:0043066; GO:0043878; GO:0046185; GO:0048149; GO:0050727; GO:0051287; GO:0052689; GO:0070404; GO:0110095; GO:1903179; GO:1905627; GO:2000377"
"g4868",59.9366102287599,0.515494971179771,0.152476001357116,3.38082692746135,0.000722680469456543,0.0358329066105536,3845,16340,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.55e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g63508",6165.06712237363,0.406007617892699,0.120089476985697,3.38087589423888,0.000722551699458168,0.0358329066105536,8325,12381,"sp|Q95V31|RS16_SPOFR","Q95V31","RS16",5.61e-21,"40S ribosomal protein S16","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g130975",153.328254618624,2.3384869604058,0.691776169506419,3.38040982544153,0.000723778204782611,0.0358580402026585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g14067",727.14866781125,-0.44759673962163,0.132421942160399,-3.38007985926886,0.000724647711899367,0.0358718349389662,2775,11127,"sp|P49793|NUP98_RAT","P49793","NUP98",2.14e-06,"Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)]","mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]","GO:0000776; GO:0003713; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0006606; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0042277; GO:0042405; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:1990841; GO:1990904"
"g21335",601.712833239055,0.277100834789927,0.082008793348687,3.37891613173411,0.000727722049331463,0.0359724289528473,21455,48498,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",6.76e-27,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g147672",2174.65448131008,0.355850765329245,0.105316749208983,3.37886203288635,0.000727865262054646,0.0359724289528473,264,1750,"sp|O00567|NOP56_HUMAN","O00567","NOP56",7.83e-55,"Nucleolar protein 56 (Nucleolar protein 5A)","rRNA processing [GO:0006364]","GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0045296; GO:0070761; GO:1990226"
"g55027",70.4053119642594,-0.539006416038247,0.159535549416591,-3.37859754775254,0.000728565795075418,0.0359777527283378,8622,15185,"sp|Q9U6A0|NCKX_DROME","Q9U6A0","NCKX",2.04e-08,"Sodium/potassium/calcium exchanger Nckx30C (Na(+)/K(+)/Ca(2+)-exchange protein Nckx30C)","calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; compound eye development [GO:0048749]; sodium ion transport [GO:0006814]","GO:0005262; GO:0005887; GO:0006814; GO:0006816; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0048749; GO:0070588"
"g15692",116.488563123374,-0.522576509512747,0.15471888178744,-3.3775871663207,0.000731247729401716,0.0360084609402716,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37824",386.800922768671,-0.429067375317092,0.127035107562163,-3.37754958885782,0.000731347650847323,0.0360084609402716,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g48548",68.7737085148768,1.10816142635322,0.328104061089922,3.37746940001912,0.000731560921722769,0.0360084609402716,0,14180,"sp|Q9VCA2|ORCT_DROME","Q9VCA2","ORCT",8.24e-07,"Organic cation transporter protein","apoptotic process [GO:0006915]; ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016021; GO:0022857"
"g72757",500.299522181033,1.77731609940454,0.526155980328237,3.37792625353376,0.000730346643025152,0.0360084609402716,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4394",430.241977895981,0.333057243149323,0.0986358231135131,3.37663571546446,0.000733781620828453,0.0360179111278966,19905,28902,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.04e-40,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g18893",797.994813679272,-0.314638902888833,0.0931908867656825,-3.37628403172035,0.000734720283017565,0.0360179111278966,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33193",148.867909942778,-0.515340029818658,0.152613588127804,-3.37676373474094,0.000733440207357775,0.0360179111278966,22852,30244,"sp|P24288|BCAT1_MOUSE","P24288","BCAT1",2.11e-27,"Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42) (Protein ECA39)","branched-chain amino acid catabolic process [GO:0009083]; leucine biosynthetic process [GO:0009098]; lipid metabolic process [GO:0006629]; valine biosynthetic process [GO:0009099]","GO:0004084; GO:0005737; GO:0005739; GO:0005829; GO:0006629; GO:0009083; GO:0009098; GO:0009099; GO:0042802; GO:0050048; GO:0052654; GO:0052655; GO:0052656"
"g110314",69.013145340434,-0.504983870471142,0.149564262279575,-3.3763672068077,0.000734498183744504,0.0360179111278966,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152891",4682.22997344854,-1.78136273167539,0.527533649624339,-3.37677555345316,0.000733408695580153,0.0360179111278966,885,1732,"sp|Q61696|HS71A_MOUSE","Q61696","HS71A",2.62e-82,"Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 3) (HSP70.3) (Hsp68)","ATP metabolic process [GO:0046034]; cellular heat acclimation [GO:0070370]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; DNA repair [GO:0006281]; lysosomal transport [GO:0007041]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein folding [GO:0006457]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein ubiquitination [GO:0031396]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; telomere maintenance [GO:0000723]; vesicle-mediated transport [GO:0016192]","GO:0000723; GO:0001664; GO:0003714; GO:0005102; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006402; GO:0006457; GO:0006986; GO:0007041; GO:0008285; GO:0009408; GO:0010628; GO:0016192; GO:0016234; GO:0016235; GO:0016607; GO:0016887; GO:0019899; GO:0030308; GO:0031072; GO:0031249; GO:0031396; GO:0031397; GO:0031625; GO:0032436; GO:0032757; GO:0032991; GO:0034605; GO:0034620; GO:0042026; GO:0042826; GO:0043066; GO:0044183; GO:0045121; GO:0045648; GO:0045666; GO:0046034; GO:0047485; GO:0048471; GO:0050821; GO:0051082; GO:0051085; GO:0051092; GO:0051787; GO:0055131; GO:0060548; GO:0070370; GO:0070434; GO:0090063; GO:0090084; GO:0097201; GO:0097718; GO:0140545; GO:1901673; GO:1903265; GO:1990904; GO:2001240"
"g33224",193.73257673197,0.701764963691692,0.207884008127331,3.37575251705679,0.000736141040065137,0.036058433996411,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3937",22.2949209107626,-0.755638673957293,0.223936660053253,-3.37434109170691,0.000739926223703766,0.0361854331318143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140691",300.066685439481,-0.603994627550186,0.178990794091518,-3.37444520884892,0.000739646384267861,0.0361854331318143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136695",49.4568001361134,-0.495772536172518,0.1469393123544,-3.37399521087165,0.000740856566327103,0.0362017592676263,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53864",108.993353873024,0.582083960060998,0.172559542700412,3.37323541168382,0.000742904073284322,0.0362434471122392,0,10780,"sp|Q66I12|CCD47_DANRE","Q66I12","CCD47",2.15e-16,"PAT complex subunit CCDC47 (Coiled-coil domain-containing protein 47)","endoplasmic reticulum calcium ion homeostasis [GO:0032469]; protein insertion into ER membrane [GO:0045048]","GO:0005509; GO:0005783; GO:0030176; GO:0030867; GO:0032469; GO:0043022; GO:0044183; GO:0045048"
"g129364",20.3657429767305,1.92837443175193,0.57166728420944,3.37324609089479,0.000742875258566416,0.0362434471122392,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107",165.840746677556,0.3614896542875,0.107202457054239,3.37202769619921,0.000746169444015364,0.0363150777401724,46978,60094,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.03e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g12270",179.9560454094,-0.447725849753329,0.132796875803812,-3.37150890819735,0.000747576209866589,0.0363150777401724,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31891",34.1114199156568,2.23772019085808,0.663872803997254,3.37070622171071,0.000749757660379568,0.0363150777401724,0,10080,"sp|P16423|POLR_DROME","P16423","POLR",6.45e-09,"Retrovirus-related Pol polyprotein from type-2 retrotransposable element R2DM (Retrovirus-related Pol polyprotein from type II retrotransposable element R2DM) [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]",NA,"GO:0003964; GO:0004190; GO:0004519; GO:0046872"
"g51515",61.4633410445347,1.42477355928441,0.422647045447551,3.37107185447301,0.000748763252982916,0.0363150777401724,3485,10490,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.95e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g56002",201.971685956694,0.33743475488169,0.100081592245485,3.37159658745251,0.000747338282536287,0.0363150777401724,0,3514,"sp|Q9GZR7|DDX24_HUMAN","Q9GZR7","DDX24",3.25e-16,"ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24)","RNA metabolic process [GO:0016070]","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016020; GO:0016070; GO:0016887"
"g59545",2615.15049411613,0.85503871032799,0.253641756964848,3.37104868125673,0.00074882624055276,0.0363150777401724,2732,13264,"sp|Q86TX2|ACOT1_HUMAN","Q86TX2","ACOT1",8.46e-37,"Acyl-coenzyme A thioesterase 1 (Acyl-CoA thioesterase 1) (EC 3.1.2.-) (CTE-I) (CTE-Ib) (Inducible cytosolic acyl-coenzyme A thioester hydrolase) (Long chain acyl-CoA thioester hydrolase) (Long chain acyl-CoA hydrolase) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2)","acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0047617; GO:0052689; GO:0102991"
"g144208",83.4663041845433,0.824600849077682,0.244636598269,3.37071744339316,0.000749727122659691,0.0363150777401724,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155130",50.8174806564539,0.616430747029828,0.182858359630356,3.37108321586133,0.000748732373169906,0.0363150777401724,0,654,"sp|Q6P286|DHTK1_XENLA","Q6P286","DHTK1",2.19e-18,"2-oxoadipate dehydrogenase complex component E1 (E1a) (OADC-E1) (OADH-E1) (EC 1.2.4.-) (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase) (Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)","glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005739; GO:0006096; GO:0006099; GO:0030976"
"g161323",498.820768202869,2.22906877526253,0.661211567650393,3.37118841278518,0.000748446508175823,0.0363150777401724,559,1107,"sp|P80067|CATC_RAT","P80067","CATC",7.5e-13,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043621; GO:0051087; GO:0051603; GO:1903052; GO:1903980; GO:2001235"
"g112623",22.8851699360515,0.650400535135125,0.192979924685611,3.3703015284865,0.000750859729951352,0.0363394553514733,0,5191,"sp|Q9CZW5|TOM70_MOUSE","Q9CZW5","TOM70",9.55e-08,"Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit) (Translocase of outer mitochondrial membrane protein 70)","activation of innate immune response [GO:0002218]; cellular response to virus [GO:0098586]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein import [GO:1904591]; protein targeting to mitochondrion [GO:0006626]; regulation of apoptotic process [GO:0042981]; response to thyroxine [GO:0097068]","GO:0002218; GO:0002230; GO:0005739; GO:0005742; GO:0006626; GO:0031307; GO:0032728; GO:0042981; GO:0061052; GO:0097068; GO:0098586; GO:1904591"
"g12079",69.1713146998902,1.04756900080291,0.310850938796294,3.37000430128796,0.000751670103614823,0.036349688118234,33338,52484,"sp|Q9GKT2|FXDC2_MACFA","Q9GKT2","FXDC2",8.52e-24,"Fatty acid hydroxylase domain-containing protein 2","lipid biosynthetic process [GO:0008610]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]","GO:0001934; GO:0005506; GO:0005737; GO:0008610; GO:0016021; GO:0016491; GO:0045654"
"g102807",247.981007477729,0.283104047350963,0.0840303052835111,3.36907079411165,0.000754220543966264,0.0363718172455654,0,6187,"sp|Q4U0S5|PAF1_DANRE","Q4U0S5","PAF1",2.84e-23,"RNA polymerase II-associated factor 1 homolog (PD2-like protein)","heart development [GO:0007507]; histone modification [GO:0016570]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0000122; GO:0000791; GO:0000993; GO:0003682; GO:0005634; GO:0006368; GO:0007507; GO:0016570; GO:0016593"
"g124101",179.546117641987,1.07186143561559,0.318102000743996,3.36955263754601,0.00075290309500104,0.0363718172455654,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g130376",513.698651718423,2.17782972014939,0.64643984844679,3.3689595797383,0.000754524928524745,0.0363718172455654,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146747",261.751342752564,0.244161254714618,0.072468654086007,3.36919814220427,0.000753872142788696,0.0363718172455654,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76257",20.6230799621064,1.91534607621771,0.568631317528003,3.36834433345009,0.000756210868849694,0.0364241568495936,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29144",48.535134001739,-0.533273453364114,0.158375752943109,-3.3671407614755,0.000759519099164745,0.0365255262506406,4386,31434,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.16e-30,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g75649",82.9495117084502,1.41729501526909,0.420911009084438,3.36720823328422,0.000759333285988088,0.0365255262506406,0,9814,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.76e-11,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g142233",44.3936838375366,-0.667071321704323,0.198136029602294,-3.36673407175511,0.000760639991921267,0.0365504680203497,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15150",771.166881484817,-0.371630699824989,0.110394485785233,-3.36638825011584,0.000761594332016024,0.0365673734256745,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7375",33.5112634251205,1.78072546090439,0.529220627046097,3.36480735991661,0.000765971179946776,0.0367484513130196,67802,79504,"sp|P21328|RTJK_DROME","P21328","RTJK",7.29e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g40226",106.536637402379,1.30385459885013,0.387551953182946,3.36433499597056,0.000767283489887822,0.036753303079157,0,4642,"sp|P35502|ESTF_MYZPE","P35502","ESTF",1.98e-17,"Esterase FE4 (EC 3.1.1.1) (Carboxylic-ester hydrolase)",NA,"GO:0080030"
"g126149",41.8383595844173,-0.931685876202471,0.276928680732639,-3.36435313864065,0.000767233047842879,0.036753303079157,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8820",283.435958496035,-0.249495355914976,0.074218946148623,-3.36161275337113,0.000774887125435972,0.0368261564421129,30158,74504,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.74e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g28906",184.033222560203,0.385470063533829,0.114647695855623,3.36221378595567,0.000773202357996218,0.0368261564421129,18810,23564,"sp|P48506|GSH1_HUMAN","P48506","GSH1",2.15e-25,"Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)","aging [GO:0007568]; blood vessel diameter maintenance [GO:0097746]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]","GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237"
"g36469",48.0167276606954,1.19428458960876,0.355195218492004,3.36233295785665,0.000772868708905046,0.0368261564421129,1283,11884,"sp|Q2QEI3|IOD1_XENLA","Q2QEI3","IOD1",1.72e-11,"Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)","hormone biosynthetic process [GO:0042446]","GO:0004800; GO:0005789; GO:0016021; GO:0042446"
"g42618",53.3004580091513,-0.531949981301698,0.158178728964919,-3.36296785783173,0.000771093412487622,0.0368261564421129,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44914",26.2405930145724,-0.584969026080118,0.174061358018183,-3.36070586108497,0.000777435706453695,0.0368261564421129,0,11167,"sp|A0A8J8|ANGP2_CANLF","A0A8J8","ANGP2",1.56e-12,"Angiopoietin-2 (ANG-2)","angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; gene expression [GO:0010467]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; Tie signaling pathway [GO:0048014]","GO:0001525; GO:0005102; GO:0005615; GO:0010467; GO:0010812; GO:0016525; GO:0030154; GO:0030971; GO:0043537; GO:0046872; GO:0048014; GO:0050928; GO:0062023"
"g52980",982.208747879753,-0.432948643635237,0.128783591060797,-3.36183080522151,0.00077427550605268,0.0368261564421129,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61425",22.9637258940895,0.515983605921408,0.153522662310248,3.36096051329984,0.00077671928913174,0.0368261564421129,0,2414,"sp|P21328|RTJK_DROME","P21328","RTJK",1.05e-21,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g65153",97.9900398847857,0.996764210260892,0.296552504433504,3.36117279523565,0.000776122541261939,0.0368261564421129,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g88315",158.079753177695,0.525394890596776,0.156342460491212,3.36053871063586,0.000777906287012501,0.0368261564421129,0,7494,"sp|Q9VUL9|FUCTA_DROME","Q9VUL9","FUCTA",3.76e-11,"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)","fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]","GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0036065; GO:0036071; GO:0046920"
"g88981",1063.8721031491,0.472136909055819,0.140475101388524,3.36100066409626,0.000776606388175071,0.0368261564421129,375,7828,"sp|P11369|LORF2_MOUSE","P11369","LORF2",1.06e-10,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g90102",62.487015298241,-0.626981518999198,0.186405955373598,-3.36352729580228,0.000769532260025816,0.0368261564421129,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101236",296.929349541503,1.2742253107111,0.379065567757201,3.36149051534869,0.000775230190247825,0.0368261564421129,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107576",500.346307132354,0.288333665887575,0.0857821412579864,3.36123185617882,0.000775956590150351,0.0368261564421129,0,3004,"sp|Q6PTT0|ACY1B_RAT","Q6PTT0","ACY1B",1.28e-11,"Aminoacylase-1B (ACY-1B) (EC 3.5.1.14) (ACY IB) (N-acyl-L-amino-acid amidohydrolase)","cellular amino acid metabolic process [GO:0006520]; protein catabolic process [GO:0030163]","GO:0004046; GO:0005737; GO:0006520; GO:0030163; GO:0042802; GO:0046872; GO:0070062"
"g119470",158.760483858911,0.633721087604396,0.188467108046789,3.36250231763024,0.000772394777288051,0.0368261564421129,0,1994,"sp|P15857|HM17_APIME","P15857","HM17",9.01e-36,"Homeobox protein H17 (Fragment)",NA,"GO:0000981; GO:0003677; GO:0005634"
"g140116",61.2515305284083,0.742209999632568,0.220771666298749,3.36188973918513,0.000774110277573341,0.0368261564421129,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18713",120.123260324458,2.17648425516437,0.647706893990776,3.36029193969853,0.000778601507400799,0.0368303394264649,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54323",59.2618347065503,-0.5916933872693,0.176097495100816,-3.36003295748503,0.000779331750506527,0.0368361712914651,3259,6264,"sp|Q09575|YRD6_CAEEL","Q09575","YRD6",2.72e-16,"Uncharacterized protein K02A2.6","DNA integration [GO:0015074]","GO:0003676; GO:0008270; GO:0015074"
"g40052",60.5249392066371,0.457899836302426,0.136293217935342,3.35966707103251,0.000780364511396458,0.0368562818650981,13622,14614,"sp|Q86AQ5|RPC1_DICDI","Q86AQ5","RPC1",3.74e-39,"DNA-directed RNA polymerase III subunit rpc1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III subunit A)","transcription by RNA polymerase III [GO:0006383]","GO:0003677; GO:0003899; GO:0005666; GO:0006383; GO:0046872"
"g73799",22.9602207664954,-1.02193450838985,0.304199935921109,-3.35941723753312,0.000781070427857541,0.0368609364437591,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76233",405.311879157361,0.233424271392821,0.0695152607329983,3.35788528923716,0.000785411998138171,0.0370370273247907,0,8874,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.59e-21,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g8243",67.4622714781595,-0.465217880914612,0.138571083711283,-3.3572507947178,0.00078721671892452,0.037082934134584,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91175",243.622262806788,-0.329478584354573,0.0981540084491966,-3.35675118683622,0.000788640483512693,0.037082934134584,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133640",125.467757019828,-0.655884307500493,0.195396448857485,-3.35668489031176,0.000788829592482254,0.037082934134584,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151012",50.996220317505,-0.680922548386003,0.202836479642122,-3.35700239713981,0.000787924294936926,0.037082934134584,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85491",2111.59677018714,0.609041820882986,0.181455881447244,3.35641818840717,0.000789590777468212,0.0370899878363357,6748,8298,"sp|Q08013|SSRG_RAT","Q08013","SSRG",1.02e-18,"Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma)","SRP-dependent cotranslational protein targeting to membrane [GO:0006614]","GO:0005783; GO:0005784; GO:0006614; GO:0016021"
"g2638",4334.00939830683,-0.362935087540222,0.108169062554629,-3.35525776935459,0.000792910633519505,0.037159649689806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34681",73.6198146490997,-0.578347905325473,0.172370262896868,-3.35526497207646,0.000792889987274034,0.037159649689806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93861",54.2136454853437,-0.606590701035799,0.180771688313753,-3.35556251476161,0.000792037531812201,0.037159649689806,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5315",502.444974366632,-0.963492658815233,0.28717874275667,-3.35502777666108,0.000793570158583783,0.0371618618244211,76195,96875,"sp|Q6C5V7|YNG2_YARLI","Q6C5V7","YNG2",3.53e-12,"Chromatin modification-related protein YNG2 (ING1 homolog 2)","chromatin organization [GO:0006325]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of transcription, DNA-templated [GO:0006355]","GO:0005634; GO:0006281; GO:0006325; GO:0006355; GO:0035064; GO:0046872; GO:0051321"
"g51273",284.342502684988,-0.724038459211051,0.215852361570314,-3.35432262099758,0.000795595431758811,0.0371992964202174,5655,16736,"sp|P21328|RTJK_DROME","P21328","RTJK",7.58e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g155557",67.5625533709318,0.493709610260747,0.147182391244999,3.35440677437371,0.000795353483545897,0.0371992964202174,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100619",1072.76002120441,0.4128089504734,0.12309353853541,3.35361998188596,0.000797618247592903,0.0372651666254144,2426,6427,"sp|Q66LN0|PGES2_BOVIN","Q66LN0","PGES2",7.37e-14,"Prostaglandin E synthase 2 (EC 5.3.99.3) (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) [Cleaved into: Prostaglandin E synthase 2 truncated form]","glutathione metabolic process [GO:0006749]; prostaglandin biosynthetic process [GO:0001516]","GO:0001516; GO:0005739; GO:0005783; GO:0006749; GO:0016021; GO:0016829; GO:0020037; GO:0036134; GO:0043295; GO:0050220"
"g42815",314.465078416687,-0.313742598502714,0.0935685003643339,-3.35307926579002,0.000799178154722156,0.0373093247769905,11343,21955,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",1.25e-69,"PiggyBac transposable element-derived protein 4",NA,NA
"g124926",813.491230324461,0.323307290435468,0.0964317331414116,3.35270641627229,0.000800255433709162,0.0373309010544266,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153214",66.1959828416371,0.493965374118285,0.14736204879986,3.35205283952834,0.0008021470737632,0.0373904039221879,0,1663,"sp|Q68FX0|IDH3B_RAT","Q68FX0","IDH3B",6.8e-32,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)","2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004449; GO:0005739; GO:0005962; GO:0006099; GO:0006102; GO:0006103; GO:0006734; GO:0051287"
"g9417",201.567592052274,-0.43448430382787,0.129663009413381,-3.35087320426663,0.000805571786571086,0.0374390091525693,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32954",1478.34525749952,-0.764760162312726,0.228214182180976,-3.35106326436043,0.000805019089426061,0.0374390091525693,18500,31555,"sp|Q80U96|XPO1_RAT","Q80U96","XPO1",3.14e-35,"Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)","mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to xenobiotic stimulus [GO:0009410]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254]","GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0006611; GO:0006913; GO:0009410; GO:0010824; GO:0015030; GO:0019904; GO:0031267; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0046825; GO:0051028; GO:1990904"
"g55019",10741.5125053175,0.81013564123018,0.241770638523117,3.35084378392258,0.000805657372767432,0.0374390091525693,3658,5934,"sp|Q7Z1E6|CALR_BOMMO","Q7Z1E6","CALR",8.63e-101,"Calreticulin","protein folding [GO:0006457]","GO:0005509; GO:0005788; GO:0006457; GO:0030246; GO:0051082"
"g105162",25.8135031199297,0.603610230101527,0.180126450718777,3.35103605102349,0.000805098204561654,0.0374390091525693,3024,4554,"sp|P41894|DEI_DROME","P41894","DEI",7.28e-18,"Helix-loop-helix protein delilah (Protein taxi)","cell adhesion mediated by integrin [GO:0033627]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm development [GO:0007498]; muscle attachment [GO:0016203]; neuron differentiation [GO:0030182]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic muscle development [GO:0007525]","GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0007474; GO:0007498; GO:0007525; GO:0016203; GO:0030182; GO:0033627; GO:0043425; GO:0046983"
"g36871",58.78817389775,0.339937229551119,0.101457383060706,3.35054206304258,0.000806535590704735,0.0374511438407578,5066,21604,"sp|Q6ZN19|ZN841_HUMAN","Q6ZN19","ZN841",9.07e-29,"Zinc finger protein 841","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872"
"g161420",25.21102923438,1.46409527240856,0.437016352790474,3.3502070644723,0.000807511710558052,0.0374678025334619,0,1100,"sp|Q6UWP2|DHR11_HUMAN","Q6UWP2","DHR11",7.22e-11,"Dehydrogenase/reductase SDR family member 11 (17-beta-hydroxysteroid dehydrogenase) (3-beta-hydroxysteroid 3-dehydrogenase) (EC 1.1.1.270) (Estradiol 17-beta-dehydrogenase) (EC 1.1.1.62) (Short-chain dehydrogenase/reductase family 24C member 1)","estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]","GO:0000166; GO:0000253; GO:0004303; GO:0005576; GO:0006694; GO:0006703; GO:0044594; GO:0072555; GO:0072582; GO:0102176"
"g3092",87.3084878508635,-0.54023303208131,0.161281752081852,-3.34962278812011,0.000809216800502601,0.037489593604964,53200,67854,"sp|Q9BZG1|RAB34_HUMAN","Q9BZG1","RAB34",7.2e-09,"Ras-related protein Rab-34 (Ras-related protein Rab-39) (Ras-related protein Rah)","antigen processing and presentation [GO:0019882]; cell projection organization [GO:0030030]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; lysosome localization [GO:0032418]; phagosome-lysosome fusion [GO:0090385]; phagosome maturation [GO:0090382]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]","GO:0003924; GO:0005525; GO:0005794; GO:0005795; GO:0005929; GO:0006897; GO:0019882; GO:0030030; GO:0030670; GO:0030742; GO:0031267; GO:0031982; GO:0031985; GO:0032418; GO:0043001; GO:0045335; GO:0045880; GO:0048471; GO:0070062; GO:0072659; GO:0090382; GO:0090385"
"g61918",177.093255496821,0.355631990810981,0.106167265446133,3.34973298329344,0.000808894963228117,0.037489593604964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g129479",52.5347409335412,-0.657616752111129,0.196348111170076,-3.34923900307604,0.000810338615225833,0.0375129294874567,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g128986",29.4421141992553,0.85423447389387,0.25507604489368,3.3489404081435,0.00081121241473118,0.0375247572027708,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60317",255.892637767459,0.346311044270819,0.103437446207444,3.34802392139778,0.000813899857791042,0.0375917674043671,2047,4644,"sp|Q9TVQ5|SPT4H_DROME","Q9TVQ5","SPT4H",7.91e-06,"Transcription elongation factor SPT4 (DRB sensitivity-inducing factor small subunit) (DSIF small subunit) (dSpt4)","chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; transcription elongation from RNA polymerase II promoter [GO:0006368]","GO:0000122; GO:0005634; GO:0005703; GO:0005705; GO:0006325; GO:0006368; GO:0006397; GO:0008023; GO:0008270; GO:0032044; GO:0032785; GO:0032786; GO:0034243; GO:0045944; GO:0046982"
"g127546",81.5350068963709,-0.583189792889266,0.174185947679536,-3.34808749304053,0.000813713178351102,0.0375917674043671,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8626",3735.38432982965,-0.495434115747595,0.147998209934296,-3.34756829807296,0.000815238968529388,0.0376065286135783,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140117",87.6689415392562,0.394135533843687,0.117747895548133,3.34728304067711,0.000816078401451354,0.0376065286135783,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g147914",895.820290540516,0.558362502756671,0.166806259507049,3.34737140204906,0.00081581829289417,0.0376065286135783,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38584",409.02729647006,0.478327662028607,0.142935710572399,3.34645317194074,0.000818525035981133,0.0376620806927179,0,5901,"sp|Q8UWA5|CAH2_TRIHK","Q8UWA5","CAH2",3.57e-09,"Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II)",NA,"GO:0004089; GO:0005737; GO:0005886; GO:0008270"
"g48697",1980.06637987997,0.572645133620901,0.171111062725885,3.34662835060678,0.000818008004994666,0.0376620806927179,0,7584,"sp|Q8VEM8|MPCP_MOUSE","Q8VEM8","MPCP",3.54e-53,"Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)","mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435]","GO:0005315; GO:0005739; GO:0005743; GO:0015293; GO:0031305; GO:0035435; GO:0043209; GO:0044877; GO:1990547"
"g43516",161.082729870996,0.473301650364344,0.141455302936202,3.34594490655334,0.000820026872160845,0.0376740581918559,13602,17634,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",4.09e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g44465",119.312285646873,-0.33078769600875,0.0988560736674618,-3.34615450256981,0.000819407242747357,0.0376740581918559,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113993",5134.37949245927,0.664231921180133,0.19853635413415,3.34564379444237,0.000820917811821314,0.0376864614216608,0,939,"sp|Q9UEW3|MARCO_HUMAN","Q9UEW3","MARCO",1.64e-08,"Macrophage receptor MARCO (Macrophage receptor with collagenous structure) (Scavenger receptor class A member 2)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amyloid-beta clearance [GO:0097242]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; receptor-mediated endocytosis [GO:0006898]","GO:0001540; GO:0001664; GO:0001934; GO:0004888; GO:0005044; GO:0005581; GO:0005737; GO:0005886; GO:0005887; GO:0006897; GO:0006898; GO:0006911; GO:0007166; GO:0007193; GO:0030666; GO:0038024; GO:0038187; GO:0043277; GO:0045087; GO:0070374; GO:0097242"
"g5462",373.693131439065,-0.529267426826605,0.158213867065717,-3.34526572570763,0.000822037724760286,0.0377093495961464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1754",18159.5028805669,0.388816654045309,0.116365021831219,3.34135333733935,0.00083371049884823,0.0377398977099585,69535,71911,"sp|Q9V3G1|RL8_DROME","Q9V3G1","RL8",1.4e-42,"60S ribosomal protein L8","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0019843; GO:0022625; GO:0022626"
"g10726",381.407576795818,-0.383678119649362,0.114709310093167,-3.34478621951206,0.000823460154055791,0.0377398977099585,26705,34513,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",7.87e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g12119",494.924010838206,1.92777786324244,0.576570140153456,3.34352705592655,0.000827206273426843,0.0377398977099585,19729,54734,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.13e-17,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g17630",174.002783849149,2.21212863757512,0.661893319341272,3.34212262449887,0.000831403224595347,0.0377398977099585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21581",371.863899125904,-0.302324367745341,0.0904906626303375,-3.34094545180162,0.000834936252241235,0.0377398977099585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g25965",4788.56518220747,0.300067107646534,0.0897960906964615,3.34165001303736,0.000832819995504777,0.0377398977099585,9715,20282,"sp|Q9UBQ5|EIF3K_HUMAN","Q9UBQ5","EIF3K",6.89e-30,"Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28)","formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]","GO:0001732; GO:0003743; GO:0005634; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0033290; GO:0043022"
"g33441",165.435090982836,-0.598248509561619,0.179019501024421,-3.34180637382075,0.000832351017284657,0.0377398977099585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40076",35.6631671138383,1.14777612267685,0.343558989826984,3.34084147602968,0.000835248981326088,0.0377398977099585,0,21574,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",2.31e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g51045",706.37475823247,-0.494024597484549,0.147866857665283,-3.34100964397878,0.000834743234946955,0.0377398977099585,0,6362,"sp|Q92519|TRIB2_HUMAN","Q92519","TRIB2",1.24e-15,"Tribbles homolog 2 (TRB-2)","negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]","GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0006469; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106; GO:0061629"
"g51591",22.0844617586459,0.9563979456775,0.286044923414004,3.34352357756501,0.000827216643711955,0.0377398977099585,0,16589,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.41e-46,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g51831",52.656233876552,-0.556763601759939,0.166500183807064,-3.34392184458549,0.000826030045442538,0.0377398977099585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60469",254.962745687447,0.403087152227339,0.120646576693964,3.34105751918533,0.000834599307548876,0.0377398977099585,3297,5864,"sp|A9URZ4|PESC_MONBE","A9URZ4","PESC",2.7e-16,"Pescadillo homolog","maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]","GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0030687; GO:0043021; GO:0070545"
"g66062",215.466720161785,-0.634451670821339,0.189758901490877,-3.34346197114679,0.000827400335266845,0.0377398977099585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78101",1016.14386400256,0.524672611391066,0.156997282510399,3.34192161164519,0.000832005537375815,0.0377398977099585,0,5954,"sp|Q24407|ATP5J_DROME","Q24407","ATP5J",2.74e-09,"ATP synthase-coupling factor 6, mitochondrial (ATPase subunit F6)","ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600]","GO:0000276; GO:0005739; GO:0005753; GO:0015078; GO:0015986; GO:1902600"
"g106653",1166.052238702,0.878601017984011,0.262854291734344,3.342540128171,0.000830153513318157,0.0377398977099585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g109090",229.872436385714,-0.485136859380624,0.145209903956293,-3.3409350613347,0.00083496749887876,0.0377398977099585,0,5538,"sp|Q8TBB1|LNX1_HUMAN","Q8TBB1","LNX1",1.83e-24,"E3 ubiquitin-protein ligase LNX (EC 2.3.2.27) (Ligand of Numb-protein X 1) (Numb-binding protein 1) (PDZ domain-containing RING finger protein 2) (RING-type E3 ubiquitin transferase LNX)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005737; GO:0006511; GO:0030165; GO:0042802; GO:0046872"
"g118611",133.652607492608,0.455826915446334,0.136444069834556,3.34076018106937,0.000835493568764657,0.0377398977099585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126020",69.4851823727609,0.63987449383287,0.191540718758567,3.34067084001819,0.000835762440635759,0.0377398977099585,0,3953,"sp|Q9YH58|FTCD_CHICK","Q9YH58","FTCD",3.25e-15,"Formimidoyltransferase-cyclodeaminase (Formiminotransferase-cyclodeaminase) (FTCD) (p60) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)]","histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005794; GO:0005814; GO:0005829; GO:0019556; GO:0019557; GO:0030409; GO:0030412; GO:0035999"
"g129080",999.067837847062,0.402226609184181,0.120321016755254,3.34294556371938,0.000828941593453335,0.0377398977099585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134025",76.4632780376016,0.342668591386335,0.102558180503857,3.34121168787164,0.000834135986100781,0.0377398977099585,0,2564,"sp|Q9VBX1|NEMF_DROME","Q9VBX1","NEMF",5.23e-20,"Ribosome quality control complex subunit NEMF homolog (Protein Caliban)","CAT tailing [GO:0140708]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; protein export from nucleus [GO:0006611]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]","GO:0000049; GO:0005634; GO:0006611; GO:0032473; GO:0043023; GO:0072344; GO:0140708; GO:1902167; GO:1902231; GO:1990112; GO:1990116"
"g144952",51.2719660809841,0.527346407677076,0.157806377223226,3.34173065091733,0.000832578104965784,0.0377398977099585,0,2433,"sp|P53914|NAT10_YEAST","P53914","NAT10",4.3e-12,"RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (Killer toxin-resistance protein 33) (Ribosomal RNA cytidine acetyltransferase 1)","maturation of SSU-rRNA [GO:0030490]; mRNA modification [GO:0016556]; ribosomal small subunit biogenesis [GO:0042274]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; tRNA acetylation [GO:0051391]","GO:0000049; GO:0005524; GO:0005730; GO:0016556; GO:0030490; GO:0030515; GO:0030686; GO:0030688; GO:0032040; GO:0042274; GO:0051391; GO:1904812; GO:1990883"
"g30674",14857.7376772183,0.323980430661829,0.0970109761272352,3.33962654119582,0.000838911215442689,0.0378257961851536,23345,34333,"sp|P62083|RS7_RAT","P62083","RS7",1.01e-22,"40S ribosomal protein S7 (S8)","cell differentiation [GO:0030154]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]","GO:0001843; GO:0003730; GO:0003735; GO:0005634; GO:0005730; GO:0005815; GO:0006364; GO:0006412; GO:0008266; GO:0010628; GO:0019901; GO:0022626; GO:0022627; GO:0030154; GO:0032040; GO:0032991; GO:0042274; GO:0045202; GO:0048027; GO:0050821; GO:1902255; GO:1904667; GO:1990904; GO:1990948; GO:2000059"
"g140741",7742.133059914,-2.14425043713076,0.642030848560054,-3.33979347244744,0.000838407145751836,0.0378257961851536,1445,2786,"sp|Q9I8F9|HSP71_ORYLA","Q9I8F9","HSP71",0,"Heat shock 70 kDa protein 1 (HSP70-1)","cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; vesicle-mediated transport [GO:0016192]","GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016192; GO:0016887; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787"
"g73485",4138.68717382911,-0.519381118585402,0.155550537249463,-3.33898633697708,0.000840846999207484,0.0378849327259853,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g13240",349.794298178234,-0.31826104859112,0.0953926488017634,-3.33632677767971,0.000848933140936901,0.0380163983197685,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29127",2926.08670826464,0.236876575653008,0.0709978641132353,3.33639016626206,0.000848739577798213,0.0380163983197685,0,6403,"sp|P67874|CSK2B_RAT","P67874","CSK2B",1.44e-54,"Casein kinase II subunit beta (CK II beta) (Phosvitin)","adiponectin-activated signaling pathway [GO:0033211]; endothelial tube morphogenesis [GO:0061154]; liver regeneration [GO:0097421]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein phosphorylation [GO:0006468]; regulation of protein serine/threonine phosphatase activity [GO:0080163]; response to testosterone [GO:0033574]; Wnt signaling pathway [GO:0016055]","GO:0000785; GO:0003682; GO:0004674; GO:0005102; GO:0005634; GO:0005737; GO:0005886; GO:0005929; GO:0005956; GO:0006468; GO:0010862; GO:0016055; GO:0016363; GO:0018107; GO:0019887; GO:0019904; GO:0032927; GO:0033211; GO:0033574; GO:0042802; GO:0042995; GO:0043021; GO:0043537; GO:0046872; GO:0061154; GO:0061629; GO:0080163; GO:0097421; GO:0098685; GO:0098794; GO:0098978; GO:0099170"
"g31717",74.4367643487444,0.526956244192737,0.157933711456029,3.33656595121206,0.00084820301565073,0.0380163983197685,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46702",46.4219005163543,0.487409619427405,0.146047116604687,3.33734503466235,0.000845828743119836,0.0380163983197685,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61710",48.2664025695185,-1.30139149913852,0.390085120430508,-3.33617313498724,0.000849402473580592,0.0380163983197685,6662,12920,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",8.01e-07,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g69128",208.28927702343,1.16552166980466,0.349246969337794,3.33724204397421,0.000846142255366865,0.0380163983197685,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114888",114.408311764313,-0.762997535633289,0.228670372943138,-3.33666983533114,0.000847886069944247,0.0380163983197685,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121439",137.777422523508,1.07711295484692,0.322822626868611,3.33654727146899,0.000848260018348418,0.0380163983197685,0,2089,"sp|P36624|DHSO_SCHPO","P36624","DHSO",2.12e-07,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (Polyol dehydrogenase) (Protein tms1)","sorbitol catabolic process [GO:0006062]","GO:0003939; GO:0005829; GO:0006062; GO:0008270; GO:0046526"
"g161081",48.7853824627042,0.445665397081159,0.133530590811119,3.33755279875574,0.000845196619751359,0.0380163983197685,0,454,"sp|Q8VE22|RT23_MOUSE","Q8VE22","RT23",9.92e-06,"28S ribosomal protein S23, mitochondrial (MRP-S23) (S23mt)","mitochondrial translation [GO:0032543]","GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0031965; GO:0032543"
"g71804",76.9076796515896,-0.537058673688169,0.161004740503373,-3.33566994368663,0.000850941258225141,0.0380572033615945,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1717",27.3038724565424,1.01083025488053,0.303124240259099,3.33470610603925,0.000853895944044405,0.0380604237194732,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4786",88.2780722154561,-0.403583703823573,0.121033151025131,-3.33448894294898,0.000854562978872338,0.0380604237194732,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g23644",434.383251811486,0.298862800203005,0.0896296124174392,3.33442031201794,0.000854773885058623,0.0380604237194732,7826,41974,"sp|P14735|IDE_HUMAN","P14735","IDE",1.25e-23,"Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin)","amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]","GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008286; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0019885; GO:0030163; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0045732; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715"
"g56895",105.625528809696,0.342722369795997,0.102791945955196,3.33413641128439,0.000855646838751822,0.0380604237194732,3935,13169,"sp|Q9VHI4|SF3B5_DROME","Q9VHI4","SF3B5",4.54e-28,"Splicing factor 3B subunit 5 (Pre-mRNA-splicing factor SF3b 10 kDa subunit)","mRNA splicing, via spliceosome [GO:0000398]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","GO:0000124; GO:0000398; GO:0005686; GO:0007283; GO:0010468; GO:0071011"
"g87660",1098.65663794337,0.503195063500312,0.150927799644463,3.33401179031085,0.000856030291268428,0.0380604237194732,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92714",313.948617093658,-0.522165997368859,0.156613720211069,-3.33410123113819,0.000855755070166691,0.0380604237194732,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112704",45.4680165108623,0.510099376167944,0.152978031160148,3.33446163674271,0.000854646886389788,0.0380604237194732,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127729",44.1525362962604,1.40519687290467,0.421345171871347,3.33502545351044,0.000852915918295063,0.0380604237194732,0,3811,"sp|Q9FR44|PEAM1_ARATH","Q9FR44","PEAM1",2.48e-09,"Phosphoethanolamine N-methyltransferase 1 (AtNMT1) (PEAMT 1) (EC 2.1.1.103) (Protein XIPOTL 1)","choline biosynthetic process [GO:0042425]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]; pollen development [GO:0009555]; pollen tube growth [GO:0009860]; pollen tube guidance [GO:0010183]; post-embryonic root development [GO:0048528]; unidimensional cell growth [GO:0009826]","GO:0000234; GO:0005737; GO:0006656; GO:0008168; GO:0009555; GO:0009826; GO:0009860; GO:0010183; GO:0032259; GO:0042425; GO:0048528; GO:0052667"
"g14457",268.652794151233,-0.362526113754697,0.108837560802975,-3.33089156978597,0.000865683154758348,0.0381288200253629,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18235",980.386722895817,0.251159345964971,0.0753549315703261,3.33301803519751,0.000859093733016381,0.0381288200253629,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30568",207.234201753068,-0.542385513480982,0.162758299042974,-3.33245995239709,0.000860818585478028,0.0381288200253629,0,10013,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.17e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g36186",112.783535757275,-0.557162920655668,0.167272259697783,-3.33087459727223,0.000865735936644424,0.0381288200253629,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g56555",335.040481779943,1.30369953718592,0.391332792788541,3.33143442412805,0.000863996535051409,0.0381288200253629,415,12624,"sp|Q2LKW6|NL1B1_MOUSE","Q2LKW6","NL1B1",3.43e-06,"NACHT, LRR and PYD domains-containing protein 1b allele 1 (EC 3.4.-.-) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1b, C-terminus (Nlrp1b1-CT); NACHT, LRR and PYD domains-containing protein 1b, N-terminus (Nlrp1b1-NT)]","activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antiviral innate immune response [GO:0140374]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; neuron apoptotic process [GO:0051402]; NLRP1 inflammasome complex assembly [GO:1904784]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; protein catabolic process [GO:0030163]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; self proteolysis [GO:0097264]","GO:0002221; GO:0003690; GO:0003725; GO:0004175; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006919; GO:0006954; GO:0008233; GO:0016020; GO:0016887; GO:0019899; GO:0019904; GO:0030163; GO:0032731; GO:0042981; GO:0043621; GO:0050729; GO:0051260; GO:0051402; GO:0051607; GO:0061702; GO:0070269; GO:0072558; GO:0097264; GO:0140374; GO:0140608; GO:1904784"
"g61264",1528.05796027795,0.496078842095767,0.148848437340729,3.33277830092493,0.000859834280654167,0.0381288200253629,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75525",181.47017914879,0.251838832395831,0.0755845443664537,3.33188265546526,0.000862606201204645,0.0381288200253629,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77489",276.508145300828,0.439324259894721,0.131877853500287,3.33129671308886,0.000864424107279814,0.0381288200253629,0,8684,"sp|Q66HF1|NDUS1_RAT","Q66HF1","NDUS1",5.91e-20,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2)","apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0032981; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g93638",33.2030312720437,1.07732307181001,0.323283769499255,3.33243785631029,0.00086088694334134,0.0381288200253629,0,7243,"sp|O23887|ALDO1_MAIZE","O23887","ALDO1",2.95e-08,"Indole-3-acetaldehyde oxidase (IAA oxidase) (EC 1.2.3.7) (Aldehyde oxidase) (ZmAO-1)","abscisic acid biosynthetic process [GO:0009688]; auxin biosynthetic process [GO:0009851]","GO:0005506; GO:0005737; GO:0009688; GO:0009851; GO:0016491; GO:0043546; GO:0050302; GO:0051537; GO:0071949"
"g100342",296.519217869113,0.671369583332268,0.201481530794716,3.33216439583392,0.000861733354852634,0.0381288200253629,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g101327",296.782166680909,1.26649693920285,0.380206738210609,3.33107441799545,0.00086511471437571,0.0381288200253629,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113501",4121.95063614232,0.312071506035064,0.0936808312163193,3.33122050672732,0.000864660800982057,0.0381288200253629,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134700",859.467970462753,0.361847056543376,0.108606333925097,3.33173069623115,0.000863077319095464,0.0381288200253629,0,3255,"sp|P53451|TCPD_TAKRU","P53451","TCPD",6.05e-34,"T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","protein folding [GO:0006457]; response to hypoxia [GO:0001666]","GO:0001666; GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082"
"g6555",134.781614504781,-0.527738175894398,0.158634580317094,-3.32675369291805,0.000878639995422409,0.038400723875663,0,30018,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.25e-33,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g18498",529.775128542285,-0.512084236306574,0.153900693491809,-3.32736795844151,0.000876705262639853,0.038400723875663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22733",81.7101716435195,1.35477383460196,0.407204939582903,3.32700736879479,0.000877840521194597,0.038400723875663,34156,37614,"sp|Q6PAY6|HYPDH_XENLA","Q6PAY6","HYPDH",1.26e-10,"Hydroxyproline dehydrogenase (HYPDH) (EC 1.5.5.3) (Probable proline dehydrogenase 2) (EC 1.5.5.2) (Probable proline oxidase 2)","proline catabolic process to glutamate [GO:0010133]","GO:0004657; GO:0010133; GO:0016645"
"g44890",1586.44138465973,-0.35535646640695,0.106820126333078,-3.32668082884405,0.00087886975553297,0.038400723875663,5487,20034,"sp|Q9VE46|SC5A7_DROME","Q9VE46","SC5A7",4.48e-27,"High-affinity choline transporter 1","acetylcholine biosynthetic process [GO:0008292]; amino acid transmembrane transport [GO:0003333]; choline transport [GO:0015871]","GO:0003333; GO:0005307; GO:0005886; GO:0008292; GO:0015171; GO:0015220; GO:0015871; GO:0016021"
"g49006",50.6244041982095,-0.592524010619876,0.17807871395692,-3.32731519368012,0.000876871298952521,0.038400723875663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g49492",1799.06963209922,-0.435587196610529,0.130867095574901,-3.32846996181117,0.000873244213017744,0.038400723875663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g60561",51.7283029327722,1.33888116405632,0.402371941798048,3.32747148837806,0.00087637956686622,0.038400723875663,0,13267,"sp|Q9Y3Q0|NALD2_HUMAN","Q9Y3Q0","NALD2",8.33e-16,"N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)","proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016021; GO:0016805; GO:0046872"
"g81548",309.552872933094,-0.646060652882403,0.194178833558373,-3.32714251622171,0.000877414871654729,0.038400723875663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92689",53.1079349008826,1.74164139699152,0.523255792818726,3.32847035980141,0.000873242965345874,0.038400723875663,0,6631,"sp|Q8CHN6|SGPL1_RAT","Q8CHN6","SGPL1",2.81e-15,"Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL) (SPL 1) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase)","androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570]","GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0006807; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0008585; GO:0009791; GO:0010761; GO:0016021; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190"
"g151256",155.809428928514,0.600335527888214,0.180398385206564,3.32783204905524,0.000875246151172214,0.038400723875663,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g153027",23.3377823760397,0.825281997457078,0.248020398853534,3.32747629336907,0.000876364453525409,0.038400723875663,0,1160,"sp|Q99NB1|ACS2L_MOUSE","Q99NB1","ACS2L",5.16e-25,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)","acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]","GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218"
"g134456",641.953040468924,0.478834255307465,0.143948616272362,3.32642485705783,0.000879677345346969,0.0384083583374875,688,3224,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.85e-14,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g5683",80.9782457088962,-0.597581342287774,0.179699314295437,-3.32545143330549,0.000882754779770028,0.0384426902970737,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85664",34.0772334518764,0.778386108227376,0.234074697467961,3.32537483396263,0.00088299736816808,0.0384426902970737,4913,7964,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",2.61e-42,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g88067",23.3612267585131,-1.16586624027086,0.350589764829114,-3.32544288861122,0.000882781837562865,0.0384426902970737,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150432",438.903274513105,1.28213903811631,0.385556208156719,3.32542703499966,0.000882832041950054,0.0384426902970737,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110873",1538.68131870549,0.601984266953988,0.181048188323312,3.32499470184688,0.000884202152656167,0.0384675474155575,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3287",78.1585577917618,-0.749497710135923,0.225455994261596,-3.32436364174147,0.00088620558950206,0.0384995112576092,665,14870,"sp|Q8C428|TMC7_MOUSE","Q8C428","TMC7",1.08e-17,"Transmembrane channel-like protein 7",NA,"GO:0005887; GO:0008381"
"g9349",1658.4618588742,0.360002855838118,0.10828843671704,3.32448105035272,0.000885832532130488,0.0384995112576092,0,5032,"sp|Q6PHD9|SBP1_DANRE","Q6PHD9","SBP1",6.05e-14,"Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1)","protein transport [GO:0015031]","GO:0005634; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549"
"g84099",22.4854822722851,0.854921800933289,0.25719293133574,3.32404859065614,0.000887207361408799,0.0385154612045065,0,8494,"sp|P83088|FUCTC_DROME","P83088","FUCTC",6.17e-29,"Alpha-(1,3)-fucosyltransferase C (EC 2.4.1.-) (Galactoside 3-L-fucosyltransferase)","fucosylation [GO:0036065]; protein glycosylation [GO:0006486]","GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0046920"
"g15085",848.222684987306,-0.371439084497819,0.111773902611311,-3.32312888626143,0.000890137765294656,0.0385629854928136,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g80375",27.0656420945088,-0.950070071678458,0.285911307552688,-3.32295382022755,0.00089069658408928,0.0385629854928136,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104668",98.7593480831706,2.11410061756718,0.636199901249298,3.32301311807146,0.000890507266247333,0.0385629854928136,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121232",310.312483212655,0.277491936101576,0.0835132303917351,3.32273024046544,0.000891410733783227,0.0385629854928136,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127082",268.330581774997,0.35191537091826,0.105912190442252,3.32270883501498,0.000891479134065209,0.0385629854928136,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15546",72.783984648169,1.86609187671419,0.561677447488104,3.32235500118369,0.000892610501393334,0.0385844240239042,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114308",201.254473032951,1.43384327598539,0.431628552104146,3.32193796957023,0.00089394564935113,0.0386146344904769,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39188",674.369264289904,0.212370905254361,0.0639375275759627,3.32153765254761,0.000895229025807466,0.0386151027549787,12685,16787,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.35e-08,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g108199",52.0094308008952,3.30127168978538,0.993891834099616,3.32156033133732,0.000895156274259231,0.0386151027549787,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7595",796.962719794523,0.437208122629575,0.131640631286568,3.32122474920237,0.000896233351626123,0.038630967407805,40788,50424,"sp|Q19QT7|CGL_PIG","Q19QT7","CGL",6.44e-08,"Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2)","cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; hydrogen sulfide biosynthetic process [GO:0070814]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; protein sulfhydration [GO:0044524]; transsulfuration [GO:0019346]","GO:0004123; GO:0005516; GO:0005737; GO:0006629; GO:0016846; GO:0018272; GO:0019343; GO:0019344; GO:0019346; GO:0030170; GO:0043066; GO:0043123; GO:0044524; GO:0044540; GO:0051092; GO:0070814; GO:0080146"
"g28380",2129.94436911082,-0.312321131998689,0.0940474744775579,-3.32088802738894,0.000897315294127159,0.038650152732844,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7363",185.103865549963,0.600333134053527,0.180835853966449,3.31976829199429,0.000900921900649166,0.0386682815773677,9615,18033,"sp|Q6NS19|ERGI1_XENLA","Q6NS19","ERGI1",1.78e-10,"Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein) (ERGIC-32)","vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005789; GO:0016021; GO:0016192; GO:0033116"
"g20936",7501.28326256663,-0.411849169169303,0.124050856304931,-3.32000262986441,0.000900166001341968,0.0386682815773677,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37773",115450.49495733,0.530042021900693,0.159659112562252,3.31983570116631,0.000900704399883232,0.0386682815773677,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85500",56.8549861448928,0.724246337800332,0.218152005418145,3.31991602099704,0.000900445305447736,0.0386682815773677,1015,7011,"sp|P21328|RTJK_DROME","P21328","RTJK",2.98e-25,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g136733",39.2456884346096,-0.472759823433881,0.14239999223605,-3.31994276130442,0.000900359062316734,0.0386682815773677,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44052",118.248712140522,0.413423989177531,0.124551407330043,3.31930403710347,0.000902421176609575,0.038682954011088,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108142",35.4033279044666,-0.663272986558695,0.199830931658385,-3.31917076627844,0.000902851991627676,0.038682954011088,1825,4706,"sp|Q6UX65|DRAM2_HUMAN","Q6UX65","DRAM2",1.29e-06,"DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77)","apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601]","GO:0001917; GO:0005737; GO:0005764; GO:0005765; GO:0005794; GO:0006914; GO:0006915; GO:0007601; GO:0010506; GO:0016021; GO:0016324; GO:0043231; GO:0045494"
"g111813",48.7144142970932,-0.409263933584236,0.123306787511733,-3.3190706030298,0.000903175907624183,0.038682954011088,0,5265,"sp|Q5XH94|TIM23_XENTR","Q5XH94","TIM23",1.71e-07,"Mitochondrial import inner membrane translocase subunit Tim23","protein import into mitochondrial matrix [GO:0030150]","GO:0005744; GO:0008320; GO:0030150; GO:0031305"
"g9872",534.137753381383,-0.361161270529794,0.108836910841614,-3.31837120088219,0.000905440694215205,0.0387005760249964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g44584",618.703235498479,-0.274670556989316,0.0827772307586749,-3.31818973009715,0.000906029187780781,0.0387005760249964,0,16131,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",1.32e-19,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g147015",197.128954250435,0.681461314549241,0.20536480574193,3.31829649236779,0.000905682924348107,0.0387005760249964,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g157659",458.770892701726,0.409810487507242,0.123505485077227,3.31815617137159,0.000906138054564507,0.0387005760249964,0,1363,"sp|Q3SZ71|MPPB_BOVIN","Q3SZ71","MPPB",9.72e-23,"Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP)","protein processing involved in protein targeting to mitochondrion [GO:0006627]","GO:0004222; GO:0006627; GO:0017087; GO:0046872"
"g66984",70.6713881465878,2.10593846043516,0.634922979788313,3.31684082553964,0.000910414688023782,0.0387649658340793,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77706",51.1925941931653,-0.712396583676286,0.214740705793275,-3.31747342007011,0.000908355580207295,0.0387649658340793,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g118685",172.358289544511,0.537159294281523,0.161931842063474,3.31719374915137,0.000909265381781056,0.0387649658340793,0,4608,"sp|Q8VHP7|ILEUB_MOUSE","Q8VHP7","ILEUB",3.32e-10,"Leukocyte elastase inhibitor B (Serine protease inhibitor EIB) (Serpin B1b)","negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta production [GO:0032691]; regulation of protein catabolic process [GO:0042176]; type B pancreatic cell proliferation [GO:0044342]","GO:0004867; GO:0005576; GO:0005615; GO:0010951; GO:0030414; GO:0032691; GO:0036464; GO:0042176; GO:0044342"
"g123559",57.4263690432797,0.488778179242765,0.147360855888629,3.31687934557172,0.000910289180973686,0.0387649658340793,0,4170,"sp|Q9VFR0|BCCIP_DROME","Q9VFR0","BCCIP",1.74e-09,"Protein BCCIP homolog","regulation of protein kinase activity [GO:0045859]","GO:0005634; GO:0019887; GO:0045859"
"g154398",482.402635990354,2.16956302784197,0.654130957181098,3.3167105210728,0.000910839368584562,0.0387649658340793,0,1604,"sp|Q3ZCJ8|CATC_BOVIN","Q3ZCJ8","CATC",7.31e-20,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","zymogen activation [GO:0031638]","GO:0005764; GO:0008234; GO:0008239; GO:0031638"
"g27676",2577.84259680219,-0.367992719644029,0.110973112463457,-3.31605297423019,0.000912985208156063,0.0388187607161907,9505,35294,"sp|C9J069|AJM1_HUMAN","C9J069","AJM1",1.42e-22,"Apical junction component 1 homolog","cell-cell junction organization [GO:0045216]","GO:0005886; GO:0005912; GO:0005929; GO:0016324; GO:0043296; GO:0045216"
"g128089",298.544804442316,0.19005306202509,0.0573151375975622,3.31593135760305,0.00091338260508684,0.0388187607161907,0,3751,"sp|Q2TL32|UBR4_RAT","Q2TL32","UBR4",2.94e-24,"E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Zinc finger UBR1-type protein 1)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0006511; GO:0008270; GO:0016021; GO:0061630"
"g80319",134.057476643655,-0.560912210266722,0.16919652216538,-3.31515212658132,0.000915932642273884,0.0388998964727796,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10765",590.246334480517,0.614267269715897,0.185346351218857,3.31415895525546,0.000919192363124612,0.0389312146399257,0,34186,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.97e-15,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g39260",1114.08675204998,-0.758969846702603,0.229022676806348,-3.3139506414221,0.000919877439341795,0.0389312146399257,2425,23731,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.29e-15,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g133752",656.558141691175,1.00661888148651,0.30373112632431,3.31417755456414,0.000919131219064085,0.0389312146399257,866,3330,"sp|Q27712|CP2L1_PANAR","Q27712","CP2L1",1.28e-06,"Cytochrome P450 2L1 (EC 1.14.14.1) (CYPIIL1)",NA,"GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"g137767",563.05189835261,0.500242717296724,0.15094421276581,3.31409007427698,0.000919418837848478,0.0389312146399257,1032,3018,"sp|Q28F07|ANM1_XENTR","Q28F07","ANM1",2.7e-23,"Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1)","cardiac muscle tissue development [GO:0048738]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; metamorphosis [GO:0007552]; negative regulation of megakaryocyte differentiation [GO:0045653]; neurogenesis [GO:0022008]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of histone modification [GO:0031056]; regulation of megakaryocyte differentiation [GO:0045652]; RNA splicing [GO:0008380]","GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006479; GO:0007552; GO:0008170; GO:0008276; GO:0008284; GO:0008380; GO:0016274; GO:0016571; GO:0018216; GO:0022008; GO:0031056; GO:0035241; GO:0035242; GO:0042054; GO:0042802; GO:0043985; GO:0044020; GO:0045652; GO:0045653; GO:0045893; GO:0048738; GO:0051260; GO:1904047"
"g146264",61.8683973624507,-0.840263257267034,0.253531353697584,-3.31423804201082,0.000918932396435559,0.0389312146399257,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g155574",56.7487374764752,0.385102549268285,0.116218209650958,3.31361626052299,0.000920978098322246,0.0389506346948969,0,794,"sp|Q13131|AAPK1_HUMAN","Q13131","AAPK1",6.07e-14,"5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26)","autophagy [GO:0006914]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to calcium ion [GO:0071277]; cellular response to ethanol [GO:0071361]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to organonitrogen compound [GO:0071417]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; chromatin organization [GO:0006325]; cold acclimation [GO:0009631]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; motor behavior [GO:0061744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of glucosylceramide biosynthetic process [GO:0046318]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; neuron cellular homeostasis [GO:0070050]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization [GO:1903829]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of skeletal muscle tissue development [GO:0048643]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of bile acid secretion [GO:0120188]; regulation of circadian rhythm [GO:0042752]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of stress granule assembly [GO:0062028]; regulation of vesicle-mediated transport [GO:0060627]; response to 17alpha-ethynylestradiol [GO:1904486]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to camptothecin [GO:1901563]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]","GO:0001666; GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006006; GO:0006325; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0007165; GO:0008022; GO:0008284; GO:0008610; GO:0009411; GO:0009631; GO:0010332; GO:0010508; GO:0010628; GO:0010629; GO:0014823; GO:0015721; GO:0016055; GO:0016324; GO:0016607; GO:0019395; GO:0030424; GO:0030425; GO:0031000; GO:0031588; GO:0031669; GO:0032007; GO:0033135; GO:0034599; GO:0035174; GO:0035556; GO:0038183; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0044877; GO:0045542; GO:0045821; GO:0046318; GO:0046627; GO:0046872; GO:0047322; GO:0048156; GO:0048511; GO:0048643; GO:0050321; GO:0050405; GO:0050995; GO:0055089; GO:0060627; GO:0061744; GO:0061762; GO:0062028; GO:0070050; GO:0070301; GO:0070507; GO:0071277; GO:0071333; GO:0071361; GO:0071380; GO:0071417; GO:0071456; GO:0071466; GO:0097009; GO:0106310; GO:0120188; GO:1901563; GO:1903109; GO:1903829; GO:1903944; GO:1903955; GO:1904428; GO:1904486; GO:1905691; GO:1990044; GO:2000758"
"g1728",102.06815763739,0.3756677736622,0.113430037147941,3.31188971729099,0.00092668068719679,0.039024912814777,110185,117050,"sp|Q9D7H3|RTCA_MOUSE","Q9D7H3","RTCA",5.53e-11,"RNA 3'-terminal phosphate cyclase (RNA cyclase) (RNA-3'-phosphate cyclase) (EC 6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1)","RNA processing [GO:0006396]","GO:0003963; GO:0005524; GO:0005634; GO:0005654; GO:0006396"
"g7832",72.374944887217,-1.23346395436353,0.372610917395114,-3.31032693026431,0.000931870598240977,0.039024912814777,55205,64583,"sp|Q6DE58|ATGA1_XENLA","Q6DE58","ATGA1",3.27e-13,"Autophagy-related protein 101","autophagy [GO:0006914]","GO:0000407; GO:0006914"
"g27775",142.507570924622,-0.386379222643853,0.116676679625507,-3.31153769445616,0.000927847389131533,0.039024912814777,4815,37405,"sp|Q96PE6|ZIM3_HUMAN","Q96PE6","ZIM3",2.03e-08,"Zinc finger imprinted 3 (Zinc finger protein 657)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g33226",183.060265343804,-0.333456094166603,0.100710061507096,-3.31105044696162,0.00092946450903703,0.039024912814777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g73724",23.5777080869692,0.484852877200105,0.146377885377921,3.31233694180172,0.00092520042074551,0.039024912814777,5085,9751,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.75e-17,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g73858",1652.66222943767,0.585997894839982,0.177039649867187,3.30998109903398,0.000933022713696514,0.039024912814777,2095,10133,"sp|Q5T750|XP32_HUMAN","Q5T750","XP32",5.52e-06,"Skin-specific protein 32","epidermis development [GO:0008544]","GO:0008544"
"g75361",52.8688942699036,0.893751210838722,0.269857122165679,3.31194227399343,0.000926506616280749,0.039024912814777,6086,9865,"sp|Q6DEB1|AT2L1_XENLA","Q6DEB1","AT2L1",2.34e-12,"Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1)",NA,"GO:0005739; GO:0008483; GO:0030170; GO:0050459"
"g84145",26.8119430049765,0.71156337318356,0.214909152703598,3.31099613130459,0.000929644938307105,0.039024912814777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89114",440.039658906138,0.340109659418863,0.102735375997933,3.31054085425946,0.000931158583612445,0.039024912814777,0,7605,"sp|Q24K02|IDE_BOVIN","Q24K02","IDE",2.88e-16,"Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]","GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005739; GO:0005782; GO:0005829; GO:0008270; GO:0008340; GO:0009897; GO:0010815; GO:0010992; GO:0016323; GO:0019885; GO:0032092; GO:0042447; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0050435; GO:0051603; GO:0140036; GO:0150094; GO:1901143; GO:1903715"
"g91319",198.35163231078,0.494675826729053,0.149322917700278,3.31279239883305,0.000923695157547481,0.039024912814777,6995,7523,"sp|B3NQ53|KAD2_DROER","B3NQ53","KAD2",5.79e-86,"Adenylate kinase (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate kinase cytosolic and mitochondrial) (Adenylate monophosphate kinase)","ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]","GO:0004017; GO:0005524; GO:0005758; GO:0005829; GO:0006172; GO:0046033; GO:0046034"
"g98162",23.3817020721088,-0.929363986456264,0.280656319761584,-3.31139518698797,0.000928320085543595,0.039024912814777,1185,6304,"sp|P04323|POL3_DROME","P04323","POL3",6.72e-83,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g147451",330.751562412091,0.270888722899961,0.0818227427771751,3.31067761487368,0.000930703660128286,0.039024912814777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g150436",98.0666546016237,1.66554016431589,0.503183170067617,3.31000769380278,0.000932934068042297,0.039024912814777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151537",30.3805704116623,1.12240732436584,0.338931985803374,3.31160047260037,0.00092763922517511,0.039024912814777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151679",191.6085927657,0.407709490113058,0.123165437501859,3.31025893613136,0.000932097012357779,0.039024912814777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162064",135.849301210565,0.923682584490007,0.278947105739976,3.31131804375497,0.000928576062256313,0.039024912814777,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17623",3282.35522605402,0.283221820797183,0.0855710119459614,3.30978697524389,0.000933670003311017,0.0390250912540948,945,51358,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.7e-31,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g32218",172.01879324224,-0.646746386864172,0.195429152822455,-3.30936494132855,0.000935078675975482,0.0390570714693407,9915,16470,"sp|O02485|YDJ1_CAEEL","O02485","YDJ1",1.03e-09,"Uncharacterized protein ZK1073.1",NA,NA
"g21076",596.332162966261,-0.336942154075725,0.101830535279258,-3.3088518404789,0.000936793965694962,0.0390660051504417,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31381",102.461531703337,2.12377239931737,0.641870629556136,3.30872344289377,0.00093722365297484,0.0390660051504417,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g145637",1000.8885467558,0.460980230264835,0.139322313185404,3.30873224629414,0.000937194186239726,0.0390660051504417,0,1489,"sp|P12261|EF1G_ARTSA","P12261","EF1G",1.75e-15,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]","GO:0003746; GO:0006749"
"g7593",1805.25819434948,0.439268835974764,0.132815530397625,3.30736047704418,0.000941796138742052,0.0391192252469181,32771,36564,"sp|P55216|CGL2_CAEEL","P55216","CGL2",6.32e-30,"Putative cystathionine gamma-lyase 2 (EC 4.4.1.1) (Gamma-cystathionase)","cysteine biosynthetic process via cystathionine [GO:0019343]; transsulfuration [GO:0019346]","GO:0004123; GO:0005737; GO:0005783; GO:0016846; GO:0019343; GO:0019346; GO:0030170; GO:0044540; GO:0080146"
"g9445",24.8407080617198,0.533602168086846,0.161355409139272,3.3069989468173,0.000943012465583146,0.0391192252469181,30145,42154,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.18e-24,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g14466",44.3696314091927,0.447672184746138,0.135352833636793,3.30744597447752,0.000941508705038703,0.0391192252469181,16236,32724,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.8e-29,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g29298",88.8201101488441,0.292921434101978,0.0885664614549737,3.30736295985921,0.00094178779062369,0.0391192252469181,365,6859,"sp|Q29RZ2|PPWD1_BOVIN","Q29RZ2","PPWD1",1.23e-17,"Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (EC 5.2.1.8)","mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380]","GO:0000413; GO:0003755; GO:0006397; GO:0008380; GO:0016018; GO:0016604; GO:0071013"
"g66077",259.894291200791,0.371194512092239,0.112209225509111,3.30805698380031,0.000939456918090668,0.0391192252469181,3200,9554,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.45e-09,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g79157",31.393477335582,-1.32682076336918,0.401133493435213,-3.30767882783011,0.000940726287685909,0.0391192252469181,0,2414,"sp|A2SXS5|MEN1_CANLF","A2SXS5","MEN1",3.63e-22,"Menin","chromatin organization [GO:0006325]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000403; GO:0000785; GO:0000976; GO:0003682; GO:0006325; GO:0006357; GO:0008285; GO:0035097; GO:0045786"
"g95972",191.267652859379,0.398422935939175,0.120476616838948,3.30705614411286,0.000942819935012193,0.0391192252469181,3046,6794,"sp|Q7Q6S8|MED14_ANOGA","Q7Q6S8","MED14",2.45e-12,"Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0003712; GO:0006357; GO:0016592; GO:0070847"
"g111770",22.0615753521275,0.812584170234731,0.245890107274583,3.30466393805476,0.000950903451326057,0.0394196246318158,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125713",32.1026750127055,1.43501144353529,0.434288843008325,3.30427886103394,0.000952210650040651,0.0394468698641414,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1505",266.08395504505,-0.424425062467877,0.128531402331538,-3.30211181679245,0.000959598082798102,0.0396998759908547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2942",1818.05750392619,0.434158947841635,0.13148295771106,3.30201689557152,0.000959922878611421,0.0396998759908547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137707",212.445492565727,0.263452192178225,0.0797877583892157,3.30191244242091,0.00096028040788556,0.0396998759908547,0,2664,"sp|Q14746|COG2_HUMAN","Q14746","COG2",6.7e-11,"Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (Low density lipoprotein receptor defect C-complementing protein)","glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]","GO:0000139; GO:0000301; GO:0005795; GO:0005829; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0044877; GO:0070085"
"g66806",44.3845905865353,-0.652011662708424,0.197501063271326,-3.30130710138352,0.00096235483961936,0.03974763115625,9353,11648,"sp|Q9VUL9|FUCTA_DROME","Q9VUL9","FUCTA",2.14e-11,"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)","fucosylation [GO:0036065]; nervous system development [GO:0007399]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486]","GO:0005797; GO:0006486; GO:0007399; GO:0008417; GO:0016021; GO:0018392; GO:0032580; GO:0036065; GO:0036071; GO:0046920"
"g100573",313.463889005763,0.811319693555269,0.245765584540681,3.30119326947901,0.000962745391327854,0.03974763115625,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g95072",92.4289437338614,0.954241937071787,0.289167588302803,3.29996159898995,0.000966980589924686,0.0398411758333532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106062",26.8099721602594,2.24578754344254,0.68051424392827,3.30013304420893,0.000966390029730103,0.0398411758333532,0,5846,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",6.21e-11,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g137831",705.839115391297,0.446916490822703,0.135422562859408,3.30016270100189,0.000966287907835996,0.0398411758333532,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5437",46.7396618916171,-0.821073215632484,0.248841958738773,-3.29957704799464,0.000968306430058704,0.0398687362552664,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16659",133.932282121988,0.366485766262278,0.111104140730999,3.29857882749483,0.000971755917428924,0.0399801597391378,0,17001,"sp|Q16HH9|MED23_AEDAE","Q16HH9","MED23",4.28e-18,"Mediator of RNA polymerase II transcription subunit 23 (Mediator complex subunit 23)",NA,"GO:0005634"
"g17338",2635.54057863851,0.531343085407255,0.161208822940614,3.29599258722329,0.000980746029801236,0.0399801597391378,18597,55264,"sp|P28765|SODM_PALVU","P28765","SODM",8.59e-25,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) (Fragment)",NA,"GO:0004784; GO:0005759; GO:0046872"
"g26322",965.381206027401,-0.382502884643927,0.116038114208164,-3.29635557466699,0.000979479608361799,0.0399801597391378,13075,37190,"sp|Q0IHQ9|PXYP1_XENTR","Q0IHQ9","PXYP1",2.18e-37,"2-phosphoxylose phosphatase 1 (EC 3.1.3.-) (Acid phosphatase-like protein 2)","chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]","GO:0000139; GO:0005794; GO:0006024; GO:0010909; GO:0016021; GO:0016311; GO:0016791; GO:0050650"
"g31308",40.9568381625986,2.04049472008677,0.618949737388703,3.29670504215002,0.000978261787382535,0.0399801597391378,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31893",263.489378710673,2.58875123807864,0.785215629905615,3.29686666882804,0.000977699026584342,0.0399801597391378,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52676",38707.5735754978,0.308752086294313,0.0936752878624722,3.29598225251896,0.000980782108584614,0.0399801597391378,4833,13924,"sp|O42248|GBLP_DANRE","O42248","GBLP",2.77e-49,"Guanine nucleotide-binding protein subunit beta-2-like 1 (Receptor of activated protein kinase C) (RACK)","angiogenesis [GO:0001525]; convergent extension involved in gastrulation [GO:0060027]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]","GO:0001525; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0015935; GO:0030178; GO:0032880; GO:0043022; GO:0051302; GO:0060027; GO:0072344; GO:2000114; GO:2000543"
"g53066",1865.5670874751,0.338314479376502,0.102584314620824,3.29791626163309,0.000974051783998111,0.0399801597391378,7615,15941,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.31e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g56697",76.5086740064842,0.451733303845286,0.137002391421878,3.29726582986602,0.000976310489513331,0.0399801597391378,0,14540,"sp|P21328|RTJK_DROME","P21328","RTJK",5.88e-26,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g83201",1188.82885350213,0.209539935758113,0.0635736870361965,3.29601672526573,0.000980661767910114,0.0399801597391378,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83571",55.9196660765641,-0.488397892608485,0.148137854536062,-3.29691485095452,0.000977531321377258,0.0399801597391378,1681,4154,"sp|P51522|ZNF83_HUMAN","P51522","ZNF83",8.6e-41,"Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g100480",129.320111108145,-0.71164998192962,0.215896716630857,-3.29625199046638,0.000979840847232671,0.0399801597391378,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114144",20.014035207042,-0.515003468010726,0.156230309145219,-3.29643761718491,0.00097919358133822,0.0399801597391378,135,3726,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.51e-45,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g119755",381.943765842678,0.666625158147657,0.202135459543637,3.29791299187537,0.000974063126528078,0.0399801597391378,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g120808",24.9094887347711,0.479485739666574,0.145477240467786,3.29595019897803,0.000980894016338377,0.0399801597391378,0,3262,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",1.74e-58,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g131896",295.636558018023,0.243710390472767,0.073903674773471,3.29767621461025,0.000974884813258975,0.0399801597391378,0,3174,"sp|Q9Y6D9|MD1L1_HUMAN","Q9Y6D9","MD1L1",6.29e-08,"Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181)","attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538]","GO:0000776; GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051220; GO:0051301; GO:0051315; GO:0072686; GO:0090235; GO:0090267; GO:1902426; GO:1990706; GO:1990728"
"g69997",170.679982037986,-0.548299344381139,0.166395057226695,-3.29516605552857,0.000983635362747214,0.0400381154695697,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85062",285.229905265192,-0.363717641529734,0.110373036110936,-3.29534870422666,0.00098299619434139,0.0400381154695697,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9410",245.571511374179,-0.343394090770831,0.104235276235793,-3.29441339987465,0.000986273299370304,0.040046404072614,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29686",742.693696381383,-0.243675244236943,0.0739657398003014,-3.29443394867457,0.00098620119225005,0.040046404072614,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39480",1043.78035213659,0.43645879213874,0.132489279619215,3.29429515650744,0.000986688318166628,0.040046404072614,2525,12299,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.44e-17,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g49051",757.150204587732,-0.273228299487918,0.0829452973038926,-3.29407824637571,0.000987450064848496,0.040046404072614,2565,10450,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.28e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g85549",1375.45631778471,0.476028935630868,0.144514858104561,3.29397919268929,0.000987798103422361,0.040046404072614,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149656",39.1100944309248,0.461963545134929,0.140243536868566,3.2940095169439,0.000987691542975919,0.040046404072614,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g33518",168.391151489157,-0.728866720463641,0.221306067072451,-3.29347825889032,0.000989559942590532,0.0400643048137554,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85771",34.5131917092801,0.766624655259181,0.232770085609742,3.29348444088512,0.00098953818211603,0.0400643048137554,0,7806,"sp|P54985|PPIA_BLAGE","P54985","PPIA",7.96e-06,"Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Cyclophilin) (Cyclosporin A-binding protein) (Rotamase)","protein folding [GO:0006457]","GO:0003755; GO:0005737; GO:0006457"
"g113864",22.2897508299533,1.10390826675958,0.335203034803135,3.2932526025843,0.000990354550731692,0.0400697451226043,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146491",29.6719055948566,1.26640114255733,0.384570326978845,3.29302874848946,0.000991143396378064,0.0400749451873316,378,2299,"sp|P10394|POL4_DROME","P10394","POL4",1.87e-41,"Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g55076",531.460432128718,0.267799732688936,0.0813392109910112,3.2923817360182,0.000993426693450246,0.040140523319238,0,8701,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.11e-54,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g63894",520.924004261278,0.446393834559645,0.135596490874109,3.29207512437832,0.0009945104210695,0.040157576483505,3526,12284,"sp|Q5XGB9|AMPL_XENTR","Q5XGB9","AMPL",2.27e-20,"Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase)",NA,"GO:0004180; GO:0005737; GO:0008233; GO:0030145; GO:0070006"
"g26668",152.221687242261,-0.637885748094985,0.193796811221327,-3.29151828698814,0.000996481378159627,0.0401836909239254,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79766",210.43336679575,-0.516303494589971,0.156857147339162,-3.29155223939908,0.000996361098251025,0.0401836909239254,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g16597",535.249919081323,0.272042438552216,0.0826928257786269,3.28979492465874,0.00100260425414967,0.0403746977916325,50266,59470,"sp|Q9VCA9|SPCS3_DROME","Q9VCA9","SPCS3",6.71e-17,"Signal peptidase complex subunit 3 (Microsomal signal peptidase 22 kDa subunit) (SPC22) (SPase 22 kDa subunit)","protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465]","GO:0005787; GO:0006465; GO:0008233; GO:0016021; GO:0045047"
"g56373",70.9808744185098,0.388689300266263,0.118150326379406,3.28978609012131,0.00100263573161433,0.0403746977916325,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g162655",267.150193928351,0.391636239390568,0.11905198021098,3.2896238995481,0.00100321377936698,0.0403746977916325,0,1019,"sp|P46471|PRS7_MOUSE","P46471","PRS7",3.17e-34,"26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)","proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0036464; GO:0043161; GO:0043197; GO:0140296"
"g15409",358.540881743098,-0.360035176753663,0.109455423290281,-3.28933154640345,0.00100425650627478,0.0403898789700574,0,46631,"sp|Q14703|MBTP1_HUMAN","Q14703","MBTP1",5.56e-82,"Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1)","ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976]","GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0007040; GO:0008203; GO:0016021; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0045540; GO:0060627"
"g38888",153.996334168844,-0.533200354146998,0.16214049576671,-3.28850822631117,0.0010071984102247,0.0404813718652565,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87283",682.943835459576,0.331744484329165,0.100893433311183,3.28806814717042,0.00100877417969114,0.0405178722471578,0,2091,"sp|P80971|COX42_THUOB","P80971","COX42",1.46e-09,"Cytochrome c oxidase subunit 4 isoform 2, mitochondrial (Cytochrome c oxidase subunit IV isoform 2) (COX IV-2)","mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]","GO:0005751; GO:0006123; GO:0016021; GO:0016491"
"g18840",39.8073248417919,0.825240232460043,0.251058396877527,3.28704493744783,0.00101244676118139,0.0406384880529751,0,42430,"sp|B3EWZ6|MLRP2_ACRMI","B3EWZ6","MLRP2",4.95e-152,"MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2) (Fragment)",NA,"GO:0005576; GO:0016020"
"g16826",206.44293124096,-0.415072606047196,0.126290645163449,-3.28664570135023,0.00101388308306842,0.0406692427702724,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g105269",37.3272435173175,-0.750108290737944,0.228264684411161,-3.28613378224909,0.00101572756159079,0.0407163181723547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148650",36.5714634726559,0.554557050647517,0.16877190209016,3.28583753444495,0.00101679638036569,0.0407322589599958,0,1767,"sp|Q8BN82|S17A5_MOUSE","Q8BN82","S17A5",6.45e-06,"Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)","amino acid transport [GO:0006865]; anion transport [GO:0006820]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739]","GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015293; GO:0015739; GO:0016021; GO:0022857; GO:0030672; GO:0031410"
"g124965",3855.40587663529,0.266126151562,0.0810162119762699,3.28485058817548,0.00102036465378933,0.0408482393393629,796,3854,"sp|O57592|RL7A_TAKRU","O57592","RL7A",6.23e-12,"60S ribosomal protein L7a (Surfeit locus protein 3)","ribosome biogenesis [GO:0042254]","GO:0005840; GO:0042254; GO:1990904"
"g138878",401.185876433361,0.417075789201939,0.127023072882364,3.28346480476183,0.00102539447502103,0.0410225383579607,0,1864,"sp|Q8AVT9|AR1AA_XENLA","Q8AVT9","AR1AA",8.05e-09,"Actin-related protein 2/3 complex subunit 1A-A","Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833]","GO:0003779; GO:0005634; GO:0005737; GO:0005885; GO:0030833; GO:0034314; GO:0035861"
"g18793",3872.98523337948,0.270365913491067,0.0823528302380159,3.28301908640731,0.00102701711940161,0.0410603879950488,0,9879,"sp|Q99PV0|PRP8_MOUSE","Q99PV0","PRP8",0,"Pre-mRNA-processing-splicing factor 8 (Splicing factor Prp8)","cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]","GO:0000244; GO:0000398; GO:0005634; GO:0005682; GO:0016607; GO:0017070; GO:0030532; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070122; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157; GO:0140492"
"g113071",158.991791512873,-0.443048940083314,0.134993696457245,-3.28199724661689,0.00103074611581228,0.0411823448114861,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55888",35806.2999617531,-1.00481187090654,0.30619604078143,-3.28159654952495,0.00103221179542267,0.0412137722790803,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6438",209.933811897033,-0.34074153978864,0.103844102749677,-3.28127963713087,0.00103337237101737,0.0412329843504562,63615,71531,"sp|P21328|RTJK_DROME","P21328","RTJK",5.2e-07,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g99137",63.3953055578869,0.425919464271009,0.129818276076684,3.28088984958803,0.00103480148118668,0.041262879036281,0,6574,"sp|Q9VCD0|GATB_DROME","Q9VCD0","GATB",1.3e-11,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-)","glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]","GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681"
"g53690",61.542630953118,-0.608337971204741,0.185457555473223,-3.2802005270288,0.00103733327936185,0.0413366754592716,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32486",141.08597763677,1.1506106602418,0.35080079701237,3.27995452131547,0.00103823821554852,0.0413455887806033,0,20981,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.84e-09,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g5629",847.889489394302,-0.200826794708416,0.0612446608313038,-3.27909065022968,0.00104142176994331,0.041349005402143,17665,37500,"sp|Q9VMJ7|KDM5_DROME","Q9VMJ7","KDM5",4.39e-17,"Lysine-specific demethylase lid (EC 1.14.11.67) (Histone demethylase lid) (Jumonji/ARID domain-containing protein lid) (Protein little imaginal disks) (Retinoblastoma-binding protein 2 homolog) ([histone H3]-trimethyl-L-lysine(4) demethylase lid)","chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone demethylation [GO:0016577]; histone H3-K4 demethylation [GO:0034720]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; histone H3-K9 acetylation [GO:0043970]; larval somatic muscle development [GO:0007526]; locomotor rhythm [GO:0045475]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of stem cell differentiation [GO:2000737]; oocyte karyosome formation [GO:0030717]; positive regulation of transcription, DNA-templated [GO:0045893]; synaptonemal complex organization [GO:0070193]","GO:0003677; GO:0005634; GO:0006325; GO:0006338; GO:0007526; GO:0016577; GO:0030717; GO:0032452; GO:0032922; GO:0033749; GO:0034647; GO:0034720; GO:0034721; GO:0036098; GO:0043970; GO:0045475; GO:0045893; GO:0046872; GO:0070193; GO:0070822; GO:2000737"
"g38164",85.7223169718418,-0.656153679953959,0.200103372335943,-3.27907357229531,0.00104148479683094,0.041349005402143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g77565",113.121143924671,0.438035398597,0.133587821262294,3.27900698175873,0.00104173058592646,0.041349005402143,6386,8664,"sp|Q94511|NDUS1_DROME","Q94511","NDUS1",8.86e-10,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)","ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]","GO:0005747; GO:0008137; GO:0042773; GO:0045333; GO:0046872; GO:0051537; GO:0051539; GO:0072593"
"g104176",1999.30479072269,-0.274000595747549,0.0835616784720299,-3.27902216372142,0.00104167454379808,0.041349005402143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115103",130.903202951756,-0.508407423062287,0.155043433333259,-3.27912902940873,0.00104128014272871,0.041349005402143,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10189",1067.99049554983,0.48748817266845,0.148689860352601,3.27855693395923,0.00104339314323505,0.0413879280149902,52465,63959,"sp|P91929|NDUAA_DROME","P91929","NDUAA",2.05e-24,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)","mitochondrial electron transport, NADH to ubiquinone [GO:0006120]","GO:0005737; GO:0005739; GO:0005747; GO:0005759; GO:0006120"
"g58250",157.316795737954,-0.409038051287301,0.12477919537106,-3.27809495862618,0.00104510231640455,0.041428647669884,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g6827",87.3692883743026,-0.755900168877153,0.230624802489651,-3.27761871540713,0.00104686698817189,0.04146897310074,9645,39902,"sp|P21328|RTJK_DROME","P21328","RTJK",1.84e-13,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g94493",508.976908733475,0.320451728617366,0.0977746582725568,3.27745178841817,0.0010474861717488,0.04146897310074,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125561",51.5651520553456,-0.949442446924343,0.289730738566037,-3.27698210974581,0.00104923017302329,0.041510938201293,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52342",39.8225164635932,-0.530131428736537,0.161801558399877,-3.27642968324426,0.00105128487004166,0.0415110466901941,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127077",28.4809351387197,1.37601017508113,0.419963043204776,3.27650300983789,0.00105101192473947,0.0415110466901941,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149648",20.6513168875028,-0.679408011926487,0.207351629405819,-3.27659837481567,0.00105065704353003,0.0415110466901941,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15378",462.398081045112,-0.602964630194356,0.184067509386855,-3.27577980602272,0.0010537067912788,0.0415796262436347,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57764",82.4344516358498,-0.382525860960193,0.116792361297548,-3.27526438125216,0.00105563131326878,0.0416248397613359,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146448",192.752535712339,0.37254757740287,0.11375131274352,3.27510574091458,0.00105622430766942,0.0416248397613359,0,864,"sp|Q9U1M2|TM120_DROME","Q9U1M2","TM120",3.74e-20,"Transmembrane protein 120 homolog","defense response to Gram-negative bacterium [GO:0050829]; positive regulation of innate immune response [GO:0045089]","GO:0016020; GO:0016021; GO:0045089; GO:0050829"
"g33248",913.777017669416,-0.372630131943141,0.113786095867473,-3.27483010206402,0.00105725537316693,0.0416384351703445,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22196",172.432792806217,-0.411811875703765,0.12576210709844,-3.27453066114278,0.00105837652886097,0.0416555587137304,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3208",426.663865745754,-0.482606273436963,0.147402113725951,-3.27407973493665,0.00106006694573257,0.041682701401694,59998,71714,"sp|O00370|LORF2_HUMAN","O00370","LORF2",2.94e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g62700",72.2961699513123,-0.636173578958696,0.194311971304751,-3.27398036614505,0.00106043979179792,0.041682701401694,4685,12625,"sp|A6NJL1|ZSA5B_HUMAN","A6NJL1","ZSA5B",2.66e-24,"Zinc finger and SCAN domain-containing protein 5B","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872"
"g24053",27.9900431458603,1.77542541410524,0.542431195519487,3.27308869543337,0.00106379090206589,0.0416989560746982,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32077",178.76123318319,-0.298248668516839,0.0911160263223516,-3.27328441060073,0.00106305451991487,0.0416989560746982,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75451",289.136844731509,0.462626840550359,0.141348302981275,3.27295645432435,0.00106428872894558,0.0416989560746982,0,6902,"sp|O88998|NOE1_MOUSE","O88998","NOE1",9.59e-07,"Noelin (Neuronal olfactomedin-related ER localized protein) (Olfactomedin-1) (Pancortin)","atrioventricular valve formation [GO:0003190]; cardiac epithelial to mesenchymal transition [GO:0060317]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neuronal signal transduction [GO:0023041]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165]","GO:0003190; GO:0005615; GO:0005783; GO:0007165; GO:0007399; GO:0010628; GO:0010629; GO:0010718; GO:0023041; GO:0030424; GO:0030516; GO:0032281; GO:0043025; GO:0043065; GO:0043204; GO:0044295; GO:0060317; GO:0097060; GO:0098978; GO:0099243"
"g79833",367.352308067168,0.637173481221179,0.194638054000358,3.27363261256202,0.00106174556892818,0.0416989560746982,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g141887",14391.2550100875,0.416478216789946,0.127227855542179,3.27348295713333,0.00106230796657684,0.0416989560746982,0,2014,"sp|Q56FH2|RS4_LYSTE","Q56FH2","RS4",2.58e-42,"40S ribosomal protein S4","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:0019843"
"g31812",1774.42940132825,-0.480016654689291,0.146697918831187,-3.27214358945113,0.00106735352792048,0.0417401386281456,16657,25914,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.22e-06,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g69303",180.290647873455,-0.335819249853046,0.102623047221986,-3.27235702840347,0.00106654799525336,0.0417401386281456,3805,9110,"sp|P21328|RTJK_DROME","P21328","RTJK",1.94e-20,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g93509",47.493049582086,0.472516910568663,0.144413887265627,3.27196310213255,0.00106803513809907,0.0417401386281456,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116543",773.575675741282,1.1290553423245,0.345082867888788,3.2718382956304,0.00106850670519548,0.0417401386281456,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g154355",91.6711953533246,0.398477413825043,0.121792747819446,3.27176634864807,0.00106877863615321,0.0417401386281456,0,1607,"sp|Q03249|GALT_MOUSE","Q03249","GALT",7.92e-21,"Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase)","galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]","GO:0005737; GO:0005794; GO:0006011; GO:0006012; GO:0006258; GO:0008108; GO:0008270; GO:0033499; GO:0061623"
"g6059",177.409264276265,-0.654502226172125,0.200231775200305,-3.26872308612049,0.00108033975392235,0.0417954860769633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7789",2571.87560360079,0.521550546880908,0.159515416384526,3.26959336409005,0.00107702188107637,0.0417954860769633,82615,86896,"sp|O61661|CHK1_DROME","O61661","CHK1",3.13e-17,"Serine/threonine-protein kinase grp (EC 2.7.11.1) (Chk1 homolog) (Protein grapes)","centrosome separation [GO:0051299]; DNA damage checkpoint signaling [GO:0000077]; intracellular signal transduction [GO:0035556]; mitotic DNA replication checkpoint signaling [GO:0033314]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of syncytial blastoderm mitotic cell cycle [GO:0007348]; spindle assembly [GO:0051225]; wound healing [GO:0042060]","GO:0000077; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0007348; GO:0033314; GO:0035556; GO:0042060; GO:0051225; GO:0051299; GO:0051726; GO:0106310"
"g9181",53.0347695291449,0.394152282210762,0.120519766074448,3.2704368341313,0.00107381520809692,0.0417954860769633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9747",67.3559257131901,-0.361438339905691,0.110621691940827,-3.26733693513773,0.0010856438822926,0.0417954860769633,80631,83434,"sp|P21328|RTJK_DROME","P21328","RTJK",8.89e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g17388",2848.5491563898,-0.427051426689744,0.130685801313384,-3.26777218640361,0.00108397579805139,0.0417954860769633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18680",3188.09950710595,0.255827611408653,0.0782680782831114,3.26860729202106,0.00108078192262153,0.0417954860769633,0,4910,"sp|O61231|RL10_DROME","O61231","RL10",1.06e-23,"60S ribosomal protein L10 (QM protein homolog) (dQM)","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003735; GO:0005737; GO:0022625; GO:0022626; GO:0043025"
"g20094",31.5866288631367,1.04730006135472,0.320383337882581,3.268896779328,0.00107967680674278,0.0417954860769633,18795,22063,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.11e-15,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g21235",3364.19561891301,-0.600872451977125,0.18386275616649,-3.26804875824349,0.00108291707887157,0.0417954860769633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32889",636.778669899374,-0.351247645597551,0.107496016433298,-3.26754104246738,0.00108486135316021,0.0417954860769633,9595,13622,"sp|O01404|PHM_DROME","O01404","PHM",6.82e-07,"Peptidylglycine alpha-hydroxylating monooxygenase (dPHM) (EC 1.14.17.3)","memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide metabolic process [GO:0006518]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620]","GO:0004504; GO:0005507; GO:0005576; GO:0005615; GO:0006518; GO:0007613; GO:0009620; GO:0016020; GO:0032504; GO:0044719"
"g38387",588.341825756715,0.352517754710196,0.107870271154605,3.26797875760367,0.0010831849514328,0.0417954860769633,2174,5474,"sp|Q9NQP4|PFD4_HUMAN","Q9NQP4","PFD4",5.23e-23,"Prefoldin subunit 4 (Protein C-1)","negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]","GO:0001540; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0051087; GO:1905907"
"g41532",2604.91993302647,-0.432270418481495,0.132251073532727,-3.26855886258288,0.00108096690380638,0.0417954860769633,6976,22863,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",2.48e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g42349",32.3934462975927,-0.52040655075816,0.159202865649754,-3.2688265291848,0.00107994489011372,0.0417954860769633,0,6856,"sp|O75122|CLAP2_HUMAN","O75122","CLAP2",1.19e-08,"CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2) (hOrbit2)","cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule-based process [GO:0032886]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; vesicle targeting [GO:0006903]","GO:0000226; GO:0000776; GO:0002162; GO:0005737; GO:0005794; GO:0005802; GO:0005815; GO:0005828; GO:0005829; GO:0005874; GO:0005876; GO:0005881; GO:0005886; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030516; GO:0031023; GO:0031110; GO:0031113; GO:0031252; GO:0032587; GO:0032886; GO:0032956; GO:0034453; GO:0035791; GO:0040001; GO:0044295; GO:0045180; GO:0045921; GO:0051010; GO:0051015; GO:0051301; GO:0051497; GO:0051895; GO:0072659; GO:0090091; GO:0090307; GO:1903690; GO:1903754; GO:1904261; GO:1990782"
"g67334",51.1682376676784,0.852311374370507,0.26070512811642,3.26925435080011,0.00107831322286486,0.0417954860769633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g85298",1057.85580373057,0.461761980749231,0.14123975499897,3.26934849718905,0.00107795446455525,0.0417954860769633,115,7219,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.23e-16,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g86176",124.990028756205,-0.428380503731945,0.131110265552076,-3.26732999836534,0.00108567048642422,0.0417954860769633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91416",57.2703165533203,0.717307334551048,0.21935012091456,3.27014788758858,0.00107491271846843,0.0417954860769633,0,7513,"sp|Q5R8G6|MCM3_PONAB","Q5R8G6","MCM3",8.97e-40,"DNA replication licensing factor MCM3 (EC 3.6.4.12)","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]","GO:0003677; GO:0003678; GO:0005524; GO:0006270; GO:0007049; GO:0016887; GO:0042555; GO:0071162"
"g93372",115.144158727819,0.382900790052164,0.117162059791565,3.26812955263297,0.00108260797786953,0.0417954860769633,0,5894,"sp|Q0VD19|ASM_BOVIN","Q0VD19","ASM",1.05e-14,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (aSMase)","cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; negative regulation of MAP kinase activity [GO:0043407]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]","GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005765; GO:0005811; GO:0005886; GO:0006685; GO:0008081; GO:0008203; GO:0008270; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0043065; GO:0043407; GO:0045121; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070555; GO:0071277"
"g98066",253.254760315141,-0.672081566262174,0.205703473316303,-3.26723489607167,0.00108603528659369,0.0417954860769633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104011",184.011453710433,1.38146880914094,0.42261193473977,3.26888262157481,0.00107973082955429,0.0417954860769633,0,2914,"sp|P50903|LIPP_CAVPO","P50903","LIPP",4.31e-17,"Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3)","lipid catabolic process [GO:0016042]","GO:0004806; GO:0005576; GO:0016042; GO:0046872; GO:0047376"
"g107204",73.0328422750897,1.72868145838475,0.528702126845354,3.26966995328618,0.00107673034190919,0.0417954860769633,175,3899,"sp|P21328|RTJK_DROME","P21328","RTJK",2.16e-19,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g116143",152.661297502866,0.548186626017525,0.167743216469345,3.26801069846963,0.00108306271521186,0.0417954860769633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160601",21.3451704449508,2.01614626665214,0.61642815505183,3.27069140195685,0.00107284913796398,0.0417954860769633,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160674",31.9779797066609,0.552967860138674,0.169183369141145,3.26845282101782,0.00108137204265821,0.0417954860769633,0,1151,"sp|P28365|RPA2_EUPOC","P28365","RPA2",3.65e-17,"DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6)","transcription, DNA-templated [GO:0006351]","GO:0003677; GO:0003899; GO:0005730; GO:0006351; GO:0032549; GO:0046872"
"g22510",962.555656375429,-0.369521441721648,0.113111657954544,-3.2668731800408,0.00108742381865095,0.0417959161202827,4094,23524,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",3.01e-45,"PiggyBac transposable element-derived protein 4",NA,NA
"g155570",20.2078628029145,0.778729604829082,0.238368433676327,3.26691581103602,0.0010872600842382,0.0417959161202827,0,1151,"sp|Q802W2|A9A1B_DANRE","Q802W2","A9A1B",6.25e-14,"4-trimethylaminobutyraldehyde dehydrogenase B (TMABA-DH) (TMABADH) (EC 1.2.1.47) (Aldehyde dehydrogenase family 9 member A1-B) (EC 1.2.1.3)","carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; protein homotetramerization [GO:0051289]","GO:0004029; GO:0005829; GO:0006081; GO:0019145; GO:0043878; GO:0045329; GO:0047105; GO:0051289"
"g798",401.828158234308,-0.317008682843952,0.0971014747339302,-3.26471543004465,0.00109574101807339,0.0420889382195405,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124773",77.623250950022,0.737544137964152,0.225945238336908,3.26426059426133,0.00109750170525665,0.0421299041695294,0,4061,"sp|Q8JG30|ST1B1_CHICK","Q8JG30","ST1B1",8.03e-08,"Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase family cytosolic 1B member 1)","sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0006805; GO:0008146; GO:0042403; GO:0051923"
"g6368",532.941780382059,0.671502592170995,0.205741501651065,3.26381690996819,0.00109922174517159,0.0421341613369925,6415,11990,"sp|Q6A2H2|SSDH_PONPY","Q6A2H2","SSDH",8.1e-09,"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)","central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; succinate metabolic process [GO:0006105]","GO:0004777; GO:0005739; GO:0006105; GO:0007417; GO:0009450; GO:0042802"
"g7897",136.80567397023,-0.346649840011529,0.106222754542101,-3.26342356217224,0.00110074872892159,0.0421341613369925,45125,55655,"sp|Q8C863|ITCH_MOUSE","Q8C863","ITCH",2.17e-25,"E3 ubiquitin-protein ligase Itchy (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase Itchy homolog)","apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; negative regulation of apoptotic process [GO:0043066]; negative regulation of defense response to virus [GO:0050687]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of T cell anergy [GO:0002669]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein deubiquitination [GO:0090085]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0002669; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006511; GO:0006915; GO:0016020; GO:0016567; GO:0016874; GO:0031410; GO:0031901; GO:0032088; GO:0032991; GO:0035519; GO:0043021; GO:0043066; GO:0043161; GO:0043231; GO:0044389; GO:0045087; GO:0045236; GO:0045732; GO:0046329; GO:0046642; GO:0050687; GO:0051607; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0090085; GO:1990763; GO:2000646"
"g14069",1631.69584519468,-0.453112609578659,0.138875761736588,-3.26271916648852,0.00110348810923397,0.0421341613369925,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22265",44.7145611233828,0.732381861146883,0.224491323986918,3.26240608385187,0.00110470770372087,0.0421341613369925,0,8783,"sp|Q9D6A1|MYO1H_MOUSE","Q9D6A1","MYO1H",3.72e-13,"Unconventional myosin-Ih","actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050]","GO:0000146; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016459; GO:0030050; GO:0031982; GO:0051015"
"g32219",88.8133184282871,-0.643689254412754,0.197275190093079,-3.26290018582188,0.00110278352753791,0.0421341613369925,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57213",131.306089953512,-1.24281705541399,0.380766277347558,-3.2639893009211,0.00109855313774807,0.0421341613369925,5355,14231,"sp|Q03278|PO21_NASVI","Q03278","PO21",9.92e-10,"Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)",NA,"GO:0003964; GO:0004519; GO:0046872"
"g59417",3124.49231489754,0.368563175150833,0.112976021371303,3.26231328274101,0.00110506944425146,0.0421341613369925,0,9649,"sp|O16797|RL3_DROME","O16797","RL3",6.9e-26,"60S ribosomal protein L3","cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g88739",33.5886396393539,0.742396523970746,0.227570733425644,3.26226713248834,0.00110524937960936,0.0421341613369925,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104541",45.3126898145727,-0.459866674385214,0.140942753666968,-3.26279047642157,0.00110321049984581,0.0421341613369925,0,5995,"sp|O75096|LRP4_HUMAN","O75096","LRP4",5.1e-20,"Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395"
"g143841",102.707926715191,-0.450129468132516,0.137937696377411,-3.26328103161096,0.00110130251931813,0.0421341613369925,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149919",55.6993437230178,-0.687914786129241,0.210851784460471,-3.26255140732852,0.00110414144997995,0.0421341613369925,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24238",959.645021161401,-0.354101222737484,0.10855831194698,-3.26185269821097,0.00110686643312207,0.042169318158304,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4682",118.561033928232,0.410994773334544,0.126045678316101,3.26068119768327,0.00111144927294149,0.0422004847598988,36905,53678,"sp|P21328|RTJK_DROME","P21328","RTJK",1.51e-09,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g16192",78.299363235844,0.475260794490657,0.145754791135384,3.26068728711095,0.00111142540617035,0.0422004847598988,20895,24611,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",5.53e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g34089",242.180169319444,0.311901546463408,0.0956583813114711,3.26057729795607,0.00111185656831567,0.0422004847598988,25866,30024,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",5.98e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g71156",54.0708973460956,0.422629527151851,0.1296124822734,3.26071625000108,0.00111131189613223,0.0422004847598988,5165,10403,"sp|Q03249|GALT_MOUSE","Q03249","GALT",2.93e-17,"Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase)","galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011]","GO:0005737; GO:0005794; GO:0006011; GO:0006012; GO:0006258; GO:0008108; GO:0008270; GO:0033499; GO:0061623"
"g91341",62.8912287016494,0.894769227884279,0.274372749490928,3.26114466376285,0.00110963412792792,0.0422004847598988,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g112131",610.619955999223,0.375544842225225,0.115155326673509,3.26120252595852,0.00110940770568976,0.0422004847598988,0,5237,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",9.3e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g51991",12393.5751270112,0.386649582683381,0.11860012315636,3.26011113979729,0.00111368564536468,0.0422040666765959,8796,11084,"sp|Q803F6|RSSA_DANRE","Q803F6","RSSA",6.04e-12,"40S ribosomal protein SA (37 kDa laminin receptor precursor) (37LRP) (37/67 kDa laminin receptor) (LRP/LR) (67 kDa laminin receptor) (67LR) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40)","cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]","GO:0000028; GO:0002181; GO:0003735; GO:0005055; GO:0005634; GO:0005886; GO:0006412; GO:0022627; GO:0043236"
"g61561",42.2504786494439,-0.649673590894387,0.199283245742287,-3.26005123247815,0.00111392090693132,0.0422040666765959,0,12333,"sp|P23978|SC6A1_RAT","P23978","SC6A1",2.4e-11,"Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1)","associative learning [GO:0008306]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; inorganic anion import across plasma membrane [GO:0098658]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neurotransmitter reuptake [GO:0098810]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]","GO:0005332; GO:0005886; GO:0005887; GO:0007612; GO:0007613; GO:0008306; GO:0009636; GO:0009744; GO:0009986; GO:0010033; GO:0010035; GO:0010243; GO:0010288; GO:0014054; GO:0014070; GO:0014074; GO:0015185; GO:0015378; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042802; GO:0043005; GO:0043025; GO:0046872; GO:0050808; GO:0051592; GO:0051939; GO:0098658; GO:0098719; GO:0098810; GO:0098982; GO:0099055; GO:0099056; GO:1902476"
"g145652",193.615763894432,0.510747517131221,0.156669977748514,3.26002163574102,0.00111403715300555,0.0422040666765959,0,2373,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.05e-13,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g83262",236.667878641777,0.608094519536967,0.186553703513939,3.25962180371043,0.00111560865905179,0.0422372361309127,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10686",867.190621512285,-0.757616993049813,0.232468753739737,-3.25900569802172,0.00111803422349564,0.0423026789426123,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g131055",84.4272540896315,2.30435834702313,0.707170134860015,3.25856287395293,0.00111978060121812,0.0423423580610141,0,3546,"sp|Q64285|CEL_MOUSE","Q64285","CEL",4.94e-08,"Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (EC 3.1.1.6) (Bile salt-stimulated lipase) (BSSL) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase)","ceramide catabolic process [GO:0046514]; chemical synaptic transmission [GO:0007268]; cholesterol catabolic process [GO:0006707]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; pancreatic juice secretion [GO:0030157]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488]","GO:0004622; GO:0004771; GO:0004806; GO:0005615; GO:0005737; GO:0005791; GO:0005794; GO:0005829; GO:0005887; GO:0006707; GO:0007158; GO:0007268; GO:0008126; GO:0009986; GO:0030157; GO:0032991; GO:0038023; GO:0042043; GO:0042588; GO:0043208; GO:0043231; GO:0044877; GO:0045121; GO:0045202; GO:0046514; GO:0048488; GO:0050253; GO:0050804; GO:0052689; GO:0097104; GO:0097105; GO:0098793; GO:0099060"
"g44424",502.895341152454,0.458396368643965,0.140688102718914,3.25824543643049,0.00112103404011031,0.0423633598345547,0,19091,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",7.86e-33,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g5037",1263.06674412776,-0.257377245240042,0.0790174291716413,-3.25722119712308,0.00112508721850792,0.0424900704985971,10335,37240,"sp|Q01484|ANK2_HUMAN","Q01484","ANK2",4e-22,"Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259"
"g64423",225.127416695455,-0.670967469412156,0.206068109084593,-3.25604710206138,0.00112975007936005,0.0426308330432344,6615,12196,"sp|Q6IQ26|DEN5A_HUMAN","Q6IQ26","DEN5A",1.37e-06,"DENN domain-containing protein 5A (Rab6-interacting protein 1) (Rab6IP1)","negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0005085; GO:0005802; GO:0005829; GO:0010977; GO:0031267; GO:0042147"
"g67827",786.224856422458,0.678733184673795,0.208460670825924,3.25592919750591,0.00113021931729386,0.0426308330432344,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31307",59.4636326225487,2.18129836721898,0.670094294875758,3.25521107088878,0.00113308121891034,0.0426985917330824,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g148297",67.3251159828921,2.17895066942282,0.669390686463933,3.25512546482109,0.00113342282553956,0.0426985917330824,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g53850",836.767176825547,0.454948645886924,0.139784338524062,3.254646770093,0.00113533478766109,0.0427440870118806,8572,13184,"sp|Q5ZJF4|PRDX6_CHICK","Q5ZJF4","PRDX6",5.72e-15,"Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx)","cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042]","GO:0004623; GO:0005615; GO:0005739; GO:0005764; GO:0005829; GO:0008379; GO:0016042; GO:0045454; GO:0047184"
"g27358",77.6169564341791,0.463323073996961,0.142375412152788,3.25423517299289,0.00113698113756001,0.042779532075956,12651,23594,"sp|P11415|QOR_CAVPO","P11415","QOR",4.4e-13,"Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin)","protein homotetramerization [GO:0051289]; quinone catabolic process [GO:1901662]; xenobiotic catabolic process [GO:0042178]","GO:0003730; GO:0003960; GO:0005212; GO:0005829; GO:0008270; GO:0042178; GO:0042802; GO:0051289; GO:0070402; GO:1901662"
"g16728",32.246248640213,-0.541962892419214,0.16655882204324,-3.25388283713076,0.00113839220090735,0.0428060859188769,41045,51838,"sp|P11369|LORF2_MOUSE","P11369","LORF2",2.82e-11,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g117397",167.577980813033,0.300055060103277,0.0922372452375383,3.25307915832206,0.00114161689890499,0.0429007613588505,1193,4257,"sp|Q6IQE9|ALKB6_DANRE","Q6IQE9","ALKB6",9.19e-14,"Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6)",NA,"GO:0005634; GO:0005737; GO:0046872; GO:0051213"
"g8877",244.483954132018,0.618868546403644,0.190265072610852,3.2526650210226,0.00114328188681143,0.0429305925221809,31760,52114,"sp|Q3TDQ1|STT3B_MOUSE","Q3TDQ1","STT3B",1.55e-26,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (B6dom1 antigen) (Source of immunodominant MHC-associated peptides)","co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433]","GO:0004579; GO:0005783; GO:0005789; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016021; GO:0018279; GO:0030433; GO:0032991; GO:0034998; GO:0043686; GO:0043687; GO:0046872"
"g37330",25.267570448055,0.447677703119231,0.13763984107612,3.25252993333267,0.00114382547550447,0.0429305925221809,10602,13074,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",8.27e-37,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g46094",97.3068140546996,-0.60084020510405,0.184780569582619,-3.2516416983735,0.0011474056594731,0.0430383494891363,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99816",846.248835844775,0.614773466557733,0.18908099524731,3.25137629910206,0.00114847740501596,0.0430455884712547,1464,6525,"sp|A7YWE4|AL4A1_BOVIN","A7YWE4","AL4A1",5.2e-09,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)","proline catabolic process to glutamate [GO:0010133]","GO:0003842; GO:0005759; GO:0010133; GO:0016620"
"g141048",37.1126469086319,1.98392558493183,0.610205314571969,3.25124271709017,0.00114901719102707,0.0430455884712547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g12176",529.220029709453,0.317915899032961,0.097805645246777,3.25048618851004,0.00115207864311583,0.0430691705146938,0,40370,"sp|P21328|RTJK_DROME","P21328","RTJK",3.96e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g43798",162.581335863549,0.69365487801074,0.213416805794931,3.25023549774831,0.0011530947779201,0.0430691705146938,11589,19434,"sp|Q10469|MGAT2_HUMAN","Q10469","MGAT2",1.07e-06,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)","oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082]","GO:0000139; GO:0005794; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016020; GO:0016021; GO:0018279; GO:0019082; GO:0030145; GO:0042803"
"g54053",27.1236465000327,0.546672418197872,0.168181455433474,3.25049165967121,0.0011520564758724,0.0430691705146938,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79918",90.7745000499174,0.459388190350118,0.14134104512142,3.25021079301825,0.00115319495940645,0.0430691705146938,0,4004,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.19e-11,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g108740",406.283727741543,0.485221115576383,0.14927946838111,3.25042097777047,0.00115234288472018,0.0430691705146938,0,5572,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.83e-21,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g2498",343.691862498383,0.361824856198534,0.111342271390345,3.24966296879325,0.00115541853911862,0.0430727120288547,13655,15709,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.22e-13,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g35122",75.3542198147582,-0.416159185032755,0.128064204905452,-3.24961362419733,0.0011556190197525,0.0430727120288547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62934",77.5489149569689,0.328035031055333,0.100949752243662,3.24948822324553,0.00115612865208443,0.0430727120288547,6266,12204,"sp|Q921I2|KLDC4_MOUSE","Q921I2","KLDC4",7.84e-07,"Kelch domain-containing protein 4",NA,NA
"g69723",800.475558161384,0.355516702776802,0.109405855523879,3.24952171046465,0.00115599253893661,0.0430727120288547,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106033",35.5769180711576,0.700902726093886,0.215810798723226,3.24776484884236,0.00116315356033316,0.0433078463660241,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90739",83.8723217870998,-0.6113579003126,0.188290127797203,-3.24689301273967,0.00116672239032211,0.0434140906613419,0,5344,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.25e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g59792",84.9765631971946,-0.459548019304151,0.141561435122577,-3.24627974353489,0.00116923884551197,0.0434810695674765,0,13499,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.53e-11,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g126094",181.72180458508,0.724995300090412,0.223348906961747,3.24602125863362,0.0011703010000405,0.0434939177541078,0,2861,"sp|Q2KJI2|STT3A_BOVIN","Q2KJI2","STT3A",1.15e-54,"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18)","co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]","GO:0004579; GO:0016021; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872"
"g69846",3856.72397149116,0.253342585681817,0.0780519474066642,3.2458201761688,0.00117112789559054,0.0434980122297366,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g22684",186.940255185985,0.331049482825253,0.102007740755444,3.24533687711915,0.00117311753688073,0.043506111481351,14995,46652,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.67e-23,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g36877",68.2850293897492,-0.414812245528687,0.127821553692462,-3.24524490233254,0.00117349653147094,0.043506111481351,0,11340,"sp|P82251|BAT1_HUMAN","P82251","BAT1",1.27e-12,"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)","L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003]","GO:0005886; GO:0005887; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0065003"
"g135294",617.177572146458,0.412272456884466,0.127034485433865,3.24535857705425,0.00117302813584555,0.043506111481351,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61854",28.7102952598121,-0.752857374804865,0.232010507613991,-3.24492792394316,0.00117480355099441,0.0435279777227415,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30813",505.228122588092,-0.316276592342396,0.097485297014461,-3.24435173332322,0.00117718284430131,0.043577069480929,16654,33134,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",4.7e-08,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g58878",1218.36340081809,-0.415360144451914,0.128029264751641,-3.24425939067646,0.00117756457322003,0.043577069480929,30,13090,"sp|Q96MY1|NOL4L_HUMAN","Q96MY1","NOL4L",1.62e-26,"Nucleolar protein 4-like",NA,"GO:0005654; GO:0005829"
"g39776",750.733699757465,-0.498570183501742,0.153696663323881,-3.24385821214036,0.00117922430583343,0.0436118970877701,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30307",35.3677994794318,-0.612620563742117,0.188931821014202,-3.24254834603044,0.00118465847030617,0.0437861891369557,0,6710,"sp|G5EFD9|ADA10_CAEEL","G5EFD9","ADA10",6.39e-47,"Disintegrin and metalloproteinase domain-containing protein 10 homolog (ADAM 10 homolog) (EC 3.4.24.81)","cell fate specification [GO:0001708]; embryo development ending in birth or egg hatching [GO:0009792]; membrane protein ectodomain proteolysis [GO:0006509]; nematode male tail tip morphogenesis [GO:0045138]; Notch signaling pathway [GO:0007219]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of axon guidance [GO:1902667]; regulation of mesodermal cell fate specification [GO:0042661]; vulval development [GO:0040025]","GO:0001708; GO:0004222; GO:0005886; GO:0006509; GO:0007219; GO:0008237; GO:0009792; GO:0016021; GO:0016323; GO:0030511; GO:0030659; GO:0040025; GO:0042661; GO:0045138; GO:0046872; GO:1902667"
"g75576",134.214038385461,1.76545332039314,0.544517842643561,3.24223226886763,0.0011859732217135,0.0438081039718761,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31683",182.462769848933,0.361407976742821,0.111493742200245,3.24150907136766,0.00118898649960245,0.0438926950491927,21915,28562,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.2e-24,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g144083",324.365490671669,0.563751667617621,0.173930268869557,3.24125105584941,0.00119006325907981,0.0439057381115826,1317,1674,"sp|P30116|GSTMU_MESAU","P30116","GSTMU",3.52e-09,"Glutathione S-transferase (EC 2.5.1.18) (GST class-mu)","glutathione metabolic process [GO:0006749]","GO:0004364; GO:0005737; GO:0006749; GO:0042802"
"g113088",25.7471186966748,3.96113065796231,1.22229184126435,3.24074048785672,0.00119219663522842,0.0439577240534707,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g67159",228.546250121063,0.57885219084832,0.178631743050604,3.24047776147119,0.00119329579721233,0.0439715372998276,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32544",6455.81898479077,-0.308964645680331,0.0953512592369686,-3.24027860935205,0.0011941296088313,0.0439723308552839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g40082",38.780688048304,-0.814925436097778,0.251510368933522,-3.24012659817287,0.00119476641259455,0.0439723308552839,7286,10514,"sp|Q5R8Q7|GTPB1_PONAB","Q5R8Q7","GTPB1",1.64e-23,"GTP-binding protein 1 (Fragment)","GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]","GO:0000177; GO:0003924; GO:0005525; GO:0005829; GO:0046039; GO:0061014"
"g8834",53.1144418305311,-0.324678292150523,0.100230842090609,-3.2393052415644,0.00119821266253945,0.0439761111953839,76572,85724,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.21e-38,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g41474",58.4218401332211,0.72075856619335,0.22251483028052,3.23914844365522,0.0011988715985577,0.0439761111953839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87491",68.5616116649553,-0.769466669727107,0.237501647379694,-3.23983718941099,0.00119597966832705,0.0439761111953839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96630",155.881356296857,1.92261400552222,0.59353824291063,3.23924200080854,0.00119847838864395,0.0439761111953839,0,6885,"sp|Q9UB00|GLCM4_CAEEL","Q9UB00","GLCM4",9.25e-08,"Putative glucosylceramidase 4 (EC 3.2.1.45)","glucosylceramide catabolic process [GO:0006680]","GO:0004348; GO:0006680"
"g108212",25.7271825212033,0.78696820948185,0.242961435573557,3.23906634657497,0.00119921674128127,0.0439761111953839,0,5625,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",7.02e-68,"PiggyBac transposable element-derived protein 4",NA,NA
"g141891",31.2151077267985,-0.596437715936124,0.184135956633729,-3.23911595996711,0.00119900815162019,0.0439761111953839,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g2452",34.828030489053,-0.637590959000919,0.196877958832851,-3.23850858054777,0.00120156406590507,0.0440122414056628,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4147",62.0855305843281,-0.420590634838489,0.129892867873816,-3.23798097403677,0.00120378837177885,0.0440122414056628,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47269",247.202892508381,-0.294372673277305,0.0909066740917881,-3.23818549318038,0.00120292570024248,0.0440122414056628,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63787",47.2068566062274,1.50189542364349,0.463838358174136,3.23797158466063,0.00120382799033449,0.0440122414056628,0,3573,"sp|P07768|SUIS_RABIT","P07768","SUIS",4.48e-09,"Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]","carbohydrate metabolic process [GO:0005975]","GO:0004574; GO:0004575; GO:0005975; GO:0016021; GO:0016324; GO:0030246"
"g91343",71.0879018030285,0.934666252042026,0.288642623926199,3.23814355388137,0.00120310255565096,0.0440122414056628,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31813",294.19796142798,-0.569590015237813,0.175937701158812,-3.23745286818126,0.00120601859142012,0.0440657846558019,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91404",25.4740385090602,1.95779956215008,0.604799746301082,3.23710380853145,0.00120749478371599,0.0440931759468854,0,6052,"sp|Q24238|APH4_DROME","Q24238","APH4",2.16e-13,"Alkaline phosphatase 4 (EC 3.1.3.1)","dephosphorylation [GO:0016311]; epithelial fluid transport [GO:0042045]; multicellular organism reproduction [GO:0032504]; nervous system development [GO:0007399]","GO:0004035; GO:0005576; GO:0005615; GO:0005886; GO:0007399; GO:0009986; GO:0016021; GO:0016311; GO:0031225; GO:0032504; GO:0042045; GO:0046872"
"g54218",189.990706992258,2.20474289082128,0.681174913633236,3.23667658144025,0.00120930382197164,0.04410615922804,2773,11044,"sp|Q9UB00|GLCM4_CAEEL","Q9UB00","GLCM4",5.9e-14,"Putative glucosylceramidase 4 (EC 3.2.1.45)","glucosylceramide catabolic process [GO:0006680]","GO:0004348; GO:0006680"
"g91791",493.994116561261,0.613398202598498,0.189507369418491,3.23680395374982,0.00120876421851944,0.04410615922804,0,7468,"sp|P21328|RTJK_DROME","P21328","RTJK",2.9e-10,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g68644",312.510919174835,0.241830562615994,0.0747204156219707,3.2364723965064,0.00121016930074854,0.044111216133591,0,11229,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.18e-35,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g15700",268.145752063384,-0.472022369529516,0.145914501226909,-3.23492432596183,0.00121674974510908,0.0442857221864955,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34088",445.438425392778,0.479268211705529,0.148158541651395,3.23483348555905,0.0012171369086977,0.0442857221864955,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g42886",5102.65593707019,-0.255826822179471,0.0790934229793613,-3.23448919698704,0.00121860530649938,0.0442857221864955,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g116309",151.068749925239,-0.59785072486984,0.184826247652313,-3.23466354191473,0.00121786151743916,0.0442857221864955,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121789",373.852925203367,0.272265597464849,0.0841727482408482,3.23460506107987,0.00121811096120113,0.0442857221864955,0,1714,"sp|Q9NDJ2|DOM_DROME","Q9NDJ2","DOM",3.63e-14,"Helicase domino (EC 3.6.4.-)","cell cycle [GO:0007049]; chromatin organization [GO:0006325]; dendrite guidance [GO:0070983]; dendrite morphogenesis [GO:0048813]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; male germ-line stem cell population maintenance [GO:0036098]; negative regulation of gene expression [GO:0010629]; negative regulation of hemocyte proliferation [GO:0035207]; oogenesis [GO:0048477]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; wing disc pattern formation [GO:0035222]","GO:0000123; GO:0000381; GO:0000812; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0006325; GO:0006355; GO:0007049; GO:0008094; GO:0010629; GO:0016573; GO:0016887; GO:0030097; GO:0035019; GO:0035207; GO:0035222; GO:0035267; GO:0036098; GO:0042393; GO:0043486; GO:0048477; GO:0048813; GO:0070983; GO:0140658"
"g33528",253.613287052778,0.345222220044029,0.106758980750989,3.23365975972781,0.00122214959531135,0.0443613988872282,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139221",79.0382046694676,0.444039625992427,0.137313456280552,3.2337662893372,0.00122169384871868,0.0443613988872282,425,2905,"sp|Q1ZXF7|GMDS_DICDI","Q1ZXF7","GMDS",5.05e-26,"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)","'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; spore germination [GO:0009847]","GO:0005737; GO:0008446; GO:0009847; GO:0019673; GO:0042351"
"g2880",1443.67751054293,0.404545663110572,0.125144203587088,3.23263604317918,0.00122653719075946,0.0444036431701871,2345,14234,"sp|Q15427|SF3B4_HUMAN","Q15427","SF3B4",2.01e-41,"Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49) (SAP 49)","mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]","GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005689; GO:0006397; GO:0008380; GO:0048026; GO:0071005; GO:1990935"
"g8759",158.157230929901,-0.538482189262992,0.166580720567598,-3.23256009115699,0.00122686329616228,0.0444036431701871,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g37846",385.4358277264,-0.434887042430861,0.134514220557178,-3.23301908623113,0.00122489378780611,0.0444036431701871,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38500",44.9034141254772,0.52782828607616,0.163310636969522,3.23205086864408,0.00122905174821739,0.0444036431701871,0,6057,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.93e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g39944",37.1900004985375,0.863763539793547,0.267250577431501,3.23203619649779,0.00122911485713685,0.0444036431701871,2286,22783,"sp|P04323|POL3_DROME","P04323","POL3",1.02e-100,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g43009",2108.5699829234,0.291014443783748,0.0900444469757143,3.23189773004255,0.00122971058669579,0.0444036431701871,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g82899",82.6303747305978,0.330097768469226,0.102125052912543,3.23228981581936,0.00122802439211339,0.0444036431701871,5750,8304,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.09e-08,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g91648",26.4850141266498,-0.514272287443472,0.159126082842039,-3.23185412635324,0.00122989823972787,0.0444036431701871,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93045",126.484858388524,-0.764950680286017,0.236638857244163,-3.23256581439938,0.00122683872022509,0.0444036431701871,3986,7124,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",9.79e-18,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g83011",1053.96604796262,-0.382477760368715,0.118382603074056,-3.230861211334,0.00123417851756954,0.0444461192080819,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83263",249.342963067182,0.554571161067716,0.171654955873101,3.23073201264107,0.00123473648022452,0.0444461192080819,2106,8374,"sp|P21439|MDR3_HUMAN","P21439","MDR3",2.41e-19,"Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3)","bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085]","GO:0005524; GO:0005548; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006629; GO:0015629; GO:0016020; GO:0016021; GO:0016324; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0042910; GO:0045121; GO:0045332; GO:0046581; GO:0055085; GO:0055088; GO:0061092; GO:0070062; GO:0090554; GO:0090555; GO:0140359; GO:1901557; GO:1903413; GO:2001140"
"g105424",73.5782728662113,0.427088412305377,0.132194093143788,3.23076774573302,0.00123458213856076,0.0444461192080819,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g106928",91.4351440748089,0.747073780224757,0.231199642822818,3.23129296872351,0.0012323156016256,0.0444461192080819,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122260",48.5379340861478,-0.626115336326848,0.193784144319529,-3.23099363224708,0.00123360688094622,0.0444461192080819,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g18002",28.8958620989064,1.11139176986314,0.344079929287392,3.23003952065698,0.0012377310764248,0.0445026382205613,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28546",60.8033169912799,0.419596887048368,0.129904958513994,3.23002979907934,0.00123777316388709,0.0445026382205613,0,13604,"sp|P08548|LIN1_NYCCO","P08548","LIN1",1.17e-14,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g40517",157.482442063186,0.440948371469506,0.136566342598417,3.22882170730854,0.0012430136340386,0.0446381641714809,20075,23732,"sp|Q922Q1|MARC2_MOUSE","Q922Q1","MARC2",7.39e-10,"Mitochondrial amidoxime reducing component 2 (mARC2) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2) (MOSC domain-containing protein 2) (Moco sulfurase C-terminal domain-containing protein 2)","cellular detoxification of nitrogen compound [GO:0070458]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809]","GO:0005739; GO:0005741; GO:0005743; GO:0005777; GO:0006809; GO:0008940; GO:0016661; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0070458; GO:0098809"
"g90406",81.4474458919506,-0.5532796750443,0.17135550959276,-3.22884088383975,0.00124293029014391,0.0446381641714809,0,5384,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.3e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g73806",1568.11341625054,0.560549111029065,0.173617402544901,3.22864587773162,0.00124377805466823,0.0446392017373241,2095,10140,"sp|Q5T750|XP32_HUMAN","Q5T750","XP32",5.53e-06,"Skin-specific protein 32","epidermis development [GO:0008544]","GO:0008544"
"g29243",1122.68995148812,1.55490964255493,0.48169338091419,3.22800707704125,0.00124655890118093,0.0447125648420041,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g126092",469.573258718899,0.348322595448726,0.107913914544785,3.22778204199208,0.00124753989726393,0.0447213209479904,1012,3014,"sp|Q8MKK4|TRE12_DROME","Q8MKK4","TRE12",2.23e-94,"Facilitated trehalose transporter Tret1-2 homolog (DmTret1-2)",NA,"GO:0005886; GO:0016020; GO:0016021; GO:0051119"
"g21283",29.3522981188231,1.27815220719194,0.396139155412049,3.22652328034187,0.00125304037978246,0.0447335415582339,45965,47152,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.48e-07,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g32490",158.919179260982,1.18915269170624,0.368528605538923,3.22675817788219,0.00125201223819139,0.0447335415582339,20565,29125,"sp|A0A291PQF1|UGT5_DACCO","A0A291PQF1","UGT5",2.93e-12,"UDP-glycosyltransferase UGT5 (EC 2.4.1.-) (UDP-glucosyltransferase 5) (DcUGT5)",NA,"GO:0005783; GO:0008194; GO:0016021"
"g64714",49.8620252671839,0.805591034605641,0.24960265404236,3.2274938649848,0.00124879718926236,0.0447335415582339,0,12131,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.33e-23,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g68629",26.3602620594664,1.32711279079388,0.411292295003218,3.22669013477021,0.00125230998129363,0.0447335415582339,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76734",353.648850307465,-0.661032928385362,0.204872044300609,-3.22656480849787,0.00125285855520781,0.0447335415582339,0,6134,"sp|P18258|TBA1_PARLI","P18258","TBA1",7.41e-40,"Tubulin alpha-1 chain","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017"
"g86219",470.050677181601,0.294879749122719,0.091369438636034,3.22733458281777,0.00124949262590757,0.0447335415582339,2298,7014,"sp|Q6PA72|LST8_XENLA","Q6PA72","LST8",4.04e-30,"Target of rapamycin complex subunit lst8 (TORC subunit lst8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (MTOR associated protein, LST8 homolog)","TOR signaling [GO:0031929]","GO:0005737; GO:0031929; GO:0031931; GO:0031932"
"g129628",21.4884134539815,-0.508581774553904,0.157605557272711,-3.22692792915852,0.00125126972534144,0.0447335415582339,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91681",33.7881893829604,0.979213832410144,0.303526049591764,3.22612781910207,0.00125477306648598,0.044769063730179,0,7390,"sp|Q9YGX2|RPE65_CHICK","Q9YGX2","RPE65",1.25e-07,"Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase)","response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]; zeaxanthin biosynthetic process [GO:1901827]","GO:0001523; GO:0001786; GO:0005789; GO:0005886; GO:0007601; GO:0016020; GO:0016702; GO:0016853; GO:0031210; GO:0046872; GO:0050251; GO:0050896; GO:0052884; GO:0052885; GO:1901612; GO:1901827"
"g55230",67.4896602680114,-0.491642116879966,0.152405739360737,-3.22587665623453,0.0012558746680153,0.044782040894153,0,8897,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.56e-08,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g118325",98.8839430243192,0.487764913606738,0.151226661776827,3.22538967584008,0.00125801311090777,0.0448319528484983,0,4639,"sp|P12955|PEPD_HUMAN","P12955","PEPD",1.03e-18,"Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)","cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]","GO:0004181; GO:0006508; GO:0006520; GO:0008233; GO:0030145; GO:0030574; GO:0070006; GO:0070062; GO:0102009"
"g155784",97.5558881375184,-0.469349923223424,0.145542760775596,-3.22482492926657,0.00126049725284704,0.0448941187061544,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50418",127.1289402249,0.300259269877051,0.093133787831538,3.22395638433782,0.00126432654781455,0.0449777128879631,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143782",35.6305804877191,2.05144348655435,0.636283959191097,3.22410058735779,0.0012636900339099,0.0449777128879631,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55697",231.408030318425,0.526524531285341,0.163342301928159,3.22344258082585,0.00126659688984332,0.0450320827443415,0,10662,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.5e-32,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g20384",472.420343414254,-0.435159027753872,0.135009195932699,-3.22318064890036,0.00126775573555614,0.0450468943740646,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g121833",816.763140390903,0.159940661678882,0.0496254997932315,3.22295316611998,0.00126876296462796,0.0450563044606619,0,4324,"sp|Q3KNM2|MARH5_MOUSE","Q3KNM2","MARH5",4.68e-17,"E3 ubiquitin-protein ligase MARCHF5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (RING-type E3 ubiquitin transferase MARCHF5)","negative regulation of cell aging [GO:0090344]; positive regulation of mitochondrial fission [GO:0090141]; protein autoubiquitination [GO:0051865]; protein localization to mitochondrion [GO:0070585]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140]","GO:0000209; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0051020; GO:0051865; GO:0061630; GO:0070585; GO:0090140; GO:0090141; GO:0090344"
"g129478",44.9731097854283,-0.665324758932822,0.206459750484579,-3.22253978013266,0.0012705952115678,0.0450949844386257,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7364",413.70000416049,0.579198273111649,0.179762142795669,3.22202586208603,0.00127287645183385,0.0451231728164697,17095,21357,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.77e-10,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g29785",8334.45280386174,0.264072035322788,0.081954997566093,3.22215902831094,0.00127228497517021,0.0451231728164697,0,22214,"sp|Q6QMZ4|RL6_CHILA","Q6QMZ4","RL6",2.16e-10,"60S ribosomal protein L6","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0005791; GO:0022625; GO:0042788"
"g107678",863.784032182936,0.276436680973538,0.0858035133451688,3.22174081452229,0.00127414338431929,0.0451417174514521,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28406",6184.29821517226,0.331253774108633,0.102859038728584,3.22046344398297,0.00127983514024502,0.0451909455288848,12842,17484,"sp|Q9M5L0|RL35_EUPES","Q9M5L0","RL35",1.05e-07,"60S ribosomal protein L35","maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]","GO:0000463; GO:0003735; GO:0006412; GO:0022625"
"g42492",5159.61186806565,0.362135314416939,0.112433241496068,3.22089187857849,0.00127792349451352,0.0451909455288848,17587,21054,"sp|P62985|RL40_CHICK","P62985","RL40",8.06e-19,"Ubiquitin-60S ribosomal protein L40 (Ubiquitin A-52 residue ribosomal protein fusion product 1) [Cleaved into: Ubiquitin; 60S ribosomal protein L40 (CEP52)] (Fragment)","modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412]","GO:0003735; GO:0005634; GO:0005654; GO:0005737; GO:0005840; GO:0006412; GO:0016567; GO:0019941; GO:0031386; GO:0031625"
"g77564",186.369672805209,0.458063192384728,0.142229736475058,3.22058666307841,0.00127928507485805,0.0451909455288848,0,8214,"sp|Q66HF1|NDUS1_RAT","Q66HF1","NDUS1",3.36e-20,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2)","apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]","GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0032981; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593"
"g122463",27.6597935248719,-0.585531725791036,0.181780938597091,-3.2210842914,0.00127706581972364,0.0451909455288848,2825,3758,"sp|B4KR21|QVR_DROMO","B4KR21","QVR",2.2e-14,"Protein quiver (Protein sleepless)","negative regulation of acetylcholine-gated cation channel activity [GO:1903049]; negative regulation of membrane potential [GO:0045837]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of synaptic transmission, cholinergic [GO:0032222]; rhythmic process [GO:0048511]; sleep [GO:0030431]","GO:0005886; GO:0009897; GO:0030431; GO:0031225; GO:0032222; GO:0034235; GO:0045187; GO:0045837; GO:0045938; GO:0048511; GO:1903049; GO:1903818"
"g132924",362.89329703134,0.231952362816721,0.0720132120028276,3.22096954663838,0.0012775772273229,0.0451909455288848,0,3394,"sp|Q0IIX9|TFP11_XENTR","Q0IIX9","TFP11",6.33e-93,"Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1)","spliceosomal complex disassembly [GO:0000390]","GO:0000390; GO:0003676; GO:0005681; GO:0071008"
"g160403",52.2243719304589,0.900573358391644,0.279644136665216,3.22042639309756,0.00128000058270148,0.0451909455288848,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50107",387.582964718102,0.247071069518884,0.0767358342525826,3.21976130090186,0.00128297376333303,0.0452695800562103,10341,17303,"sp|P21328|RTJK_DROME","P21328","RTJK",2.78e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g8447",129.271724930661,-0.559122793544685,0.173675874386751,-3.21934635722404,0.00128483192580359,0.0453020495381738,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31966",196.638973313661,1.62925431561109,0.50612256866391,3.21909042687443,0.00128597924774572,0.0453020495381738,25845,32670,"sp|O95497|VNN1_HUMAN","O95497","VNN1",4.8e-08,"Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1)","acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; pantothenate metabolic process [GO:0015939]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979]","GO:0002526; GO:0002544; GO:0005576; GO:0005886; GO:0006954; GO:0006979; GO:0015939; GO:0016021; GO:0017159; GO:0031225; GO:0033089; GO:0035577; GO:0045087; GO:0098609; GO:1902176"
"g94674",128.438326586254,0.947381673085914,0.294304184632501,3.21905607379968,0.00128613332269358,0.0453020495381738,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1800",114.631370974174,-0.264750065365634,0.082280693852147,-3.21764502668599,0.00129247667023912,0.0453150832563907,38180,104304,"sp|P0C5Y8|ALS2_RAT","P0C5Y8","ALS2",2.44e-18,"Alsin (Amyotrophic lateral sclerosis 2 protein homolog)","axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of GTPase activity [GO:0043087]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]","GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043087; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260"
"g36398",901.804523427182,0.496985995860751,0.154447645984769,3.21782823358643,0.00129165143742404,0.0453150832563907,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g79035",7180.15949756356,0.451683920253729,0.140373037111963,3.2177398847149,0.00129204933325097,0.0453150832563907,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92001",21.3555229684875,0.545181808364482,0.169377722516543,3.21873384683889,0.00128757935353094,0.0453150832563907,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g93930",73.9310521219523,2.22773335283101,0.692231624682836,3.21819066537404,0.00129002034078291,0.0453150832563907,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g96900",29.3055201381037,-0.53540148458988,0.166356416528801,-3.21839996173028,0.00128907928464001,0.0453150832563907,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g124191",342.776723009096,2.46730358510709,0.766762559732667,3.21781958937499,0.00129169036327047,0.0453150832563907,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g127569",26.8198439542722,-0.623316100507878,0.1936744618811,-3.21837011681253,0.00128921343716003,0.0453150832563907,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99029",463.755809905411,-0.350750639410942,0.109026475697443,-3.21711434921828,0.00129486978833944,0.045372775666467,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17756",2393.81088364067,0.785312564961132,0.244132657528766,3.21674524379681,0.00129653669955258,0.0454049695879089,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26539",1742.47601792042,0.718110276527549,0.223261805048148,3.2164492998374,0.00129787463777224,0.0454080070564748,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136863",102.959987139421,0.511580506571167,0.159054000293191,3.2163950961821,0.00129811982605015,0.0454080070564748,797,3083,"sp|A0JC51|ZIC4_XENLA","A0JC51","ZIC4",1.27e-36,"Zinc finger protein ZIC 4 (XlZic4) (Zinc finger protein of the cerebellum 4)","nervous system development [GO:0007399]; neural crest formation [GO:0014029]","GO:0003677; GO:0005634; GO:0007399; GO:0014029; GO:0046872"
"g31292",65.331934470743,0.519667983743081,0.16158185654058,3.21612831334545,0.0012993272317159,0.045424060882971,1801,26226,"sp|P21328|RTJK_DROME","P21328","RTJK",8.92e-28,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g128137",123.77468209031,0.454015453198197,0.141181246009646,3.21583401500209,0.00130066036934441,0.0454444892432425,0,3674,"sp|O00462|MANBA_HUMAN","O00462","MANBA",8.66e-12,"Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase)","cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; oligosaccharide catabolic process [GO:0009313]","GO:0004567; GO:0005537; GO:0005886; GO:0006464; GO:0006516; GO:0009313; GO:0035577; GO:0043202"
"g38846",1114.45893989439,-0.40025391980864,0.124478574566183,-3.21544427387247,0.00130242779472667,0.0454800591840977,0,20154,"sp|A8WGS4|TLCD2_DANRE","A8WGS4","TLCD2",7.81e-17,"TLC domain-containing protein 2","lipid homeostasis [GO:0055088]; membrane assembly [GO:0071709]; phospholipid homeostasis [GO:0055091]; plasma membrane organization [GO:0007009]; regulation of membrane lipid distribution [GO:0097035]","GO:0005886; GO:0007009; GO:0016021; GO:0055088; GO:0055091; GO:0071709; GO:0097035"
"g91263",27.5483110351903,-0.506650947097864,0.157588627810187,-3.21502226485605,0.00130434405000971,0.0454946209167181,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103288",37.9311787371432,-0.405455645318487,0.126107349043123,-3.2151627037996,0.00130370605725858,0.0454946209167181,0,5904,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.09e-26,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g18595",42.3411577577233,-0.476348948009224,0.148181272462532,-3.21463664127778,0.0013060973613718,0.0455258066617217,19565,23738,"sp|P11369|LORF2_MOUSE","P11369","LORF2",4.66e-27,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g118078",23.864157416531,0.945215859579412,0.294047940614177,3.21449576421159,0.00130673842815487,0.0455258066617217,0,4663,"sp|P04323|POL3_DROME","P04323","POL3",1.19e-81,"Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g13015",97.262734632536,0.400619702867124,0.124650346831842,3.21394775906701,0.00130923491048343,0.0455866131481581,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g68372",24.0828786008753,-1.38787702922877,0.43190009971765,-3.21342141420223,0.00131163686089358,0.0455917761097544,0,9904,"sp|Q5F3L4|DEN6A_CHICK","Q5F3L4","DEN6A",3.01e-06,"Protein DENND6A (DENN domain-containing protein 6A)",NA,"GO:0005085; GO:0055037"
"g83224",84.7339229201168,0.294889410167658,0.0917656165434075,3.21350655371195,0.00131124805518969,0.0455917761097544,0,8625,"sp|P20825|POL2_DROME","P20825","POL2",4.67e-56,"Retrovirus-related Pol polyprotein from transposon 297 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074"
"g118044",208.582932651226,0.324803351547484,0.101069622916754,3.21365947723984,0.00131054996799515,0.0455917761097544,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15980",10830.7329603821,0.422434651221756,0.131525410787826,3.21181016422155,0.0013190150268573,0.0456511031204565,0,18120,"sp|P56649|G3P_PANVR","P56649","G3P",3.66e-177,"Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12)","glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]","GO:0004365; GO:0005737; GO:0006006; GO:0006096; GO:0050661; GO:0051287"
"g32313",33.0164276921368,1.66554184413332,0.51852308951033,3.21208809757379,0.00131773959936256,0.0456511031204565,0,18476,"sp|P21328|RTJK_DROME","P21328","RTJK",8.55e-10,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g51272",4096.43387820463,-0.446979696209657,0.139170800171596,-3.21173475799906,0.00131936126006394,0.0456511031204565,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52879",601.34678463602,0.392694579009253,0.122251057363384,3.21219781226097,0.00131723643544699,0.0456511031204565,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g70597",25.054598389022,-0.487420842623016,0.151762000158561,-3.21174498302447,0.00131931430619462,0.0456511031204565,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125326",767.868532648213,-2.41717374366684,0.7523909609037,-3.21265654329973,0.00131513456295789,0.0456511031204565,3504,4012,"sp|P39674|MAG29_DERFA","P39674","MAG29",4.06e-13,"Allergen MAG29 (Fragment)",NA,"GO:0005524; GO:0016887"
"g125524",59.6164537567082,1.44669004536761,0.450383796209594,3.21212720693524,0.00131756021908578,0.0456511031204565,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g143676",55.1721668343828,0.84420063036391,0.262763394285656,3.2127786774065,0.00131457547523619,0.0456511031204565,0,2544,"sp|Q9I7S8|PUR6_DROME","Q9I7S8","PUR6",1.08e-21,"Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS) (Protein adenosine-5) [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase); Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)]","'de novo' IMP biosynthetic process [GO:0006189]","GO:0004638; GO:0004639; GO:0005524; GO:0005737; GO:0005829; GO:0006189; GO:0043727"
"g30755",250.277154964834,0.301394755680248,0.093864547632002,3.21095411722296,0.00132295056088287,0.0457231603302855,0,18930,"sp|Q0IFL2|RUVB1_AEDAE","Q0IFL2","RUVB1",3.34e-14,"RuvB-like helicase 1 (EC 3.6.4.12) (Pontin)","cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of cell population proliferation [GO:0042127]","GO:0003678; GO:0003713; GO:0005524; GO:0005634; GO:0006281; GO:0006310; GO:0006325; GO:0007049; GO:0016887; GO:0031011; GO:0035267; GO:0042127; GO:0051301; GO:0090263; GO:0097255"
"g103587",58.6028185092918,-0.739240900798444,0.230221197140371,-3.21100276595171,0.00132272661636597,0.0457231603302855,3495,6101,"sp|P46527|CDN1B_HUMAN","P46527","CDN1B",2.27e-11,"Cyclin-dependent kinase inhibitor 1B (Cyclin-dependent kinase inhibitor p27) (p27Kip1)","autophagic cell death [GO:0048102]; cellular response to antibiotic [GO:0071236]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; G1/S transition of mitotic cell cycle [GO:0000082]; heart development [GO:0007507]; inner ear development [GO:0048839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle tissue regeneration [GO:1905179]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular component movement [GO:0051271]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; Notch signaling pathway [GO:0007219]; placenta development [GO:0001890]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein catabolic process [GO:0045732]; potassium ion transport [GO:0006813]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of exit from mitosis [GO:0007096]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of lens fiber cell differentiation [GO:1902746]; response to amino acid [GO:0043200]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]","GO:0000079; GO:0000082; GO:0001666; GO:0001890; GO:0004860; GO:0004861; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0006813; GO:0006977; GO:0007096; GO:0007219; GO:0007507; GO:0007605; GO:0008284; GO:0008285; GO:0009410; GO:0009749; GO:0010942; GO:0019901; GO:0019903; GO:0030308; GO:0030332; GO:0030544; GO:0031116; GO:0031464; GO:0032355; GO:0033673; GO:0042326; GO:0043066; GO:0043200; GO:0043231; GO:0043434; GO:0044877; GO:0045732; GO:0045736; GO:0045737; GO:0045892; GO:0045930; GO:0046686; GO:0048102; GO:0048839; GO:0051087; GO:0051271; GO:0051726; GO:0060770; GO:0071236; GO:0071285; GO:0071407; GO:0090398; GO:1902746; GO:1902806; GO:1902807; GO:1904030; GO:1904706; GO:1905179; GO:2000045"
"g140636",98.0645338459856,0.535046398123675,0.166652742197554,3.2105466196855,0.00132482776713809,0.0457619790481562,0,2794,"sp|Q920P6|ADA_RAT","Q920P6","ADA",7.92e-10,"Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase)","adenosine catabolic process [GO:0006154]; adenosine metabolic process [GO:0046085]; aging [GO:0007568]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; AMP salvage [GO:0044209]; cell adhesion [GO:0007155]; dAMP catabolic process [GO:0046059]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; GMP salvage [GO:0032263]; histamine secretion [GO:0001821]; hypoxanthine biosynthetic process [GO:0046101]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian sleep/wake cycle, non-REM sleep [GO:0042323]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine nucleotide salvage [GO:0032261]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; regulation of T cell differentiation [GO:0045580]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to morphine [GO:0043278]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; T cell activation [GO:0042110]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111]","GO:0000255; GO:0001666; GO:0001701; GO:0001821; GO:0001829; GO:0001883; GO:0001889; GO:0001890; GO:0002314; GO:0002636; GO:0002686; GO:0002906; GO:0004000; GO:0005615; GO:0005737; GO:0005764; GO:0005829; GO:0006154; GO:0006157; GO:0006196; GO:0007155; GO:0007568; GO:0008270; GO:0009410; GO:0009897; GO:0009986; GO:0010035; GO:0010460; GO:0016020; GO:0030054; GO:0030324; GO:0030890; GO:0032261; GO:0032263; GO:0032839; GO:0033089; GO:0033197; GO:0033632; GO:0042110; GO:0042323; GO:0042542; GO:0043025; GO:0043066; GO:0043103; GO:0043278; GO:0044209; GO:0045187; GO:0045580; GO:0045582; GO:0045987; GO:0046059; GO:0046061; GO:0046085; GO:0046101; GO:0046103; GO:0046111; GO:0046638; GO:0046936; GO:0048286; GO:0048541; GO:0048566; GO:0050728; GO:0050850; GO:0050862; GO:0050870; GO:0060169; GO:0060205; GO:0060407; GO:0070244; GO:0070256"
"g83435",3005.6185891257,0.25992233087538,0.0809748358146575,3.20991488603094,0.00132774281410393,0.0458365821319496,3883,7804,"sp|Q90YW0|RL9_ICTPU","Q90YW0","RL9",4.33e-08,"60S ribosomal protein L9","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412; GO:0019843"
"g94257",119.57653622733,-0.316502128055074,0.0986300629005894,-3.20898231986408,0.00133205682866088,0.0459593683521482,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113665",303.215245873589,0.234429087851171,0.0730632936680156,3.20857541567134,0.00133394320094728,0.0459983027644833,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g52749",62.6209222020882,2.03984048193994,0.635868747058011,3.20795838980563,0.00133680838181978,0.0460186617655374,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62901",263.965527818297,0.315164441325906,0.0982438071981646,3.2079827758527,0.00133669503668839,0.0460186617655374,8280,12586,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",6.23e-12,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g101504",2856.28501602339,2.50501319578674,0.78083417877984,3.20812441855602,0.00133603686376011,0.0460186617655374,0,6325,"sp|P26225|GUNB_CELFI","P26225","GUNB",7.27e-07,"Endoglucanase B (EC 3.2.1.4) (Cellulase B) (Endo-1,4-beta-glucanase B)","cellulose catabolic process [GO:0030245]","GO:0008810; GO:0030245; GO:0030248"
"g27767",738.108476187958,-0.353635632735771,0.110247235691455,-3.20765986120033,0.00133819664679391,0.0460403370146952,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g38835",90.6174422815925,0.752983836128356,0.234789660321824,3.20705705309274,0.00134100397599237,0.0461107826079191,0,24324,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.93e-20,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g19329",93.2474177846701,0.401599741724618,0.125234737489881,3.20677592953846,0.00134231504947557,0.0461199488629608,10012,12814,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",3.19e-10,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g52751",39.0710578431299,2.38355394227165,0.743310325180605,3.20667406536094,0.00134279040436401,0.0461199488629608,5535,12926,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.4e-26,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g24996",877.978631317022,-0.26490625138258,0.0826199053672972,-3.2063247979395,0.00134442145973353,0.0461307953178585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27333",59.0651122846697,0.524853110622317,0.163710122984443,3.20599057073698,0.00134598398949677,0.0461307953178585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g76064",21.4782205182859,-0.84642491715896,0.264004229085253,-3.20610362982341,0.00134545524490737,0.0461307953178585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g125876",248.160658348395,-0.344058210249875,0.107318450812087,-3.20595580393082,0.0013461466223089,0.0461307953178585,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g91225",36.7690910325589,0.692379277332987,0.216000575268306,3.20545108027117,0.00134850967084343,0.0461856952164152,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69666",55.9506919322885,-0.323816738277946,0.101028524757049,-3.20520109599396,0.00134968148022075,0.0461997569287069,0,10986,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",3.11e-28,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g62560",220.139495735605,0.718619443132251,0.224224745375826,3.20490694248649,0.00135106153723499,0.0462009740334542,0,4054,"sp|P50897|PPT1_HUMAN","P50897","PPT1",3.05e-14,"Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1)","adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular protein catabolic process [GO:0044257]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601]","GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016020; GO:0016042; GO:0016290; GO:0016790; GO:0030149; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0031579; GO:0032429; GO:0035727; GO:0043025; GO:0043066; GO:0043202; GO:0043231; GO:0043524; GO:0044257; GO:0045121; GO:0046949; GO:0048260; GO:0048549; GO:0048666; GO:0050803; GO:0050896; GO:0070062; GO:0120146"
"g85619",72.2961294215697,0.437294216968269,0.136453732313622,3.20470689627751,0.00135200082193796,0.0462009740334542,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132105",97.8030002994918,0.701850561748904,0.218999828339178,3.20479959765953,0.00135156548268298,0.0462009740334542,0,3460,"sp|O00370|LORF2_HUMAN","O00370","LORF2",3.69e-08,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g69382",2609.25885039776,0.371563236688872,0.115948941122224,3.20454187069463,0.00135277612633834,0.0462014536339188,0,7284,"sp|P56252|ENO_HOMGA","P56252","ENO",9.82e-102,"Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)","glycolytic process [GO:0006096]","GO:0000015; GO:0000287; GO:0004634; GO:0006096"
"g121325",78.3442148500367,0.708705269557327,0.221220463709651,3.20361533319762,0.00135713670012722,0.0463243117720589,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30260",718.258026916116,-0.437956428534698,0.136714415389208,-3.20344001243683,0.00135796327159004,0.0463264704625068,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10782",30.8053573197419,-0.511406768791842,0.159672738770241,-3.20284334527339,0.00136077981367086,0.0463444034184537,48555,52001,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",2.38e-19,"PiggyBac transposable element-derived protein 4",NA,NA
"g84569",1198.79935202991,0.275928013873981,0.0861507755437045,3.20285002813471,0.00136074823769058,0.0463444034184537,0,8310,"sp|Q4R5X8|NDUS6_MACFA","Q4R5X8","NDUS6",5.53e-16,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A) (CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)","mitochondrial electron transport, NADH to ubiquinone [GO:0006120]","GO:0005747; GO:0006120"
"g147472",30.2796603384545,0.559886042744614,0.174807153134654,3.20287833023248,0.00136061452005499,0.0463444034184537,0,1754,"sp|Q8R2K1|FUCM_MOUSE","Q8R2K1","FUCM",3.4e-06,"Fucose mutarotase (EC 5.1.3.29)","female mating behavior [GO:0060180]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; negative regulation of neuron differentiation [GO:0045665]","GO:0006004; GO:0016857; GO:0036065; GO:0036373; GO:0042806; GO:0045665; GO:0060180"
"g106475",112.870897681964,0.889941172878548,0.277886771728827,3.20253161869464,0.00136225344785599,0.0463685708078408,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g5120",125.021617343909,0.811517248421759,0.253465384928726,3.20168865918301,0.00136624577050197,0.0464329306064088,13311,40384,"sp|A7NF38|ARLY_ROSCS","A7NF38","ARLY",1.77e-21,"Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase)","arginine biosynthetic process via ornithine [GO:0042450]","GO:0004056; GO:0005737; GO:0042450"
"g5931",150.083653823362,0.625089438455998,0.195289044275585,3.20084232464108,0.00137026493188463,0.0464329306064088,26915,30354,"sp|P21328|RTJK_DROME","P21328","RTJK",5.49e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g6612",888.270964462862,0.301530939001981,0.0941922490535741,3.20122878508271,0.00136842831743143,0.0464329306064088,91281,103704,"sp|P11369|LORF2_MOUSE","P11369","LORF2",3.32e-25,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g14597",79.2307618894785,-0.566361033477035,0.176940312816492,-3.20085923022199,0.00137018454227971,0.0464329306064088,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g21660",41.6348181885285,0.470609680354098,0.146979651799177,3.20186960979541,0.00136538786559671,0.0464329306064088,0,7776,"sp|P30628|VPP1_CAEEL","P30628","VPP1",9.06e-22,"V-type proton ATPase 116 kDa subunit a 1 (V-ATPase 116 kDa isoform a 1) (Uncoordinated protein 32) (Vacuolar proton translocating ATPase 116 kDa subunit a 1)","ATP synthesis coupled proton transport [GO:0015986]; defense response to Gram-positive bacterium [GO:0050830]; embryo development ending in birth or egg hatching [GO:0009792]; locomotion [GO:0040011]; negative regulation of locomotion [GO:0040013]; nematode larval development [GO:0002119]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of programmed cell death [GO:0043068]; response to hypoxia [GO:0001666]; synaptic transmission, cholinergic [GO:0007271]; vacuolar acidification [GO:0007035]","GO:0000220; GO:0001666; GO:0001956; GO:0002119; GO:0005886; GO:0007035; GO:0007271; GO:0009792; GO:0015986; GO:0016021; GO:0016471; GO:0040011; GO:0040013; GO:0043068; GO:0045202; GO:0046961; GO:0050830; GO:0051117"
"g28104",1944.97312460722,-0.330761016347295,0.103313271239363,-3.20153463712292,0.00136697639613755,0.0464329306064088,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g29015",128.728153719056,-0.406954679035032,0.127128916308153,-3.20111813152405,0.00136895395524244,0.0464329306064088,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113105",29.7050289743764,-0.647910772835374,0.202408206645327,-3.2010103916917,0.00136946593090434,0.0464329306064088,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9701",148.264859102637,0.292779700696199,0.0914897841309286,3.20013544110247,0.00137363020869477,0.0465096180302741,0,8330,"sp|Q9JMD1|SMBT1_MOUSE","Q9JMD1","SMBT1",9.43e-19,"Scm-like with four MBT domains protein 1","cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]","GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635"
"g60660",58.2782371366169,0.323606570064476,0.101125627070148,3.20004512644457,0.00137406072051873,0.0465096180302741,0,13230,"sp|P08548|LIN1_NYCCO","P08548","LIN1",6.66e-20,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g71374",61.6375764133884,-0.495604297313867,0.154895292935717,-3.19960850921111,0.00137614374268551,0.0465282249267876,0,10606,"sp|Q95168|ZO2_CANLF","Q95168","ZO2",1.05e-06,"Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2)","cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]","GO:0005634; GO:0005886; GO:0005923; GO:0009986; GO:0045216; GO:0050839; GO:0090557; GO:0098609; GO:0150105; GO:1905605"
"g111335",205.469734522683,0.704449988147809,0.220162073590426,3.19968819633448,0.00137576335264565,0.0465282249267876,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g26070",53.459749876971,0.619291244844269,0.193584700032418,3.19907123207858,0.00137871099192631,0.0465372469966671,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g104713",56.7313758657741,-0.368893328861833,0.115305364552527,-3.19927290714894,0.00137774681885192,0.0465372469966671,0,3800,"sp|Q6PD29|ZN513_MOUSE","Q6PD29","ZN513",9.74e-10,"Zinc finger protein 513","regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]","GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0046872; GO:0060041"
"g121725",20.7278693953117,-0.934866091919718,0.292226877525541,-3.19911056722703,0.00137852288865705,0.0465372469966671,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g146533",54.9314899281782,0.521127293807227,0.162915590086353,3.19875644516897,0.00138021717659596,0.0465621903544242,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31851",2743.61298582295,-0.250851785513939,0.078436929049303,-3.19813369231043,0.00138320138079689,0.0466110448642772,0,22596,"sp|P21329|RTJK_DROFU","P21329","RTJK",5.38e-33,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g149484",60.2573418221623,-0.528829359424373,0.165347391832541,-3.19829271912529,0.00138243876610228,0.0466110448642772,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g27601",206.080007111038,0.807871341127316,0.252637570486293,3.19774821920697,0.00138505153122131,0.0466313591298688,28915,37178,"sp|P37898|AAP1_YEAST","P37898","AAP1",9.3e-09,"Alanine/arginine aminopeptidase (EC 3.4.11.-)","glycogen metabolic process [GO:0005977]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]","GO:0005634; GO:0005737; GO:0005977; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006"
"g66779",118.202492663658,-0.605674300437029,0.189410069517947,-3.19768796864119,0.00138534092125809,0.0466313591298688,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7876",177.782739537343,-0.584264347528071,0.182787711639601,-3.19640933346797,0.00139149550885237,0.0468033976756855,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g99170",164.280661650507,-0.376116200699376,0.11767215268239,-3.19630594091836,0.00139199427919941,0.0468033976756855,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65225",40.2586130622422,-0.997811156082689,0.312197935015857,-3.19608506069077,0.00139306036778625,0.0468133077081657,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64715",1329.70843001509,-0.315669683215178,0.0987945939933059,-3.19521211086274,0.00139728107238824,0.0468772737884147,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g75500",443.589142506864,0.404169146670657,0.12648850210267,3.19530344617881,0.00139683891525665,0.0468772737884147,205,5304,"sp|Q3TMX7|QSOX2_MOUSE","Q3TMX7","QSOX2",2.18e-47,"Sulfhydryl oxidase 2 (EC 1.8.3.2) (Quiescin Q6-like protein 1)","protein folding [GO:0006457]","GO:0003756; GO:0005615; GO:0005654; GO:0005794; GO:0006457; GO:0016971; GO:0030173"
"g81576",76.7128563790694,0.356844846429097,0.111669999702934,3.19553010995237,0.0013957421861397,0.0468772737884147,0,6654,"sp|Q9UI36|DACH1_HUMAN","Q9UI36","DACH1",1.68e-40,"Dachshund homolog 1 (Dach1)","cell population proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]","GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0008283; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279"
"g102303",479.632570098293,-0.64614754548689,0.202234723516315,-3.19503759914287,0.00139812624799163,0.0468797138069678,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28357",3488.57534385355,-0.265694289632695,0.0831636873432622,-3.19483536770116,0.00139910626229621,0.0468866698281376,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87009",244.255297098508,0.604822521583231,0.189353890213041,3.19413834541634,0.00140248889082346,0.0469740898366863,0,2227,"sp|P61166|TM258_MOUSE","P61166","TM258",4.59e-19,"Transmembrane protein 258 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258) (Oligosaccharyl transferase subunit TMEM258)","protein N-linked glycosylation [GO:0006487]","GO:0005737; GO:0005783; GO:0005789; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0032991; GO:0034998; GO:0043227"
"g26057",33.4372333326286,-0.4986326851949,0.156137402887176,-3.19355052648858,0.00140534741821391,0.0469920301991197,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g41060",442.447082641819,-0.632839739950982,0.198160394179938,-3.1935732797157,0.00140523667079545,0.0469920301991197,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134394",26.960735074974,0.539011766154417,0.168776997330126,3.19363286870258,0.00140494666978624,0.0469920301991197,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54384",1343.49755644635,0.434508557318825,0.136066306380756,3.19335895032629,0.00140628020141017,0.046997326775101,10665,12684,"sp|Q9VWG3|RS10B_DROME","Q9VWG3","RS10B",4.93e-07,"40S ribosomal protein S10b","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0022626; GO:0022627"
"g57439",951.716739800236,0.250945473911399,0.0785986258993175,3.19274632399875,0.0014092669082513,0.0470712210576618,0,9665,"sp|Q9BUQ8|DDX23_HUMAN","Q9BUQ8","DDX23",0,"Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD)","cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]","GO:0000354; GO:0000375; GO:0000398; GO:0000785; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0016887; GO:0046540; GO:0062176; GO:0070062; GO:0071013"
"g17904",1402.52614104804,0.263489615703918,0.082554471339249,3.19170617205136,0.00141435130778685,0.0470917521244292,10184,25384,"sp|Q5R874|DHX9_PONAB","Q5R874","DHX9",9.64e-47,"ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II)","alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; rhythmic process [GO:0048511]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]","GO:0000380; GO:0000978; GO:0000993; GO:0001069; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005844; GO:0006260; GO:0006353; GO:0006954; GO:0010501; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0030423; GO:0031490; GO:0032508; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0033679; GO:0034458; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0051028; GO:0051092; GO:0060760; GO:0061629; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:1900152; GO:1903608; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767"
"g18974",7249.80140283183,0.235982512221784,0.0739366313475516,3.19168601437233,0.00141445000801516,0.0470917521244292,20858,35994,"sp|P36241|RL19_DROME","P36241","RL19",3.62e-20,"60S ribosomal protein L19","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0022626"
"g38753",161.783885574636,0.515681825811933,0.161571251451376,3.1916682032207,0.00141453722397157,0.0470917521244292,0,6401,"sp|Q8UWA5|CAH2_TRIHK","Q8UWA5","CAH2",3.91e-09,"Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II)",NA,"GO:0004089; GO:0005737; GO:0005886; GO:0008270"
"g58340",32.9098692779799,-0.493182148001188,0.154486328958275,-3.19239994455684,0.00141095818194765,0.0470917521244292,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g61723",54.737451783953,0.62082916003597,0.194512198170555,3.19172353135203,0.00141426631465054,0.0470917521244292,0,12919,"sp|P15535|B4GT1_MOUSE","P15535","B4GT1",1.65e-09,"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]","acute inflammatory response [GO:0002526]; angiogenesis involved in wound healing [GO:0060055]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; development of secondary sexual characteristics [GO:0045136]; epithelial cell development [GO:0002064]; extracellular matrix organization [GO:0030198]; galactose metabolic process [GO:0006012]; glycoprotein biosynthetic process [GO:0009101]; glycosylation [GO:0070085]; lactose biosynthetic process [GO:0005989]; leukocyte migration [GO:0050900]; lipid metabolic process [GO:0006629]; negative regulation of cell population proliferation [GO:0008285]; oligosaccharide biosynthetic process [GO:0009312]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; regulation of acrosome reaction [GO:0060046]; wound healing [GO:0042060]","GO:0000138; GO:0002064; GO:0002526; GO:0003831; GO:0003945; GO:0004461; GO:0005576; GO:0005794; GO:0005886; GO:0005989; GO:0006012; GO:0006486; GO:0006487; GO:0006629; GO:0007155; GO:0007339; GO:0007341; GO:0008092; GO:0008285; GO:0008378; GO:0009101; GO:0009312; GO:0009897; GO:0009986; GO:0016021; GO:0016323; GO:0030057; GO:0030145; GO:0030175; GO:0030198; GO:0031526; GO:0032580; GO:0035250; GO:0042060; GO:0042802; GO:0043014; GO:0043065; GO:0045136; GO:0048487; GO:0050900; GO:0060046; GO:0060054; GO:0060055; GO:0070085"
"g104425",158.845505573931,0.377970403208171,0.11840561485862,3.19216621322797,0.00141210048372406,0.0470917521244292,0,3214,"sp|Q5U526|I4A3A_XENLA","Q5U526","I4A3A",9.42e-11,"Eukaryotic initiation factor 4A-III-A (eIF-4A-III-A) (eIF4A-III-A) (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48-A) (ATP-dependent RNA helicase eIF4A-3-A) (DEAD box protein 48-A) (Eukaryotic translation initiation factor 4A isoform 3 A)","mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]","GO:0000184; GO:0000381; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0005737; GO:0006397; GO:0006417; GO:0008380; GO:0016607; GO:0016887; GO:0051028"
"g114579",177.995806575189,0.425907586464942,0.133462043394117,3.19122632647864,0.00141670255203191,0.0471379812954039,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g7037",9785.93586274958,0.238747077702821,0.0748320111000699,3.19044048386664,0.00142056096714619,0.0472267029118473,79585,102106,"sp|P37276|DYHC_DROME","P37276","DYHC",0,"Dynein heavy chain, cytoplasmic (Dynein heavy chain, cytosolic) (DYHC)","axo-dendritic transport [GO:0008088]; border follicle cell migration [GO:0007298]; cellularization [GO:0007349]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; chitin-based cuticle development [GO:0040003]; cystoblast division [GO:0007282]; cytoplasmic microtubule organization [GO:0031122]; dendrite morphogenesis [GO:0048813]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle localization [GO:0051293]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fusome organization [GO:0045478]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; intracellular mRNA localization [GO:0008298]; intracellular protein transport [GO:0006886]; lumen formation, open tracheal system [GO:0035149]; maintenance of RNA location [GO:0051237]; melanotic encapsulation of foreign target [GO:0035011]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitochondrion distribution [GO:0048311]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; mushroom body development [GO:0016319]; neuroblast proliferation [GO:0007405]; nuclear migration [GO:0007097]; oocyte nucleus migration involved in oocyte dorsal/ventral axis specification [GO:0007312]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; pole cell formation [GO:0007279]; positive regulation of mitotic centrosome separation [GO:0046604]; positive regulation of neuron remodeling [GO:1904801]; protein localization to kinetochore [GO:0034501]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; retrograde axonal transport [GO:0008090]; retrograde axonal transport of mitochondrion [GO:0098958]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; stress granule assembly [GO:0034063]","GO:0000278; GO:0000776; GO:0003777; GO:0005524; GO:0005737; GO:0005794; GO:0005868; GO:0005875; GO:0005881; GO:0005938; GO:0006886; GO:0007018; GO:0007051; GO:0007052; GO:0007097; GO:0007098; GO:0007279; GO:0007282; GO:0007294; GO:0007298; GO:0007312; GO:0007349; GO:0007405; GO:0008088; GO:0008090; GO:0008298; GO:0008569; GO:0016319; GO:0030071; GO:0030286; GO:0030723; GO:0031122; GO:0034063; GO:0034501; GO:0035011; GO:0035149; GO:0040001; GO:0040003; GO:0045169; GO:0045197; GO:0045198; GO:0045478; GO:0045505; GO:0046604; GO:0048134; GO:0048311; GO:0048477; GO:0048813; GO:0050658; GO:0051237; GO:0051293; GO:0051642; GO:0051683; GO:0051959; GO:0072382; GO:0098958; GO:1904115; GO:1904801; GO:1990904"
"g7862",250.73186733918,0.919418305782515,0.288214384747146,3.1900500267852,0.00142248167610573,0.0472267029118473,43695,54155,"sp|Q9DBT9|M2GD_MOUSE","Q9DBT9","M2GD",4.29e-26,"Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH)","amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; tetrahydrofolate interconversion [GO:0035999]","GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0016491; GO:0035999; GO:0042426; GO:0047865; GO:0050660"
"g15100",345.57306160835,0.454815571313998,0.142567080247011,3.19018647591004,0.00142181019321395,0.0472267029118473,36305,43009,"sp|Q27640|ALDH_ENCBU","Q27640","ALDH",4.29e-16,"Aldehyde dehydrogenase (EC 1.2.1.3) (Aldehyde dehydrogenase [NAD(+)])","ethanol catabolic process [GO:0006068]","GO:0004029; GO:0006068; GO:0043878"
"g151075",1077.89341130092,2.07391117576844,0.650066865419553,3.19030439188734,0.00142123014960913,0.0472267029118473,0,1888,"sp|Q3ZCJ8|CATC_BOVIN","Q3ZCJ8","CATC",1.09e-19,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","zymogen activation [GO:0031638]","GO:0005764; GO:0008234; GO:0008239; GO:0031638"
"g19142",548.270044016034,2.12411362421222,0.665890270750004,3.18988535726734,0.00142329242431946,0.0472277841618085,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g30497",307.036508993937,-0.460965549670574,0.144527360426961,-3.18946909643126,0.00142534377897281,0.0472700076206885,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g15053",1710.69311487932,-0.489686882400154,0.153548712500802,-3.18913050083435,0.00142701440521957,0.0472995654029358,14224,18364,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",1.27e-10,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g58994",38.9179595885838,-0.47190833892421,0.148013614555823,-3.18827656726288,0.00143123572244252,0.0473638960404105,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g94113",48.79881999202,1.94461378600005,0.609928666811443,3.18826428697967,0.00143129651240918,0.0473638960404105,0,7188,"sp|Q1JPJ2|XPP1_BOVIN","Q1JPJ2","XPP1",1.42e-12,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)","bradykinin catabolic process [GO:0010815]","GO:0005737; GO:0010815; GO:0030145; GO:0070006"
"g130829",39.095023730033,-0.690450593497332,0.216542851650727,-3.1885171375271,0.00143004532929206,0.0473638960404105,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62870",260.088620415483,-0.337652740038377,0.105924996092726,-3.18765874433261,0.00143429702899167,0.0474114851250023,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g103363",71.4921622233636,0.523515481522849,0.164229711615954,3.18770261709449,0.00143407944095494,0.0474114851250023,0,6127,"sp|O15438|MRP3_HUMAN","O15438","MRP3",2.35e-20,"ATP-binding cassette sub-family C member 3 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3)","bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908]","GO:0005524; GO:0005886; GO:0005887; GO:0006855; GO:0008559; GO:0015164; GO:0015431; GO:0015432; GO:0015721; GO:0016020; GO:0016323; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0071714; GO:0071716; GO:0150104"
"g37734",51.2640495923845,-0.693201778920319,0.217508017441617,-3.1870171365356,0.00143748257734008,0.0474909186819649,9597,22254,"sp|Q810B6|ANFY1_MOUSE","Q810B6","ANFY1",1.39e-29,"Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif)","endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0010008; GO:0016020; GO:0016197; GO:0030904; GO:0031267; GO:0034058; GO:0042147; GO:0043231; GO:0044354; GO:0046872; GO:0048549; GO:0090160; GO:1901981"
"g33404",44.0045270377175,-0.432298564408277,0.135654100119468,-3.18677108931878,0.00143870591765789,0.0475054745063425,27535,31040,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",1.91e-19,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g12989",49.1604331131925,-0.470800751481728,0.14776429031235,-3.18616054316323,0.00144174568349155,0.0475081570859884,67071,69394,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",4.48e-24,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g23027",230.912458006078,0.449638863703185,0.141111979138357,3.18639754362969,0.00144056501156358,0.0475081570859884,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g92304",157.453282190163,0.291939196625938,0.0916248466281703,3.18624486009432,0.00144132553727335,0.0475081570859884,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115365",994.357645586972,0.433871201241469,0.136175159242117,3.18612589591362,0.00144191836138393,0.0475081570859884,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59054",5262.68576020179,0.423114232663283,0.132817428997628,3.18568305271772,0.00144412712036367,0.0475293248019909,0,3122,"sp|P48162|R23A1_CAEEL","P48162","R23A1",6.16e-12,"60S ribosomal protein L23a 1","ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]","GO:0000027; GO:0003735; GO:0006412; GO:0019843; GO:0022625"
"g93052",29.3408625554279,0.801142302748343,0.251475692612036,3.18576437518478,0.00144372127652008,0.0475293248019909,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g351",671.837079986524,-0.311186522980577,0.0977369463727138,-3.18391902478605,0.00145295651165067,0.0476046077659466,115228,120894,"sp|Q64321|ZBT7B_MOUSE","Q64321","ZBT7B",7.96e-09,"Zinc finger and BTB domain-containing protein 7B (Krueppel-related zinc finger protein cKrox) (c-Krox) (T-helper-inducing POZ/Krueppel-like factor) (Zinc finger protein 67) (Zfp-67) (Zinc finger protein Th-POK)","adaptive thermogenesis [GO:1990845]; lactation [GO:0007595]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of gene expression [GO:0010629]; negative regulation of NK T cell proliferation [GO:0051141]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NK T cell differentiation [GO:0001865]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of SREBP signaling pathway [GO:2000640]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043376]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]","GO:0000122; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001865; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0007595; GO:0010468; GO:0010628; GO:0010629; GO:0031065; GO:0032740; GO:0032868; GO:0042802; GO:0042803; GO:0042826; GO:0043370; GO:0043372; GO:0043376; GO:0043377; GO:0045944; GO:0046628; GO:0046872; GO:0051141; GO:0090336; GO:0120162; GO:1990837; GO:1990845; GO:2000320; GO:2000640"
"g20160",102.476797467488,-0.459810055008506,0.144399345359643,-3.18429459540345,0.00145107253058157,0.0476046077659466,42468,51307,"sp|Q95SX7|RTBS_DROME","Q95SX7","RTBS",5.05e-09,"Probable RNA-directed DNA polymerase from transposon BS (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g20773",1100.3830523122,-0.656547868454209,0.206193140168961,-3.18414020910789,0.00145184670839267,0.0476046077659466,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34451",428.00576226317,0.220514575054971,0.0692487502469012,3.18438346206599,0.00145062707680864,0.0476046077659466,0,2713,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.75e-15,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g45497",44.0700347768269,0.911834064363583,0.286388294519855,3.1839082874959,0.00145301040642841,0.0476046077659466,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47285",544.540526914845,2.01474709449885,0.632824188786591,3.18373907034437,0.00145386001873742,0.0476046077659466,6797,18850,"sp|Q9VZ49|ENDOU_DROME","Q9VZ49","ENDOU",1.39e-15,"Endoribonuclease CG2145 (EC 4.6.1.-) (Poly(U)-specific endoribonuclease homolog) (Uridylate-specific endoribonuclease homolog)","RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]","GO:0003723; GO:0004521; GO:0005576; GO:0016829; GO:0046872; GO:0090502"
"g84772",139.965479407865,0.813987427296757,0.255676639481933,3.1836597545482,0.00145425840827262,0.0476046077659466,0,3889,"sp|O75132|ZBED4_HUMAN","O75132","ZBED4",2.65e-16,"Zinc finger BED domain-containing protein 4","positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0001917; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0042802; GO:0045944; GO:0046872; GO:0046983"
"g95266",117.889615957307,0.329538221111305,0.103488056261843,3.18431162990942,0.00145098713350914,0.0476046077659466,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139444",234.556935337753,-0.330594445199117,0.103831555087566,-3.18394966655667,0.00145280271841129,0.0476046077659466,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144283",48.52481752625,-0.463248603828368,0.145484480747602,-3.18417883095069,0.00145165300153092,0.0476046077659466,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g8169",154.717190040744,0.34078855438937,0.107059309327836,3.18317534952341,0.00145669367543032,0.0476072908787646,5737,15834,"sp|Q5ZLS8|INT10_CHICK","Q5ZLS8","INT10",4.83e-07,"Integrator complex subunit 10 (Int10)","snRNA processing [GO:0016180]","GO:0016180; GO:0032039"
"g79363",2179.66831263399,-0.765329866868381,0.240429105157147,-3.18318311074756,0.00145665462753435,0.0476072908787646,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g132776",7884.9713952647,0.335856356875701,0.105508472074869,3.18321695188019,0.00145648437893612,0.0476072908787646,0,3405,"sp|A7S3J7|RS3A_NEMVE","A7S3J7","RS3A",3.91e-15,"40S ribosomal protein S3a","translation [GO:0006412]","GO:0003735; GO:0005829; GO:0006412; GO:0022627"
"g57204",272.286207561105,-0.353574424328017,0.111096607609017,-3.18258524663827,0.00145966539922638,0.0476427405384286,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g100341",162.806797785141,0.747824180583377,0.234980664209948,3.1824924110148,0.00146013342233444,0.0476427405384286,1680,3730,"sp|A5PMF6|GT251_DANRE","A5PMF6","GT251",4.11e-07,"Procollagen galactosyltransferase 1 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 1) (Glycosyltransferase 25 family member 1) (Hydroxylysine galactosyltransferase 1)","positive regulation of collagen fibril organization [GO:1904028]","GO:0005788; GO:0050211; GO:1904028"
"g108677",53.7881190725839,0.521021364557991,0.16369905087461,3.18280015537221,0.00145858248507554,0.0476427405384286,0,5579,"sp|Q8QZR0|TR1L1_MOUSE","Q8QZR0","TR1L1",3.57e-07,"Translocating chain-associated membrane protein 1-like 1","protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0006616; GO:0030176; GO:0045048"
"g27198",140.091365222823,-0.829148000705085,0.260547916856621,-3.18232442887411,0.00146098064193501,0.0476447690268864,23915,27390,"sp|Q8R511|FNBP1_RAT","Q8R511","FNBP1",7.02e-06,"Formin-binding protein 1 (Formin-binding protein 17) (Rapostlin)","cell differentiation [GO:0030154]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; signal transduction [GO:0007165]","GO:0005764; GO:0005856; GO:0005905; GO:0005938; GO:0006897; GO:0007165; GO:0007399; GO:0008289; GO:0030154; GO:0031410; GO:0042802"
"g24453",91.3990102800859,0.702131456700444,0.220651091681632,3.18208920404309,0.00146216776209626,0.0476578740502804,25700,31294,"sp|P21328|RTJK_DROME","P21328","RTJK",1.15e-23,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g74760",94.9827948811989,-0.524780380935546,0.164941687005473,-3.18161157717596,0.00146458095950773,0.0476810103450245,0,9971,"sp|P21328|RTJK_DROME","P21328","RTJK",2.45e-16,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g114427",58.7933820008523,0.690296431835302,0.216973208508005,3.18148234329048,0.00146523454100298,0.0476810103450245,3952,5017,"sp|Q9M2U3|ALPL_ARATH","Q9M2U3","ALPL",4.76e-10,"Protein ALP1-like (EC 3.1.-.-)",NA,"GO:0000118; GO:0004518; GO:0046872"
"g139632",71.3314290458464,0.40670811107949,0.127831329759163,3.18159962699078,0.00146464138454827,0.0476810103450245,0,2564,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.17e-08,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g147155",1441.62144985048,0.270288209784256,0.0849714477210321,3.18092979504872,0.00146803200553059,0.0477464428808421,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g108661",630.816910096654,0.251676481575842,0.079141304079816,3.18009015017013,0.00147229241856091,0.0478593609440072,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g114648",81.5033731165511,-1.08541997918261,0.34140400848318,-3.17928305530157,0.00147639840767453,0.0479671409859568,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47028",478.828818919102,-0.572907984557419,0.180260584567607,-3.17822105110587,0.00148181729183541,0.0480773891575831,8458,15044,"sp|Q2KI51|PR15A_BOVIN","Q2KI51","PR15A",1.75e-10,"Protein phosphatase 1 regulatory subunit 15A (Growth arrest and DNA damage-inducible protein GADD34)","apoptotic process [GO:0006915]; regulation of translation [GO:0006417]","GO:0005741; GO:0005789; GO:0006417; GO:0006915"
"g48344",309.67613931517,1.38767019737253,0.436627962229781,3.17815238008567,0.00148216831626031,0.0480773891575831,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g64061",93.5534624290718,0.425172158697926,0.133771515744376,3.17834597546453,0.00148117891464881,0.0480773891575831,6024,10044,"sp|O00370|LORF2_HUMAN","O00370","LORF2",1.07e-07,"LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]","GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305"
"g2527",845.810468461736,0.680798543338136,0.214295075219705,3.17692108715121,0.00148847531190895,0.0481905702981098,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g39990",967.497314900121,0.324275304415279,0.102065672607604,3.17712406268041,0.00148743392033758,0.0481905702981098,13255,23527,"sp|Q6NT04|TIGD7_HUMAN","Q6NT04","TIGD7",1.7e-42,"Tigger transposable element-derived protein 7",NA,"GO:0003677; GO:0005634"
"g77718",532.008780910912,0.323914351191414,0.101960817449053,3.17685125811457,0.00148883373387635,0.0481905702981098,0,8661,"sp|Q5R922|COPB_PONAB","Q5R922","COPB",1.17e-33,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192]","GO:0000139; GO:0005198; GO:0005793; GO:0005886; GO:0006886; GO:0016192; GO:0030126"
"g157957",58.9212935936063,1.27199116908406,0.400343536802493,3.1772491676607,0.00148679238788867,0.0481905702981098,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9861",203.120220010096,-0.955659704789768,0.30087831798531,-3.17623320679566,0.00149200956703175,0.048223815709615,0,10066,"sp|P18700|TBB_STRPU","P18700","TBB",3.7e-62,"Tubulin beta chain (Beta-tubulin) (Fragment)","microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]","GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874"
"g32852",834.047177984041,0.227540937558002,0.0716793953799076,3.17442601673764,0.0015013315863985,0.048223815709615,29375,31699,"sp|Q9W4P5|VA0D1_DROME","Q9W4P5","VA0D1",3.73e-25,"V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (V-ATPase 39 kDa subunit) (Vacuolar H+ ATPase subunit AC39-1) (Vacuolar proton pump subunit d 1)","cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; proton transmembrane transport [GO:1902600]; terminal branching, open tracheal system [GO:0007430]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034]","GO:0000220; GO:0005769; GO:0005886; GO:0006879; GO:0007034; GO:0007035; GO:0007430; GO:0016471; GO:0033181; GO:0036295; GO:0046961; GO:1902600"
"g36240",983.815080153778,0.509798424237744,0.160540860478937,3.17550574175869,0.00149575561469468,0.048223815709615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g43303",59.9882776940022,-0.34172559094517,0.107644468325089,-3.17457642052866,0.00150055371706463,0.048223815709615,2368,15854,"sp|Q8I7P9|POL5_DROME","Q8I7P9","POL5",1.67e-70,"Retrovirus-related Pol polyprotein from transposon opus [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","DNA integration [GO:0015074]; transposition, DNA-mediated [GO:0006313]","GO:0003676; GO:0003964; GO:0004519; GO:0005634; GO:0006313; GO:0008233; GO:0015074"
"g67706",302.75718525043,0.555633193069897,0.174995539758158,3.17512774232861,0.00149770552462746,0.048223815709615,10245,11378,"sp|Q96DM1|PGBD4_HUMAN","Q96DM1","PGBD4",5e-38,"PiggyBac transposable element-derived protein 4",NA,NA
"g73348",90.0434210734501,0.366298995898994,0.115368345742604,3.17503898960497,0.00149816369488467,0.048223815709615,4815,10141,"sp|Q0IFL2|RUVB1_AEDAE","Q0IFL2","RUVB1",3.67e-28,"RuvB-like helicase 1 (EC 3.6.4.12) (Pontin)","cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of cell population proliferation [GO:0042127]","GO:0003678; GO:0003713; GO:0005524; GO:0005634; GO:0006281; GO:0006310; GO:0006325; GO:0007049; GO:0016887; GO:0031011; GO:0035267; GO:0042127; GO:0051301; GO:0090263; GO:0097255"
"g81370",1111.46232683445,0.312652651111678,0.0984981863693138,3.17419703485101,0.00150251656502599,0.048223815709615,4394,8904,"sp|P09623|DLDH_PIG","P09623","DLDH",1.98e-45,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)","cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077]","GO:0001669; GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0031514; GO:0045252; GO:0045454; GO:0050660; GO:0106077"
"g88534",158.011950013821,0.483670547768382,0.152316500621586,3.17543106488514,0.00149614064983027,0.048223815709615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g90910",146.12190071923,1.69275367881128,0.533174382389376,3.17485936069425,0.00149909139258142,0.048223815709615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g97061",1026.99021109545,-0.253494155517636,0.0798611565962559,-3.17418587861424,0.00150257432042976,0.048223815709615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110411",119.892762680501,2.53703993056953,0.799176712210545,3.17456689090953,0.00150060299202645,0.048223815709615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g110507",477.177272144915,0.901643508650063,0.283902505061136,3.1758913450091,0.00149376889064394,0.048223815709615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g113657",223.35504323926,0.372268563158655,0.11727217046174,3.17439816874634,0.0015014756534314,0.048223815709615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g136483",504.238134936018,0.998686681971033,0.314538584275576,3.17508481279377,0.00149792712464566,0.048223815709615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g138482",153.088639985045,2.08247285226476,0.655976836345195,3.17461339620977,0.00150036254040115,0.048223815709615,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g144190",83.9404255041981,0.750622522852465,0.236326823235854,3.17620536075731,0.00149215279967215,0.048223815709615,1052,2499,"sp|P21328|RTJK_DROME","P21328","RTJK",4.03e-06,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g309",20.245427477936,-0.764561616257637,0.241010082229883,-3.17232212521455,0.00151225166139492,0.0483152460305321,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19147",540.496272752147,2.08589488655045,0.657390557619299,3.17299185754111,0.00150876755796982,0.0483152460305321,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g32908",801.549151331158,-0.447463618727427,0.141046799958437,-3.17244786027958,0.00151159699374901,0.0483152460305321,0,19481,"sp|Q9CXP4|RHG08_MOUSE","Q9CXP4","RHG08",2.56e-23,"Rho GTPase-activating protein 8 (Rho-type GTPase-activating protein 8)","positive regulation of ERK1 and ERK2 cascade [GO:0070374]; signal transduction [GO:0007165]","GO:0005096; GO:0007165; GO:0070374"
"g47054",672.540761192335,-0.384407353463781,0.121174440685299,-3.17234683560144,0.00151212298063912,0.0483152460305321,0,18968,"sp|P21328|RTJK_DROME","P21328","RTJK",1.49e-18,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g98418",102.701930677787,0.37616265195048,0.118542497577389,3.17323035736535,0.00150752861299324,0.0483152460305321,0,4964,"sp|P21328|RTJK_DROME","P21328","RTJK",3.21e-13,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g110286",228.132964628213,-0.52079383756647,0.164147107886675,-3.17272624703214,0.0015101484399,0.0483152460305321,0,2120,"sp|Q10126|YSM6_CAEEL","Q10126","YSM6",3.71e-06,"Putative uncharacterized transposon-derived protein F52C9.6",NA,NA
"g133372",401.912963958413,0.412998656350799,0.130190771352305,3.17225754222776,0.00151258802863752,0.0483152460305321,0,3359,"sp|O96347|SODM_CHAFE","O96347","SODM",2.14e-25,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)",NA,"GO:0004784; GO:0005759; GO:0046872"
"g138677",99.3155373003552,-0.770596374526722,0.242855563783875,-3.17306452658626,0.0015083899617287,0.0483152460305321,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151184",63.3502919733222,0.430316580524667,0.135627786263731,3.1727759655968,0.00150988986961986,0.0483152460305321,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g152522",93.4968627060656,0.467293493193945,0.147314087736212,3.17208965126746,0.0015134627767696,0.048317756929062,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g19221",128.853263401797,0.280262517253071,0.0883736898314996,3.17133433929762,0.00151740388216511,0.0483480021348063,0,31074,"sp|P11369|LORF2_MOUSE","P11369","LORF2",7.53e-17,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g60499",130.995303006387,0.657895969714782,0.207453253441955,3.17129743110469,0.00151759670566495,0.0483480021348063,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g78144",57.9956306766673,0.679116918029885,0.214117289012922,3.17170519559913,0.00151546762939825,0.0483480021348063,0,9305,"sp|P21329|RTJK_DROFU","P21329","RTJK",1.3e-07,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g148944",196.009367803785,0.466775915506672,0.147187287174634,3.17130592231688,0.00151755234209958,0.0483480021348063,0,2081,"sp|Q9U2G5|MRP7_CAEEL","Q9U2G5","MRP7",1.04e-23,"Multidrug resistance protein mrp-7","response to methylmercury [GO:0051597]; transmembrane transport [GO:0055085]","GO:0005524; GO:0005886; GO:0016020; GO:0016021; GO:0042626; GO:0051597; GO:0055085; GO:0140359"
"g112112",348.786031118632,0.519942625579908,0.163972974843513,3.17090438882452,0.00151965151981158,0.0483626904758076,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g160084",488.920495386232,2.06835265490975,0.652265408382883,3.17102919812608,0.00151899874271744,0.0483626904758076,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1298",1500.64500850127,-0.320712480583432,0.101150959319013,-3.17063211997783,0.00152107643600288,0.0483826671388967,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g9807",115.014792288698,-1.99032093821653,0.627888594838892,-3.1698631804695,0.00152510732155619,0.0483962027075784,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g31819",1537.80409222306,-0.473049203640237,0.14921012950974,-3.17035582768097,0.00152252366690659,0.0483962027075784,17694,26194,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.03e-06,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g45844",61.3152412094011,0.423154075752407,0.133502311152509,3.16963857853374,0.00152628657080747,0.0483962027075784,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g63789",30.7029038005329,1.5445003273081,0.487267349527235,3.16971848987345,0.00152586690836066,0.0483962027075784,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g123493",26.1965265939569,1.3898176329427,0.438454040944937,3.16981371627327,0.00152536695612355,0.0483962027075784,0,3254,"sp|Q96MW7|TIGD1_HUMAN","Q96MW7","TIGD1",5.35e-39,"Tigger transposable element-derived protein 1",NA,"GO:0003677; GO:0005634"
"g145975",31.6770473096724,-0.60923440318741,0.192187713443548,-3.16999662606613,0.00152440707673662,0.0483962027075784,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50087",79.4826085167689,1.42052671806024,0.448241767577857,3.16910832682166,0.00152907393533137,0.0484592674335566,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g46713",103.072892151197,0.270280612095515,0.0853022763262598,3.16850409784798,0.00153225588973651,0.0485094470256175,706,3964,"sp|Q5REU2|RL23_PONAB","Q5REU2","RL23",6.16e-17,"60S ribosomal protein L23","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g107455",1281.16438216569,0.339987745482917,0.107299264098491,3.16859345065815,0.00153178496138888,0.0485094470256175,0,2834,"sp|Q9NJH0|EF1G_DROME","Q9NJH0","EF1G",4.68e-13,"Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","glutathione metabolic process [GO:0006749]; translational elongation [GO:0006414]","GO:0003746; GO:0005634; GO:0005737; GO:0005853; GO:0006414; GO:0006749"
"g128003",701.306426729941,0.786282683013642,0.248209215040707,3.16782228606899,0.00153585372897174,0.0485979993802373,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g140389",5881.65279736169,0.40673432862697,0.12841334942077,3.16738353497993,0.00153817307874767,0.0486460261329839,0,2813,"sp|Q90YX1|RLA0_ICTPU","Q90YX1","RLA0",2.17e-19,"60S acidic ribosomal protein P0 (60S ribosomal protein L10E)","ribosome biogenesis [GO:0042254]","GO:0005840; GO:0042254"
"g13487",70.7686752870117,-0.413877035377746,0.130683162746869,-3.16702646827899,0.00154006300448495,0.0486599398829935,28505,43538,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.63e-33,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g52809",47.0626076596695,-0.425097838546729,0.134227400744317,-3.16699746988676,0.00154021658453173,0.0486599398829935,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g122915",146.378272665092,-0.275292767290752,0.0869357593710397,-3.16662290963387,0.00154220158269746,0.0486973017970388,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g137538",38.7524617706633,1.89781237558558,0.599363637070867,3.16637890289829,0.00154349597394407,0.0487128292556763,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g4357",1668.91742318159,-0.301018206561496,0.0950758982682931,-3.16608322449984,0.00154506581045034,0.0487370291248602,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g828",2148.74325006687,-0.228461912225767,0.0721640421196377,-3.16586911590969,0.00154620348854503,0.0487475790752197,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50625",40.6333668516062,-0.73147039416318,0.231073531151066,-3.1655308616242,0.00154800239403259,0.0487564574925729,0,2764,"sp|P03359|POL_WMSV","P03359","POL",2.79e-10,"Gag-Pol polyprotein [Cleaved into: Matrix protein p15 (MA); RNA-binding phosphoprotein p12 (pp12); Capsid protein p30 (CA); Nucleocapsid protein p10-Pol (NC-pol); Protease (PR) (EC 3.4.23.-); Reverse transcriptase/ribonuclease H (RT) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p80); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (p46)]","DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826]; virion assembly [GO:0019068]","GO:0003677; GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0006310; GO:0008270; GO:0015074; GO:0016020; GO:0019013; GO:0019068; GO:0020002; GO:0039660; GO:0044185; GO:0044826; GO:0046718; GO:0072494; GO:0075713"
"g147565",1792.44625442956,2.04848666666909,0.647126069414458,3.16551405280679,0.00154809183701084,0.0487564574925729,0,1968,"sp|P53634|CATC_HUMAN","P53634","CATC",1.77e-22,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005794; GO:0005813; GO:0006508; GO:0006955; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0043621; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235"
"g83170",113.013745052561,0.534605415258505,0.168905147691451,3.16512209701921,0.00155017885968821,0.0487968646236916,1076,8384,"sp|P21439|MDR3_HUMAN","P21439","MDR3",2.91e-19,"Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3)","bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085]","GO:0005524; GO:0005548; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006629; GO:0015629; GO:0016020; GO:0016021; GO:0016324; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0042910; GO:0045121; GO:0045332; GO:0046581; GO:0055085; GO:0055088; GO:0061092; GO:0070062; GO:0090554; GO:0090555; GO:0140359; GO:1901557; GO:1903413; GO:2001140"
"g64297",59.2030329710087,-0.468176017099686,0.14794830542979,-3.16445677251683,0.00155372740456494,0.0488771105847781,0,12224,"sp|Q8SVY9|Y3G1_ENCCU","Q8SVY9","Y3G1",3.01e-08,"Uncharacterized protein ECU03_1610",NA,NA
"g93046",3435.62637613554,0.380972888527726,0.120395600473718,3.16434227686661,0.00155433882729645,0.0488771105847781,0,7319,"sp|P56252|ENO_HOMGA","P56252","ENO",6.7e-40,"Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase)","glycolytic process [GO:0006096]","GO:0000015; GO:0000287; GO:0004634; GO:0006096"
"g14627",345.104141633826,-0.363460297234795,0.114882978175055,-3.16374368952175,0.00155753897586406,0.0489297997263288,26373,44984,"sp|Q9NBX4|RTXE_DROME","Q9NBX4","RTXE",2.18e-16,"Probable RNA-directed DNA polymerase from transposon X-element (EC 2.7.7.49) (Reverse transcriptase)","transposition, DNA-mediated [GO:0006313]","GO:0003964; GO:0006313"
"g110298",1599.88839878691,-0.262423681667979,0.08294763083766,-3.16372727006005,0.00155762684249905,0.0489297997263288,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134338",37.9778888170174,1.37120181532782,0.433449334120754,3.16346504052033,0.00155903074882268,0.0489485650005423,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g50314",1490.6098906486,-0.466756473073458,0.147559108914279,-3.16318305598205,0.00156054171817597,0.0489706705667527,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g1696",76.52557903376,2.35918117130359,0.745936228438668,3.16271161174412,0.00156307088933053,0.0489919244609619,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g69740",234.908982169652,0.512534875058137,0.162053051037848,3.16275979857011,0.00156281220693923,0.0489919244609619,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g89100",8168.72585265144,0.326657192789905,0.103287366856386,3.16260548343824,0.00156364075928297,0.0489919244609619,0,7670,"sp|Q962T1|RL32_SPOFR","Q962T1","RL32",5.5e-25,"60S ribosomal protein L32","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g50626",283.807993507263,-0.618026988279873,0.195456432614929,-3.16196801513028,0.00156706775714899,0.0490233722584392,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g87316",87.5545972690819,0.636988747297302,0.201453207696952,3.16196874986241,0.00156706380328785,0.0490233722584392,0,8051,"sp|Q86WI1|PKHL1_HUMAN","Q86WI1","PKHL1",5.34e-12,"Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1)","immune response [GO:0006955]; sensory perception of sound [GO:0007605]","GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016021; GO:0032426; GO:0038023; GO:0120234"
"g121809",52.7817789562674,0.498056792217416,0.157511011063316,3.16204428411173,0.00156665737499643,0.0490233722584392,0,3531,"sp|Q03278|PO21_NASVI","Q03278","PO21",8.54e-11,"Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Retrovirus-related Pol polyprotein from type I retrotransposable element R2) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease] (Fragment)",NA,"GO:0003964; GO:0004519; GO:0046872"
"g19997",413.749989476433,-0.337866119413141,0.106866880697217,-3.16156059958753,0.00156926162383289,0.049031583398325,12669,21164,"sp|P18719|ZG32_XENLA","P18719","ZG32",5.14e-13,"Gastrula zinc finger protein XlCGF32.1 (Fragment)",NA,"GO:0003677; GO:0005634; GO:0046872"
"g34084",465.937129550079,0.565758534609999,0.178962788997459,3.1613193881217,0.00157056184093498,0.049031583398325,19832,28904,"sp|O88844|IDHC_MOUSE","O88844","IDHC",6.77e-32,"Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (IDH1) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)","2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004448; GO:0004450; GO:0005737; GO:0005739; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0006749; GO:0006979; GO:0008585; GO:0014070; GO:0042802; GO:0042803; GO:0048545; GO:0050661; GO:0051287; GO:0060696; GO:0071071"
"g60017",38.9678900922444,0.813789744750713,0.257408153538663,3.16147617533988,0.00156971658830233,0.049031583398325,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107002",20.8382379119772,-0.733150224062166,0.231905711597443,-3.16141512432784,0.00157004566946221,0.049031583398325,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g55957",298.020827347166,1.14578399889388,0.362558295585437,3.16027522427459,0.00157620171055459,0.0491330718459636,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g57554",100.718981849394,0.499741270147552,0.158121255196275,3.16049394831343,0.00157501876904988,0.0491330718459636,0,2304,"sp|Q55E60|PEPD_DICDI","Q55E60","PEPD",1.58e-07,"Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)",NA,"GO:0008233; GO:0030145; GO:0070006; GO:0102009"
"g115358",81.875619388758,0.402033400538147,0.127214975078464,3.16026788741012,0.00157624140524125,0.0491330718459636,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g107554",662.252519678594,0.282583846702521,0.089428653310276,3.15988037661806,0.00157833926600699,0.0491732084465937,0,5690,"sp|Q5R8D7|PRS7_PONAB","Q5R8D7","PRS7",7.58e-27,"26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2)","ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0006511; GO:0016887; GO:0022624; GO:0036402"
"g102626",29.8691832780143,2.04469718420003,0.647116020295728,3.15970725506938,0.00157927732177327,0.0491771886395177,4195,6163,"sp|P14410|SUIS_HUMAN","P14410","SUIS",1.12e-09,"Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]","polysaccharide digestion [GO:0044245]; sucrose catabolic process [GO:0005987]","GO:0004553; GO:0004558; GO:0004574; GO:0004575; GO:0005794; GO:0005886; GO:0005903; GO:0005987; GO:0016021; GO:0016324; GO:0030246; GO:0044245; GO:0070062"
"g35232",882.080144701155,0.268266717177771,0.0849098474644554,3.15942997412723,0.00158078083269067,0.0491987634543573,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g10772",97.6607226714715,-0.641161544090729,0.202963477406792,-3.15899960072951,0.00158311707287607,0.0492174535765445,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g28887",1032.36774646416,-0.258344960374769,0.0817832011444635,-3.15890007678256,0.00158365778130019,0.0492174535765445,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g47644",53.857643533505,0.771825504044426,0.244340350192646,3.15881312045225,0.0015841303496849,0.0492174535765445,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g59018",465.112751216951,0.329663978608394,0.104366249874277,3.15872208693439,0.00158462521483882,0.0492174535765445,0,5302,"sp|Q96AG4|LRC59_HUMAN","Q96AG4","LRC59",2.45e-14,"Leucine-rich repeat-containing protein 59 (Ribosome-binding protein p34) (p34) [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed]","positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165]","GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0007165; GO:0016020; GO:0016021; GO:0042645; GO:0045296; GO:0046579"
"g26158",36.2450903538669,-0.445139053492859,0.140933033742901,-3.15851466239568,0.00158575332211296,0.0492272987821154,615,8364,"sp|A4F4L4|DNAL4_PIG","A4F4L4","DNAL4",4.19e-19,"Dynein axonemal light chain 4","microtubule-based process [GO:0007017]","GO:0005737; GO:0005874; GO:0005929; GO:0007017; GO:0030286; GO:0045505; GO:0051959"
"g17938",43.7501547620454,0.633615811757147,0.200653547932163,3.15776032014824,0.00158986215421207,0.0492555036121464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g34083",947.884914782637,0.559305033325158,0.17712005764779,3.15777355062383,0.00158979000467692,0.0492555036121464,7441,12924,"sp|Q9Z2K9|IDHC_MICME","Q9Z2K9","IDHC",1.25e-17,"Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (IDH1) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)","2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004450; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0051287"
"g37150",218.626369972874,-0.428830253010264,0.135783760509474,-3.15818512759736,0.00158754706353107,0.0492555036121464,0,12714,"sp|P21328|RTJK_DROME","P21328","RTJK",9.69e-24,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g42874",1465.40728590133,-0.392188811505395,0.124200197387255,-3.15771488093981,0.00159010997005572,0.0492555036121464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g81491",54.6139429371547,1.33698677246825,0.42343138290313,3.15750515066125,0.00159125425561346,0.0492555036121464,5405,8290,"sp|P21329|RTJK_DROFU","P21329","RTJK",2.02e-22,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g138966",60.6791848633566,0.438032381609638,0.138729599977186,3.15745436937518,0.00159153143159366,0.0492555036121464,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g62977",74.717379930715,0.598916556995956,0.189698305229587,3.15720562854318,0.00159288975863843,0.0492701639027518,8263,12569,"sp|P80685|CUG1A_TENMO","P80685","CUG1A",1.06e-06,"Pupal cuticle protein G1A (TM-PCP G1A) (TM-G1A)",NA,"GO:0042302"
"g70901",59.8508691403938,0.453474268405824,0.143637681288669,3.15707037552685,0.00159362879784317,0.0492701639027518,0,4710,"sp|Q54UQ2|PGM2_DICDI","Q54UQ2","PGM2",6.29e-18,"Probable phosphoglucomutase-2 (PGM 2) (EC 5.4.2.2) (Glucose phosphomutase 2)","glucose metabolic process [GO:0006006]","GO:0000287; GO:0004614; GO:0005737; GO:0006006"
"g6369",1002.43690991042,0.648179936193018,0.205358187693226,3.15633841277027,0.00159763381219957,0.0493541622350729,10765,14607,"sp|P51649|SSDH_HUMAN","P51649","SSDH",1.11e-21,"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)","central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; neurotransmitter catabolic process [GO:0042135]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]","GO:0004777; GO:0005739; GO:0005759; GO:0006105; GO:0006536; GO:0007417; GO:0009450; GO:0009791; GO:0042135; GO:0042802"
"g7864",728.131147485495,0.623406367937246,0.197513220635155,3.15627665800051,0.00159797213366153,0.0493541622350729,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139306",203.73747438079,-0.433427476223273,0.137368867027087,-3.15520893200501,0.00160383207273721,0.049509953455962,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g115029",1031.79801840557,1.75359728314196,0.555820691585942,3.15496941673466,0.00160514930398446,0.0495254251442892,0,4959,"sp|P97821|CATC_MOUSE","P97821","CATC",1.16e-09,"Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)]","aging [GO:0007568]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913]","GO:0001913; GO:0004197; GO:0004252; GO:0005615; GO:0005654; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0005813; GO:0006508; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016505; GO:0019902; GO:0031404; GO:0031642; GO:0042802; GO:0043231; GO:0043621; GO:0051087; GO:0051603; GO:0062023; GO:1903052; GO:1903980; GO:2001235"
"g75717",735.04504654244,0.346736197483987,0.109922121501915,3.15438050818502,0.0016083922838709,0.0496002681443724,3081,5184,"sp|P45437|COPB_DROME","P45437","COPB",1.16e-28,"Coatomer subunit beta (Beta-coat protein) (Beta-COP)","cell morphogenesis [GO:0000902]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of innate immune response [GO:0045089]; regulation of lipid storage [GO:0010883]","GO:0000139; GO:0000902; GO:0005198; GO:0005794; GO:0006886; GO:0006888; GO:0006891; GO:0010883; GO:0030126; GO:0045089; GO:0046597; GO:0050829"
"g4807",396.741822281008,1.7092459866183,0.542022218828089,3.15346110776395,0.00161346726330414,0.0496073348064688,99995,119783,"sp|P08548|LIN1_NYCCO","P08548","LIN1",4.81e-11,"LINE-1 reverse transcriptase homolog (EC 2.7.7.49)",NA,"GO:0003964; GO:0046872"
"g14982",199.830679557117,-0.384309822468733,0.121875334966529,-3.1533026971723,0.00161434315773234,0.0496073348064688,0,42242,"sp|Q80U62|RUBIC_MOUSE","Q80U62","RUBIC",3.28e-10,"Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon)","autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]","GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006897; GO:0006914; GO:0010507; GO:0043231; GO:0043553; GO:0045806; GO:1901097; GO:1901981"
"g35229",206.713079359675,0.313493202827518,0.0994104416215506,3.15352389260041,0.00161312023024728,0.0496073348064688,8475,15867,"sp|P21328|RTJK_DROME","P21328","RTJK",1.96e-10,"RNA-directed DNA polymerase from mobile element jockey (EC 2.7.7.49) (Reverse transcriptase)",NA,"GO:0003964"
"g41793",354.495785811567,0.52928986639912,0.167808316849475,3.15413369454087,0.00160975322070892,0.0496073348064688,0,22404,"sp|P06795|MDR1B_MOUSE","P06795","MDR1B",1.53e-19,"ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1B) (Multidrug resistance protein 1B) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243)","carboxylic acid transmembrane transport [GO:1905039]; ceramide translocation [GO:0099040]; establishment of endothelial blood-brain barrier [GO:0014045]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell barrier remodeling [GO:0061843]; stem cell proliferation [GO:0072089]; transepithelial transport [GO:0070633]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962]","GO:0000086; GO:0000139; GO:0005524; GO:0005654; GO:0005739; GO:0005886; GO:0008559; GO:0009410; GO:0009986; GO:0014045; GO:0015562; GO:0016020; GO:0016021; GO:0016324; GO:0031625; GO:0042626; GO:0042910; GO:0045332; GO:0046581; GO:0046943; GO:0047484; GO:0061843; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:1901529; GO:1905039; GO:1990961; GO:1990962; GO:2001225"
"g50841",6088.20935218903,-1.9643664950283,0.622931458744217,-3.15342316952223,0.00161367699412135,0.0496073348064688,0,1361,"sp|Q91233|HSP70_ONCTS","Q91233","HSP70",9.36e-178,"Heat shock 70 kDa protein (HSP70)",NA,"GO:0005524; GO:0005634; GO:0005737; GO:0016887"
"g91322",455.095613254031,-0.587787450348694,0.186371292408091,-3.15385187683109,0.00161130846692838,0.0496073348064688,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g139728",107.832568971879,0.391678976440133,0.124189097435275,3.1538918031373,0.00161108804456364,0.0496073348064688,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g11642",234.442730933422,0.357590480517183,0.113417099100718,3.15287979813019,0.00161668362356982,0.049639694284372,4055,7603,"sp|Q9VFS6|INT5_DROME","Q9VFS6","INT5",3.87e-31,"Integrator complex subunit 5 (Protein oocyte maintenance defects)","positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; snRNA 3'-end processing [GO:0034472]","GO:0003677; GO:0005634; GO:0005737; GO:0010628; GO:0016021; GO:0031965; GO:0032039; GO:0034472; GO:0045666"
"g28798",759.568654425794,0.465677379617658,0.147715836390973,3.15252169973914,0.0016186679022701,0.049639694284372,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g83241",40.8823759801332,-1.08234432592681,0.343310557334716,-3.15266834299988,0.00161785505836732,0.049639694284372,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g86925",114.294457466147,1.38143071048327,0.438166861512538,3.15275031460531,0.00161740085330059,0.049639694284372,2405,7874,"sp|O62839|CATA_PIG","O62839","CATA",3.74e-27,"Catalase (EC 1.11.1.6)","hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell division [GO:0051781]; response to hydrogen peroxide [GO:0042542]","GO:0004096; GO:0005737; GO:0005739; GO:0005777; GO:0020037; GO:0042542; GO:0042744; GO:0046872; GO:0051781"
"g161524",14074.1178683664,0.440363195988786,0.139692975240773,3.15236464274444,0.00161953888637254,0.0496413207141159,394,1093,"sp|Q90YS3|RS2_ICTPU","Q90YS3","RS2",1.62e-43,"40S ribosomal protein S2","translation [GO:0006412]","GO:0003723; GO:0003735; GO:0006412; GO:0015935"
"g33764",135.811905553447,-0.443037583190516,0.140553961747232,-3.15208178896631,0.00162110858423245,0.0496643513261318,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g151917",1164.1506318015,0.384613855117162,0.122029878292135,3.15180069422351,0.00162266990741706,0.0496871022609188,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g3592",4901.81039949749,0.294056246480159,0.093329494699018,3.1507322248821,0.00162861729049424,0.0497187039034686,0,14341,"sp|Q6XIM8|RS15A_DROYA","Q6XIM8","RS15A",3.47e-25,"40S ribosomal protein S15a","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412"
"g64114",1015.99665906131,0.431680960812133,0.136978316090881,3.1514547202181,0.00162459349838078,0.0497187039034686,0,12272,"sp|P91623|GATAC_DROME","P91623","GATAC",2.69e-21,"GATA-binding factor C (Protein grain) (Transcription factor GATA-C) (dGATA-C)","animal organ morphogenesis [GO:0009887]; cell fate commitment [GO:0045165]; motor neuron axon guidance [GO:0008045]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tissue development [GO:0009888]","GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0008045; GO:0008270; GO:0009887; GO:0009888; GO:0043565; GO:0045165; GO:0045944"
"g85361",124.152591706583,-0.357418673464534,0.113420395155607,-3.15127339288647,0.00162560250349616,0.0497187039034686,0,5984,"sp|Q588U8|CFDP2_TRAJA","Q588U8","CFDP2",6.88e-09,"Craniofacial development protein 2 (p97 bucentaur protein)",NA,"GO:0003824; GO:0005634; GO:0005737"
"g100013",133.451324326259,-0.403025584584563,0.127904065104498,-3.15099902614737,0.00162713032771672,0.0497187039034686,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g133809",24.8211754620038,0.557149584274965,0.176826635611197,3.15082386965737,0.0016281063859642,0.0497187039034686,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g149995",311.077266839848,0.271958723466932,0.0863054063759137,3.15112036298609,0.00162645449485359,0.0497187039034686,0,1987,"sp|Q71U00|SKP1_XENLA","Q71U00","SKP1",1.08e-12,"S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (S-phase kinase-associated protein 1A) (p19A) (p19skp1)","protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0006511; GO:0016567; GO:0019005; GO:0031467"
"g28975",120.010677760121,-0.284040707654302,0.0901603356971551,-3.15039540900095,0.0016304962514511,0.0497362397437056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g65980",2635.49960883459,0.34628711420451,0.109930950423804,3.15004202974241,0.00163246975728228,0.0497362397437056,1999,5244,"sp|Q1HDZ5|EIF3B_BOMMO","Q1HDZ5","EIF3B",7.6e-24,"Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9)","formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]","GO:0001732; GO:0003743; GO:0005852; GO:0006446; GO:0016282; GO:0031369; GO:0033290"
"g127766",2472.49777087073,0.218173009784803,0.0692559275046973,3.15024312929757,0.00163134641366389,0.0497362397437056,0,3808,"sp|P29693|EF1D_XENLA","P29693","EF1D",1.98e-25,"Elongation factor 1-delta (EF-1-delta) (P36)",NA,"GO:0003746; GO:0005853"
"g131143",45.683070816097,-0.911604070267645,0.28938108922057,-3.15018535842475,0.00163166904934189,0.0497362397437056,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g24722",384.773664259805,-0.322170938758931,0.102280909185167,-3.14986385363155,0.00163346564510029,0.0497416106378006,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g17567",964.124028871687,-0.329357526572841,0.104598256896487,-3.14878599648921,0.0016395020918896,0.0498905782835608,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g134349",24.9452857886076,1.49474605083954,0.474718931280501,3.14869694959842,0.00164000170828314,0.0498905782835608,0,3283,"sp|Q2M2H8|MGAL_HUMAN","Q2M2H8","MGAL",1.19e-14,"Probable maltase-glucoamylase 2 (Maltase-glucoamylase (alpha-glucosidase) pseudogene) [Includes: Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)]","carbohydrate metabolic process [GO:0005975]","GO:0004339; GO:0004553; GO:0004558; GO:0005975; GO:0016021; GO:0030246"
"g77824",974.674280293415,0.396914586430832,0.126075609898308,3.14822658205645,0.00164264313020094,0.0499458975811097,NA,NA,NA,NA,NA,NA,NA,NA,NA
"g54899",105.90745978532,-0.563962562145015,0.179145823105529,-3.14806425496621,0.00164355561143809,0.0499486179560229,6651,10374,"sp|P11369|LORF2_MOUSE","P11369","LORF2",5.27e-09,"LINE-1 retrotransposable element ORF2 protein (ORF2p) (Long interspersed element-1) (L1) (Retrovirus-related Pol polyprotein LINE-1) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)]","DNA recombination [GO:0006310]","GO:0003964; GO:0004519; GO:0006310; GO:0046872"
"g6211",1456.95090825051,0.253392476109471,0.0804995775364385,3.14774914184825,0.00164532827290753,0.0499774639052843,NA,NA,NA,NA,NA,NA,NA,NA,NA
